HEADER RECORD*******LIBRARY HEADER RECORD!!!!!!!000000000000000000000000000000 SAS SAS SASLIB 9.4 X64_SR12 21MAY21:01:41:4421MAY21:01:41:44 HEADER RECORD*******MEMBER HEADER RECORD!!!!!!!000000000000000001600000000140 HEADER RECORD*******DSCRPTR HEADER RECORD!!!!!!!000000000000000000000000000000 SAS HO SASDATA 9.4 X64_SR12 21MAY21:01:41:4421MAY21:01:41:44 Healthcare Encounters HEADER RECORD*******NAMESTR HEADER RECORD!!!!!!!000000002000000000000000000000 STUDYID Study Identifier DOMAIN Domain Abbreviation USUBJID Unique Subject Identifier HOSEQ Sequence Number )#HOREFID Reference ID 1HHOSPID Sponsor-Defined Identifier THOTERM Reported Term for Healthcare Encounter œHODECOD Dictionary-Derived Term ® HOCAT Category for Healthcare Encounter ¶ HOSCAT Subcategory for Healthcare Encounter ÄHOPRESP Pre-Specified Healthcare Encounter ÕHOOCCUR Healthcare Encounter Occurrence Ö( EPOCH Epoch × HODTC Date/Time of Event Collection ÿHOSTDTC Start Date/Time of Healthcare Encounter HOENDTC End Date/Time of Healthcare Encounter HODY Study Day of Event Collection )HOSTDY Study Day of Start of Observation 1HOENDY Study Day of End of Healthcare Encounter 9HODUR Duration of Healthcare Encounter AHEADER RECORD*******OBS HEADER RECORD!!!!!!!000000000000000000000000000000 mRNA-1273-P301HOmRNA-1273-P301-US300-2004A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-28T13:282020-07-28T13:28.A A mRNA-1273-P301HOmRNA-1273-P301-US300-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-14 BP.. mRNA-1273-P301HOmRNA-1273-P301-US300-2019A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T20:362020-08-04T20:36.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US300-2031AUSA-US005-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-09-09 2020-09-12 .B,B/ mRNA-1273-P301HOmRNA-1273-P301-US300-2031A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-28 B?.. mRNA-1273-P301HOmRNA-1273-P301-US300-2032A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T21:082020-08-01T21:08.APAP mRNA-1273-P301HOmRNA-1273-P301-US300-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T17:042020-08-02T16:37.APA` mRNA-1273-P301HOmRNA-1273-P301-US300-2033A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T12:032020-08-29T12:03.B!B! mRNA-1273-P301HOmRNA-1273-P301-US300-2037A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US300-2040A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-29T19:032020-07-29T19:03.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2046AUSA-US005-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-12 .Að. mRNA-1273-P301HOmRNA-1273-P301-US300-2050A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T22:232020-08-04T22:23.ApAp mRNA-1273-P301HOmRNA-1273-P301-US300-2057A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B .. mRNA-1273-P301HOmRNA-1273-P301-US300-2072A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T12:022020-09-24T12:03.B3B9 mRNA-1273-P301HOmRNA-1273-P301-US300-2076A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-15 Bl.. mRNA-1273-P301HOmRNA-1273-P301-US300-2079A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T20:012020-09-03T20:01.B#B# mRNA-1273-P301HOmRNA-1273-P301-US300-2079A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bt.. mRNA-1273-P301HOmRNA-1273-P301-US300-2081A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US300-2097A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-22 B2.. mRNA-1273-P301HOmRNA-1273-P301-US300-2100A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T12:012020-08-09T12:01.APAP mRNA-1273-P301HOmRNA-1273-P301-US300-2106A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 B].. mRNA-1273-P301HOmRNA-1273-P301-US300-2109A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T18:162020-09-04T18:16.BB mRNA-1273-P301HOmRNA-1273-P301-US300-2110A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T12:002020-08-11T12:00.A`A` mRNA-1273-P301HOmRNA-1273-P301-US300-2131AUSA-US005-2020-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-07 2020-12-12 .B{B€ mRNA-1273-P301HOmRNA-1273-P301-US300-2132A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 B†.. mRNA-1273-P301HOmRNA-1273-P301-US300-2137A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T09:382020-09-12T09:38.B"B" mRNA-1273-P301HOmRNA-1273-P301-US300-2140A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:012020-09-09T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US300-2141A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T19:312020-09-08T19:31.BB mRNA-1273-P301HOmRNA-1273-P301-US300-2143A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T15:422020-09-09T15:42.BB mRNA-1273-P301HOmRNA-1273-P301-US300-2156A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T11:042020-08-15T11:04.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US300-2162A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T00:192020-08-21T00:19.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US300-2165A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US300-2167A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T00:432020-08-21T00:43.APAP mRNA-1273-P301HOmRNA-1273-P301-US300-2167A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T09:462020-09-21T09:46.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US300-2169A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T12:032020-08-25T12:03.A`A` mRNA-1273-P301HOmRNA-1273-P301-US300-2196A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T14:342020-08-30T14:34.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US300-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T12:532020-09-03T12:53.ApAp mRNA-1273-P301HOmRNA-1273-P301-US300-2198A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T18:062020-10-15T18:10.B'B1 mRNA-1273-P301HOmRNA-1273-P301-US300-2209A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T19:402020-08-28T19:40.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2213A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T13:352020-08-31T13:35.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2227A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T18:032020-09-01T18:03.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2231A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T05:172020-09-17T05:17.BB mRNA-1273-P301HOmRNA-1273-P301-US300-2236A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 BM.. mRNA-1273-P301HOmRNA-1273-P301-US300-2259AUSA-US005-2020-mRNA-1273-P301000011HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-07 2020-12-22 .B[Bj mRNA-1273-P301HOmRNA-1273-P301-US300-2260A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-12-02T15:102020-12-02T15:10.BVBV mRNA-1273-P301HOmRNA-1273-P301-US300-2260A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 BU.. mRNA-1273-P301HOmRNA-1273-P301-US300-2263A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T17:242020-09-08T17:24.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2272A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T15:222020-09-09T15:22.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2279A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-08 B.. mRNA-1273-P301HOmRNA-1273-P301-US300-2302A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-09 B.. mRNA-1273-P301HOmRNA-1273-P301-US300-2308A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T13:482020-09-24T13:48.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2312A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 BY.. mRNA-1273-P301HOmRNA-1273-P301-US300-2324A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T13:222020-09-27T13:22.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US300-2327A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:572020-09-26T12:03.AA mRNA-1273-P301HOmRNA-1273-P301-US300-2333A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T05:572020-10-02T05:57.APAP mRNA-1273-P301HOmRNA-1273-P301-US300-2333A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T17:042020-10-27T17:04.BB mRNA-1273-P301HOmRNA-1273-P301-US300-2334A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US300-2339A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T13:482020-10-03T13:48.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US300-2349A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T12:222020-11-12T12:22.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US300-2356A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T09:592020-10-14T09:59.A`A` mRNA-1273-P301HOmRNA-1273-P301-US300-2366A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B<.. mRNA-1273-P301HOmRNA-1273-P301-US300-2369A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T17:102020-10-20T17:10.A A mRNA-1273-P301HOmRNA-1273-P301-US301-2023A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T16:162020-08-26T16:16.BB mRNA-1273-P301HOmRNA-1273-P301-US301-2028A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-20 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US301-2053A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T17:292020-08-20T13:26.A Að mRNA-1273-P301HOmRNA-1273-P301-US301-2073AUSA-US006-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-26 2021-03-02 .BÍBÑ mRNA-1273-P301HOmRNA-1273-P301-US301-2083A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T17:472020-09-05T17:47.BB mRNA-1273-P301HOmRNA-1273-P301-US301-2096AUSA-US006-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-04 2020-11-07 .BWBZ mRNA-1273-P301HOmRNA-1273-P301-US301-2098AUSA-US006-2020-mRNA-1273-P301000002HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P5D mRNA-1273-P301HOmRNA-1273-P301-US301-2098A USA-US006-2020-mRNA-1273-P301000002HO-AE-001/AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-26 2020-10-12 .B0B@ mRNA-1273-P301HOmRNA-1273-P301-US301-2104A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T23:062020-09-11T22:38.BB mRNA-1273-P301HOmRNA-1273-P301-US301-2112A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T16:492020-09-08T16:49.BB mRNA-1273-P301HOmRNA-1273-P301-US301-2114A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US301-2117A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T20:162020-08-14T20:16.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US301-2131AUSA-US006-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-11 2020-12-13 .ByB{ mRNA-1273-P301HOmRNA-1273-P301-US301-2154A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T10:362020-09-19T10:36.B%B% mRNA-1273-P301HOmRNA-1273-P301-US301-2154A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-18 B$.. mRNA-1273-P301HOmRNA-1273-P301-US301-2167A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T18:572020-08-25T18:57.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US301-2170A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T21:532020-09-18T23:10.BB mRNA-1273-P301HOmRNA-1273-P301-US301-2171AUSA-US006-2021-mRNA-1273-P301000007HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-12 2021-03-17 .BÏBÔ mRNA-1273-P301HOmRNA-1273-P301-US301-2232A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T08:282020-09-05T08:28.A°A° mRNA-1273-P301HOmRNA-1273-P301-US301-2248A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T18:172020-09-03T18:17.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US301-2263AUSA-US006-2020-mRNA-1273-P301000003HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-08 2020-11-15 .BDBK mRNA-1273-P301HOmRNA-1273-P301-US301-2276A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 B“.. mRNA-1273-P301HOmRNA-1273-P301-US301-2297A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T21:232020-09-20T21:23.ApAp mRNA-1273-P301HOmRNA-1273-P301-US301-2312A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T21:032020-10-14T21:03.BB mRNA-1273-P301HOmRNA-1273-P301-US301-2317A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-22 B¾.. mRNA-1273-P301HOmRNA-1273-P301-US301-2318A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T05:092020-09-20T05:09.A`A` mRNA-1273-P301HOmRNA-1273-P301-US301-2328A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 B\.. mRNA-1273-P301HOmRNA-1273-P301-US301-2329A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US301-2334A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 BV.. mRNA-1273-P301HOmRNA-1273-P301-US301-2338A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-13T21:062020-11-13T21:06.BB mRNA-1273-P301HOmRNA-1273-P301-US301-2349A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T22:262020-10-20T22:26.A A mRNA-1273-P301HOmRNA-1273-P301-US301-2359A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T22:042020-10-30T19:11.APA€ mRNA-1273-P301HOmRNA-1273-P301-US302-2012A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-03 A€.. mRNA-1273-P301HOmRNA-1273-P301-US302-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T00:392020-09-02T00:39.B&B& mRNA-1273-P301HOmRNA-1273-P301-US302-2031AUSA-US051-2020-mRNA-1273-P301000001HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-10 2020-08-19 .AðB mRNA-1273-P301HOmRNA-1273-P301-US302-2034A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T12:192020-08-01T12:19.A`A` mRNA-1273-P301HOmRNA-1273-P301-US302-2052AUSA-US051-2020-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-15 2020-10-18 .BPBS mRNA-1273-P301HOmRNA-1273-P301-US302-2063AUSA-US051-2021-mRNA-1273-P301000001HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-21 2020-10-22 .BUBV mRNA-1273-P301HOmRNA-1273-P301-US302-2064A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T17:472020-08-28T17:47.BB mRNA-1273-P301HOmRNA-1273-P301-US302-2075A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 Bš.. mRNA-1273-P301HOmRNA-1273-P301-US302-2082A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-31T00:162020-07-31T00:16.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US302-2103AUSA-US051-2020-mRNA-1273-P301000004HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-16 2020-08-17 .BB mRNA-1273-P301HOmRNA-1273-P301-US302-2108A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:002020-09-10T12:00.B*B* mRNA-1273-P301HOmRNA-1273-P301-US302-2111A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US302-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T00:002020-09-30T00:00.B9B9 mRNA-1273-P301HOmRNA-1273-P301-US302-2134A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T19:552020-08-15T21:54.APA` mRNA-1273-P301HOmRNA-1273-P301-US302-2136A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T20:592020-08-11T20:59.A A mRNA-1273-P301HOmRNA-1273-P301-US302-2147A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T19:322020-09-15T19:32.B#B# mRNA-1273-P301HOmRNA-1273-P301-US302-2167AUSA-US051-2021-mRNA-1273-P301000007HO-AE-013 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-19 2021-03-22 .B×BÚ mRNA-1273-P301HOmRNA-1273-P301-US302-2167A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T09:412020-09-18T09:41.B!B! mRNA-1273-P301HOmRNA-1273-P301-US302-2183A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T11:082020-09-17T11:08.BB mRNA-1273-P301HOmRNA-1273-P301-US302-2186AUSA-US051-2021-mRNA-1273-P301000006HO-AE-008 ADMITTED TO ICU ICU ADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US302-2186A USA-US051-2020-mRNA-1273-P301000009HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-11 2020-10-14 .B5B8 mRNA-1273-P301HOmRNA-1273-P301-US302-2186A0USA-US051-2020-mRNA-1273-P301000012HO-AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-11 2020-11-13 .BTBV mRNA-1273-P301HOmRNA-1273-P301-US302-2186A@USA-US051-2021-mRNA-1273-P301000006HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-14 2021-01-25 .B”BŸ mRNA-1273-P301HOmRNA-1273-P301-US302-2192A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T20:082020-08-26T20:08.ApAp mRNA-1273-P301HOmRNA-1273-P301-US302-2193AUSA-US051-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-06 2020-10-07 .B0B1 mRNA-1273-P301HOmRNA-1273-P301-US302-2208AUSA-US051-2020-mRNA-1273-P301000003HO-AE-001/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-10 2020-09-14 .BB mRNA-1273-P301HOmRNA-1273-P301-US302-2211A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B|.. mRNA-1273-P301HOmRNA-1273-P301-US302-2219A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T21:492020-09-23T21:49.B#B# mRNA-1273-P301HOmRNA-1273-P301-US302-2220A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T21:402020-08-26T21:40.ApAp mRNA-1273-P301HOmRNA-1273-P301-US302-2223A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 BU.. mRNA-1273-P301HOmRNA-1273-P301-US302-2233A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-09 B3.. mRNA-1273-P301HOmRNA-1273-P301-US302-2246AUSA-US051-2020-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-14 2020-11-15 .BVBW mRNA-1273-P301HOmRNA-1273-P301-US302-2254A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T20:502020-09-29T20:50.B(B( mRNA-1273-P301HOmRNA-1273-P301-US302-2276AUSA-US051-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-02 2020-10-03 .B+B, mRNA-1273-P301HOmRNA-1273-P301-US302-2291AUSA-US051-2020-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-09 2020-11-12 .BNBQ mRNA-1273-P301HOmRNA-1273-P301-US302-2305A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T12:582020-09-29T12:58.BB mRNA-1273-P301HOmRNA-1273-P301-US302-2308A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T20:282020-09-03T20:28.AA mRNA-1273-P301HOmRNA-1273-P301-US302-2324A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-15 BŸ.. mRNA-1273-P301HOmRNA-1273-P301-US302-2336A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-08T16:592020-11-08T16:59.BB mRNA-1273-P301HOmRNA-1273-P301-US303-2002A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T18:122020-08-28T18:12.B!B! mRNA-1273-P301HOmRNA-1273-P301-US303-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 B•.. mRNA-1273-P301HOmRNA-1273-P301-US303-2009A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-27 B\.. mRNA-1273-P301HOmRNA-1273-P301-US303-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T11:032020-08-06T11:03.AA mRNA-1273-P301HOmRNA-1273-P301-US303-2035A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US303-2040A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T12:022020-08-04T12:02.ApAp mRNA-1273-P301HOmRNA-1273-P301-US303-2041A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T19:022020-08-14T20:46.A B mRNA-1273-P301HOmRNA-1273-P301-US303-2046A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 BR.. mRNA-1273-P301HOmRNA-1273-P301-US303-2054A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T20:272020-09-03T20:27.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US303-2080A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T12:022020-08-10T12:02.ApAp mRNA-1273-P301HOmRNA-1273-P301-US303-2083A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T13:572020-08-05T13:57.A A mRNA-1273-P301HOmRNA-1273-P301-US303-2084A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US303-2095A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 Be.. mRNA-1273-P301HOmRNA-1273-P301-US303-2108AUSA-US032-2021-mRNA-1273-P301000012HO-AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-22 2021-04-25 .CPC€ mRNA-1273-P301HOmRNA-1273-P301-US303-2108A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T16:282020-08-19T16:28.AðAð mRNA-1273-P301HOmRNA-1273-P301-US303-2109A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US303-2110A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US303-2112A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T21:152020-08-05T21:15.AA mRNA-1273-P301HOmRNA-1273-P301-US303-2113A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-28 B6.. mRNA-1273-P301HOmRNA-1273-P301-US303-2115AUSA-US032-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-21 2020-12-24 .BŠB mRNA-1273-P301HOmRNA-1273-P301-US303-2123A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T23:052020-09-10T23:05.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US303-2123A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US303-2129A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US303-2134A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T08:342020-08-08T08:34.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US303-2137A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T18:402020-09-13T18:40.B'B' mRNA-1273-P301HOmRNA-1273-P301-US303-2142A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T20:072020-08-08T20:07.A A mRNA-1273-P301HOmRNA-1273-P301-US303-2143A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bt.. mRNA-1273-P301HOmRNA-1273-P301-US303-2159A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T13:432020-09-15T13:43.B'B' mRNA-1273-P301HOmRNA-1273-P301-US303-2160A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T21:312020-09-14T21:31.B&B& mRNA-1273-P301HOmRNA-1273-P301-US303-2163A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T14:162020-08-08T14:16.AA mRNA-1273-P301HOmRNA-1273-P301-US303-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T12:012020-09-13T12:01.B%B% mRNA-1273-P301HOmRNA-1273-P301-US303-2171A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-08 B.. mRNA-1273-P301HOmRNA-1273-P301-US303-2172A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-01 B.. mRNA-1273-P301HOmRNA-1273-P301-US303-2185A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US303-2187AUSA-US032-2020-mRNA-1273-P301000021HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-03 2020-12-07 .BsBw mRNA-1273-P301HOmRNA-1273-P301-US303-2187A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US303-2204A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US303-2213A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T20:052020-09-02T20:26.AðB mRNA-1273-P301HOmRNA-1273-P301-US303-2213A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 B\.. mRNA-1273-P301HOmRNA-1273-P301-US303-2223A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B>.. mRNA-1273-P301HOmRNA-1273-P301-US303-2225A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-31 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US303-2241A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US303-2249AUSA-US032-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-09 2021-02-12 .B¯B² mRNA-1273-P301HOmRNA-1273-P301-US303-2249A USA-US032-2021-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-01 2021-03-05 .BÃBÇ mRNA-1273-P301HOmRNA-1273-P301-US303-2249A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-08 B®.. mRNA-1273-P301HOmRNA-1273-P301-US303-2253A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T06:022020-08-20T06:02.A A mRNA-1273-P301HOmRNA-1273-P301-US303-2263AUSA-US032-2021-mRNA-1273-P301000005HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P5D mRNA-1273-P301HOmRNA-1273-P301-US303-2263A USA-US032-2021-mRNA-1273-P301000005HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-07 2020-12-12 .BnBs mRNA-1273-P301HOmRNA-1273-P301-US303-2263A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US303-2267A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T19:212020-09-02T12:37.A0Aà mRNA-1273-P301HOmRNA-1273-P301-US303-2277AUSA-US032-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-12 2020-09-17 .BB mRNA-1273-P301HOmRNA-1273-P301-US303-2278A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US303-2286A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T22:052020-09-20T22:05.B B mRNA-1273-P301HOmRNA-1273-P301-US303-2292A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T20:432020-09-19T20:43.BB mRNA-1273-P301HOmRNA-1273-P301-US303-2297A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T13:112020-09-19T13:11.BB mRNA-1273-P301HOmRNA-1273-P301-US303-2316A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B;.. mRNA-1273-P301HOmRNA-1273-P301-US303-2344A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BA.. mRNA-1273-P301HOmRNA-1273-P301-US303-2351A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T19:332020-11-17T19:33.B#B# mRNA-1273-P301HOmRNA-1273-P301-US304-2011A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US304-2026A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-13 BM.. mRNA-1273-P301HOmRNA-1273-P301-US304-2028A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T19:382020-09-04T12:32.B#B& mRNA-1273-P301HOmRNA-1273-P301-US304-2028A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-24 B:.. mRNA-1273-P301HOmRNA-1273-P301-US304-2031A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T21:532020-08-06T21:53.AA mRNA-1273-P301HOmRNA-1273-P301-US304-2041A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T21:512020-07-30T21:51.AA mRNA-1273-P301HOmRNA-1273-P301-US304-2044A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T07:472020-09-05T07:47.B%B% mRNA-1273-P301HOmRNA-1273-P301-US304-2047A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B¢.. mRNA-1273-P301HOmRNA-1273-P301-US304-2052A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T18:142020-09-09T18:14.B&B& mRNA-1273-P301HOmRNA-1273-P301-US304-2062A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T12:482020-08-13T12:48.A A mRNA-1273-P301HOmRNA-1273-P301-US304-2063A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-06 A0.. mRNA-1273-P301HOmRNA-1273-P301-US304-2066A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T18:122020-09-03T18:12.BB mRNA-1273-P301HOmRNA-1273-P301-US304-2067A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T22:152020-09-10T22:15.B&B& mRNA-1273-P301HOmRNA-1273-P301-US304-2069A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 BV.. mRNA-1273-P301HOmRNA-1273-P301-US304-2072A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US304-2072A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 B.. mRNA-1273-P301HOmRNA-1273-P301-US304-2083A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T05:352020-09-17T05:35.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US304-2090A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T17:592020-08-26T17:59.BB mRNA-1273-P301HOmRNA-1273-P301-US304-2091A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-21 B/.. mRNA-1273-P301HOmRNA-1273-P301-US304-2094A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 B|.. mRNA-1273-P301HOmRNA-1273-P301-US304-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T17:042020-09-07T17:04.B!B! mRNA-1273-P301HOmRNA-1273-P301-US304-2095A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US304-2097A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T12:262020-09-11T12:26.B%B% mRNA-1273-P301HOmRNA-1273-P301-US304-2100A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-16 BH.. mRNA-1273-P301HOmRNA-1273-P301-US304-2104A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T05:592020-08-14T05:59.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US304-2107A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T17:502020-08-21T17:50.AðAð mRNA-1273-P301HOmRNA-1273-P301-US304-2112A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T19:482020-08-10T19:48.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US304-2113A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T14:102020-09-17T12:01.B'B* mRNA-1273-P301HOmRNA-1273-P301-US304-2115A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 B[.. mRNA-1273-P301HOmRNA-1273-P301-US304-2117A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T19:362020-09-09T18:22.B!B" mRNA-1273-P301HOmRNA-1273-P301-US304-2119A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T21:392020-08-09T21:39.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US304-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T00:002020-09-09T00:00.B"B" mRNA-1273-P301HOmRNA-1273-P301-US304-2138A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T21:072020-09-10T21:07.BB mRNA-1273-P301HOmRNA-1273-P301-US304-2142A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T10:512020-08-12T10:51.A A mRNA-1273-P301HOmRNA-1273-P301-US304-2144A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-18 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US304-2150A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T21:442020-08-21T21:44.A A mRNA-1273-P301HOmRNA-1273-P301-US304-2150A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-14 A0.. mRNA-1273-P301HOmRNA-1273-P301-US304-2152A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B“.. mRNA-1273-P301HOmRNA-1273-P301-US304-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 BV.. mRNA-1273-P301HOmRNA-1273-P301-US304-2169A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T20:152020-09-17T20:15.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US304-2170A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T12:292020-08-13T12:29.AA mRNA-1273-P301HOmRNA-1273-P301-US304-2171A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-09-10T01:082020-09-10T01:08.BB mRNA-1273-P301HOmRNA-1273-P301-US304-2185A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US304-2187A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US304-2189A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:142020-09-17T12:14.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US304-2189A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-16 B#.. mRNA-1273-P301HOmRNA-1273-P301-US304-2190AUSA-US052-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-09 2020-09-10 .BB mRNA-1273-P301HOmRNA-1273-P301-US304-2203AUSA-US052-2020-mRNA-1273-P301000022HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-30 2020-12-14 .BmB{ mRNA-1273-P301HOmRNA-1273-P301-US304-2208A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T20:342020-09-21T20:34.B'B' mRNA-1273-P301HOmRNA-1273-P301-US304-2209A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-08 B.. mRNA-1273-P301HOmRNA-1273-P301-US304-2210AUSA-US052-2020-mRNA-1273-P301000020HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-03 2020-11-06 .BOBR mRNA-1273-P301HOmRNA-1273-P301-US304-2213AUSA-US052-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-15 2021-01-20 .B˜B mRNA-1273-P301HOmRNA-1273-P301-US304-2213A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US304-2217A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T12:132020-09-16T12:13.BB mRNA-1273-P301HOmRNA-1273-P301-US304-2226A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 BH.. mRNA-1273-P301HOmRNA-1273-P301-US304-2232A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 BN.. mRNA-1273-P301HOmRNA-1273-P301-US304-2238A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 Bl.. mRNA-1273-P301HOmRNA-1273-P301-US304-2241A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B.. mRNA-1273-P301HOmRNA-1273-P301-US304-2244A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BL.. mRNA-1273-P301HOmRNA-1273-P301-US304-2248A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B.. mRNA-1273-P301HOmRNA-1273-P301-US304-2251A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T18:562020-09-18T18:56.BB mRNA-1273-P301HOmRNA-1273-P301-US304-2252A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T16:212020-09-24T13:24.B$B% mRNA-1273-P301HOmRNA-1273-P301-US304-2252A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-24 B%.. mRNA-1273-P301HOmRNA-1273-P301-US304-2253A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T16:182020-09-23T16:18.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US304-2253A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-24 B%.. mRNA-1273-P301HOmRNA-1273-P301-US304-2256A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T09:532020-08-31T09:53.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US304-2264AUSA-US052-2020-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-26 2020-10-28 .BDBF mRNA-1273-P301HOmRNA-1273-P301-US304-2278A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US304-2288AUSA-US052-2020-mRNA-1273-P301000025HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-01 2020-12-05 .BgBk mRNA-1273-P301HOmRNA-1273-P301-US304-2288A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYYFOLLOW-UP BLINDED PHASE 2020-12-01 2020-12-05 .BgBk mRNA-1273-P301HOmRNA-1273-P301-US304-2295A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T14:392020-08-28T12:21.APA€ mRNA-1273-P301HOmRNA-1273-P301-US304-2305A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T12:032020-09-26T12:03.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US304-2309AUSA-US052-2021-mRNA-1273-P301000005HO-AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-13 2021-02-16 .B°B³ mRNA-1273-P301HOmRNA-1273-P301-US304-2316A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US305-2005AUSA-US117-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-24 2021-02-25 .BÒBÓ mRNA-1273-P301HOmRNA-1273-P301-US305-2012A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-01 B".. mRNA-1273-P301HOmRNA-1273-P301-US305-2014A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T16:152020-08-28T16:15.BB mRNA-1273-P301HOmRNA-1273-P301-US305-2025A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-10-15T12:032020-10-15T12:03.BNBN mRNA-1273-P301HOmRNA-1273-P301-US305-2028AUSA-US117-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-05 2020-08-06 .ApA€ mRNA-1273-P301HOmRNA-1273-P301-US305-2028A USA-US117-2021-mRNA-1273-P301000006HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-03 2021-04-04 .BøBù mRNA-1273-P301HOmRNA-1273-P301-US305-2028A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T22:302020-08-06T22:30.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US305-2034A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T19:292020-10-13T08:49.B7BK mRNA-1273-P301HOmRNA-1273-P301-US305-2044AUSA-US117-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-06 2020-12-10 .BB… mRNA-1273-P301HOmRNA-1273-P301-US305-2073A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T14:122020-08-21T16:17.BB mRNA-1273-P301HOmRNA-1273-P301-US305-2073A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T16:092020-09-28T09:35.B3B9 mRNA-1273-P301HOmRNA-1273-P301-US305-2078A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:442020-09-10T12:44.B'B' mRNA-1273-P301HOmRNA-1273-P301-US305-2117A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T16:332020-08-11T09:35.AA` mRNA-1273-P301HOmRNA-1273-P301-US305-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T00:012020-09-14T00:01.B(B( mRNA-1273-P301HOmRNA-1273-P301-US305-2131A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T21:162020-08-11T13:15.A AP mRNA-1273-P301HOmRNA-1273-P301-US305-2141A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US305-2143A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T10:562020-08-10T10:56.AA mRNA-1273-P301HOmRNA-1273-P301-US305-2148A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-11-02T02:562020-11-02T02:56.BUBU mRNA-1273-P301HOmRNA-1273-P301-US305-2149A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T20:402020-08-11T20:40.A A mRNA-1273-P301HOmRNA-1273-P301-US305-2167A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T10:182020-08-12T10:18.A A mRNA-1273-P301HOmRNA-1273-P301-US305-2175A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T19:492020-08-31T12:30.A B mRNA-1273-P301HOmRNA-1273-P301-US305-2179A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T14:242020-08-16T14:24.APAP mRNA-1273-P301HOmRNA-1273-P301-US305-2183A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:042020-09-15T12:04.B#B# mRNA-1273-P301HOmRNA-1273-P301-US305-2199A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T19:192020-08-13T19:19.AA mRNA-1273-P301HOmRNA-1273-P301-US305-2205A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T17:582020-08-31T17:58.BB mRNA-1273-P301HOmRNA-1273-P301-US305-2205A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-10-29T16:452020-10-29T16:45.BNBN mRNA-1273-P301HOmRNA-1273-P301-US305-2209A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-18 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US305-2219A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T16:282020-08-18T16:28.APAP mRNA-1273-P301HOmRNA-1273-P301-US305-2219A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-18 AP.. mRNA-1273-P301HOmRNA-1273-P301-US305-2224A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T20:142020-09-10T20:14.BB mRNA-1273-P301HOmRNA-1273-P301-US305-2234A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T18:162020-09-18T18:16.B!B! mRNA-1273-P301HOmRNA-1273-P301-US305-2241A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T14:102020-10-09T14:10.B6B6 mRNA-1273-P301HOmRNA-1273-P301-US305-2248A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:262020-09-17T12:26.B B mRNA-1273-P301HOmRNA-1273-P301-US305-2262A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T12:372020-09-19T12:37.B!B! mRNA-1273-P301HOmRNA-1273-P301-US305-2268A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T10:532020-08-26T10:45.APA€ mRNA-1273-P301HOmRNA-1273-P301-US305-2271A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T15:502020-09-22T12:17.BB# mRNA-1273-P301HOmRNA-1273-P301-US305-2295AUSA-US117-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-24 2020-09-26 .B B" mRNA-1273-P301HOmRNA-1273-P301-US305-2295A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T13:312020-09-29T07:15.B"B% mRNA-1273-P301HOmRNA-1273-P301-US305-2305A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:432020-09-10T12:43.BB mRNA-1273-P301HOmRNA-1273-P301-US305-2305A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:432020-09-10T12:43.BB mRNA-1273-P301HOmRNA-1273-P301-US305-2312AUSA-US117-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-27 2021-01-29 .B™B› mRNA-1273-P301HOmRNA-1273-P301-US305-2315AUSA-US117-2020-mRNA-1273-P301000005HO-AE-001/AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-09 2020-12-18 .BhBq mRNA-1273-P301HOmRNA-1273-P301-US305-2315A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US305-2331A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T14:222020-09-28T14:22.BB mRNA-1273-P301HOmRNA-1273-P301-US305-2334A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T17:002020-09-07T17:00.ApAp mRNA-1273-P301HOmRNA-1273-P301-US305-2334A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T22:032020-10-06T22:03.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US305-2358A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T09:472020-09-05T09:47.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US305-2365A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 BF.. mRNA-1273-P301HOmRNA-1273-P301-US305-2367A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T12:212020-10-07T12:21.B#B# mRNA-1273-P301HOmRNA-1273-P301-US305-2374A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T12:142020-10-21T14:50.B*B0 mRNA-1273-P301HOmRNA-1273-P301-US305-2380AUSA-US117-2021-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-18 2021-02-19 .B¤B¥ mRNA-1273-P301HOmRNA-1273-P301-US306-2003A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 B¢.. mRNA-1273-P301HOmRNA-1273-P301-US306-2015A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-01 Bº.. mRNA-1273-P301HOmRNA-1273-P301-US306-2016A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T22:382020-08-07T22:38.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US306-2018AUSA-US090-2020-mRNA-1273-P301000011HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-13 2020-12-14 .BˆB‰ mRNA-1273-P301HOmRNA-1273-P301-US306-2019AUSA-US090-2020-mRNA-1273-P301000003HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-22 2020-09-26 .B6B: mRNA-1273-P301HOmRNA-1273-P301-US306-2026A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T22:462020-08-06T22:46.A`A` mRNA-1273-P301HOmRNA-1273-P301-US306-2035A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T21:492020-08-30T21:49.BB mRNA-1273-P301HOmRNA-1273-P301-US306-2040A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T22:022020-08-04T22:02.A A mRNA-1273-P301HOmRNA-1273-P301-US306-2045A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-26 B7.. mRNA-1273-P301HOmRNA-1273-P301-US306-2048AUSA-US090-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-11 2021-01-12 .B¢B£ mRNA-1273-P301HOmRNA-1273-P301-US306-2050A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T22:082020-08-05T22:08.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US306-2070A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T18:562020-09-06T18:56.B"B" mRNA-1273-P301HOmRNA-1273-P301-US306-2075AUSA-US090-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-28 2021-01-08 .B“Bž mRNA-1273-P301HOmRNA-1273-P301-US306-2079AUSA-US090-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-07 2020-09-10 .B#B& mRNA-1273-P301HOmRNA-1273-P301-US306-2079A USA-US090-2021-mRNA-1273-P301000007HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-10 2020-12-11 .BB‚ mRNA-1273-P301HOmRNA-1273-P301-US306-2079A0USA-US090-2021-mRNA-1273-P301000012HO-AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-19 .C0. mRNA-1273-P301HOmRNA-1273-P301-US306-2079A@ HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T22:552020-09-11T07:02.B#B' mRNA-1273-P301HOmRNA-1273-P301-US306-2086A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T20:182020-09-04T20:18.B B mRNA-1273-P301HOmRNA-1273-P301-US306-2089A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 B.. mRNA-1273-P301HOmRNA-1273-P301-US306-2098A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T12:252020-08-27T12:03.BB mRNA-1273-P301HOmRNA-1273-P301-US306-2102AUSA-US090-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-27 2021-02-03 .B°B· mRNA-1273-P301HOmRNA-1273-P301-US306-2107A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T12:022020-09-05T12:02.B B mRNA-1273-P301HOmRNA-1273-P301-US306-2118AUSA-US090-2021-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-20 2021-04-21 .C C0 mRNA-1273-P301HOmRNA-1273-P301-US306-2124A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T19:542020-08-09T12:11.AA@ mRNA-1273-P301HOmRNA-1273-P301-US306-2128AUSA-US090-2020-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-03 2020-12-04 .BxBy mRNA-1273-P301HOmRNA-1273-P301-US306-2131A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US306-2135A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T22:232020-08-07T22:23.A A mRNA-1273-P301HOmRNA-1273-P301-US306-2135A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B.. mRNA-1273-P301HOmRNA-1273-P301-US306-2151AUSA-US090-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-14 2020-10-15 .BEBF mRNA-1273-P301HOmRNA-1273-P301-US306-2151A USA-US090-2020-mRNA-1273-P301000005HO-AE-002/AE-008/AE-019 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-20 2020-10-28 .BKBS mRNA-1273-P301HOmRNA-1273-P301-US306-2155A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T17:432020-09-16T17:43.B)B) mRNA-1273-P301HOmRNA-1273-P301-US306-2157AUSA-US090-2021-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-11 2021-03-27 .B½Bé mRNA-1273-P301HOmRNA-1273-P301-US306-2165A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B—.. mRNA-1273-P301HOmRNA-1273-P301-US306-2167A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B}.. mRNA-1273-P301HOmRNA-1273-P301-US306-2171A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T20:322020-09-09T20:32.B!B! mRNA-1273-P301HOmRNA-1273-P301-US306-2210A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B•.. mRNA-1273-P301HOmRNA-1273-P301-US306-2215A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T09:202020-09-14T09:20.B#B# mRNA-1273-P301HOmRNA-1273-P301-US306-2223A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T21:252020-08-18T21:25.A`A` mRNA-1273-P301HOmRNA-1273-P301-US306-2258A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T22:342020-09-13T22:34.BB mRNA-1273-P301HOmRNA-1273-P301-US306-2265AUSA-US090-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-17 2020-09-23 .B"B( mRNA-1273-P301HOmRNA-1273-P301-US306-2265A USA-US090-2020-mRNA-1273-P301000006HO-AE-002/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-13 2020-10-20 .B<BC mRNA-1273-P301HOmRNA-1273-P301-US306-2265A0USA-US090-2020-mRNA-1273-P301000009HO-AE-021 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-27 2020-11-02 .BJBP mRNA-1273-P301HOmRNA-1273-P301-US306-2270A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T15:022020-09-13T15:02.BB mRNA-1273-P301HOmRNA-1273-P301-US306-2271A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T16:082020-08-18T16:08.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US306-2279A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T19:582020-09-15T19:58.BB mRNA-1273-P301HOmRNA-1273-P301-US306-2281A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T18:082020-08-26T18:08.AA mRNA-1273-P301HOmRNA-1273-P301-US306-2292A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T20:442020-09-08T20:44.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US306-2293A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T00:002020-09-08T00:00.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US306-2312A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B.. mRNA-1273-P301HOmRNA-1273-P301-US306-2315A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T22:092020-09-17T22:09.AA mRNA-1273-P301HOmRNA-1273-P301-US306-2317A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-08T18:242020-11-08T18:24.B*B* mRNA-1273-P301HOmRNA-1273-P301-US308-2006A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T17:282020-09-08T17:28.B!B! mRNA-1273-P301HOmRNA-1273-P301-US308-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T22:242020-08-18T04:40.APAp mRNA-1273-P301HOmRNA-1273-P301-US308-2021A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US308-2045A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T16:592020-09-16T12:08.BB mRNA-1273-P301HOmRNA-1273-P301-US308-2049A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-01-05 Ââ.. mRNA-1273-P301HOmRNA-1273-P301-US308-2051AUSA-US114-2020-mRNA-1273-P301000002HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-26 2020-09-30 .AB, mRNA-1273-P301HOmRNA-1273-P301-US308-2081AUSA-US114-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-02 2020-10-05 .B+B. mRNA-1273-P301HOmRNA-1273-P301-US308-2082A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T12:322020-08-26T12:32.A`A` mRNA-1273-P301HOmRNA-1273-P301-US308-2100A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US308-2110A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T15:092020-09-01T15:09.ApAp mRNA-1273-P301HOmRNA-1273-P301-US308-2119A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T19:332020-08-26T19:33.AA mRNA-1273-P301HOmRNA-1273-P301-US308-2122AUSA-US114-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-26 2021-02-27 .B¸B¹ mRNA-1273-P301HOmRNA-1273-P301-US308-2129A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T18:582020-08-27T18:58.AA mRNA-1273-P301HOmRNA-1273-P301-US308-2141A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T00:002020-10-02T00:00.B!B! mRNA-1273-P301HOmRNA-1273-P301-US308-2163A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T18:272020-09-02T18:27.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US308-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T08:352020-10-19T08:35.B2B2 mRNA-1273-P301HOmRNA-1273-P301-US308-2166A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US308-2171A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T12:572020-10-06T12:57.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US308-2181A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T12:002020-09-19T12:16.BB mRNA-1273-P301HOmRNA-1273-P301-US308-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:032020-09-10T12:03.ApAp mRNA-1273-P301HOmRNA-1273-P301-US308-2200A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T10:592020-10-02T10:59.BB mRNA-1273-P301HOmRNA-1273-P301-US308-2216A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US308-2218A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T17:192020-09-16T17:19.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US308-2221A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B~.. mRNA-1273-P301HOmRNA-1273-P301-US308-2226A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T21:412020-10-09T21:41.BB mRNA-1273-P301HOmRNA-1273-P301-US308-2237A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T13:142020-10-15T12:09.BB mRNA-1273-P301HOmRNA-1273-P301-US308-2247A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-14 B.. mRNA-1273-P301HOmRNA-1273-P301-US308-2269AUSA-US114-2020-mRNA-1273-P301000003HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US308-2269A USA-US114-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-02 2020-10-03 .AÀAÐ mRNA-1273-P301HOmRNA-1273-P301-US309-2003A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T14:522020-08-16T20:23.A°AÐ mRNA-1273-P301HOmRNA-1273-P301-US309-2019A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US309-2021AUSA-US086-2021-mRNA-1273-P301000002HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-15 2020-11-17 .BgBi mRNA-1273-P301HOmRNA-1273-P301-US309-2022AUSA-US086-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-03 2020-10-06 .B<B? mRNA-1273-P301HOmRNA-1273-P301-US309-2026A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-18 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US309-2034A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-27 BS.. mRNA-1273-P301HOmRNA-1273-P301-US309-2039A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T17:472020-08-06T17:47.AA mRNA-1273-P301HOmRNA-1273-P301-US309-2039A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T17:372020-09-11T17:37.B%B% mRNA-1273-P301HOmRNA-1273-P301-US309-2040A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T14:582020-08-11T14:58.A`A` mRNA-1273-P301HOmRNA-1273-P301-US309-2041A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T17:272020-08-11T17:27.A`A` mRNA-1273-P301HOmRNA-1273-P301-US309-2043AUSA-US086-2020-mRNA-1273-P301000005HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-28 2020-11-04 .BTB[ mRNA-1273-P301HOmRNA-1273-P301-US309-2047AUSA-US086-2021-mRNA-1273-P301000013HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-14 2021-03-18 .BÝBá mRNA-1273-P301HOmRNA-1273-P301-US309-2047A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T21:352020-08-10T21:35.APAP mRNA-1273-P301HOmRNA-1273-P301-US309-2054A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T16:222020-08-07T16:22.AA mRNA-1273-P301HOmRNA-1273-P301-US309-2055A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T19:352020-08-13T19:35.ApAp mRNA-1273-P301HOmRNA-1273-P301-US309-2061A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T12:272020-09-13T06:54.B$B& mRNA-1273-P301HOmRNA-1273-P301-US309-2063A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T17:072020-08-07T17:07.AA mRNA-1273-P301HOmRNA-1273-P301-US309-2065A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T17:332020-08-09T17:33.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US309-2065A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US309-2075A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 Bž.. mRNA-1273-P301HOmRNA-1273-P301-US309-2076A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T08:122020-08-17T01:09.ApA mRNA-1273-P301HOmRNA-1273-P301-US309-2080A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T10:012020-09-20T10:01.B,B, mRNA-1273-P301HOmRNA-1273-P301-US309-2086A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T05:282020-09-13T05:28.B%B% mRNA-1273-P301HOmRNA-1273-P301-US309-2091AUSA-US086-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-22 2020-09-22 .B,B, mRNA-1273-P301HOmRNA-1273-P301-US309-2091A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T13:392020-09-11T13:39.B!B! mRNA-1273-P301HOmRNA-1273-P301-US309-2112AUSA-US086-2021-mRNA-1273-P301000009HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P5D mRNA-1273-P301HOmRNA-1273-P301-US309-2112A USA-US086-2021-mRNA-1273-P301000009HO-AE-003/AE-004/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-01 2021-02-06 .B¯B´ mRNA-1273-P301HOmRNA-1273-P301-US309-2118A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T16:152020-08-15T16:15.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US309-2130A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 B.. mRNA-1273-P301HOmRNA-1273-P301-US309-2131A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T11:382020-08-19T11:38.AA mRNA-1273-P301HOmRNA-1273-P301-US309-2134A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 Bž.. mRNA-1273-P301HOmRNA-1273-P301-US309-2135A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US309-2136A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T12:002020-08-16T12:00.A A mRNA-1273-P301HOmRNA-1273-P301-US309-2144A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T22:142020-09-19T22:14.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US309-2153A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T10:422020-08-19T10:42.AA mRNA-1273-P301HOmRNA-1273-P301-US309-2162A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US309-2163A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US309-2176AUSA-US086-2021-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-30 2021-04-10 .BßBê mRNA-1273-P301HOmRNA-1273-P301-US309-2177A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T15:202020-08-26T15:20.ApAp mRNA-1273-P301HOmRNA-1273-P301-US309-2199A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T20:032020-08-30T20:03.ApAp mRNA-1273-P301HOmRNA-1273-P301-US309-2205A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T06:032020-10-16T00:06.B5B6 mRNA-1273-P301HOmRNA-1273-P301-US309-2213A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T12:032020-09-09T12:32.APB mRNA-1273-P301HOmRNA-1273-P301-US309-2222A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T04:022020-10-12T04:02.B0B0 mRNA-1273-P301HOmRNA-1273-P301-US309-2224A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T13:482020-09-01T13:48.ApAp mRNA-1273-P301HOmRNA-1273-P301-US309-2234A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T00:002020-09-04T00:00.A A mRNA-1273-P301HOmRNA-1273-P301-US309-2238AUSA-US086-2021-mRNA-1273-P301000016HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-04-18 2021-04-21 .BëBî mRNA-1273-P301HOmRNA-1273-P301-US309-2245AUSA-US086-2020-mRNA-1273-P301000007HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-21 2020-11-25 .BWB[ mRNA-1273-P301HOmRNA-1273-P301-US309-2246A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T14:532020-10-03T12:04.B%B& mRNA-1273-P301HOmRNA-1273-P301-US309-2246A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-02 B%.. mRNA-1273-P301HOmRNA-1273-P301-US309-2259AUSA-US086-2021-mRNA-1273-P301000007HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P9D mRNA-1273-P301HOmRNA-1273-P301-US309-2259A USA-US086-2021-mRNA-1273-P301000007HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-25 2021-02-03 .B—B mRNA-1273-P301HOmRNA-1273-P301-US309-2264A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T14:082020-08-30T14:08.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US309-2272A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US309-2287A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T09:452020-09-03T23:59.A A mRNA-1273-P301HOmRNA-1273-P301-US310-2009A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T15:252020-08-25T15:25.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2018A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-31T07:462020-07-31T07:46.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US310-2041A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-29T21:382020-07-29T21:38.AA mRNA-1273-P301HOmRNA-1273-P301-US310-2052AUSA-US206-2021-mRNA-1273-P301000004HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-16 2020-12-23 .BB” mRNA-1273-P301HOmRNA-1273-P301-US310-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T15:582020-07-30T15:58.AA mRNA-1273-P301HOmRNA-1273-P301-US310-2061AUSA-US206-2020-mRNA-1273-P301000001HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-20 2020-08-23 .BB mRNA-1273-P301HOmRNA-1273-P301-US310-2067A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T19:262020-08-31T19:26.B!B! mRNA-1273-P301HOmRNA-1273-P301-US310-2081A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 B€.. mRNA-1273-P301HOmRNA-1273-P301-US310-2082AUSA-US206-2020-mRNA-1273-P301000002HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-11 2020-11-16 .BeBj mRNA-1273-P301HOmRNA-1273-P301-US310-2139A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T14:022020-08-14T14:02.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US310-2149A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T15:182020-09-04T15:18.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2185A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T14:042020-08-17T14:04.A`A` mRNA-1273-P301HOmRNA-1273-P301-US310-2191A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T19:492020-08-12T19:49.AA mRNA-1273-P301HOmRNA-1273-P301-US310-2216A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T19:332020-08-18T19:33.AA mRNA-1273-P301HOmRNA-1273-P301-US310-2236A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T19:002020-09-18T19:00.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2239A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T20:382020-10-04T11:02.B$B. mRNA-1273-P301HOmRNA-1273-P301-US310-2260A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T00:022020-09-20T00:02.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2263A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T17:282020-08-31T17:28.ApAp mRNA-1273-P301HOmRNA-1273-P301-US310-2271A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B“.. mRNA-1273-P301HOmRNA-1273-P301-US310-2275A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T19:412020-09-01T19:41.A`A` mRNA-1273-P301HOmRNA-1273-P301-US310-2276A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B|.. mRNA-1273-P301HOmRNA-1273-P301-US310-2283AUSA-US206-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-14 2020-11-18 .BPBT mRNA-1273-P301HOmRNA-1273-P301-US310-2283A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BR.. mRNA-1273-P301HOmRNA-1273-P301-US310-2295A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T23:082020-09-24T23:08.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2299A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T13:162020-09-25T13:16.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2311AUSA-US206-2021-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-13 2021-01-18 .B‡BŒ mRNA-1273-P301HOmRNA-1273-P301-US310-2320A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T15:072020-10-04T15:07.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2351A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-23 Bà.. mRNA-1273-P301HOmRNA-1273-P301-US310-2357A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T18:062020-09-15T18:06.A A mRNA-1273-P301HOmRNA-1273-P301-US310-2358A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T21:222020-10-10T21:22.BB mRNA-1273-P301HOmRNA-1273-P301-US310-2361A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T18:242020-09-20T18:24.ApAp mRNA-1273-P301HOmRNA-1273-P301-US310-2361A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 BH.. mRNA-1273-P301HOmRNA-1273-P301-US310-2368A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T18:362020-09-22T18:36.ApAp mRNA-1273-P301HOmRNA-1273-P301-US310-2381A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US310-2415A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T14:062020-10-08T14:06.AA mRNA-1273-P301HOmRNA-1273-P301-US311-2002A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-02T17:482020-08-02T17:48.A`A` mRNA-1273-P301HOmRNA-1273-P301-US311-2005A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T17:452020-08-26T17:45.BB mRNA-1273-P301HOmRNA-1273-P301-US311-2017A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T13:362020-08-28T13:36.BB mRNA-1273-P301HOmRNA-1273-P301-US311-2030AUSA-US062-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-26 2020-10-30 .BYB] mRNA-1273-P301HOmRNA-1273-P301-US311-2034A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T20:462020-08-01T20:46.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US311-2043AUSA-US062-2021-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-09 2021-03-13 .BÞBâ mRNA-1273-P301HOmRNA-1273-P301-US311-2046A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T02:332020-09-03T22:46.B!B# mRNA-1273-P301HOmRNA-1273-P301-US311-2049A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US311-2063A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T16:432020-08-05T14:24.A A0 mRNA-1273-P301HOmRNA-1273-P301-US311-2071AUSA-US062-2021-mRNA-1273-P301000008HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-18 2021-01-21 .B©B¬ mRNA-1273-P301HOmRNA-1273-P301-US311-2076A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T15:482020-09-10T15:48.B&B& mRNA-1273-P301HOmRNA-1273-P301-US311-2076A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-24 B.. mRNA-1273-P301HOmRNA-1273-P301-US311-2077A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US311-2113AUSA-US062-2021-mRNA-1273-P301000014HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-25 2021-03-27 .BéBë mRNA-1273-P301HOmRNA-1273-P301-US311-2113A USA-US062-2021-mRNA-1273-P301000014HO-AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-23 2021-04-24 .C`Cp mRNA-1273-P301HOmRNA-1273-P301-US311-2113A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T09:522020-08-27T12:15.A0B mRNA-1273-P301HOmRNA-1273-P301-US311-2119AUSA-US062-2021-mRNA-1273-P301000015HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-01 2021-04-02 .BðBñ mRNA-1273-P301HOmRNA-1273-P301-US311-2128AUSA-US062-2020-mRNA-1273-P301000011HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-22 2020-11-24 .BmBo mRNA-1273-P301HOmRNA-1273-P301-US311-2128A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T18:412020-08-12T18:41.ApAp mRNA-1273-P301HOmRNA-1273-P301-US311-2145AUSA-US062-2021-mRNA-1273-P301000011HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-03 2021-02-05 .BµB· mRNA-1273-P301HOmRNA-1273-P301-US311-2145A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T19:052020-08-18T21:13.A€AÀ mRNA-1273-P301HOmRNA-1273-P301-US311-2149A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B™.. mRNA-1273-P301HOmRNA-1273-P301-US311-2153A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T22:392020-09-14T22:39.B'B' mRNA-1273-P301HOmRNA-1273-P301-US311-2164AUSA-US062-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-18 2020-09-24 .B(B. mRNA-1273-P301HOmRNA-1273-P301-US311-2164A USA-US062-2020-mRNA-1273-P301000002HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-02 2020-10-04 .B6B8 mRNA-1273-P301HOmRNA-1273-P301-US311-2170A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T12:142020-08-15T12:14.A`A` mRNA-1273-P301HOmRNA-1273-P301-US311-2173AUSA-US062-2021-mRNA-1273-P301000017HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-19 2021-04-20 .BýBþ mRNA-1273-P301HOmRNA-1273-P301-US311-2173A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T18:282020-08-25T17:05.AðB mRNA-1273-P301HOmRNA-1273-P301-US311-2173A0 HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T03:312020-10-07T13:44.B(B; mRNA-1273-P301HOmRNA-1273-P301-US311-2190A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T22:312020-08-14T22:31.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US311-2192AUSA-US062-2020-mRNA-1273-P301000006HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-17 2020-10-20 .BDBG mRNA-1273-P301HOmRNA-1273-P301-US311-2192A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T01:012020-09-29T23:15.B(B2 mRNA-1273-P301HOmRNA-1273-P301-US311-2211A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B‹.. mRNA-1273-P301HOmRNA-1273-P301-US311-2219A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 B.. mRNA-1273-P301HOmRNA-1273-P301-US311-2221A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T04:392020-09-15T04:39.B#B# mRNA-1273-P301HOmRNA-1273-P301-US311-2223AUSA-US062-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-02 2020-09-03 .BB mRNA-1273-P301HOmRNA-1273-P301-US311-2256A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T16:342020-09-15T16:34.B!B! mRNA-1273-P301HOmRNA-1273-P301-US311-2260A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T22:072020-09-12T22:07.BB mRNA-1273-P301HOmRNA-1273-P301-US311-2262AUSA-US062-2021-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-28 2021-03-31 .BãBæ mRNA-1273-P301HOmRNA-1273-P301-US311-2265A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T13:332020-09-23T13:33.B)B) mRNA-1273-P301HOmRNA-1273-P301-US311-2266A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-10 B.. mRNA-1273-P301HOmRNA-1273-P301-US311-2267A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T09:352020-08-18T09:35.APAP mRNA-1273-P301HOmRNA-1273-P301-US311-2267A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-10 B.. mRNA-1273-P301HOmRNA-1273-P301-US311-2281A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T21:122020-09-21T21:12.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US311-2296A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T20:002020-08-19T20:00.A A mRNA-1273-P301HOmRNA-1273-P301-US311-2297A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T22:552020-08-18T22:55.AA mRNA-1273-P301HOmRNA-1273-P301-US311-2297A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T23:052020-09-17T23:05.BB mRNA-1273-P301HOmRNA-1273-P301-US311-2313A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T12:052020-08-19T12:05.A A mRNA-1273-P301HOmRNA-1273-P301-US311-2313A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:412020-09-15T12:41.BB mRNA-1273-P301HOmRNA-1273-P301-US311-2314A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T12:562020-08-21T12:56.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US311-2324A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T14:312020-09-16T14:31.BB mRNA-1273-P301HOmRNA-1273-P301-US311-2324A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T18:452021-01-10T15:56.B%B‘ mRNA-1273-P301HOmRNA-1273-P301-US311-2329A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-17 Bñ.. mRNA-1273-P301HOmRNA-1273-P301-US311-2343A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T14:052020-08-22T14:05.A A mRNA-1273-P301HOmRNA-1273-P301-US311-2363A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T12:012020-08-31T12:01.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US311-2363A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T22:362020-09-24T22:36.B B mRNA-1273-P301HOmRNA-1273-P301-US311-2365AUSA-US062-2020-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-02 2020-11-06 .BGBK mRNA-1273-P301HOmRNA-1273-P301-US311-2366A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 B.. mRNA-1273-P301HOmRNA-1273-P301-US311-2367A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T23:362020-08-29T23:36.A`A` mRNA-1273-P301HOmRNA-1273-P301-US311-2401A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T12:002020-09-05T12:00.A A mRNA-1273-P301HOmRNA-1273-P301-US311-2413A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US311-2435A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T12:122020-10-02T12:12.B B mRNA-1273-P301HOmRNA-1273-P301-US311-2452A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:282020-09-10T12:28.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US311-2475A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 BW.. mRNA-1273-P301HOmRNA-1273-P301-US312-2021A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T14:222020-08-27T14:22.B B mRNA-1273-P301HOmRNA-1273-P301-US312-2023A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T18:252020-08-14T18:42.BB mRNA-1273-P301HOmRNA-1273-P301-US312-2026A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-31T21:082020-07-31T21:08.APAP mRNA-1273-P301HOmRNA-1273-P301-US312-2027A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T10:482020-08-27T10:48.B B mRNA-1273-P301HOmRNA-1273-P301-US312-2032A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US312-2034A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T07:062020-07-30T07:06.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US312-2034A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T06:232020-08-27T06:23.B B mRNA-1273-P301HOmRNA-1273-P301-US312-2054A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T12:052020-08-27T12:05.BB mRNA-1273-P301HOmRNA-1273-P301-US312-2055A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US312-2059A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-07 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US312-2060A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T12:022020-09-01T12:02.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US312-2065A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T12:082020-07-30T12:08.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US312-2084A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T23:592020-08-01T23:59.APAP mRNA-1273-P301HOmRNA-1273-P301-US312-2085AUSA-US063-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-08 2021-01-13 .B¥Bª mRNA-1273-P301HOmRNA-1273-P301-US312-2100A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T18:112020-08-05T18:11.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US312-2101A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-29T13:052020-07-29T13:05.AA mRNA-1273-P301HOmRNA-1273-P301-US312-2107A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T12:192020-08-13T12:19.BB mRNA-1273-P301HOmRNA-1273-P301-US312-2109A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T21:292020-08-06T21:29.AA mRNA-1273-P301HOmRNA-1273-P301-US312-2128A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T09:522020-08-29T09:52.B B mRNA-1273-P301HOmRNA-1273-P301-US313-2004AUSA-US058-2021-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-26 .C€. mRNA-1273-P301HOmRNA-1273-P301-US313-2012A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T20:062020-08-16T17:59.AAP mRNA-1273-P301HOmRNA-1273-P301-US313-2019AUSA-US058-2020-mRNA-1273-P301000003HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-23 2020-11-27 .BcBg mRNA-1273-P301HOmRNA-1273-P301-US313-2027A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 BV.. mRNA-1273-P301HOmRNA-1273-P301-US313-2037AUSA-US058-2021-mRNA-1273-P301000007HO-AE-020 ADMITTED TO ICU ICU ADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US313-2037A USA-US058-2020-mRNA-1273-P301000005HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-14 2020-11-24 .BJBT mRNA-1273-P301HOmRNA-1273-P301-US313-2037A0USA-US058-2021-mRNA-1273-P301000007HO-AE-020 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-24 2021-01-03 .BrB| mRNA-1273-P301HOmRNA-1273-P301-US313-2039A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 B\.. mRNA-1273-P301HOmRNA-1273-P301-US313-2042A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T12:242020-09-13T12:24.APAP mRNA-1273-P301HOmRNA-1273-P301-US313-2043A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US313-2046AUSA-US058-2021-mRNA-1273-P301000006HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-20 2021-01-21 .BB‚ mRNA-1273-P301HOmRNA-1273-P301-US313-2065A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T06:002020-09-22T06:12.A@A` mRNA-1273-P301HOmRNA-1273-P301-US313-2078A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 BW.. mRNA-1273-P301HOmRNA-1273-P301-US313-2084A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 Br.. mRNA-1273-P301HOmRNA-1273-P301-US313-2100A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T08:402020-10-03T08:40.A A mRNA-1273-P301HOmRNA-1273-P301-US313-2101A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T14:362020-10-08T14:36.ApAp mRNA-1273-P301HOmRNA-1273-P301-US313-2110A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 BY.. mRNA-1273-P301HOmRNA-1273-P301-US313-2111AUSA-US058-2021-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-14 2021-03-19 .BB¢ mRNA-1273-P301HOmRNA-1273-P301-US313-2114A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-08T19:432020-11-08T19:43.BB mRNA-1273-P301HOmRNA-1273-P301-US313-2116A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T23:122020-10-14T23:12.A`A` mRNA-1273-P301HOmRNA-1273-P301-US313-2124A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T15:122020-10-16T15:12.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US313-2132A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T03:432020-10-19T03:43.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US313-2138AUSA-US058-2021-mRNA-1273-P301000008HO-AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US313-2138A USA-US058-2021-mRNA-1273-P301000008HO-AE-002/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-26 2021-03-07 .BƒBŒ mRNA-1273-P301HOmRNA-1273-P301-US313-2138A0USA-US058-2021-mRNA-1273-P301000008HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-15 2021-03-19 .B”B˜ mRNA-1273-P301HOmRNA-1273-P301-US313-2144A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T12:152020-10-26T12:15.ApAp mRNA-1273-P301HOmRNA-1273-P301-US313-2149AUSA-US058-2021-mRNA-1273-P301000004HO-AE-001/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-27 2021-01-15 .BDBW mRNA-1273-P301HOmRNA-1273-P301-US313-2149A USA-US058-2021-mRNA-1273-P301000011HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-09 2021-04-13 .B«B¯ mRNA-1273-P301HOmRNA-1273-P301-US314-2013A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-30 B].. mRNA-1273-P301HOmRNA-1273-P301-US314-2034A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US314-2043A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 B|.. mRNA-1273-P301HOmRNA-1273-P301-US314-2047A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T18:462020-08-31T18:46.BB mRNA-1273-P301HOmRNA-1273-P301-US314-2051A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T17:032020-09-01T17:03.B B mRNA-1273-P301HOmRNA-1273-P301-US314-2056A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B.. mRNA-1273-P301HOmRNA-1273-P301-US314-2092A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T17:442020-09-03T17:44.BB mRNA-1273-P301HOmRNA-1273-P301-US314-2100A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-23 B3.. mRNA-1273-P301HOmRNA-1273-P301-US314-2107A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B¡.. mRNA-1273-P301HOmRNA-1273-P301-US314-2114A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T13:312020-08-05T13:31.AA mRNA-1273-P301HOmRNA-1273-P301-US314-2137AUSA-US064-2021-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-04 2021-03-07 .BÓBÖ mRNA-1273-P301HOmRNA-1273-P301-US314-2139AUSA-US064-2021-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-02 2021-04-04 .BðBò mRNA-1273-P301HOmRNA-1273-P301-US314-2141A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T17:582020-09-04T17:58.BB mRNA-1273-P301HOmRNA-1273-P301-US314-2149A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T07:122020-09-12T07:12.B%B% mRNA-1273-P301HOmRNA-1273-P301-US314-2161AUSA-US064-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-23 2020-11-24 .BlBm mRNA-1273-P301HOmRNA-1273-P301-US314-2185AUSA-US064-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-18 2020-09-26 .B'B/ mRNA-1273-P301HOmRNA-1273-P301-US314-2185A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T20:272020-09-18T20:27.B'B' mRNA-1273-P301HOmRNA-1273-P301-US314-2228A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US314-2232A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US314-2233A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T07:232020-08-21T07:23.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US314-2236AUSA-US064-2021-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-21 2021-01-21 .BœBœ mRNA-1273-P301HOmRNA-1273-P301-US314-2252A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 BO.. mRNA-1273-P301HOmRNA-1273-P301-US314-2254A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T18:282020-08-27T18:28.A A mRNA-1273-P301HOmRNA-1273-P301-US314-2255A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BS.. mRNA-1273-P301HOmRNA-1273-P301-US314-2264A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T15:592020-09-03T15:59.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US314-2264A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T17:192020-10-06T17:19.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US314-2268AUSA-US064-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-22 2020-10-23 .B1B2 mRNA-1273-P301HOmRNA-1273-P301-US315-2003A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T14:402020-07-30T14:40.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US315-2018A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T20:332020-08-05T20:33.AA mRNA-1273-P301HOmRNA-1273-P301-US315-2025A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-17 B.. mRNA-1273-P301HOmRNA-1273-P301-US315-2026A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:102020-09-15T12:10.B1B1 mRNA-1273-P301HOmRNA-1273-P301-US315-2034A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US315-2036A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T17:372020-08-28T17:37.BB mRNA-1273-P301HOmRNA-1273-P301-US315-2037AUSA-US073-2021-mRNA-1273-P301000013HO-AE-003/AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US315-2037A USA-US073-2021-mRNA-1273-P301000013HO-AE-003/AE-005/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-14 2021-01-19 .BªB¯ mRNA-1273-P301HOmRNA-1273-P301-US315-2057A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T19:192020-08-05T19:19.A`A` mRNA-1273-P301HOmRNA-1273-P301-US315-2061A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 B`.. mRNA-1273-P301HOmRNA-1273-P301-US315-2064A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T19:212020-09-07T19:21.B'B' mRNA-1273-P301HOmRNA-1273-P301-US315-2071A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-27 B².. mRNA-1273-P301HOmRNA-1273-P301-US315-2072A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T23:312020-09-06T08:50.BB# mRNA-1273-P301HOmRNA-1273-P301-US315-2076A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T13:072020-09-09T13:07.B"B" mRNA-1273-P301HOmRNA-1273-P301-US315-2079A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T19:312020-08-08T19:31.APAP mRNA-1273-P301HOmRNA-1273-P301-US315-2088A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US315-2105A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B¦.. mRNA-1273-P301HOmRNA-1273-P301-US315-2113A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-25 BË.. mRNA-1273-P301HOmRNA-1273-P301-US315-2117A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US315-2118AUSA-US073-2021-mRNA-1273-P301000014HO-AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-23 2021-03-26 .BåBè mRNA-1273-P301HOmRNA-1273-P301-US315-2118A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T17:282020-09-16T12:30.B#B) mRNA-1273-P301HOmRNA-1273-P301-US315-2130A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-05 BÐ.. mRNA-1273-P301HOmRNA-1273-P301-US315-2136AUSA-US073-2021-mRNA-1273-P301000006HO-AE-002/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-03 2020-11-05 .BUBW mRNA-1273-P301HOmRNA-1273-P301-US315-2137A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T15:162020-09-17T15:16.B&B& mRNA-1273-P301HOmRNA-1273-P301-US315-2150A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T23:582020-09-15T23:58.B#B# mRNA-1273-P301HOmRNA-1273-P301-US315-2162AUSA-US073-2021-mRNA-1273-P301000011HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US315-2162A USA-US073-2021-mRNA-1273-P301000011HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-01 2021-04-03 .BèBê mRNA-1273-P301HOmRNA-1273-P301-US315-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T16:272020-09-28T21:13.B&B/ mRNA-1273-P301HOmRNA-1273-P301-US315-2169A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US315-2175AUSA-US073-2021-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-03 2021-03-04 .BËBÌ mRNA-1273-P301HOmRNA-1273-P301-US315-2189A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US315-2190A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T09:452020-08-20T21:53.ApAp mRNA-1273-P301HOmRNA-1273-P301-US315-2195A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T13:192020-08-18T13:19.APAP mRNA-1273-P301HOmRNA-1273-P301-US315-2202A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T14:032020-09-15T14:03.B!B! mRNA-1273-P301HOmRNA-1273-P301-US315-2207A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-02 B.. mRNA-1273-P301HOmRNA-1273-P301-US315-2210A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T18:522020-08-31T18:52.BB mRNA-1273-P301HOmRNA-1273-P301-US315-2211A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 B_.. mRNA-1273-P301HOmRNA-1273-P301-US315-2231A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T12:082020-10-02T12:08.BB mRNA-1273-P301HOmRNA-1273-P301-US315-2235A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T12:042020-09-16T12:04.B"B" mRNA-1273-P301HOmRNA-1273-P301-US315-2238A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T08:132020-09-23T08:13.B)B) mRNA-1273-P301HOmRNA-1273-P301-US315-2248A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T19:092020-08-22T19:09.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US315-2255A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T20:022020-09-15T20:02.B B mRNA-1273-P301HOmRNA-1273-P301-US315-2259A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-16 B?.. mRNA-1273-P301HOmRNA-1273-P301-US315-2274A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-08 BÎ.. mRNA-1273-P301HOmRNA-1273-P301-US315-2297A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B“.. mRNA-1273-P301HOmRNA-1273-P301-US315-2315A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:162020-09-23T12:16.B#B# mRNA-1273-P301HOmRNA-1273-P301-US315-2351A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T15:012020-08-25T15:01.APAP mRNA-1273-P301HOmRNA-1273-P301-US315-2357A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T18:292020-09-27T18:29.B&B& mRNA-1273-P301HOmRNA-1273-P301-US315-2371A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T10:192020-09-26T10:19.B%B% mRNA-1273-P301HOmRNA-1273-P301-US315-2373A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T07:242020-08-27T07:24.ApAp mRNA-1273-P301HOmRNA-1273-P301-US315-2374A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T23:002020-08-27T23:00.ApAp mRNA-1273-P301HOmRNA-1273-P301-US315-2377A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T12:562020-08-28T12:56.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US315-2377A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T00:012020-09-25T00:00.B#B$ mRNA-1273-P301HOmRNA-1273-P301-US315-2380A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T19:482020-08-24T19:48.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US315-2386A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T00:002020-09-30T00:00.B%B% mRNA-1273-P301HOmRNA-1273-P301-US315-2391A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T13:002020-10-01T13:00.B#B# mRNA-1273-P301HOmRNA-1273-P301-US315-2396A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T22:372020-10-07T22:37.B#B# mRNA-1273-P301HOmRNA-1273-P301-US315-2397A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T23:232020-10-06T23:23.B!B! mRNA-1273-P301HOmRNA-1273-P301-US315-2402A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T16:512020-10-09T17:16.BB mRNA-1273-P301HOmRNA-1273-P301-US315-2403A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T21:232020-09-16T21:23.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US315-2410A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T22:312020-10-03T22:31.A`A` mRNA-1273-P301HOmRNA-1273-P301-US315-2413AUSA-US073-2021-mRNA-1273-P301000012HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-08 .BÀ. mRNA-1273-P301HOmRNA-1273-P301-US315-2421A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T21:222020-10-02T21:22.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US315-2421A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-02T20:122020-11-02T20:12.B"B" mRNA-1273-P301HOmRNA-1273-P301-US315-2430A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T13:032020-10-13T12:02.AAÀ mRNA-1273-P301HOmRNA-1273-P301-US315-2439A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-10T21:422020-11-10T21:42.B%B% mRNA-1273-P301HOmRNA-1273-P301-US315-2455A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 BS.. mRNA-1273-P301HOmRNA-1273-P301-US315-2456A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T21:432020-10-13T21:43.A`A` mRNA-1273-P301HOmRNA-1273-P301-US315-2459A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-09T17:202020-11-11T19:57.B!B# mRNA-1273-P301HOmRNA-1273-P301-US315-2465A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T12:202020-11-17T12:20.B%B% mRNA-1273-P301HOmRNA-1273-P301-US315-2486A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BL.. mRNA-1273-P301HOmRNA-1273-P301-US315-2487A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T01:072020-10-23T01:07.A A mRNA-1273-P301HOmRNA-1273-P301-US315-2499A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 B%.. mRNA-1273-P301HOmRNA-1273-P301-US315-2517A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T00:042020-10-24T00:04.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US315-2522A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 BU.. mRNA-1273-P301HOmRNA-1273-P301-US315-2523A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 BL.. mRNA-1273-P301HOmRNA-1273-P301-US316-2003AUSA-US074-2020-mRNA-1273-P301000004HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US316-2003A USA-US074-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-08 2020-09-10 .B,B. mRNA-1273-P301HOmRNA-1273-P301-US316-2003A0 HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T16:172020-08-28T16:17.B!B! mRNA-1273-P301HOmRNA-1273-P301-US316-2006AUSA-US074-2020-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-11 2020-11-12 .BlBm mRNA-1273-P301HOmRNA-1273-P301-US316-2006A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US316-2007AUSA-US074-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-07-30 2020-07-31 .A@AP mRNA-1273-P301HOmRNA-1273-P301-US316-2011A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T11:052020-08-26T11:05.BB mRNA-1273-P301HOmRNA-1273-P301-US316-2028A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-26 B–.. mRNA-1273-P301HOmRNA-1273-P301-US316-2031A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-06 BE.. mRNA-1273-P301HOmRNA-1273-P301-US316-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T16:412020-08-09T20:50.AA° mRNA-1273-P301HOmRNA-1273-P301-US316-2034A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T15:592020-09-02T15:59.B"B" mRNA-1273-P301HOmRNA-1273-P301-US316-2034A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-25 B”.. mRNA-1273-P301HOmRNA-1273-P301-US316-2034A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-09 BÞ.. mRNA-1273-P301HOmRNA-1273-P301-US316-2036A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T14:532020-08-07T14:53.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US316-2036A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T22:452020-09-02T22:45.B"B" mRNA-1273-P301HOmRNA-1273-P301-US316-2037AUSA-US074-2021-mRNA-1273-P301000012HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-08 2021-02-09 .BÁBÂ mRNA-1273-P301HOmRNA-1273-P301-US316-2040A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-27 B–.. mRNA-1273-P301HOmRNA-1273-P301-US316-2044A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US316-2047A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B.. mRNA-1273-P301HOmRNA-1273-P301-US316-2048A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-03T17:122020-08-03T17:12.AA mRNA-1273-P301HOmRNA-1273-P301-US316-2048A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-10 BÀ.. mRNA-1273-P301HOmRNA-1273-P301-US316-2050A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-26 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US316-2051A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 B†.. mRNA-1273-P301HOmRNA-1273-P301-US316-2057A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-23 BË.. mRNA-1273-P301HOmRNA-1273-P301-US316-2058A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-31 Bï.. mRNA-1273-P301HOmRNA-1273-P301-US316-2063A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 B}.. mRNA-1273-P301HOmRNA-1273-P301-US316-2066A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T20:482020-09-09T20:48.B#B# mRNA-1273-P301HOmRNA-1273-P301-US316-2068AUSA-US074-2021-mRNA-1273-P301000021HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-07 2021-04-10 .BõBø mRNA-1273-P301HOmRNA-1273-P301-US316-2071A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T16:202020-08-07T16:20.A A mRNA-1273-P301HOmRNA-1273-P301-US316-2072AUSA-US074-2021-mRNA-1273-P301000020HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US316-2072A USA-US074-2021-mRNA-1273-P301000020HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-11 2021-03-23 .BÚBæ mRNA-1273-P301HOmRNA-1273-P301-US316-2078A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-18 AÀ.. mRNA-1273-P301HOmRNA-1273-P301-US316-2081A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T14:142020-08-07T14:14.AA mRNA-1273-P301HOmRNA-1273-P301-US316-2090AUSA-US074-2021-mRNA-1273-P301000022HO-AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US316-2090A USA-US074-2021-mRNA-1273-P301000022HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-27 2021-04-29 .CPCp mRNA-1273-P301HOmRNA-1273-P301-US316-2091A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T04:582020-08-14T04:58.APAP mRNA-1273-P301HOmRNA-1273-P301-US316-2105A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T17:272020-08-12T17:27.AA mRNA-1273-P301HOmRNA-1273-P301-US316-2105A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T12:482020-09-14T12:48.B"B" mRNA-1273-P301HOmRNA-1273-P301-US316-2116A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T12:122020-08-18T12:12.A`A` mRNA-1273-P301HOmRNA-1273-P301-US316-2116A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B“.. mRNA-1273-P301HOmRNA-1273-P301-US316-2123A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-17 B.. mRNA-1273-P301HOmRNA-1273-P301-US316-2125A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T12:232020-08-19T12:23.A`A` mRNA-1273-P301HOmRNA-1273-P301-US316-2130A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T19:012020-09-21T19:01.B'B' mRNA-1273-P301HOmRNA-1273-P301-US316-2139AUSA-US074-2021-mRNA-1273-P301000013HO-AE-006/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-16 2021-02-17 .B·B¸ mRNA-1273-P301HOmRNA-1273-P301-US316-2148A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T16:532020-08-22T18:32.A A@ mRNA-1273-P301HOmRNA-1273-P301-US316-2149A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US316-2159A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T13:502020-08-27T13:50.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US316-2159A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-26 Ap.. mRNA-1273-P301HOmRNA-1273-P301-US316-2173A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T12:022020-08-23T12:02.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US316-2181A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T16:432020-08-27T16:43.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US316-2181A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T16:182020-09-24T16:18.BB mRNA-1273-P301HOmRNA-1273-P301-US316-2182A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T19:382020-09-29T19:38.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US316-2182A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-23 B.. mRNA-1273-P301HOmRNA-1273-P301-US316-2184A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T20:272020-09-22T20:27.BB mRNA-1273-P301HOmRNA-1273-P301-US316-2188A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US316-2201A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T17:052020-09-03T17:05.ApAp mRNA-1273-P301HOmRNA-1273-P301-US316-2203A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B|.. mRNA-1273-P301HOmRNA-1273-P301-US316-2215A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-06 B`.. mRNA-1273-P301HOmRNA-1273-P301-US316-2219A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-24 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US316-2226A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T21:352020-10-10T21:35.B!B! mRNA-1273-P301HOmRNA-1273-P301-US316-2231A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T22:242020-09-14T22:24.A`A` mRNA-1273-P301HOmRNA-1273-P301-US316-2238AUSA-US074-2021-mRNA-1273-P301000019HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-25 2021-02-26 .B¤B¥ mRNA-1273-P301HOmRNA-1273-P301-US316-2238A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T12:292020-10-16T12:29.B B mRNA-1273-P301HOmRNA-1273-P301-US316-2261A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 BO.. mRNA-1273-P301HOmRNA-1273-P301-US316-2271A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 B5.. mRNA-1273-P301HOmRNA-1273-P301-US316-2279A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T17:042020-11-18T17:04.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US316-2283A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 B2.. mRNA-1273-P301HOmRNA-1273-P301-US316-2290AUSA-US074-2021-mRNA-1273-P301000018HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-10 2021-03-11 .BB mRNA-1273-P301HOmRNA-1273-P301-US316-2297A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-23T03:522020-11-23T03:52.B"B" mRNA-1273-P301HOmRNA-1273-P301-US316-2299A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 BS.. mRNA-1273-P301HOmRNA-1273-P301-US316-2300A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-22T15:032020-11-22T15:03.BB mRNA-1273-P301HOmRNA-1273-P301-US316-2301A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BD.. mRNA-1273-P301HOmRNA-1273-P301-US316-2302A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 B(.. mRNA-1273-P301HOmRNA-1273-P301-US317-2002A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T16:472020-08-07T16:47.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2003A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T14:272020-08-08T14:27.A A mRNA-1273-P301HOmRNA-1273-P301-US317-2015A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T18:062020-08-14T18:06.APAP mRNA-1273-P301HOmRNA-1273-P301-US317-2017A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T18:112020-09-16T00:01.B B& mRNA-1273-P301HOmRNA-1273-P301-US317-2028AUSA-US118-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-08 2020-12-12 .BxB| mRNA-1273-P301HOmRNA-1273-P301-US317-2028A USA-US118-2021-mRNA-1273-P301000014HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-04-05 2021-04-06 .BîBï mRNA-1273-P301HOmRNA-1273-P301-US317-2038AUSA-US118-2020-mRNA-1273-P301000001HO-AE-002/AE-003/AE-006/AE-007 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US317-2038A USA-US118-2020-mRNA-1273-P301000001HO-AE-002/AE-003/AE-006/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-01 2020-09-04 .BB mRNA-1273-P301HOmRNA-1273-P301-US317-2040AUSA-US118-2021-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-21 2021-02-22 .BÃBÄ mRNA-1273-P301HOmRNA-1273-P301-US317-2043A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B….. mRNA-1273-P301HOmRNA-1273-P301-US317-2075A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T23:002020-08-21T23:00.A A mRNA-1273-P301HOmRNA-1273-P301-US317-2077A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:142020-09-10T12:14.BB mRNA-1273-P301HOmRNA-1273-P301-US317-2078A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 B.. mRNA-1273-P301HOmRNA-1273-P301-US317-2093A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T22:082020-09-10T22:08.BB mRNA-1273-P301HOmRNA-1273-P301-US317-2102A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-22 BF.. mRNA-1273-P301HOmRNA-1273-P301-US317-2105A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-22 BF.. mRNA-1273-P301HOmRNA-1273-P301-US317-2108A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T13:232020-08-14T17:20.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2114AUSA-US118-2020-mRNA-1273-P301000013HO-AE-001/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-15 2020-11-17 .B^B` mRNA-1273-P301HOmRNA-1273-P301-US317-2114A USA-US118-2020-mRNA-1273-P301000014HO-AE-002/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-04 2020-12-11 .BqBx mRNA-1273-P301HOmRNA-1273-P301-US317-2119AUSA-US118-2021-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-09 2021-02-12 .B´B· mRNA-1273-P301HOmRNA-1273-P301-US317-2119A USA-US118-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-19 2021-02-21 .B¾BÀ mRNA-1273-P301HOmRNA-1273-P301-US317-2124A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T22:492020-09-17T22:49.B#B# mRNA-1273-P301HOmRNA-1273-P301-US317-2183A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T13:032020-09-15T13:03.BB mRNA-1273-P301HOmRNA-1273-P301-US317-2185AUSA-US118-2020-mRNA-1273-P301000003HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-07 2020-09-15 .BB mRNA-1273-P301HOmRNA-1273-P301-US317-2188A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T17:582020-08-24T17:58.ApAp mRNA-1273-P301HOmRNA-1273-P301-US317-2188A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T12:022020-09-18T12:02.B B mRNA-1273-P301HOmRNA-1273-P301-US317-2198A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T19:492020-09-17T19:49.BB mRNA-1273-P301HOmRNA-1273-P301-US317-2202A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T11:452020-08-19T11:45.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2211AUSA-US118-2021-mRNA-1273-P301000015HO-AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-04-10 2021-04-11 .BëBì mRNA-1273-P301HOmRNA-1273-P301-US317-2224AUSA-US118-2021-mRNA-1273-P301000004HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-23 2021-01-27 .BžB¢ mRNA-1273-P301HOmRNA-1273-P301-US317-2234A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 B•.. mRNA-1273-P301HOmRNA-1273-P301-US317-2250AUSA-US118-2021-mRNA-1273-P301000008HO-AE-014 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US317-2250A USA-US118-2020-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-12 2020-09-16 .BB mRNA-1273-P301HOmRNA-1273-P301-US317-2250A0USA-US118-2021-mRNA-1273-P301000008HO-AE-014 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-08 2021-02-16 .BBµ mRNA-1273-P301HOmRNA-1273-P301-US317-2250A@USA-US118-2021-mRNA-1273-P301000013HO-AE-004/AE-005/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-26 2021-03-03 .B¿BÄ mRNA-1273-P301HOmRNA-1273-P301-US317-2252A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T19:502020-08-20T19:50.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2265A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T12:372020-08-21T12:37.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2274A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T21:502020-08-25T21:50.APAP mRNA-1273-P301HOmRNA-1273-P301-US317-2278A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T17:212020-08-21T17:21.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2311A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T12:182020-10-09T16:41.B-B. mRNA-1273-P301HOmRNA-1273-P301-US317-2315A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T14:052020-08-25T14:05.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2318A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T15:312020-08-25T15:31.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2320A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T11:372020-09-01T11:37.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US317-2322AUSA-US118-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-10 .B/. mRNA-1273-P301HOmRNA-1273-P301-US317-2333AUSA-US118-2020-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-09 2020-11-12 .BMBP mRNA-1273-P301HOmRNA-1273-P301-US317-2333A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T17:402020-08-26T12:37.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2352A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T05:332020-08-29T05:33.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US317-2352A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T11:292020-09-25T11:29.BB mRNA-1273-P301HOmRNA-1273-P301-US317-2353A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T19:542020-09-27T21:59.BB! mRNA-1273-P301HOmRNA-1273-P301-US317-2354A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T17:502020-09-24T17:50.BB mRNA-1273-P301HOmRNA-1273-P301-US317-2374AUSA-US118-2021-mRNA-1273-P301000018HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-19 2021-04-22 .BºB½ mRNA-1273-P301HOmRNA-1273-P301-US317-2376A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T20:222020-10-20T20:12.A@AP mRNA-1273-P301HOmRNA-1273-P301-US317-2380A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T17:532020-10-22T17:53.ApAp mRNA-1273-P301HOmRNA-1273-P301-US317-2390A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T20:472020-10-21T19:36.AA` mRNA-1273-P301HOmRNA-1273-P301-US317-2395A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T19:262020-11-18T19:26.BB mRNA-1273-P301HOmRNA-1273-P301-US317-2406AUSA-US118-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-09 2021-02-12 .BrBu mRNA-1273-P301HOmRNA-1273-P301-US317-2430A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T15:192020-10-20T15:19.AA mRNA-1273-P301HOmRNA-1273-P301-US317-2431A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T12:042020-10-23T12:04.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US317-2431A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-20T12:442020-11-20T12:44.B B mRNA-1273-P301HOmRNA-1273-P301-US317-2432A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T15:302020-11-23T14:55.BB# mRNA-1273-P301HOmRNA-1273-P301-US317-2435A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-18 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US317-2443A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 A€.. mRNA-1273-P301HOmRNA-1273-P301-US317-2462A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B\.. mRNA-1273-P301HOmRNA-1273-P301-US317-2469AUSA-US118-2021-mRNA-1273-P301000006HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-14 2021-01-15 .BBW mRNA-1273-P301HOmRNA-1273-P301-US317-2469A USA-US118-2021-mRNA-1273-P301000016HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-22 2021-04-12 .B™B® mRNA-1273-P301HOmRNA-1273-P301-US317-2470A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T12:202020-10-25T12:20.APAP mRNA-1273-P301HOmRNA-1273-P301-US317-2474A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T14:472020-10-24T14:47.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US317-2474A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-19T11:152020-11-20T12:38.BB mRNA-1273-P301HOmRNA-1273-P301-US318-2006A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T14:262020-07-31T14:18.A@AP mRNA-1273-P301HOmRNA-1273-P301-US318-2006A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 Bœ.. mRNA-1273-P301HOmRNA-1273-P301-US318-2012A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US318-2014A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T12:052020-08-22T12:05.BB mRNA-1273-P301HOmRNA-1273-P301-US318-2021A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-13 BN.. mRNA-1273-P301HOmRNA-1273-P301-US318-2025AUSA-US075-2021-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-07 2021-01-08 .B¤B¥ mRNA-1273-P301HOmRNA-1273-P301-US318-2025A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T12:012020-08-25T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US318-2035A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-28T18:512020-07-28T18:51.AA mRNA-1273-P301HOmRNA-1273-P301-US318-2050A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B™.. mRNA-1273-P301HOmRNA-1273-P301-US318-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-02T12:492020-08-02T12:49.APAP mRNA-1273-P301HOmRNA-1273-P301-US318-2099A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T10:082020-08-29T10:08.BB mRNA-1273-P301HOmRNA-1273-P301-US318-2103A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US318-2114AUSA-US075-2021-mRNA-1273-P301000013HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-06 .Bú. mRNA-1273-P301HOmRNA-1273-P301-US318-2127A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T05:592020-08-09T05:59.ApAp mRNA-1273-P301HOmRNA-1273-P301-US318-2145A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bš.. mRNA-1273-P301HOmRNA-1273-P301-US318-2149A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T14:502020-09-06T15:21.BB" mRNA-1273-P301HOmRNA-1273-P301-US318-2154A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T21:022020-08-09T21:02.A`A` mRNA-1273-P301HOmRNA-1273-P301-US318-2158AUSA-US075-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-12 2021-01-13 .B¢B£ mRNA-1273-P301HOmRNA-1273-P301-US318-2158A USA-US075-2021-mRNA-1273-P301000011HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-16 2021-01-18 .B¦B¨ mRNA-1273-P301HOmRNA-1273-P301-US318-2166AUSA-US075-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-21 .Bm. mRNA-1273-P301HOmRNA-1273-P301-US318-2178A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T12:442020-08-06T12:44.A A mRNA-1273-P301HOmRNA-1273-P301-US318-2192AUSA-US075-2020-mRNA-1273-P301000005HO-AE-001/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-23 2020-11-26 .BnBq mRNA-1273-P301HOmRNA-1273-P301-US318-2194A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T11:002020-09-25T11:00.B3B3 mRNA-1273-P301HOmRNA-1273-P301-US318-2204A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T15:072020-08-10T15:07.APAP mRNA-1273-P301HOmRNA-1273-P301-US318-2211A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-01 BÐ.. mRNA-1273-P301HOmRNA-1273-P301-US318-2218A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T12:132020-08-15T20:55.A€A mRNA-1273-P301HOmRNA-1273-P301-US318-2218A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T14:592020-09-15T12:32.B'B( mRNA-1273-P301HOmRNA-1273-P301-US318-2227AUSA-US075-2020-mRNA-1273-P301000004HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-06 2020-10-09 .B=B@ mRNA-1273-P301HOmRNA-1273-P301-US318-2227A USA-US075-2020-mRNA-1273-P301000004HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-24 2020-10-26 .BOBQ mRNA-1273-P301HOmRNA-1273-P301-US318-2236AUSA-US075-2021-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-18 2021-01-19 .B¥B¦ mRNA-1273-P301HOmRNA-1273-P301-US318-2238A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US318-2242A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T09:132020-08-24T09:13.A°A° mRNA-1273-P301HOmRNA-1273-P301-US318-2242A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US318-2265A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 By.. mRNA-1273-P301HOmRNA-1273-P301-US318-2274A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T09:372020-08-13T09:37.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US318-2276A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US318-2280A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T21:332020-08-11T21:33.AA mRNA-1273-P301HOmRNA-1273-P301-US318-2281A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T12:032020-09-03T22:35.A B mRNA-1273-P301HOmRNA-1273-P301-US318-2283A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US318-2292A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-25 Að.. mRNA-1273-P301HOmRNA-1273-P301-US318-2307A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T02:422020-09-20T02:42.B(B( mRNA-1273-P301HOmRNA-1273-P301-US318-2314A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T18:022020-09-10T18:02.BB mRNA-1273-P301HOmRNA-1273-P301-US318-2341A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T12:012020-09-12T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US318-2362A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-05 B2.. mRNA-1273-P301HOmRNA-1273-P301-US319-2006AUSA-US097-2020-mRNA-1273-P301000001HO-AE-001/AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-16 2020-08-17 .BB mRNA-1273-P301HOmRNA-1273-P301-US319-2021A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T21:482020-08-04T21:48.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US319-2022A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T12:022020-09-03T12:02.B!B! mRNA-1273-P301HOmRNA-1273-P301-US319-2023A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T14:142020-09-01T14:14.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2024A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-02T20:072020-08-02T20:07.AA mRNA-1273-P301HOmRNA-1273-P301-US319-2026A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T09:442020-09-02T09:44.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2036A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-03T19:132020-08-03T19:13.AA mRNA-1273-P301HOmRNA-1273-P301-US319-2038A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T14:502020-09-16T10:54.B+B- mRNA-1273-P301HOmRNA-1273-P301-US319-2067A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T18:182020-08-12T22:37.A0A€ mRNA-1273-P301HOmRNA-1273-P301-US319-2081A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T17:292020-08-13T19:40.APA€ mRNA-1273-P301HOmRNA-1273-P301-US319-2111A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B~.. mRNA-1273-P301HOmRNA-1273-P301-US319-2128A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T06:062020-09-17T06:06.B)B) mRNA-1273-P301HOmRNA-1273-P301-US319-2155A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US319-2172A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T16:192020-09-22T16:19.B,B, mRNA-1273-P301HOmRNA-1273-P301-US319-2178A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T18:052020-08-20T18:05.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US319-2195A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:012020-09-23T12:01.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US319-2201A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US319-2203A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 B.. mRNA-1273-P301HOmRNA-1273-P301-US319-2244A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T20:092020-08-20T20:09.ApAp mRNA-1273-P301HOmRNA-1273-P301-US319-2244A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T19:032020-10-08T18:26.B$B8 mRNA-1273-P301HOmRNA-1273-P301-US319-2269A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T12:112020-09-18T12:11.B#B# mRNA-1273-P301HOmRNA-1273-P301-US319-2280A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T15:172020-09-18T15:17.B#B# mRNA-1273-P301HOmRNA-1273-P301-US319-2291AUSA-US097-2020-mRNA-1273-P301000004HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US319-2291A USA-US097-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-02 2020-11-10 .BOBW mRNA-1273-P301HOmRNA-1273-P301-US319-2299A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T00:012020-09-18T00:01.B"B" mRNA-1273-P301HOmRNA-1273-P301-US319-2322A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T20:102020-09-18T00:37.AðB mRNA-1273-P301HOmRNA-1273-P301-US319-2322A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T10:412020-09-26T10:41.B!B! mRNA-1273-P301HOmRNA-1273-P301-US319-2335A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US319-2336A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T18:392020-09-02T18:39.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US319-2345AUSA-US097-2020-mRNA-1273-P301000003HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-28 2020-09-04 .A`AÐ mRNA-1273-P301HOmRNA-1273-P301-US319-2345A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T20:242020-09-02T04:41.A`A° mRNA-1273-P301HOmRNA-1273-P301-US319-2355A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T00:022020-09-27T00:02.B#B# mRNA-1273-P301HOmRNA-1273-P301-US319-2357A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-09 B§.. mRNA-1273-P301HOmRNA-1273-P301-US319-2363A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T17:422020-08-27T17:42.A A mRNA-1273-P301HOmRNA-1273-P301-US319-2367A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T17:402020-08-29T17:40.A A mRNA-1273-P301HOmRNA-1273-P301-US319-2388A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T19:112020-09-21T19:11.B B mRNA-1273-P301HOmRNA-1273-P301-US319-2393A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T17:402020-08-22T17:40.A A mRNA-1273-P301HOmRNA-1273-P301-US319-2400A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 B”.. mRNA-1273-P301HOmRNA-1273-P301-US319-2405A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T23:172020-09-19T23:17.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2408A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T18:292020-09-25T18:29.B#B# mRNA-1273-P301HOmRNA-1273-P301-US319-2417A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US319-2423A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T13:332020-09-21T13:33.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2441A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US319-2452A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T19:222020-09-23T19:22.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2458A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 Bl.. mRNA-1273-P301HOmRNA-1273-P301-US319-2459A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T20:132020-08-30T20:13.ApAp mRNA-1273-P301HOmRNA-1273-P301-US319-2466A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US319-2484A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T19:402020-08-27T19:40.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US319-2486AUSA-US097-2020-mRNA-1273-P301000006HO-AE-002/AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P7D mRNA-1273-P301HOmRNA-1273-P301-US319-2486A USA-US097-2020-mRNA-1273-P301000006HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-02 2020-11-08 .BEBK mRNA-1273-P301HOmRNA-1273-P301-US319-2487A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-20 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US319-2501A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US319-2506A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T13:262020-09-29T13:26.B#B# mRNA-1273-P301HOmRNA-1273-P301-US319-2514A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T16:372020-09-28T12:36.BB! mRNA-1273-P301HOmRNA-1273-P301-US319-2515A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T23:592020-09-23T23:59.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2531A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BR.. mRNA-1273-P301HOmRNA-1273-P301-US319-2536A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T13:272020-08-29T13:27.A A mRNA-1273-P301HOmRNA-1273-P301-US319-2551A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T20:522020-09-04T16:58.A`A€ mRNA-1273-P301HOmRNA-1273-P301-US319-2561A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T23:482020-09-23T23:48.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2563A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US319-2564A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US319-2569AUSA-US097-2021-mRNA-1273-P301000020HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US319-2569A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B.. mRNA-1273-P301HOmRNA-1273-P301-US319-2595A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-02 BØ.. mRNA-1273-P301HOmRNA-1273-P301-US319-2597A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T17:112020-10-15T18:20.BB/ mRNA-1273-P301HOmRNA-1273-P301-US319-2600A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T21:442020-10-02T21:44.B!B! mRNA-1273-P301HOmRNA-1273-P301-US319-2601A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T20:032020-09-29T20:03.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2608A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T23:072020-09-03T18:52.A A@ mRNA-1273-P301HOmRNA-1273-P301-US319-2614AUSA-US097-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-14 2020-09-15 .AðB mRNA-1273-P301HOmRNA-1273-P301-US319-2617A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T18:242020-09-04T18:24.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US319-2618A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T06:042020-10-06T06:04.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US319-2619A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T13:472020-09-02T13:47.A A mRNA-1273-P301HOmRNA-1273-P301-US319-2622A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B~.. mRNA-1273-P301HOmRNA-1273-P301-US319-2626A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B“.. mRNA-1273-P301HOmRNA-1273-P301-US319-2638A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-13 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US319-2642A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T18:422020-09-05T18:54.A A@ mRNA-1273-P301HOmRNA-1273-P301-US319-2647A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T17:222020-09-02T17:22.AA mRNA-1273-P301HOmRNA-1273-P301-US319-2655A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T14:062020-10-08T14:06.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US319-2704A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 BC.. mRNA-1273-P301HOmRNA-1273-P301-US319-2716A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T15:272020-10-01T15:27.AA mRNA-1273-P301HOmRNA-1273-P301-US319-2732A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 BE.. mRNA-1273-P301HOmRNA-1273-P301-US319-2734AUSA-US097-2021-mRNA-1273-P301000006HO-AE-001/AE-002/AE-003/AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-18 2020-11-25 .B.B5 mRNA-1273-P301HOmRNA-1273-P301-US319-2734A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-11T08:432020-11-16T12:09.B'B, mRNA-1273-P301HOmRNA-1273-P301-US319-2798A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T12:002020-11-06T12:00.BB mRNA-1273-P301HOmRNA-1273-P301-US319-2798A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T19:552020-11-17T19:55.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US319-2819A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-16T17:222020-11-16T17:22.B"B" mRNA-1273-P301HOmRNA-1273-P301-US319-2821A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US319-2824A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B9.. mRNA-1273-P301HOmRNA-1273-P301-US319-2835A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T17:162020-10-18T17:16.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US319-2849A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T12:062020-10-19T12:06.A A mRNA-1273-P301HOmRNA-1273-P301-US319-2856A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 BQ.. mRNA-1273-P301HOmRNA-1273-P301-US319-2860A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T12:482020-10-20T12:48.A A mRNA-1273-P301HOmRNA-1273-P301-US319-2906A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 B+.. mRNA-1273-P301HOmRNA-1273-P301-US319-2907A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T16:572020-10-27T16:57.A`A` mRNA-1273-P301HOmRNA-1273-P301-US319-2909A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-19T10:542020-11-19T10:54.BB mRNA-1273-P301HOmRNA-1273-P301-US320-2017A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B.. mRNA-1273-P301HOmRNA-1273-P301-US320-2019A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T17:522020-08-05T17:52.AA mRNA-1273-P301HOmRNA-1273-P301-US320-2023A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T17:042020-09-10T17:04.B%B% mRNA-1273-P301HOmRNA-1273-P301-US320-2025AUSA-US128-2021-mRNA-1273-P301000021HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-28 .C . mRNA-1273-P301HOmRNA-1273-P301-US320-2030A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T16:052020-08-12T16:05.ApAp mRNA-1273-P301HOmRNA-1273-P301-US320-2036AUSA-US128-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-10 2021-01-15 .BžB£ mRNA-1273-P301HOmRNA-1273-P301-US320-2037A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T13:302020-08-11T13:30.A`A` mRNA-1273-P301HOmRNA-1273-P301-US320-2042AUSA-US128-2021-mRNA-1273-P301000005HO-AE-001/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-07 2021-01-11 .B›BŸ mRNA-1273-P301HOmRNA-1273-P301-US320-2043A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B¦.. mRNA-1273-P301HOmRNA-1273-P301-US320-2047A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 B[.. mRNA-1273-P301HOmRNA-1273-P301-US320-2049AUSA-US128-2020-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-03 2020-12-07 .BwB{ mRNA-1273-P301HOmRNA-1273-P301-US320-2049A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US320-2057A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T21:412020-09-10T21:41.B#B# mRNA-1273-P301HOmRNA-1273-P301-US320-2070AUSA-US128-2021-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-19 2021-02-20 .BÄBÅ mRNA-1273-P301HOmRNA-1273-P301-US320-2073A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T16:462020-08-11T16:46.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US320-2078A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T18:422020-09-12T18:42.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US320-2085AUSA-US128-2021-mRNA-1273-P301000010HO-AE-002/AE-003/AE-004/AE-005/AE-006/AE-014 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P13DmRNA-1273-P301HOmRNA-1273-P301-US320-2085A USA-US128-2021-mRNA-1273-P301000010HO-AE-002/AE-003/AE-004/AE-005/AE-006/AE-014 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-15 2021-02-09 .B B¹ mRNA-1273-P301HOmRNA-1273-P301-US320-2105A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T12:042020-08-18T12:04.AA mRNA-1273-P301HOmRNA-1273-P301-US320-2106A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T18:262020-08-14T18:26.APAP mRNA-1273-P301HOmRNA-1273-P301-US320-2125A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-31 B.. mRNA-1273-P301HOmRNA-1273-P301-US320-2152A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-21 B).. mRNA-1273-P301HOmRNA-1273-P301-US320-2154A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B„.. mRNA-1273-P301HOmRNA-1273-P301-US320-2167A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US320-2170A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T19:552020-09-16T19:55.B#B# mRNA-1273-P301HOmRNA-1273-P301-US320-2179AUSA-US128-2021-mRNA-1273-P301000013HO-AE-002/AE-004/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-19 2021-03-24 .BÚBß mRNA-1273-P301HOmRNA-1273-P301-US320-2182A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T09:532020-08-21T09:53.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US320-2183AUSA-US128-2021-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-01 2021-03-02 .BÈBÉ mRNA-1273-P301HOmRNA-1273-P301-US320-2185AUSA-US128-2021-mRNA-1273-P301000019HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-06 2021-04-13 .BìBó mRNA-1273-P301HOmRNA-1273-P301-US320-2187A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T10:452020-09-14T10:45.B B mRNA-1273-P301HOmRNA-1273-P301-US320-2191AUSA-US128-2020-mRNA-1273-P301000009HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-30 2020-11-03 .BNBR mRNA-1273-P301HOmRNA-1273-P301-US320-2197AUSA-US128-2021-mRNA-1273-P301000015HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-21 2020-10-22 .BDBE mRNA-1273-P301HOmRNA-1273-P301-US320-2197A USA-US128-2021-mRNA-1273-P301000017HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-19 2021-01-20 .BžBŸ mRNA-1273-P301HOmRNA-1273-P301-US320-2202A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T19:362020-09-15T19:36.B B mRNA-1273-P301HOmRNA-1273-P301-US320-2208A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T09:382020-09-13T09:38.BB mRNA-1273-P301HOmRNA-1273-P301-US320-2210A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 B^.. mRNA-1273-P301HOmRNA-1273-P301-US320-2217AUSA-US128-2021-mRNA-1273-P301000020HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-11 2021-02-12 .B³B´ mRNA-1273-P301HOmRNA-1273-P301-US320-2217A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T21:142020-08-18T21:14.A A mRNA-1273-P301HOmRNA-1273-P301-US320-2225A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T02:062020-09-01T02:06.BB mRNA-1273-P301HOmRNA-1273-P301-US320-2231AUSA-US128-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-31 2020-11-03 .BLBO mRNA-1273-P301HOmRNA-1273-P301-US320-2235A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T12:552020-09-12T00:15.A B mRNA-1273-P301HOmRNA-1273-P301-US320-2249A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T22:402020-09-18T22:40.B B mRNA-1273-P301HOmRNA-1273-P301-US320-2253A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US320-2264A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T20:292020-08-24T20:29.A`A` mRNA-1273-P301HOmRNA-1273-P301-US320-2268A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US320-2286A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T17:022020-08-25T17:02.APAP mRNA-1273-P301HOmRNA-1273-P301-US320-2296A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T17:322020-09-01T17:32.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US320-2304AUSA-US128-2020-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-17 2020-12-18 .BpBq mRNA-1273-P301HOmRNA-1273-P301-US320-2310AUSA-US128-2020-mRNA-1273-P301000005HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-23 2020-10-24 .B<B= mRNA-1273-P301HOmRNA-1273-P301-US320-2312A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T12:032020-09-30T12:03.B%B% mRNA-1273-P301HOmRNA-1273-P301-US320-2314A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B~.. mRNA-1273-P301HOmRNA-1273-P301-US320-2323A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T19:022020-10-08T09:12.B B- mRNA-1273-P301HOmRNA-1273-P301-US320-2327A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T14:142020-08-30T13:36.AAP mRNA-1273-P301HOmRNA-1273-P301-US320-2327A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T11:452020-09-23T11:45.BB mRNA-1273-P301HOmRNA-1273-P301-US320-2328A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US320-2337A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T19:042020-09-29T19:04.B#B# mRNA-1273-P301HOmRNA-1273-P301-US320-2346A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-09 B,.. mRNA-1273-P301HOmRNA-1273-P301-US320-2350A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US320-2351A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T11:392020-08-28T11:39.AA mRNA-1273-P301HOmRNA-1273-P301-US320-2352A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T21:352020-09-27T21:35.BB mRNA-1273-P301HOmRNA-1273-P301-US320-2366AUSA-US128-2021-mRNA-1273-P301000014HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-01 2021-04-03 .BÖBØ mRNA-1273-P301HOmRNA-1273-P301-US320-2366A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T11:232020-09-05T11:23.A`A` mRNA-1273-P301HOmRNA-1273-P301-US320-2371A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T03:152020-10-06T03:15.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US320-2373A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T21:232020-09-30T13:00.BB mRNA-1273-P301HOmRNA-1273-P301-US320-2390A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T12:162020-09-03T12:16.AA mRNA-1273-P301HOmRNA-1273-P301-US320-2395AUSA-US128-2021-mRNA-1273-P301000018HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-08 2021-04-09 .BÚBÛ mRNA-1273-P301HOmRNA-1273-P301-US320-2405A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 BS.. mRNA-1273-P301HOmRNA-1273-P301-US321-2004A HO-AE-004/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-07 2020-12-10 .BB‚ mRNA-1273-P301HOmRNA-1273-P301-US321-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US321-2004A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2013AUSA-US115-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-27 2020-08-28 .BB mRNA-1273-P301HOmRNA-1273-P301-US321-2013A USA-US115-2020-mRNA-1273-P301000013HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-22 2020-09-23 .B3B4 mRNA-1273-P301HOmRNA-1273-P301-US321-2016A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T17:442020-08-09T06:07.APAp mRNA-1273-P301HOmRNA-1273-P301-US321-2016A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-07 AP.. mRNA-1273-P301HOmRNA-1273-P301-US321-2027A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2028AUSA-US115-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-23 2020-10-29 .BQBW mRNA-1273-P301HOmRNA-1273-P301-US321-2044A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-30 B9.. mRNA-1273-P301HOmRNA-1273-P301-US321-2051A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T21:002020-08-10T20:19.AA` mRNA-1273-P301HOmRNA-1273-P301-US321-2058A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T20:532020-09-03T20:53.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2066A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-14 A.. mRNA-1273-P301HOmRNA-1273-P301-US321-2100AUSA-US115-2021-mRNA-1273-P301000001HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-15 2020-12-17 .B€B‚ mRNA-1273-P301HOmRNA-1273-P301-US321-2108A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T20:002020-09-14T20:05.B B$ mRNA-1273-P301HOmRNA-1273-P301-US321-2112A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 BP.. mRNA-1273-P301HOmRNA-1273-P301-US321-2115A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US321-2117A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-20 BÂ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2121AUSA-US115-2021-mRNA-1273-P301000020HO-AE-006/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-23 .C. mRNA-1273-P301HOmRNA-1273-P301-US321-2123A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T23:052020-08-14T23:05.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US321-2131A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T10:112020-09-11T10:11.B B mRNA-1273-P301HOmRNA-1273-P301-US321-2133A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 B{.. mRNA-1273-P301HOmRNA-1273-P301-US321-2140A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 By.. mRNA-1273-P301HOmRNA-1273-P301-US321-2140A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 B–.. mRNA-1273-P301HOmRNA-1273-P301-US321-2149A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US321-2150A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-27 B©.. mRNA-1273-P301HOmRNA-1273-P301-US321-2151A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2158A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T12:092020-08-20T12:09.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US321-2166AUSA-US115-2021-mRNA-1273-P301000019HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-18 2021-04-23 .BùBþ mRNA-1273-P301HOmRNA-1273-P301-US321-2179A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2180A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2181AUSA-US115-2021-mRNA-1273-P301000017HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-24 2021-04-08 .BßBî mRNA-1273-P301HOmRNA-1273-P301-US321-2187A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-15 Bõ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2195A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T18:062020-08-19T18:06.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US321-2226A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T21:412020-09-25T21:41.B'B' mRNA-1273-P301HOmRNA-1273-P301-US321-2226A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BM.. mRNA-1273-P301HOmRNA-1273-P301-US321-2233A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T21:052020-09-18T21:05.B B mRNA-1273-P301HOmRNA-1273-P301-US321-2237A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T20:152020-09-15T20:15.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2241A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B’.. mRNA-1273-P301HOmRNA-1273-P301-US321-2246A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T15:352020-08-19T15:35.AA mRNA-1273-P301HOmRNA-1273-P301-US321-2250AUSA-US115-2021-mRNA-1273-P301000013HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-11 2021-02-12 .B±B² mRNA-1273-P301HOmRNA-1273-P301-US321-2250A USA-US115-2021-mRNA-1273-P301000013HO-AE-015 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-05 2021-04-08 .BæBé mRNA-1273-P301HOmRNA-1273-P301-US321-2261A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US321-2262A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T18:082020-09-23T18:08.B#B# mRNA-1273-P301HOmRNA-1273-P301-US321-2269A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B˜.. mRNA-1273-P301HOmRNA-1273-P301-US321-2276A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T18:502020-09-11T18:50.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2278A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T11:432020-08-24T11:43.AA mRNA-1273-P301HOmRNA-1273-P301-US321-2281A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B†.. mRNA-1273-P301HOmRNA-1273-P301-US321-2283A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T12:102020-09-30T12:10.B&B& mRNA-1273-P301HOmRNA-1273-P301-US321-2288A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T13:312020-09-29T13:31.B%B% mRNA-1273-P301HOmRNA-1273-P301-US321-2291A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:122020-09-23T12:12.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2294A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T23:442020-08-31T21:16.A`Ap mRNA-1273-P301HOmRNA-1273-P301-US321-2296A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BF.. mRNA-1273-P301HOmRNA-1273-P301-US321-2297A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T14:402020-08-25T14:40.AA mRNA-1273-P301HOmRNA-1273-P301-US321-2301A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T19:092020-09-21T19:09.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2302A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B….. mRNA-1273-P301HOmRNA-1273-P301-US321-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-18 BV.. mRNA-1273-P301HOmRNA-1273-P301-US321-2308A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T00:002020-09-01T00:00.ApAp mRNA-1273-P301HOmRNA-1273-P301-US321-2308A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T16:012020-09-30T16:01.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US321-2310A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T12:292020-09-24T12:29.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2311A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B.. mRNA-1273-P301HOmRNA-1273-P301-US321-2323A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T18:012020-08-29T18:01.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US321-2335A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T18:142020-10-01T18:14.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2336A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T18:182020-09-29T18:18.BB mRNA-1273-P301HOmRNA-1273-P301-US321-2336A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B“.. mRNA-1273-P301HOmRNA-1273-P301-US321-2342A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T06:222020-09-09T06:22.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US321-2360A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T18:352020-10-07T18:35.B"B" mRNA-1273-P301HOmRNA-1273-P301-US321-2374A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T11:582020-10-12T11:58.B!B! mRNA-1273-P301HOmRNA-1273-P301-US321-2380A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T08:372020-10-16T15:24.B$B% mRNA-1273-P301HOmRNA-1273-P301-US321-2387A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T22:162020-10-17T22:16.B%B% mRNA-1273-P301HOmRNA-1273-P301-US321-2394AUSA-US115-2020-mRNA-1273-P301000014HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-19 2020-11-20 .BFBG mRNA-1273-P301HOmRNA-1273-P301-US321-2396A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US321-2407A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T22:032020-09-20T22:03.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US321-2412A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 BU.. mRNA-1273-P301HOmRNA-1273-P301-US322-2004AUSA-US104-2020-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-01 2020-10-02 .B9B: mRNA-1273-P301HOmRNA-1273-P301-US322-2013AUSA-US104-2020-mRNA-1273-P301000018HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-14 2020-11-16 .BeBg mRNA-1273-P301HOmRNA-1273-P301-US322-2015A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T16:142020-08-08T13:39.A A0 mRNA-1273-P301HOmRNA-1273-P301-US322-2031A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T15:242020-08-13T15:11.APAp mRNA-1273-P301HOmRNA-1273-P301-US322-2032AUSA-US104-2020-mRNA-1273-P301000025HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-13 2020-12-21 .BB‰ mRNA-1273-P301HOmRNA-1273-P301-US322-2032A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T14:402020-09-06T14:40.BB mRNA-1273-P301HOmRNA-1273-P301-US322-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T21:122020-09-04T06:57.BB mRNA-1273-P301HOmRNA-1273-P301-US322-2033A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T21:232020-09-28T16:51.B#B5 mRNA-1273-P301HOmRNA-1273-P301-US322-2055A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T13:412020-09-10T13:41.B"B" mRNA-1273-P301HOmRNA-1273-P301-US322-2059AUSA-US104-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-03 2020-09-05 .BB mRNA-1273-P301HOmRNA-1273-P301-US322-2068AUSA-US104-2020-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-24 2020-10-05 .B.B9 mRNA-1273-P301HOmRNA-1273-P301-US322-2074A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T09:362020-08-15T09:36.A`A` mRNA-1273-P301HOmRNA-1273-P301-US322-2077AUSA-US104-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-22 2020-09-23 .B,B- mRNA-1273-P301HOmRNA-1273-P301-US322-2077A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T20:302020-10-08T12:00.B%B< mRNA-1273-P301HOmRNA-1273-P301-US322-2085A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T12:322020-08-19T12:32.AA mRNA-1273-P301HOmRNA-1273-P301-US322-2089AUSA-US104-2021-mRNA-1273-P301000004HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-23 2021-01-23 .B¦B¦ mRNA-1273-P301HOmRNA-1273-P301-US322-2089A USA-US104-2021-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-24 2021-01-27 .B§Bª mRNA-1273-P301HOmRNA-1273-P301-US322-2090A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T17:502020-09-12T17:50.B!B! mRNA-1273-P301HOmRNA-1273-P301-US322-2109A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T10:252020-08-13T10:25.A A mRNA-1273-P301HOmRNA-1273-P301-US322-2116A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T08:452020-08-13T08:45.A A mRNA-1273-P301HOmRNA-1273-P301-US322-2117AUSA-US104-2020-mRNA-1273-P301000024HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-11 2020-12-15 .BzB~ mRNA-1273-P301HOmRNA-1273-P301-US322-2117A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US322-2120A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T00:022020-08-16T00:02.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US322-2137A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T17:502020-08-25T17:50.AÐAÐ mRNA-1273-P301HOmRNA-1273-P301-US322-2137A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T17:482020-09-15T17:48.B"B" mRNA-1273-P301HOmRNA-1273-P301-US322-2143AUSA-US104-2020-mRNA-1273-P301000026HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-11 2020-12-12 .BxBy mRNA-1273-P301HOmRNA-1273-P301-US322-2143A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T14:202020-09-20T14:20.B&B& mRNA-1273-P301HOmRNA-1273-P301-US322-2153A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T00:012020-08-21T00:01.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US322-2156A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T18:122020-09-15T18:12.B!B! mRNA-1273-P301HOmRNA-1273-P301-US322-2159A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T20:592020-09-15T16:21.BB mRNA-1273-P301HOmRNA-1273-P301-US322-2176A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T15:562020-08-17T15:56.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US322-2189AUSA-US104-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-02 2020-10-03 .B/B0 mRNA-1273-P301HOmRNA-1273-P301-US322-2189A USA-US104-2020-mRNA-1273-P301000007HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-10 2020-10-30 .B7BK mRNA-1273-P301HOmRNA-1273-P301-US322-2190A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:142020-09-15T12:14.BB mRNA-1273-P301HOmRNA-1273-P301-US322-2203A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T13:432020-08-20T15:01.AA0 mRNA-1273-P301HOmRNA-1273-P301-US322-2203A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T10:462020-09-24T10:46.B&B& mRNA-1273-P301HOmRNA-1273-P301-US322-2216A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US322-2220AUSA-US104-2021-mRNA-1273-P301000015HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US322-2220A USA-US104-2021-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-11 2021-03-15 .BÍBÑ mRNA-1273-P301HOmRNA-1273-P301-US322-2227A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T13:022020-08-24T13:02.A`A` mRNA-1273-P301HOmRNA-1273-P301-US322-2270A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T16:402020-08-25T16:40.APAP mRNA-1273-P301HOmRNA-1273-P301-US322-2274A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T12:592020-08-25T12:59.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US322-2274A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T16:302020-10-01T16:30.B)B) mRNA-1273-P301HOmRNA-1273-P301-US322-2285A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 B{.. mRNA-1273-P301HOmRNA-1273-P301-US322-2291A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T06:162020-10-02T05:59.B B) mRNA-1273-P301HOmRNA-1273-P301-US322-2296AUSA-US104-2021-mRNA-1273-P301000008HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US322-2296A USA-US104-2021-mRNA-1273-P301000017HO-AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US322-2296A0USA-US104-2021-mRNA-1273-P301000017HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-04 2020-12-11 .BhBo mRNA-1273-P301HOmRNA-1273-P301-US322-2296A@USA-US104-2021-mRNA-1273-P301000009HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-14 2021-02-04 .B‘B¦ mRNA-1273-P301HOmRNA-1273-P301-US322-2299AUSA-US104-2020-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-03 2020-10-05 .B*B, mRNA-1273-P301HOmRNA-1273-P301-US322-2311AUSA-US104-2020-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-28 2020-09-30 .B$B& mRNA-1273-P301HOmRNA-1273-P301-US322-2311A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T17:012020-09-29T17:01.B%B% mRNA-1273-P301HOmRNA-1273-P301-US322-2315AUSA-US104-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-09 2020-09-10 .BB mRNA-1273-P301HOmRNA-1273-P301-US322-2320A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T14:232020-10-09T14:23.B.B. mRNA-1273-P301HOmRNA-1273-P301-US322-2323A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T13:582020-08-27T13:58.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US322-2330A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T08:122020-08-31T08:12.ApAp mRNA-1273-P301HOmRNA-1273-P301-US322-2330A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T23:132020-09-24T23:13.BB mRNA-1273-P301HOmRNA-1273-P301-US322-2344A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T15:372020-08-27T15:37.A A mRNA-1273-P301HOmRNA-1273-P301-US322-2348A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T20:342020-08-26T20:34.AA mRNA-1273-P301HOmRNA-1273-P301-US322-2364A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T05:502020-09-01T05:50.A`A` mRNA-1273-P301HOmRNA-1273-P301-US322-2367AUSA-US104-2020-mRNA-1273-P301000020HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-23 .BY. mRNA-1273-P301HOmRNA-1273-P301-US322-2385A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T14:572020-09-12T14:57.BB mRNA-1273-P301HOmRNA-1273-P301-US322-2388AUSA-US104-2020-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-25 2020-09-30 .BB" mRNA-1273-P301HOmRNA-1273-P301-US322-2388A USA-US104-2020-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-08 2020-10-09 .B*B+ mRNA-1273-P301HOmRNA-1273-P301-US322-2392A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T09:502020-08-29T09:50.AA mRNA-1273-P301HOmRNA-1273-P301-US322-2400A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T22:062020-10-10T20:29.B)B+ mRNA-1273-P301HOmRNA-1273-P301-US322-2414A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T13:182020-09-29T13:18.BB mRNA-1273-P301HOmRNA-1273-P301-US322-2415A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-02 B}.. mRNA-1273-P301HOmRNA-1273-P301-US322-2422A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 B—.. mRNA-1273-P301HOmRNA-1273-P301-US322-2424A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-10 A°.. mRNA-1273-P301HOmRNA-1273-P301-US322-2425A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T01:002020-09-19T10:52.A€B mRNA-1273-P301HOmRNA-1273-P301-US322-2430A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B€.. mRNA-1273-P301HOmRNA-1273-P301-US322-2443A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T09:372020-09-07T09:37.A`A` mRNA-1273-P301HOmRNA-1273-P301-US322-2450A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US322-2452AUSA-US104-2020-mRNA-1273-P301000014HO-AE-001/AE-002/AE-003/AE-004/AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US322-2452A USA-US104-2020-mRNA-1273-P301000014HO-AE-001/AE-002/AE-003/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-26 2020-10-30 .B7B; mRNA-1273-P301HOmRNA-1273-P301-US322-2462AUSA-US104-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-25 .B’. mRNA-1273-P301HOmRNA-1273-P301-US322-2462A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T18:122020-09-02T18:12.AA mRNA-1273-P301HOmRNA-1273-P301-US322-2485A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T08:472020-10-04T08:47.B B mRNA-1273-P301HOmRNA-1273-P301-US322-2487A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US322-2497A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T19:492020-09-08T19:49.APAP mRNA-1273-P301HOmRNA-1273-P301-US322-2497A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-11-12T17:172021-02-19T18:51.BFB© mRNA-1273-P301HOmRNA-1273-P301-US322-2501A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T16:412020-09-09T16:41.A`A` mRNA-1273-P301HOmRNA-1273-P301-US322-2509A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T19:112020-10-09T19:11.B#B# mRNA-1273-P301HOmRNA-1273-P301-US322-2514A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T11:012020-10-10T11:01.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US322-2524AUSA-US104-2021-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-01 2021-03-03 .B²B´ mRNA-1273-P301HOmRNA-1273-P301-US322-2524A USA-US104-2021-mRNA-1273-P301000012HO-AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-12 2021-03-12 .B½B½ mRNA-1273-P301HOmRNA-1273-P301-US322-2526A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T12:042020-10-07T12:04.B B mRNA-1273-P301HOmRNA-1273-P301-US322-2545A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T10:112020-09-07T10:11.AA mRNA-1273-P301HOmRNA-1273-P301-US322-2545A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 By.. mRNA-1273-P301HOmRNA-1273-P301-US322-2552A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T16:492020-09-13T16:49.ApAp mRNA-1273-P301HOmRNA-1273-P301-US322-2554AUSA-US104-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-28 2021-01-30 .BB’ mRNA-1273-P301HOmRNA-1273-P301-US322-2558A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T13:422020-09-07T13:42.AA mRNA-1273-P301HOmRNA-1273-P301-US322-2574A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T21:192020-10-12T21:19.B!B! mRNA-1273-P301HOmRNA-1273-P301-US322-2577A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 B<.. mRNA-1273-P301HOmRNA-1273-P301-US322-2578A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T12:012020-10-17T12:01.B%B% mRNA-1273-P301HOmRNA-1273-P301-US322-2581A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T13:122020-10-12T13:12.B B mRNA-1273-P301HOmRNA-1273-P301-US322-2583A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T12:012020-10-19T12:01.B'B' mRNA-1273-P301HOmRNA-1273-P301-US322-2604A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T09:072020-09-17T09:07.A A mRNA-1273-P301HOmRNA-1273-P301-US322-2610A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-08 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US322-2611AUSA-US104-2020-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-29 2020-11-10 .B+B7 mRNA-1273-P301HOmRNA-1273-P301-US322-2613A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T23:502020-09-18T23:50.A A mRNA-1273-P301HOmRNA-1273-P301-US322-2614A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T11:082020-10-19T11:08.B!B! mRNA-1273-P301HOmRNA-1273-P301-US322-2616A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T03:462020-10-27T03:46.B(B( mRNA-1273-P301HOmRNA-1273-P301-US322-2619A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T09:362020-09-23T09:36.APAP mRNA-1273-P301HOmRNA-1273-P301-US322-2625A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T13:262020-10-12T14:16.A Ap mRNA-1273-P301HOmRNA-1273-P301-US322-2642A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T12:022020-10-03T12:02.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US322-2657AUSA-US104-2020-mRNA-1273-P301000027HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-27 2020-12-27 .BXBX mRNA-1273-P301HOmRNA-1273-P301-US322-2657A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BY.. mRNA-1273-P301HOmRNA-1273-P301-US323-2003A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T15:512020-09-04T15:51.BB mRNA-1273-P301HOmRNA-1273-P301-US323-2004A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T05:192020-08-13T05:19.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US323-2017A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T12:122020-09-14T04:05.B"B$ mRNA-1273-P301HOmRNA-1273-P301-US323-2017A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-29 B.. mRNA-1273-P301HOmRNA-1273-P301-US323-2020A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T10:582020-09-11T14:29.B B! mRNA-1273-P301HOmRNA-1273-P301-US323-2022A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T17:222020-08-10T17:22.AA mRNA-1273-P301HOmRNA-1273-P301-US323-2023A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T00:002020-08-15T00:00.A`A` mRNA-1273-P301HOmRNA-1273-P301-US323-2023A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T23:592020-09-15T00:21.B#B% mRNA-1273-P301HOmRNA-1273-P301-US323-2028A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US323-2047A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T20:052020-08-27T20:21.A`Ap mRNA-1273-P301HOmRNA-1273-P301-US323-2048A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T20:232020-08-27T20:23.ApAp mRNA-1273-P301HOmRNA-1273-P301-US323-2050AUSA-US105-2021-mRNA-1273-P301000007HO-AE-004/AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-04 2021-03-06 .BËBÍ mRNA-1273-P301HOmRNA-1273-P301-US323-2052A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T18:172020-09-12T18:17.BB mRNA-1273-P301HOmRNA-1273-P301-US323-2054A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T21:422020-08-21T21:42.APAP mRNA-1273-P301HOmRNA-1273-P301-US323-2054A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T09:362020-09-20T20:48.B#B# mRNA-1273-P301HOmRNA-1273-P301-US323-2056AUSA-US105-2021-mRNA-1273-P301000002HO-AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-16 2021-01-19 .B™Bœ mRNA-1273-P301HOmRNA-1273-P301-US323-2056A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US323-2063AUSA-US105-2021-mRNA-1273-P301000009HO-AE-019 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-13 2021-04-16 .BïBò mRNA-1273-P301HOmRNA-1273-P301-US323-2074A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T20:092020-08-25T20:09.A`A` mRNA-1273-P301HOmRNA-1273-P301-US323-2074A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T22:212020-09-22T22:21.B"B" mRNA-1273-P301HOmRNA-1273-P301-US323-2078A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T21:102020-08-25T21:10.A`A` mRNA-1273-P301HOmRNA-1273-P301-US323-2097A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T20:112020-10-08T20:11.B&B& mRNA-1273-P301HOmRNA-1273-P301-US323-2102A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T19:072020-08-26T19:07.A A mRNA-1273-P301HOmRNA-1273-P301-US323-2103A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B8.. mRNA-1273-P301HOmRNA-1273-P301-US323-2110A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T19:022020-09-03T19:02.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US323-2115A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T07:502020-09-28T07:50.B!B! mRNA-1273-P301HOmRNA-1273-P301-US323-2118A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T19:492020-09-05T19:49.AA mRNA-1273-P301HOmRNA-1273-P301-US323-2132A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T00:022020-09-06T00:02.ApAp mRNA-1273-P301HOmRNA-1273-P301-US323-2135A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T21:012020-09-30T21:01.BB mRNA-1273-P301HOmRNA-1273-P301-US323-2137A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T22:262020-09-08T16:14.A`A€ mRNA-1273-P301HOmRNA-1273-P301-US323-2137A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B….. mRNA-1273-P301HOmRNA-1273-P301-US323-2137A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US323-2143A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T14:072020-10-06T14:07.B#B# mRNA-1273-P301HOmRNA-1273-P301-US323-2145A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T12:012020-10-07T10:18.BB# mRNA-1273-P301HOmRNA-1273-P301-US323-2145A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-05 B!.. mRNA-1273-P301HOmRNA-1273-P301-US323-2157A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US323-2162AUSA-US105-2021-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-31 2021-02-02 .BB‘ mRNA-1273-P301HOmRNA-1273-P301-US323-2163A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T09:362020-10-16T09:36.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US323-2169A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T12:052020-09-18T12:05.ApAp mRNA-1273-P301HOmRNA-1273-P301-US323-2178A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T10:262020-10-26T10:26.B'B' mRNA-1273-P301HOmRNA-1273-P301-US323-2179A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T06:002020-09-24T06:00.A`A` mRNA-1273-P301HOmRNA-1273-P301-US324-2002A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T21:252020-08-13T21:25.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US324-2002A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-10 AP.. mRNA-1273-P301HOmRNA-1273-P301-US324-2003A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B¦.. mRNA-1273-P301HOmRNA-1273-P301-US324-2008A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B.. mRNA-1273-P301HOmRNA-1273-P301-US324-2012A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T13:262020-09-09T13:26.B#B# mRNA-1273-P301HOmRNA-1273-P301-US324-2017AUSA-US067-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-19 2020-10-21 .BJBL mRNA-1273-P301HOmRNA-1273-P301-US324-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T12:062020-09-04T12:06.BB mRNA-1273-P301HOmRNA-1273-P301-US324-2047A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B.. mRNA-1273-P301HOmRNA-1273-P301-US324-2049A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-19 AÀ.. mRNA-1273-P301HOmRNA-1273-P301-US324-2050A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T17:232020-09-10T17:23.B"B" mRNA-1273-P301HOmRNA-1273-P301-US324-2051AUSA-US067-2020-mRNA-1273-P301000011HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-02 2020-11-05 .BWBZ mRNA-1273-P301HOmRNA-1273-P301-US324-2072A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T17:192020-08-13T17:19.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2076A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-14 B?.. mRNA-1273-P301HOmRNA-1273-P301-US324-2081AUSA-US067-2021-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-01 2021-04-03 .BèBê mRNA-1273-P301HOmRNA-1273-P301-US324-2089A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 BS.. mRNA-1273-P301HOmRNA-1273-P301-US324-2097A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T22:202020-08-14T22:20.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2097A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T15:102020-09-21T15:10.B'B' mRNA-1273-P301HOmRNA-1273-P301-US324-2102AUSA-US067-2021-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-04 2021-04-07 .BéBì mRNA-1273-P301HOmRNA-1273-P301-US324-2107AUSA-US067-2021-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYSCREENING 2020-01-09 2021-01-12 .ÂÛB— mRNA-1273-P301HOmRNA-1273-P301-US324-2112A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-29 BJ.. mRNA-1273-P301HOmRNA-1273-P301-US324-2116A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T22:132020-08-21T22:13.APAP mRNA-1273-P301HOmRNA-1273-P301-US324-2116A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-10 B“.. mRNA-1273-P301HOmRNA-1273-P301-US324-2121A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T18:102020-09-21T22:32.B#B$ mRNA-1273-P301HOmRNA-1273-P301-US324-2123A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T23:202020-08-17T23:20.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2127A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-27 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US324-2128A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T21:292020-08-19T21:29.A A mRNA-1273-P301HOmRNA-1273-P301-US324-2131A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T06:282020-08-27T06:28.A A mRNA-1273-P301HOmRNA-1273-P301-US324-2131A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T22:362020-09-22T22:36.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US324-2144A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T20:182020-09-19T20:18.B B mRNA-1273-P301HOmRNA-1273-P301-US324-2147A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T13:252020-09-18T13:25.BB mRNA-1273-P301HOmRNA-1273-P301-US324-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US324-2157A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T15:272020-09-20T15:27.B B mRNA-1273-P301HOmRNA-1273-P301-US324-2163A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US324-2169A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T17:452020-08-20T17:45.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2171A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T02:442020-08-27T02:05.A`A€ mRNA-1273-P301HOmRNA-1273-P301-US324-2187A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T22:062020-09-26T22:06.B%B% mRNA-1273-P301HOmRNA-1273-P301-US324-2192A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T23:342020-08-24T23:34.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T16:552020-08-30T16:55.A`A` mRNA-1273-P301HOmRNA-1273-P301-US324-2203A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T19:462020-08-29T19:46.APAP mRNA-1273-P301HOmRNA-1273-P301-US324-2203A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T11:412020-09-24T12:10.BB mRNA-1273-P301HOmRNA-1273-P301-US324-2209A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T18:182020-08-26T18:18.A A mRNA-1273-P301HOmRNA-1273-P301-US324-2215A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T13:272020-09-30T16:41.B"B$ mRNA-1273-P301HOmRNA-1273-P301-US324-2224A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T19:552020-08-31T19:55.A`A` mRNA-1273-P301HOmRNA-1273-P301-US324-2226A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US324-2230A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 BL.. mRNA-1273-P301HOmRNA-1273-P301-US324-2231AUSA-US067-2020-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-08 2020-09-09 .AÐAà mRNA-1273-P301HOmRNA-1273-P301-US324-2231A USA-US067-2020-mRNA-1273-P301000013HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-27 2020-11-06 .B>BH mRNA-1273-P301HOmRNA-1273-P301-US324-2241A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T18:192020-10-02T18:19.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US324-2248A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T17:392020-08-30T17:39.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US324-2250A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T13:042020-09-02T13:04.A`A` mRNA-1273-P301HOmRNA-1273-P301-US324-2262A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T17:392020-09-01T17:39.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2264AUSA-US067-2020-mRNA-1273-P301000015HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-20 2020-11-22 .BQBS mRNA-1273-P301HOmRNA-1273-P301-US324-2276A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 B•.. mRNA-1273-P301HOmRNA-1273-P301-US324-2284A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T17:362020-09-02T17:36.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2285A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T20:462020-09-07T20:46.A`A` mRNA-1273-P301HOmRNA-1273-P301-US324-2288A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-11 A.. mRNA-1273-P301HOmRNA-1273-P301-US324-2290A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:182020-09-09T12:18.ApAp mRNA-1273-P301HOmRNA-1273-P301-US324-2306A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T19:002020-09-13T19:00.A`A` mRNA-1273-P301HOmRNA-1273-P301-US324-2321A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T08:082020-10-16T12:01.B B! mRNA-1273-P301HOmRNA-1273-P301-US324-2335A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T01:412020-10-15T01:41.BB mRNA-1273-P301HOmRNA-1273-P301-US324-2342A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US324-2354A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T21:232020-09-24T21:23.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US324-2356A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T22:162020-09-22T22:16.A A mRNA-1273-P301HOmRNA-1273-P301-US324-2357A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T19:402020-10-02T20:15.A AÀ mRNA-1273-P301HOmRNA-1273-P301-US324-2368A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T20:522020-09-22T20:52.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2370AUSA-US067-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-29 2020-10-03 .ApA° mRNA-1273-P301HOmRNA-1273-P301-US324-2384A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-06 BI.. mRNA-1273-P301HOmRNA-1273-P301-US324-2394A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T18:532020-10-05T18:48.A@Ap mRNA-1273-P301HOmRNA-1273-P301-US324-2395A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T13:572020-09-29T13:57.AA mRNA-1273-P301HOmRNA-1273-P301-US324-2397A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-01T23:142020-11-07T21:40.B"B( mRNA-1273-P301HOmRNA-1273-P301-US324-2397A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 B#.. mRNA-1273-P301HOmRNA-1273-P301-US324-2398A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US324-2401A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T20:452020-10-05T20:45.A`A` mRNA-1273-P301HOmRNA-1273-P301-US325-2007A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-21 B¬.. mRNA-1273-P301HOmRNA-1273-P301-US325-2011A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T12:162020-08-12T15:26.A@A mRNA-1273-P301HOmRNA-1273-P301-US325-2016A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T12:342020-09-07T12:34.B#B# mRNA-1273-P301HOmRNA-1273-P301-US325-2020A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-17 Aà.. mRNA-1273-P301HOmRNA-1273-P301-US325-2024A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T00:102020-09-10T00:05.B%B& mRNA-1273-P301HOmRNA-1273-P301-US325-2031A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T14:042020-08-04T14:04.AA mRNA-1273-P301HOmRNA-1273-P301-US325-2046A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T18:582020-08-11T18:58.ApAp mRNA-1273-P301HOmRNA-1273-P301-US325-2052A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T08:412020-09-04T08:41.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2055A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T19:362020-08-09T19:36.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US325-2055A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T22:122020-09-08T22:12.B"B" mRNA-1273-P301HOmRNA-1273-P301-US325-2065A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T14:382020-09-03T14:38.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2075A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-13 Ap.. mRNA-1273-P301HOmRNA-1273-P301-US325-2083A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-20 BJ.. mRNA-1273-P301HOmRNA-1273-P301-US325-2107A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T17:292020-08-15T17:29.A`A` mRNA-1273-P301HOmRNA-1273-P301-US325-2109A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T07:322020-09-15T07:32.B%B% mRNA-1273-P301HOmRNA-1273-P301-US325-2111A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T06:172020-08-25T00:39.A B mRNA-1273-P301HOmRNA-1273-P301-US325-2119AUSA-US108-2020-mRNA-1273-P301000006HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US325-2119A USA-US108-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-14 2020-10-20 .BABG mRNA-1273-P301HOmRNA-1273-P301-US325-2125A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 Bž.. mRNA-1273-P301HOmRNA-1273-P301-US325-2127AUSA-US108-2020-mRNA-1273-P301000013HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-28 2020-10-29 .BOBP mRNA-1273-P301HOmRNA-1273-P301-US325-2134A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T18:062020-08-19T18:06.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US325-2139A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T13:042020-08-13T13:04.A A mRNA-1273-P301HOmRNA-1273-P301-US325-2178A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T12:012020-09-20T12:01.B&B& mRNA-1273-P301HOmRNA-1273-P301-US325-2179A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T10:482020-09-09T10:48.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2202A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 BŸ.. mRNA-1273-P301HOmRNA-1273-P301-US325-2211A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-02 B/.. mRNA-1273-P301HOmRNA-1273-P301-US325-2212A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-30 B-.. mRNA-1273-P301HOmRNA-1273-P301-US325-2215AUSA-US108-2021-mRNA-1273-P301000018HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-23 2021-03-24 .BÛBÜ mRNA-1273-P301HOmRNA-1273-P301-US325-2219A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T16:562020-08-25T07:38.APA€ mRNA-1273-P301HOmRNA-1273-P301-US325-2248A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T22:312020-08-25T22:31.ApAp mRNA-1273-P301HOmRNA-1273-P301-US325-2251A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T19:532020-09-22T19:53.B#B# mRNA-1273-P301HOmRNA-1273-P301-US325-2261AUSA-US108-2020-mRNA-1273-P301000017HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-01 2020-11-03 .BJBL mRNA-1273-P301HOmRNA-1273-P301-US325-2292A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T12:012020-08-22T12:01.A A mRNA-1273-P301HOmRNA-1273-P301-US325-2294A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T07:432020-10-02T07:43.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US325-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US325-2331A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T10:122020-09-01T18:40.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US325-2334A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:312020-10-03T12:37.B B( mRNA-1273-P301HOmRNA-1273-P301-US325-2334A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 B].. mRNA-1273-P301HOmRNA-1273-P301-US325-2382AUSA-US108-2021-mRNA-1273-P301000019HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-13 2021-04-15 .BäBæ mRNA-1273-P301HOmRNA-1273-P301-US325-2388A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US325-2399AUSA-US108-2021-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-08 2021-03-09 .B½B¾ mRNA-1273-P301HOmRNA-1273-P301-US325-2408A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US325-2410A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T17:112020-10-02T19:07.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2417A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T18:542020-10-01T16:41.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2437A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T07:402020-10-13T07:40.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US325-2450A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T13:022020-09-14T13:02.APAP mRNA-1273-P301HOmRNA-1273-P301-US325-2450A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T11:152020-10-09T13:58.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2455A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-21 B†.. mRNA-1273-P301HOmRNA-1273-P301-US325-2487A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T12:382020-10-20T12:38.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US325-2491A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T00:072020-10-23T00:07.B&B& mRNA-1273-P301HOmRNA-1273-P301-US325-2500A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T16:232020-10-16T16:23.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2516AUSA-US108-2021-mRNA-1273-P301000020HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US325-2516A HO-AE-001/AE-002/AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-30 2020-10-10 .A B mRNA-1273-P301HOmRNA-1273-P301-US325-2516A0USA-US108-2021-mRNA-1273-P301000020HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-05 2021-04-13 .BÅBÍ mRNA-1273-P301HOmRNA-1273-P301-US325-2516A@ HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T09:472020-10-26T09:47.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US325-2519A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T15:502020-09-21T15:50.AA mRNA-1273-P301HOmRNA-1273-P301-US325-2527A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-25 A@.. mRNA-1273-P301HOmRNA-1273-P301-US325-2537A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T20:222020-09-26T20:22.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US325-2542A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T13:232020-10-01T15:50.APA€ mRNA-1273-P301HOmRNA-1273-P301-US325-2550A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T23:532020-09-30T23:53.ApAp mRNA-1273-P301HOmRNA-1273-P301-US325-2551A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T17:232020-10-23T17:23.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2553AUSA-US108-2020-mRNA-1273-P301000011HO-AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P12DmRNA-1273-P301HOmRNA-1273-P301-US325-2553A USA-US108-2020-mRNA-1273-P301000011HO-AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-23 2020-11-04 .BB* mRNA-1273-P301HOmRNA-1273-P301-US325-2555A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T19:372020-10-29T19:37.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US325-2564A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T12:022020-11-14T22:43.B1B3 mRNA-1273-P301HOmRNA-1273-P301-US325-2584A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T14:462020-09-30T21:01.AA mRNA-1273-P301HOmRNA-1273-P301-US325-2595A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-05T21:192020-11-08T12:50.B$B' mRNA-1273-P301HOmRNA-1273-P301-US325-2599A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T06:092020-10-08T06:09.ApAp mRNA-1273-P301HOmRNA-1273-P301-US325-2600A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T12:012020-10-07T12:01.A`A` mRNA-1273-P301HOmRNA-1273-P301-US325-2602AUSA-US108-2020-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-06 2020-11-07 .B$B% mRNA-1273-P301HOmRNA-1273-P301-US325-2602A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T17:352020-11-06T17:35.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US325-2602A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 BD.. mRNA-1273-P301HOmRNA-1273-P301-US325-2610A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T08:012020-11-06T08:01.B#B# mRNA-1273-P301HOmRNA-1273-P301-US325-2624AUSA-US108-2021-mRNA-1273-P301000021HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYSCREENING 2020-04-12 2021-04-17 .Â°BÃ mRNA-1273-P301HOmRNA-1273-P301-US325-2629A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T22:112020-10-14T22:11.AA mRNA-1273-P301HOmRNA-1273-P301-US325-2632A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US325-2638A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 B.. mRNA-1273-P301HOmRNA-1273-P301-US325-2642A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 BT.. mRNA-1273-P301HOmRNA-1273-P301-US325-2653A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T21:592020-10-12T21:59.AA mRNA-1273-P301HOmRNA-1273-P301-US325-2659A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 B+.. mRNA-1273-P301HOmRNA-1273-P301-US325-2669A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T20:562020-10-17T20:56.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US325-2678A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 B?.. mRNA-1273-P301HOmRNA-1273-P301-US325-2679A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T12:222020-10-16T17:30.AA mRNA-1273-P301HOmRNA-1273-P301-US325-2679A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-13T15:562020-11-20T18:03.BB$ mRNA-1273-P301HOmRNA-1273-P301-US325-2685A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 B.. mRNA-1273-P301HOmRNA-1273-P301-US325-2690A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T10:072020-11-18T10:07.BB mRNA-1273-P301HOmRNA-1273-P301-US325-2697A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-03 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US325-2700A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 BE.. mRNA-1273-P301HOmRNA-1273-P301-US325-2701A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-24T07:442020-11-24T07:44.B!B! mRNA-1273-P301HOmRNA-1273-P301-US326-2007A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 B.. mRNA-1273-P301HOmRNA-1273-P301-US326-2027AUSA-US069-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-08 2021-04-11 .BÿC mRNA-1273-P301HOmRNA-1273-P301-US326-2042A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-02T20:262020-08-02T20:26.APAP mRNA-1273-P301HOmRNA-1273-P301-US326-2054A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B´.. mRNA-1273-P301HOmRNA-1273-P301-US326-2055AUSA-US069-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-05 2021-02-11 .B¿BÅ mRNA-1273-P301HOmRNA-1273-P301-US326-2061A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T14:052020-08-30T14:05.BB mRNA-1273-P301HOmRNA-1273-P301-US326-2068A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T12:462020-08-06T12:46.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US326-2080A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T15:492020-08-06T15:49.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US326-2081A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T18:232020-08-05T18:23.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US326-2099A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-12 BE.. mRNA-1273-P301HOmRNA-1273-P301-US326-2102A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T23:232020-08-10T23:23.A`A` mRNA-1273-P301HOmRNA-1273-P301-US326-2115AUSA-US069-2021-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-03 2021-04-06 .BñBô mRNA-1273-P301HOmRNA-1273-P301-US326-2133AUSA-US069-2021-mRNA-1273-P301000003HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-08 2021-03-10 .BÖBØ mRNA-1273-P301HOmRNA-1273-P301-US326-2133A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T13:172020-09-06T13:17.BB mRNA-1273-P301HOmRNA-1273-P301-US326-2134A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T21:202020-08-12T21:20.A`A` mRNA-1273-P301HOmRNA-1273-P301-US326-2142A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T00:002020-09-23T00:00.B/B/ mRNA-1273-P301HOmRNA-1273-P301-US326-2143A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T07:372020-09-17T07:13.B(B) mRNA-1273-P301HOmRNA-1273-P301-US326-2144A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T12:062020-09-12T12:06.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US326-2145AUSA-US069-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-19 2020-12-25 .B†BŒ mRNA-1273-P301HOmRNA-1273-P301-US326-2145A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B.. mRNA-1273-P301HOmRNA-1273-P301-US326-2152A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T12:012021-02-28T09:13.B*BË mRNA-1273-P301HOmRNA-1273-P301-US326-2162A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T23:042020-08-14T23:04.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US326-2186A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T16:582020-09-24T16:58.B)B) mRNA-1273-P301HOmRNA-1273-P301-US326-2219A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T12:232020-08-24T12:23.APAP mRNA-1273-P301HOmRNA-1273-P301-US326-2228A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T18:362020-09-25T18:36.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US326-2255A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T13:342020-08-31T23:03.AA mRNA-1273-P301HOmRNA-1273-P301-US326-2256A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T18:422020-10-07T18:42.B&B& mRNA-1273-P301HOmRNA-1273-P301-US326-2259AUSA-US069-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-05-01 .Bë. mRNA-1273-P301HOmRNA-1273-P301-US326-2268A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T03:352020-10-12T03:35.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US326-2275A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US327-2005AUSA-US070-2021-mRNA-1273-P301000003HO-AE-027/AE-029 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-12 2021-01-14 .B¨Bª mRNA-1273-P301HOmRNA-1273-P301-US327-2005A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-31T22:322020-07-31T22:32.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US327-2005A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 B†.. mRNA-1273-P301HOmRNA-1273-P301-US327-2010A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 Br.. mRNA-1273-P301HOmRNA-1273-P301-US327-2021A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B™.. mRNA-1273-P301HOmRNA-1273-P301-US327-2026AUSA-US070-2020-mRNA-1273-P301000019HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P20DmRNA-1273-P301HOmRNA-1273-P301-US327-2026A USA-US070-2020-mRNA-1273-P301000019HO-AE-002/AE-004/AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P28DmRNA-1273-P301HOmRNA-1273-P301-US327-2026A0USA-US070-2020-mRNA-1273-P301000019HO-AE-015/AE-019/AE-020 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P60DmRNA-1273-P301HOmRNA-1273-P301-US327-2026A@USA-US070-2020-mRNA-1273-P301000019HO-AE-001/AE-002/AE-004/AE-005/AE-006/AE-013/AE-015/AE-019/AE-020 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-16 2021-01-28 .BlBµ mRNA-1273-P301HOmRNA-1273-P301-US327-2026AP HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYYFOLLOW-UP BLINDED PHASE 2020-11-16 2021-02-12 .BlBÄ mRNA-1273-P301HOmRNA-1273-P301-US327-2027A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T18:302020-09-30T16:56.B<B= mRNA-1273-P301HOmRNA-1273-P301-US327-2055A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-06 B?.. mRNA-1273-P301HOmRNA-1273-P301-US327-2074A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T17:402020-08-13T17:40.ApAp mRNA-1273-P301HOmRNA-1273-P301-US327-2074A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-13 Ap.. mRNA-1273-P301HOmRNA-1273-P301-US327-2078AUSA-US070-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-25 2021-03-28 .BçBê mRNA-1273-P301HOmRNA-1273-P301-US327-2081A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T19:552020-09-09T19:55.B"B" mRNA-1273-P301HOmRNA-1273-P301-US327-2085AUSA-US070-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-09 2020-10-10 .B@BA mRNA-1273-P301HOmRNA-1273-P301-US327-2085A USA-US070-2021-mRNA-1273-P301000011HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-01 2021-01-02 .B”B• mRNA-1273-P301HOmRNA-1273-P301-US327-2097A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US327-2104A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-02 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US327-2117A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T20:402020-08-17T20:40.A`A` mRNA-1273-P301HOmRNA-1273-P301-US327-2120A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T18:172020-09-11T18:17.BB mRNA-1273-P301HOmRNA-1273-P301-US327-2121A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T15:122020-09-10T15:12.BB mRNA-1273-P301HOmRNA-1273-P301-US327-2125A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T17:572020-08-18T18:24.A@A` mRNA-1273-P301HOmRNA-1273-P301-US327-2137A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T18:542020-09-30T12:48.B/B1 mRNA-1273-P301HOmRNA-1273-P301-US327-2142A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-30 BN.. mRNA-1273-P301HOmRNA-1273-P301-US327-2144AUSA-US070-2020-mRNA-1273-P301000017HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-12 2020-11-19 .B[Bb mRNA-1273-P301HOmRNA-1273-P301-US327-2144A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 BS.. mRNA-1273-P301HOmRNA-1273-P301-US327-2169AUSA-US070-2020-mRNA-1273-P301000018HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-19 2020-10-24 .BBBG mRNA-1273-P301HOmRNA-1273-P301-US327-2169A USA-US070-2020-mRNA-1273-P301000018HO-AE-007/AE-013 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-05 2020-11-07 .BSBU mRNA-1273-P301HOmRNA-1273-P301-US327-2169A0 HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T21:162020-09-28T21:16.B-B- mRNA-1273-P301HOmRNA-1273-P301-US327-2174A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BR.. mRNA-1273-P301HOmRNA-1273-P301-US327-2184A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-30 BI.. mRNA-1273-P301HOmRNA-1273-P301-US327-2185A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T12:082020-09-19T12:08.B B mRNA-1273-P301HOmRNA-1273-P301-US327-2186A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 BM.. mRNA-1273-P301HOmRNA-1273-P301-US327-2188A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US327-2190A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T07:352020-08-25T07:35.ApAp mRNA-1273-P301HOmRNA-1273-P301-US327-2195AUSA-US070-2020-mRNA-1273-P301000015HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-07 2020-11-12 .BQBV mRNA-1273-P301HOmRNA-1273-P301-US327-2195A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BL.. mRNA-1273-P301HOmRNA-1273-P301-US327-2196A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BS.. mRNA-1273-P301HOmRNA-1273-P301-US327-2203A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US327-2204A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T17:572020-08-22T17:57.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US327-2210A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T12:202020-09-29T12:20.B)B) mRNA-1273-P301HOmRNA-1273-P301-US327-2210A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-05 B/.. mRNA-1273-P301HOmRNA-1273-P301-US327-2218A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T06:112020-08-23T07:39.A0A@ mRNA-1273-P301HOmRNA-1273-P301-US327-2218A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T17:052020-09-27T17:05.B'B' mRNA-1273-P301HOmRNA-1273-P301-US327-2219A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-20 B>.. mRNA-1273-P301HOmRNA-1273-P301-US327-2219A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BY.. mRNA-1273-P301HOmRNA-1273-P301-US327-2234A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B˜.. mRNA-1273-P301HOmRNA-1273-P301-US327-2235A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T12:012020-09-21T12:01.B B mRNA-1273-P301HOmRNA-1273-P301-US327-2237A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T18:522020-08-27T18:52.ApAp mRNA-1273-P301HOmRNA-1273-P301-US327-2260A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T21:102020-08-28T21:10.ApAp mRNA-1273-P301HOmRNA-1273-P301-US327-2260A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-28 Ap.. mRNA-1273-P301HOmRNA-1273-P301-US327-2270A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T17:362020-08-25T17:36.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US327-2270A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T12:552020-09-22T12:55.B B mRNA-1273-P301HOmRNA-1273-P301-US327-2271A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 BD.. mRNA-1273-P301HOmRNA-1273-P301-US327-2272A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US327-2278A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T20:092020-08-27T20:09.A`A` mRNA-1273-P301HOmRNA-1273-P301-US327-2299A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T20:552020-09-29T20:55.B'B' mRNA-1273-P301HOmRNA-1273-P301-US327-2305A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-21 B<.. mRNA-1273-P301HOmRNA-1273-P301-US327-2305A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 BW.. mRNA-1273-P301HOmRNA-1273-P301-US327-2311A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T00:512020-09-28T16:08.B$B% mRNA-1273-P301HOmRNA-1273-P301-US327-2312A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T20:172020-08-25T20:17.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US327-2315AUSA-US070-2021-mRNA-1273-P301000010HO-AE-003/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-29 2021-04-01 .BÛBÞ mRNA-1273-P301HOmRNA-1273-P301-US327-2317A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 BS.. mRNA-1273-P301HOmRNA-1273-P301-US327-2318A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T14:152020-08-23T14:15.AA mRNA-1273-P301HOmRNA-1273-P301-US327-2320A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T18:172020-09-22T18:17.BB mRNA-1273-P301HOmRNA-1273-P301-US327-2327A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T13:042020-09-27T13:04.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US327-2329A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BH.. mRNA-1273-P301HOmRNA-1273-P301-US327-2342A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US327-2346A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T22:302020-08-26T22:30.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US327-2347A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 BK.. mRNA-1273-P301HOmRNA-1273-P301-US327-2347A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US327-2348A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T21:532020-09-28T21:53.B%B% mRNA-1273-P301HOmRNA-1273-P301-US327-2357A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 BN.. mRNA-1273-P301HOmRNA-1273-P301-US327-2361A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-02 B&.. mRNA-1273-P301HOmRNA-1273-P301-US327-2366A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 BX.. mRNA-1273-P301HOmRNA-1273-P301-US327-2377AUSA-US070-2020-mRNA-1273-P301000026HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-21 2020-11-30 .B&B/ mRNA-1273-P301HOmRNA-1273-P301-US328-2026A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T13:472020-08-12T13:47.A A mRNA-1273-P301HOmRNA-1273-P301-US328-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T20:412020-09-16T20:41.B#B# mRNA-1273-P301HOmRNA-1273-P301-US328-2050A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T23:242020-08-17T23:24.APAP mRNA-1273-P301HOmRNA-1273-P301-US328-2060A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T13:522020-09-17T13:52.BB mRNA-1273-P301HOmRNA-1273-P301-US328-2063A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T12:192020-09-16T12:19.BB mRNA-1273-P301HOmRNA-1273-P301-US328-2072A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 BR.. mRNA-1273-P301HOmRNA-1273-P301-US328-2085A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T18:492020-09-01T22:18.A`Ap mRNA-1273-P301HOmRNA-1273-P301-US328-2090A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B’.. mRNA-1273-P301HOmRNA-1273-P301-US328-2113AUSA-US201-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-23 2020-10-25 .A€A mRNA-1273-P301HOmRNA-1273-P301-US328-2113A USA-US201-2020-mRNA-1273-P301000001HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-06 2020-11-10 .BB mRNA-1273-P301HOmRNA-1273-P301-US329-2002A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-26 B´.. mRNA-1273-P301HOmRNA-1273-P301-US329-2004A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-03T10:592020-08-03T10:59.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US329-2004A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T14:342020-09-09T14:34.B)B) mRNA-1273-P301HOmRNA-1273-P301-US329-2022A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T03:192020-08-11T03:19.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US329-2023AUSA-US072-2021-mRNA-1273-P301000014HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P32DmRNA-1273-P301HOmRNA-1273-P301-US329-2023A USA-US072-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-22 2020-10-26 .BPBT mRNA-1273-P301HOmRNA-1273-P301-US329-2023A0USA-US072-2021-mRNA-1273-P301000014HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-19 2021-01-20 .BŠBª mRNA-1273-P301HOmRNA-1273-P301-US329-2024A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T12:312020-09-04T12:31.B B mRNA-1273-P301HOmRNA-1273-P301-US329-2025A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T16:302020-09-06T13:00.B!B" mRNA-1273-P301HOmRNA-1273-P301-US329-2029A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T21:022020-09-25T21:09.B+B5 mRNA-1273-P301HOmRNA-1273-P301-US329-2048A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T13:212020-09-01T13:21.BB mRNA-1273-P301HOmRNA-1273-P301-US329-2057A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T17:082020-09-05T18:50.BB mRNA-1273-P301HOmRNA-1273-P301-US329-2065A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T00:032020-08-11T00:03.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US329-2068A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T18:312020-09-07T18:31.BB mRNA-1273-P301HOmRNA-1273-P301-US329-2068A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-07 B.. mRNA-1273-P301HOmRNA-1273-P301-US329-2088A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T12:452020-08-11T12:45.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US329-2102A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US329-2103AUSA-US072-2020-mRNA-1273-P301000013HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US329-2103A USA-US072-2020-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-15 2020-11-17 .BdBf mRNA-1273-P301HOmRNA-1273-P301-US329-2109A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-02 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US329-2121A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T20:402020-09-10T20:40.BB mRNA-1273-P301HOmRNA-1273-P301-US329-2126A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T18:482020-08-11T18:48.AA mRNA-1273-P301HOmRNA-1273-P301-US329-2127AUSA-US072-2020-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-25 2020-12-04 .BkBt mRNA-1273-P301HOmRNA-1273-P301-US329-2127A USA-US072-2020-mRNA-1273-P301000015HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-17 2021-01-11 .BBš mRNA-1273-P301HOmRNA-1273-P301-US329-2128AUSA-US072-2021-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-04 2021-03-05 .BÎBÏ mRNA-1273-P301HOmRNA-1273-P301-US329-2149AUSA-US072-2021-mRNA-1273-P301000013HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US329-2149A USA-US072-2021-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-01 2021-02-03 .BB¯ mRNA-1273-P301HOmRNA-1273-P301-US329-2156A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T14:032020-09-16T14:03.B#B# mRNA-1273-P301HOmRNA-1273-P301-US329-2158AUSA-US072-2021-mRNA-1273-P301000019HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-28 2021-03-29 .BäBå mRNA-1273-P301HOmRNA-1273-P301-US329-2158A USA-US072-2021-mRNA-1273-P301000019HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-07 2021-04-09 .BîBð mRNA-1273-P301HOmRNA-1273-P301-US329-2162A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T19:372020-08-14T20:07.AA mRNA-1273-P301HOmRNA-1273-P301-US329-2173AUSA-US072-2021-mRNA-1273-P301000022HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-28 2021-04-30 .C0CP mRNA-1273-P301HOmRNA-1273-P301-US329-2188A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 Bž.. mRNA-1273-P301HOmRNA-1273-P301-US329-2193A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T13:182020-10-10T15:02.B&B9 mRNA-1273-P301HOmRNA-1273-P301-US329-2196A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T19:062020-08-19T19:06.APAP mRNA-1273-P301HOmRNA-1273-P301-US329-2204A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T18:482020-08-17T18:48.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US329-2218A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B“.. mRNA-1273-P301HOmRNA-1273-P301-US329-2228A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T17:482020-08-19T17:48.A A mRNA-1273-P301HOmRNA-1273-P301-US329-2229A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T22:092020-08-23T22:09.A`A` mRNA-1273-P301HOmRNA-1273-P301-US329-2236AUSA-US072-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-04 2020-09-05 .BB mRNA-1273-P301HOmRNA-1273-P301-US329-2241A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T19:042020-08-27T19:04.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US329-2259AUSA-US072-2021-mRNA-1273-P301000006HO-AE-017 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-31 2021-01-04 .B†BŠ mRNA-1273-P301HOmRNA-1273-P301-US329-2259A USA-US072-2021-mRNA-1273-P301000006HO-AE-024 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-13 2021-02-18 .B²B· mRNA-1273-P301HOmRNA-1273-P301-US329-2265A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T05:262020-08-26T05:26.ApAp mRNA-1273-P301HOmRNA-1273-P301-US329-2271A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T22:362020-10-20T19:51.B7B= mRNA-1273-P301HOmRNA-1273-P301-US329-2280A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-06 Bl.. mRNA-1273-P301HOmRNA-1273-P301-US329-2286A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T21:082020-09-24T21:08.B#B# mRNA-1273-P301HOmRNA-1273-P301-US329-2289A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 BH.. mRNA-1273-P301HOmRNA-1273-P301-US329-2292A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T22:252020-09-24T22:25.BB mRNA-1273-P301HOmRNA-1273-P301-US329-2304AUSA-US072-2020-mRNA-1273-P301000005HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-04 2020-10-16 .B)B5 mRNA-1273-P301HOmRNA-1273-P301-US329-2304A USA-US072-2021-mRNA-1273-P301000010HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-15 2021-01-23 .BB˜ mRNA-1273-P301HOmRNA-1273-P301-US329-2312AUSA-US072-2020-mRNA-1273-P301000006HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US329-2312A USA-US072-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-25 2020-10-29 .B>BB mRNA-1273-P301HOmRNA-1273-P301-US329-2316AUSA-US072-2021-mRNA-1273-P301000005HO-AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-08 2021-01-15 .B‰B mRNA-1273-P301HOmRNA-1273-P301-US329-2320AUSA-US072-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-30 2020-09-04 .A`A° mRNA-1273-P301HOmRNA-1273-P301-US329-2320A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 BU.. mRNA-1273-P301HOmRNA-1273-P301-US329-2322A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B….. mRNA-1273-P301HOmRNA-1273-P301-US329-2324AUSA-US072-2020-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-03 2020-11-19 .BEBU mRNA-1273-P301HOmRNA-1273-P301-US329-2330A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T11:332020-09-02T21:24.AAp mRNA-1273-P301HOmRNA-1273-P301-US329-2335A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T21:322020-09-30T21:32.B#B# mRNA-1273-P301HOmRNA-1273-P301-US329-2339AUSA-US072-2020-mRNA-1273-P301000002HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US329-2339A USA-US072-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-17 2020-09-18 .BB mRNA-1273-P301HOmRNA-1273-P301-US329-2376A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T18:562020-10-01T18:56.B"B" mRNA-1273-P301HOmRNA-1273-P301-US329-2395A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T11:082020-09-17T11:08.AA mRNA-1273-P301HOmRNA-1273-P301-US329-2395A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 B8.. mRNA-1273-P301HOmRNA-1273-P301-US329-2407A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 B#.. mRNA-1273-P301HOmRNA-1273-P301-US329-2411A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-26 B^.. mRNA-1273-P301HOmRNA-1273-P301-US329-2412A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T21:492020-09-25T21:49.A A mRNA-1273-P301HOmRNA-1273-P301-US329-2412A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-25 A .. mRNA-1273-P301HOmRNA-1273-P301-US329-2412A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 B+.. mRNA-1273-P301HOmRNA-1273-P301-US329-2412A@ HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 BK.. mRNA-1273-P301HOmRNA-1273-P301-US329-2413A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US329-2424A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T19:032020-09-30T19:03.A A mRNA-1273-P301HOmRNA-1273-P301-US329-2427A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-07T21:292020-11-10T21:34.B(B+ mRNA-1273-P301HOmRNA-1273-P301-US329-2429A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T19:052020-10-21T19:05.BB mRNA-1273-P301HOmRNA-1273-P301-US329-2429A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T21:512020-10-29T21:51.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2002A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-03T16:132020-08-03T16:13.AA mRNA-1273-P301HOmRNA-1273-P301-US330-2005A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-23 BÍ.. mRNA-1273-P301HOmRNA-1273-P301-US330-2022A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T10:562020-09-01T10:56.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2031A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T18:072020-09-15T14:02.B*B+ mRNA-1273-P301HOmRNA-1273-P301-US330-2041A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T09:592020-08-05T09:59.AA mRNA-1273-P301HOmRNA-1273-P301-US330-2042A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B‹.. mRNA-1273-P301HOmRNA-1273-P301-US330-2044A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T18:182020-09-15T18:18.B*B* mRNA-1273-P301HOmRNA-1273-P301-US330-2045A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T16:482020-08-27T16:49.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2051A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-26 B¯.. mRNA-1273-P301HOmRNA-1273-P301-US330-2061A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-10-08T15:572020-10-08T15:57.B@B@ mRNA-1273-P301HOmRNA-1273-P301-US330-2062A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 B~.. mRNA-1273-P301HOmRNA-1273-P301-US330-2065A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B.. mRNA-1273-P301HOmRNA-1273-P301-US330-2069A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T08:582020-08-15T08:58.A A mRNA-1273-P301HOmRNA-1273-P301-US330-2091A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T14:102020-09-03T17:33.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2091A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T15:182020-09-10T15:18.B#B# mRNA-1273-P301HOmRNA-1273-P301-US330-2096A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T07:462020-09-08T07:46.B!B! mRNA-1273-P301HOmRNA-1273-P301-US330-2105AUSA-US087-2021-mRNA-1273-P301000020HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-19 2021-02-22 .BÅBÈ mRNA-1273-P301HOmRNA-1273-P301-US330-2114A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T08:452020-08-10T08:45.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US330-2115A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T12:102020-09-12T12:10.B"B" mRNA-1273-P301HOmRNA-1273-P301-US330-2127A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T09:362020-09-05T09:36.APAP mRNA-1273-P301HOmRNA-1273-P301-US330-2141A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T09:442020-09-12T09:44.B!B! mRNA-1273-P301HOmRNA-1273-P301-US330-2143A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-24 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US330-2159A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:552020-09-17T12:04.BB% mRNA-1273-P301HOmRNA-1273-P301-US330-2161A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B}.. mRNA-1273-P301HOmRNA-1273-P301-US330-2174A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T20:272020-09-14T20:27.B"B" mRNA-1273-P301HOmRNA-1273-P301-US330-2182A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-24 BI.. mRNA-1273-P301HOmRNA-1273-P301-US330-2187A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US330-2194A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T00:012020-08-21T00:01.AA mRNA-1273-P301HOmRNA-1273-P301-US330-2194A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T12:162020-09-11T12:16.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2212AUSA-US087-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-28 2020-09-30 .B.B0 mRNA-1273-P301HOmRNA-1273-P301-US330-2221A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US330-2229A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B.. mRNA-1273-P301HOmRNA-1273-P301-US330-2236A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 B{.. mRNA-1273-P301HOmRNA-1273-P301-US330-2242A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T18:272020-09-18T18:27.B!B! mRNA-1273-P301HOmRNA-1273-P301-US330-2267A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T17:242020-08-21T17:24.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US330-2287A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T10:262020-08-25T10:26.ApAp mRNA-1273-P301HOmRNA-1273-P301-US330-2292A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T13:162020-09-20T13:16.B B mRNA-1273-P301HOmRNA-1273-P301-US330-2292A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 BŸ.. mRNA-1273-P301HOmRNA-1273-P301-US330-2295A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T12:022020-09-27T12:02.B'B' mRNA-1273-P301HOmRNA-1273-P301-US330-2300A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T12:362020-08-20T12:36.AA mRNA-1273-P301HOmRNA-1273-P301-US330-2303A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 B”.. mRNA-1273-P301HOmRNA-1273-P301-US330-2310A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 BD.. mRNA-1273-P301HOmRNA-1273-P301-US330-2310A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 B`.. mRNA-1273-P301HOmRNA-1273-P301-US330-2312A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T19:112020-08-29T09:35.A0A mRNA-1273-P301HOmRNA-1273-P301-US330-2318A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US330-2320A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T20:522020-09-19T20:52.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2333A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-12 B2.. mRNA-1273-P301HOmRNA-1273-P301-US330-2339A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T09:512020-08-27T09:51.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US330-2348A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 By.. mRNA-1273-P301HOmRNA-1273-P301-US330-2352A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T07:482020-08-27T07:48.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US330-2375A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T20:142020-09-28T20:14.B"B" mRNA-1273-P301HOmRNA-1273-P301-US330-2377A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T17:102020-09-24T17:10.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2379AUSA-US087-2021-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-21 2021-01-29 .B•B mRNA-1273-P301HOmRNA-1273-P301-US330-2379A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B”.. mRNA-1273-P301HOmRNA-1273-P301-US330-2381A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US330-2383AUSA-US087-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-09-26 2020-09-28 .B B" mRNA-1273-P301HOmRNA-1273-P301-US330-2383A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-22 B.. mRNA-1273-P301HOmRNA-1273-P301-US330-2387A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T02:392020-09-19T09:59.BB mRNA-1273-P301HOmRNA-1273-P301-US330-2394A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T12:522020-08-27T12:52.AA mRNA-1273-P301HOmRNA-1273-P301-US330-2432A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T12:002020-09-02T12:00.A`A` mRNA-1273-P301HOmRNA-1273-P301-US330-2450A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T07:242020-10-19T07:24.B#B# mRNA-1273-P301HOmRNA-1273-P301-US330-2455AUSA-US087-2021-mRNA-1273-P301000023HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-06 2021-03-10 .B§B« mRNA-1273-P301HOmRNA-1273-P301-US330-2458A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US330-2470A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 B_.. mRNA-1273-P301HOmRNA-1273-P301-US330-2471A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T09:392020-10-14T09:39.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US330-2472AUSA-US087-2021-mRNA-1273-P301000017HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-22 2020-12-30 .BHBP mRNA-1273-P301HOmRNA-1273-P301-US331-2005A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B”.. mRNA-1273-P301HOmRNA-1273-P301-US331-2008AUSA-US300-2021-mRNA-1273-P301000024HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-15 2021-04-18 .BùBü mRNA-1273-P301HOmRNA-1273-P301-US331-2017A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T23:002020-09-08T23:00.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T18:292020-08-14T18:29.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US331-2023AUSA-US300-2020-mRNA-1273-P301000027HO-AE-018 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-18 2020-12-19 .B‚Bƒ mRNA-1273-P301HOmRNA-1273-P301-US331-2023A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T17:252020-08-17T16:38.APAp mRNA-1273-P301HOmRNA-1273-P301-US331-2042A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T22:012020-08-17T22:01.A`A` mRNA-1273-P301HOmRNA-1273-P301-US331-2046AUSA-US300-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-07 2020-10-09 .B9B; mRNA-1273-P301HOmRNA-1273-P301-US331-2053A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 B•.. mRNA-1273-P301HOmRNA-1273-P301-US331-2056A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T16:262020-08-12T16:26.AA mRNA-1273-P301HOmRNA-1273-P301-US331-2060A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T23:002020-09-12T23:00.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2068A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-25 AÐ.. mRNA-1273-P301HOmRNA-1273-P301-US331-2070A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T16:132020-09-12T16:13.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2079A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T19:372020-09-11T19:37.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2086A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B™.. mRNA-1273-P301HOmRNA-1273-P301-US331-2093AUSA-US300-2021-mRNA-1273-P301000014HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-08 2021-02-10 .B³Bµ mRNA-1273-P301HOmRNA-1273-P301-US331-2095AUSA-US300-2021-mRNA-1273-P301000019HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-19 2021-02-22 .B»B¾ mRNA-1273-P301HOmRNA-1273-P301-US331-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T21:372020-09-21T21:37.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US331-2095A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US331-2096A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 B—.. mRNA-1273-P301HOmRNA-1273-P301-US331-2103A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B›.. mRNA-1273-P301HOmRNA-1273-P301-US331-2110A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B†.. mRNA-1273-P301HOmRNA-1273-P301-US331-2112A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T22:082020-08-20T22:08.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US331-2112A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T19:162020-09-15T19:16.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2130AUSA-US300-2020-mRNA-1273-P301000022HO-AE-002/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-16 2020-12-18 .ByB{ mRNA-1273-P301HOmRNA-1273-P301-US331-2130A USA-US300-2021-mRNA-1273-P301000015HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-11 2021-02-13 .B²B´ mRNA-1273-P301HOmRNA-1273-P301-US331-2130A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US331-2148A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T21:272020-08-25T21:27.ApAp mRNA-1273-P301HOmRNA-1273-P301-US331-2169A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T07:472020-08-20T07:47.A A mRNA-1273-P301HOmRNA-1273-P301-US331-2177A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US331-2187AUSA-US300-2020-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-12 2020-11-14 .BUBW mRNA-1273-P301HOmRNA-1273-P301-US331-2197AUSA-US300-2020-mRNA-1273-P301000015HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-28 2020-12-01 .BeBh mRNA-1273-P301HOmRNA-1273-P301-US331-2197A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T18:382020-08-25T18:38.A`A` mRNA-1273-P301HOmRNA-1273-P301-US331-2197A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US331-2199A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T21:532020-09-25T21:53.B%B% mRNA-1273-P301HOmRNA-1273-P301-US331-2206A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US331-2212AUSA-US300-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-03 2020-09-09 .AàB mRNA-1273-P301HOmRNA-1273-P301-US331-2213A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T20:382020-09-24T15:09.B B# mRNA-1273-P301HOmRNA-1273-P301-US331-2224AUSA-US300-2021-mRNA-1273-P301000018HO-AE-002/AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US331-2224A USA-US300-2021-mRNA-1273-P301000018HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-19 2021-02-25 .B´Bº mRNA-1273-P301HOmRNA-1273-P301-US331-2225A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BN.. mRNA-1273-P301HOmRNA-1273-P301-US331-2235A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BN.. mRNA-1273-P301HOmRNA-1273-P301-US331-2281A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T20:242020-08-28T20:24.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US331-2291AUSA-US300-2020-mRNA-1273-P301000025HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-28 2020-11-29 .B_B` mRNA-1273-P301HOmRNA-1273-P301-US331-2296A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 B@.. mRNA-1273-P301HOmRNA-1273-P301-US331-2305A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:262020-09-25T12:26.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2307A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US331-2325AUSA-US300-2020-mRNA-1273-P301000020HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-11 2020-12-12 .BkBl mRNA-1273-P301HOmRNA-1273-P301-US331-2330A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B|.. mRNA-1273-P301HOmRNA-1273-P301-US331-2334A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T14:022020-08-27T14:02.AA mRNA-1273-P301HOmRNA-1273-P301-US331-2342A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US331-2355A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T22:292020-09-28T22:29.B B mRNA-1273-P301HOmRNA-1273-P301-US331-2356A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 B.. mRNA-1273-P301HOmRNA-1273-P301-US331-2372A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T12:012020-09-28T12:01.B B mRNA-1273-P301HOmRNA-1273-P301-US331-2379AUSA-US300-2021-mRNA-1273-P301000020HO-AE-022 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-16 2021-03-17 .BÉBÊ mRNA-1273-P301HOmRNA-1273-P301-US331-2379A USA-US300-2021-mRNA-1273-P301000023HO-AE-020 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-11 2021-04-13 .BãBå mRNA-1273-P301HOmRNA-1273-P301-US331-2384A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T21:462020-09-04T21:46.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US331-2388A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Br.. mRNA-1273-P301HOmRNA-1273-P301-US331-2391A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T21:042020-09-28T21:04.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2395AUSA-US300-2021-mRNA-1273-P301000016HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-02 2021-02-15 .BœB© mRNA-1273-P301HOmRNA-1273-P301-US331-2402A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-23 B6.. mRNA-1273-P301HOmRNA-1273-P301-US331-2406A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T20:292020-09-28T20:29.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2413A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T22:572020-09-04T22:57.APAP mRNA-1273-P301HOmRNA-1273-P301-US331-2414A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T18:392020-09-06T18:39.ApAp mRNA-1273-P301HOmRNA-1273-P301-US331-2422A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T17:122020-10-03T16:00.B B! mRNA-1273-P301HOmRNA-1273-P301-US331-2431A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T00:012020-09-04T00:01.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US331-2434AUSA-US300-2021-mRNA-1273-P301000017HO-AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-01 2021-02-03 .BšBœ mRNA-1273-P301HOmRNA-1273-P301-US331-2435A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T00:012020-10-05T19:34.B!B# mRNA-1273-P301HOmRNA-1273-P301-US331-2437A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US331-2437A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B“.. mRNA-1273-P301HOmRNA-1273-P301-US331-2439A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B“.. mRNA-1273-P301HOmRNA-1273-P301-US331-2455A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T18:502020-09-03T18:50.A A mRNA-1273-P301HOmRNA-1273-P301-US331-2464A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T20:012020-09-05T20:01.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US331-2465AUSA-US300-2021-mRNA-1273-P301000021HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-02 2021-03-05 .B¶B¹ mRNA-1273-P301HOmRNA-1273-P301-US331-2481A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T00:372020-09-07T00:37.APAP mRNA-1273-P301HOmRNA-1273-P301-US331-2484A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T18:022020-09-05T18:02.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US331-2499A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T19:032020-10-02T19:03.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2539A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T17:142020-10-12T17:14.B#B# mRNA-1273-P301HOmRNA-1273-P301-US331-2548A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-07 B.. mRNA-1273-P301HOmRNA-1273-P301-US331-2551A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-11-19T20:002020-12-04T21:20.BIBX mRNA-1273-P301HOmRNA-1273-P301-US331-2558A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T11:022020-10-13T11:02.B#B# mRNA-1273-P301HOmRNA-1273-P301-US331-2560A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T10:132020-10-10T22:19.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2563A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-09 BÕ.. mRNA-1273-P301HOmRNA-1273-P301-US331-2581A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 BT.. mRNA-1273-P301HOmRNA-1273-P301-US331-2582A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T19:082020-09-10T22:37.AA mRNA-1273-P301HOmRNA-1273-P301-US331-2587A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-07 B.. mRNA-1273-P301HOmRNA-1273-P301-US331-2595A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T21:042020-09-13T21:04.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US331-2598A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T20:542020-09-18T20:54.AA mRNA-1273-P301HOmRNA-1273-P301-US331-2605AUSA-US300-2020-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-27 2020-10-29 .B0B2 mRNA-1273-P301HOmRNA-1273-P301-US331-2605A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 B8.. mRNA-1273-P301HOmRNA-1273-P301-US331-2608A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-18 BF.. mRNA-1273-P301HOmRNA-1273-P301-US331-2617A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T16:242020-10-09T16:24.BB mRNA-1273-P301HOmRNA-1273-P301-US331-2622A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T00:572020-09-17T22:58.A`Ap mRNA-1273-P301HOmRNA-1273-P301-US331-2622A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-23 B+.. mRNA-1273-P301HOmRNA-1273-P301-US331-2623A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B_.. mRNA-1273-P301HOmRNA-1273-P301-US331-2629AUSA-US300-2020-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-06 2020-11-10 .B9B= mRNA-1273-P301HOmRNA-1273-P301-US331-2633A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T21:262020-10-12T21:26.B B mRNA-1273-P301HOmRNA-1273-P301-US331-2637AUSA-US300-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-15 2020-10-16 .B#B$ mRNA-1273-P301HOmRNA-1273-P301-US332-2006A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-14 B.. mRNA-1273-P301HOmRNA-1273-P301-US332-2056A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T16:582020-09-23T16:58.B"B" mRNA-1273-P301HOmRNA-1273-P301-US332-2061A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-11 B.. mRNA-1273-P301HOmRNA-1273-P301-US332-2064A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US332-2073A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T06:502020-08-29T06:50.AA mRNA-1273-P301HOmRNA-1273-P301-US332-2123A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B“.. mRNA-1273-P301HOmRNA-1273-P301-US332-2131A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T19:162020-09-02T19:16.APAP mRNA-1273-P301HOmRNA-1273-P301-US332-2135A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T14:032020-08-31T14:03.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US332-2139A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T00:002020-10-09T12:06.B"B$ mRNA-1273-P301HOmRNA-1273-P301-US332-2144A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 BV.. mRNA-1273-P301HOmRNA-1273-P301-US332-2159A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T22:582020-10-19T22:58.B'B' mRNA-1273-P301HOmRNA-1273-P301-US332-2167A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-12-01T23:282020-12-01T23:28.B\B\ mRNA-1273-P301HOmRNA-1273-P301-US332-2204A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US332-2223A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T20:242020-09-08T21:34.A0AP mRNA-1273-P301HOmRNA-1273-P301-US332-2226A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-25 B¯.. mRNA-1273-P301HOmRNA-1273-P301-US332-2239A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-23 B... mRNA-1273-P301HOmRNA-1273-P301-US332-2241A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T12:102020-09-08T12:10.AA mRNA-1273-P301HOmRNA-1273-P301-US332-2256A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US332-2257A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T15:332020-09-14T15:33.ApAp mRNA-1273-P301HOmRNA-1273-P301-US332-2275A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T15:202020-10-18T15:20.B(B( mRNA-1273-P301HOmRNA-1273-P301-US332-2293A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T11:572020-09-29T11:57.APAP mRNA-1273-P301HOmRNA-1273-P301-US332-2296A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US332-2301A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B\.. mRNA-1273-P301HOmRNA-1273-P301-US332-2308A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T19:062020-09-12T19:06.AA mRNA-1273-P301HOmRNA-1273-P301-US332-2314AUSA-US060-2021-mRNA-1273-P301000011HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-05 2021-04-06 .BÏBÐ mRNA-1273-P301HOmRNA-1273-P301-US332-2320A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T12:132020-10-13T15:26.B B! mRNA-1273-P301HOmRNA-1273-P301-US332-2323A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T00:122020-10-21T00:12.B)B) mRNA-1273-P301HOmRNA-1273-P301-US332-2323A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US332-2329A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T12:022020-10-17T12:02.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US332-2336A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-04T18:432020-11-04T18:43.BB mRNA-1273-P301HOmRNA-1273-P301-US332-2341AUSA-US060-2021-mRNA-1273-P301000007HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-13 2021-01-14 .BiBj mRNA-1273-P301HOmRNA-1273-P301-US332-2347A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-25 B).. mRNA-1273-P301HOmRNA-1273-P301-US332-2353A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T13:312020-09-20T13:31.A`A` mRNA-1273-P301HOmRNA-1273-P301-US332-2360A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T13:182020-09-17T13:18.AA mRNA-1273-P301HOmRNA-1273-P301-US332-2365A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 BN.. mRNA-1273-P301HOmRNA-1273-P301-US332-2379A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T22:422020-10-02T22:42.A A mRNA-1273-P301HOmRNA-1273-P301-US332-2388A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 BU.. mRNA-1273-P301HOmRNA-1273-P301-US332-2396A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T23:182020-11-06T23:18.B'B' mRNA-1273-P301HOmRNA-1273-P301-US332-2400A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 B7.. mRNA-1273-P301HOmRNA-1273-P301-US332-2401A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-26T13:062020-11-26T13:06.B:B: mRNA-1273-P301HOmRNA-1273-P301-US332-2403A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T14:532020-10-02T14:53.A A mRNA-1273-P301HOmRNA-1273-P301-US332-2404A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T12:032020-10-07T14:53.A Ap mRNA-1273-P301HOmRNA-1273-P301-US332-2409A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 B+.. mRNA-1273-P301HOmRNA-1273-P301-US332-2412A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 B_.. mRNA-1273-P301HOmRNA-1273-P301-US332-2413A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-05T20:292020-11-05T20:29.B B mRNA-1273-P301HOmRNA-1273-P301-US332-2414A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T12:492020-10-11T22:58.A@Ap mRNA-1273-P301HOmRNA-1273-P301-US332-2416A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T22:562020-10-11T15:20.APA` mRNA-1273-P301HOmRNA-1273-P301-US332-2429AUSA-US060-2021-mRNA-1273-P301000009HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-31 2021-01-01 .BOBP mRNA-1273-P301HOmRNA-1273-P301-US333-2001A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-29 B:.. mRNA-1273-P301HOmRNA-1273-P301-US333-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T13:032020-09-01T13:03.BB mRNA-1273-P301HOmRNA-1273-P301-US333-2031A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T09:352020-08-12T09:35.A`A` mRNA-1273-P301HOmRNA-1273-P301-US333-2033AUSA-US202-2021-mRNA-1273-P301000005HO-AE-007 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US333-2033A USA-US202-2021-mRNA-1273-P301000005HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-26 2021-02-27 .BÉBÊ mRNA-1273-P301HOmRNA-1273-P301-US333-2033A0USA-US202-2021-mRNA-1273-P301000005HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-28 2021-03-05 .BËBÐ mRNA-1273-P301HOmRNA-1273-P301-US333-2035A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T16:012020-09-14T16:01.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US333-2045A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T13:112020-09-17T13:11.B%B% mRNA-1273-P301HOmRNA-1273-P301-US333-2055A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T23:092020-09-18T23:09.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US333-2059AUSA-US202-2021-mRNA-1273-P301000006HO-AE-003/AE-004/AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-22 .Bò. mRNA-1273-P301HOmRNA-1273-P301-US333-2065A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T17:412020-08-26T17:41.AA mRNA-1273-P301HOmRNA-1273-P301-US333-2068A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B.. mRNA-1273-P301HOmRNA-1273-P301-US333-2076A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T15:012020-09-08T15:01.ApAp mRNA-1273-P301HOmRNA-1273-P301-US333-2079A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T11:462020-09-04T11:46.AA mRNA-1273-P301HOmRNA-1273-P301-US333-2089A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-25 A.. mRNA-1273-P301HOmRNA-1273-P301-US333-2095A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T00:002020-10-07T00:00.ApAp mRNA-1273-P301HOmRNA-1273-P301-US333-2101A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 BS.. mRNA-1273-P301HOmRNA-1273-P301-US334-2019A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US334-2023AUSA-US203-2021-mRNA-1273-P301000013HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-01 2021-04-02 .BêBë mRNA-1273-P301HOmRNA-1273-P301-US334-2025A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US334-2026A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US334-2028A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T19:112020-08-12T19:11.A A mRNA-1273-P301HOmRNA-1273-P301-US334-2030A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T21:582020-08-11T21:58.AA mRNA-1273-P301HOmRNA-1273-P301-US334-2034A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T00:562020-08-14T00:56.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US334-2046A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US334-2048A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 B™.. mRNA-1273-P301HOmRNA-1273-P301-US334-2049A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T18:552020-09-12T18:55.BB mRNA-1273-P301HOmRNA-1273-P301-US334-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T19:432020-08-15T21:16.AA mRNA-1273-P301HOmRNA-1273-P301-US334-2063A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T18:192020-09-21T18:19.B'B' mRNA-1273-P301HOmRNA-1273-P301-US334-2085AUSA-US203-2021-mRNA-1273-P301000007HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-02 2021-02-03 .BªB« mRNA-1273-P301HOmRNA-1273-P301-US334-2085A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T07:222020-09-22T07:22.B%B% mRNA-1273-P301HOmRNA-1273-P301-US334-2086A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T22:402020-08-17T22:40.AA mRNA-1273-P301HOmRNA-1273-P301-US334-2092A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T12:062020-08-23T12:06.A`A` mRNA-1273-P301HOmRNA-1273-P301-US334-2093A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T15:012020-09-17T15:01.BB mRNA-1273-P301HOmRNA-1273-P301-US334-2105A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T17:242020-09-22T17:24.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US334-2127AUSA-US203-2021-mRNA-1273-P301000012HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-06 2021-03-22 .BÇB× mRNA-1273-P301HOmRNA-1273-P301-US334-2127A USA-US203-2021-mRNA-1273-P301000015HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-16 2021-04-18 .BðBò mRNA-1273-P301HOmRNA-1273-P301-US334-2131A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US334-2132A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-26 B .. mRNA-1273-P301HOmRNA-1273-P301-US334-2142A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T00:242020-09-28T00:24.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US334-2146A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 BN.. mRNA-1273-P301HOmRNA-1273-P301-US334-2152A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B|.. mRNA-1273-P301HOmRNA-1273-P301-US334-2167A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T17:172020-09-01T17:17.AA mRNA-1273-P301HOmRNA-1273-P301-US334-2170A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-26 B“.. mRNA-1273-P301HOmRNA-1273-P301-US334-2182A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T22:212020-10-26T20:04.B1B6 mRNA-1273-P301HOmRNA-1273-P301-US334-2182A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US334-2191A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T12:052020-10-13T12:05.B(B( mRNA-1273-P301HOmRNA-1273-P301-US334-2199AUSA-US203-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-13 2020-09-15 .A AÀ mRNA-1273-P301HOmRNA-1273-P301-US334-2200A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T16:022020-12-07T12:07.B'B_ mRNA-1273-P301HOmRNA-1273-P301-US334-2218A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T14:142020-09-13T14:14.APAP mRNA-1273-P301HOmRNA-1273-P301-US334-2218A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T07:022020-10-21T07:02.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US334-2229A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:212020-09-10T12:21.AA mRNA-1273-P301HOmRNA-1273-P301-US334-2232A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T13:522020-09-13T13:52.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US334-2272A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T21:582020-10-22T13:18.A B# mRNA-1273-P301HOmRNA-1273-P301-US334-2277A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T12:212020-10-20T12:21.BB mRNA-1273-P301HOmRNA-1273-P301-US334-2278A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T15:542020-10-21T15:54.BB mRNA-1273-P301HOmRNA-1273-P301-US334-2278A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-19 BÑ.. mRNA-1273-P301HOmRNA-1273-P301-US334-2281AUSA-US203-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-29 2020-10-30 .B$B% mRNA-1273-P301HOmRNA-1273-P301-US334-2281A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-31T09:242020-10-31T09:24.B&B& mRNA-1273-P301HOmRNA-1273-P301-US334-2288A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T19:452020-10-23T19:45.BB mRNA-1273-P301HOmRNA-1273-P301-US334-2302A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T10:152020-10-29T10:15.BB mRNA-1273-P301HOmRNA-1273-P301-US334-2310A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T20:572020-10-02T20:57.A A mRNA-1273-P301HOmRNA-1273-P301-US334-2323A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 B.. mRNA-1273-P301HOmRNA-1273-P301-US334-2340A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T09:412020-10-20T09:41.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US334-2343AUSA-US203-2021-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-31 2021-04-02 .B«B mRNA-1273-P301HOmRNA-1273-P301-US334-2354AUSA-US203-2020-mRNA-1273-P301000011HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US334-2354A USA-US203-2021-mRNA-1273-P301000016HO-AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US334-2354A0USA-US203-2020-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-11 2020-12-13 .B<B> mRNA-1273-P301HOmRNA-1273-P301-US334-2354A@USA-US203-2021-mRNA-1273-P301000016HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-18 2021-04-24 .B¼BÂ mRNA-1273-P301HOmRNA-1273-P301-US335-2015AUSA-US066-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-26 2021-03-28 .BëBí mRNA-1273-P301HOmRNA-1273-P301-US335-2015A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T12:232020-09-04T12:23.B B mRNA-1273-P301HOmRNA-1273-P301-US335-2033AUSA-US066-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-05 2020-11-10 .B\Ba mRNA-1273-P301HOmRNA-1273-P301-US335-2041A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T15:312020-09-08T15:31.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2046A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T02:462020-09-12T02:46.B!B! mRNA-1273-P301HOmRNA-1273-P301-US335-2064A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T20:302020-08-18T20:30.A`A` mRNA-1273-P301HOmRNA-1273-P301-US335-2070AUSA-US066-2021-mRNA-1273-P301000011HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-20 .B‚. mRNA-1273-P301HOmRNA-1273-P301-US335-2070A USA-US066-2021-mRNA-1273-P301000008HO-AE-002/AE-003/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-10 .BÒ. mRNA-1273-P301HOmRNA-1273-P301-US335-2071A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US335-2072A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T22:022020-09-08T06:35.AB mRNA-1273-P301HOmRNA-1273-P301-US335-2072A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-21 A.. mRNA-1273-P301HOmRNA-1273-P301-US335-2087A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T20:142020-08-14T20:14.A A mRNA-1273-P301HOmRNA-1273-P301-US335-2090A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US335-2114A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-22 Bø.. mRNA-1273-P301HOmRNA-1273-P301-US335-2130A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T18:462020-09-18T18:46.B B mRNA-1273-P301HOmRNA-1273-P301-US335-2134A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T19:592020-08-25T19:59.A`A` mRNA-1273-P301HOmRNA-1273-P301-US335-2143A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T16:122020-08-20T16:12.AA mRNA-1273-P301HOmRNA-1273-P301-US335-2146A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T20:392020-08-26T21:26.A Ap mRNA-1273-P301HOmRNA-1273-P301-US335-2146A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T15:292020-09-23T15:11.BB# mRNA-1273-P301HOmRNA-1273-P301-US335-2154A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T19:012020-09-23T19:01.B#B# mRNA-1273-P301HOmRNA-1273-P301-US335-2187A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US335-2188A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US335-2190A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T20:402020-08-28T20:40.ApAp mRNA-1273-P301HOmRNA-1273-P301-US335-2213AUSA-US066-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-29 2021-02-03 .B¡B¦ mRNA-1273-P301HOmRNA-1273-P301-US335-2217A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T19:262020-09-22T19:26.B B mRNA-1273-P301HOmRNA-1273-P301-US335-2245A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 B?.. mRNA-1273-P301HOmRNA-1273-P301-US335-2261A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-21 BY.. mRNA-1273-P301HOmRNA-1273-P301-US335-2297AUSA-US066-2021-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-20 2021-01-23 .BŽB‘ mRNA-1273-P301HOmRNA-1273-P301-US335-2299AUSA-US066-2020-mRNA-1273-P301000005HO-AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-11 2020-11-13 .BHBJ mRNA-1273-P301HOmRNA-1273-P301-US335-2299A USA-US066-2020-mRNA-1273-P301000009HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-29 2020-12-01 .BZB\ mRNA-1273-P301HOmRNA-1273-P301-US335-2304AUSA-US066-2021-mRNA-1273-P301000012HO-AE-014 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-04-09 2021-04-09 .BÝBÝ mRNA-1273-P301HOmRNA-1273-P301-US335-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US335-2307A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US335-2321A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T13:042020-10-09T13:04.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2337A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B~.. mRNA-1273-P301HOmRNA-1273-P301-US335-2349AUSA-US066-2021-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-26 2021-03-26 .BªBÆ mRNA-1273-P301HOmRNA-1273-P301-US335-2357A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T13:372020-10-08T13:37.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2376A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T23:282020-09-24T00:22.A0A` mRNA-1273-P301HOmRNA-1273-P301-US335-2376A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T00:072020-10-22T00:07.B"B" mRNA-1273-P301HOmRNA-1273-P301-US335-2381A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-15 B–.. mRNA-1273-P301HOmRNA-1273-P301-US335-2406A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T18:452020-09-27T18:45.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US335-2406A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T11:102020-10-22T11:10.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2424AUSA-US066-2020-mRNA-1273-P301000002HO-AE-001/AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-17 2020-10-18 .BB mRNA-1273-P301HOmRNA-1273-P301-US335-2424A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-31T00:502020-10-31T00:50.B&B& mRNA-1273-P301HOmRNA-1273-P301-US335-2425A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T07:172020-10-23T07:17.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2436A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T10:222020-10-02T10:22.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US335-2448A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US335-2467A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T17:472020-10-14T17:47.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2476A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T16:492020-10-18T16:49.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2507A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T17:442020-10-07T17:44.A A mRNA-1273-P301HOmRNA-1273-P301-US335-2511A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-03 B“.. mRNA-1273-P301HOmRNA-1273-P301-US335-2517A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T19:212020-10-09T19:21.A A mRNA-1273-P301HOmRNA-1273-P301-US335-2526A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T14:522020-10-11T12:27.A0A@ mRNA-1273-P301HOmRNA-1273-P301-US335-2528A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T04:122020-10-14T04:12.ApAp mRNA-1273-P301HOmRNA-1273-P301-US335-2538A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T08:222020-11-17T08:22.B"B" mRNA-1273-P301HOmRNA-1273-P301-US335-2542A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-14T00:012020-11-14T00:01.BB mRNA-1273-P301HOmRNA-1273-P301-US335-2551A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T12:512020-10-17T12:51.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US335-2557A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T21:152020-10-21T20:36.APAp mRNA-1273-P301HOmRNA-1273-P301-US335-2570A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T20:242020-11-17T20:24.B"B" mRNA-1273-P301HOmRNA-1273-P301-US335-2581A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-30 B.. mRNA-1273-P301HOmRNA-1273-P301-US335-2594A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T17:582020-10-23T17:58.A A mRNA-1273-P301HOmRNA-1273-P301-US336-2001A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T15:552020-08-13T15:55.AàAà mRNA-1273-P301HOmRNA-1273-P301-US336-2003A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T12:562020-08-03T20:19.AA0 mRNA-1273-P301HOmRNA-1273-P301-US336-2012A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T02:232020-08-08T02:23.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US336-2018A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 B\.. mRNA-1273-P301HOmRNA-1273-P301-US336-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T12:072020-08-09T12:07.ApAp mRNA-1273-P301HOmRNA-1273-P301-US336-2032A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T13:542020-08-06T13:54.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US336-2039A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B¡.. mRNA-1273-P301HOmRNA-1273-P301-US336-2040A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 B\.. mRNA-1273-P301HOmRNA-1273-P301-US336-2046A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US336-2055A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B›.. mRNA-1273-P301HOmRNA-1273-P301-US336-2061A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US336-2069AUSA-US112-2020-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-06 2020-12-11 .BzB mRNA-1273-P301HOmRNA-1273-P301-US336-2071AUSA-US112-2020-mRNA-1273-P301000013HO-AE-001/AE-002/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-03 2020-12-05 .BwBy mRNA-1273-P301HOmRNA-1273-P301-US336-2071A USA-US112-2021-mRNA-1273-P301000013HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-05 2021-03-10 .BÓBØ mRNA-1273-P301HOmRNA-1273-P301-US336-2081A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T13:342020-09-11T13:34.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US336-2082A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 Bš.. mRNA-1273-P301HOmRNA-1273-P301-US336-2083A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-31 B.. mRNA-1273-P301HOmRNA-1273-P301-US336-2086A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T22:302020-08-11T22:30.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US336-2090A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B.. mRNA-1273-P301HOmRNA-1273-P301-US336-2099AUSA-US112-2021-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-26 2021-01-28 .BªB¬ mRNA-1273-P301HOmRNA-1273-P301-US336-2116AUSA-US112-2021-mRNA-1273-P301000009HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-30 2021-02-02 .B¬B¯ mRNA-1273-P301HOmRNA-1273-P301-US336-2116A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T14:042020-09-20T14:04.B(B( mRNA-1273-P301HOmRNA-1273-P301-US336-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T11:512020-09-09T11:51.BB mRNA-1273-P301HOmRNA-1273-P301-US336-2124A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T10:472020-08-13T10:47.AA mRNA-1273-P301HOmRNA-1273-P301-US336-2124A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-21 A.. mRNA-1273-P301HOmRNA-1273-P301-US336-2125AUSA-US112-2021-mRNA-1273-P301000015HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-17 2021-03-20 .BÙBÜ mRNA-1273-P301HOmRNA-1273-P301-US336-2125A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BY.. mRNA-1273-P301HOmRNA-1273-P301-US336-2133A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US336-2141A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US336-2142A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US336-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US336-2157A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T22:212020-09-18T22:21.B#B# mRNA-1273-P301HOmRNA-1273-P301-US336-2166AUSA-US112-2020-mRNA-1273-P301000015HO-AE-006/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-24 2020-11-25 .BdBe mRNA-1273-P301HOmRNA-1273-P301-US336-2168A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US336-2176A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T19:092020-09-16T19:09.BB mRNA-1273-P301HOmRNA-1273-P301-US336-2183A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T05:222020-08-23T05:22.A`A` mRNA-1273-P301HOmRNA-1273-P301-US336-2184A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T20:192020-09-01T20:56.AAð mRNA-1273-P301HOmRNA-1273-P301-US336-2199A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T22:432020-09-23T22:43.B#B# mRNA-1273-P301HOmRNA-1273-P301-US336-2203A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-25 B¾.. mRNA-1273-P301HOmRNA-1273-P301-US336-2210AUSA-US112-2021-mRNA-1273-P301000005HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-08 2021-01-09 .BBŽ mRNA-1273-P301HOmRNA-1273-P301-US336-2222AUSA-US112-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-10 2020-10-11 .B,B- mRNA-1273-P301HOmRNA-1273-P301-US336-2223A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:162020-09-25T12:16.B#B# mRNA-1273-P301HOmRNA-1273-P301-US336-2227A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US336-2244AUSA-US112-2020-mRNA-1273-P301000007HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-09-29 2020-10-05 .B%B+ mRNA-1273-P301HOmRNA-1273-P301-US336-2244A USA-US112-2020-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-12 2020-10-20 .B2B: mRNA-1273-P301HOmRNA-1273-P301-US336-2255A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-26 Bš.. mRNA-1273-P301HOmRNA-1273-P301-US336-2257A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T17:072020-10-03T17:07.B'B' mRNA-1273-P301HOmRNA-1273-P301-US336-2269A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T12:012020-10-06T12:01.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US336-2281A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 BJ.. mRNA-1273-P301HOmRNA-1273-P301-US336-2283A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bt.. mRNA-1273-P301HOmRNA-1273-P301-US336-2285AUSA-US112-2020-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-16 2020-11-18 .B6B8 mRNA-1273-P301HOmRNA-1273-P301-US336-2294A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T16:532020-10-29T16:53.B"B" mRNA-1273-P301HOmRNA-1273-P301-US336-2303A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-04T19:522020-11-05T12:07.BB mRNA-1273-P301HOmRNA-1273-P301-US336-2306A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T11:392020-10-08T11:39.AA mRNA-1273-P301HOmRNA-1273-P301-US336-2310A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T12:502020-11-18T12:50.B&B& mRNA-1273-P301HOmRNA-1273-P301-US336-2315A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-16T12:342020-11-16T12:34.B!B! mRNA-1273-P301HOmRNA-1273-P301-US337-2005AUSA-US056-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-25 2020-08-31 .BB mRNA-1273-P301HOmRNA-1273-P301-US337-2058A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 B„.. mRNA-1273-P301HOmRNA-1273-P301-US337-2059AUSA-US056-2020-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-18 2020-12-22 .B†BŠ mRNA-1273-P301HOmRNA-1273-P301-US337-2059A USA-US056-2020-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-18 2021-01-22 .B¥B© mRNA-1273-P301HOmRNA-1273-P301-US337-2059A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-19 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US337-2060AUSA-US056-2020-mRNA-1273-P301000004HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-14 2020-08-16 .A€A mRNA-1273-P301HOmRNA-1273-P301-US337-2086A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 B.. mRNA-1273-P301HOmRNA-1273-P301-US337-2089AUSA-US056-2021-mRNA-1273-P301000010HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-16 2021-02-17 .B¾B¿ mRNA-1273-P301HOmRNA-1273-P301-US337-2089A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T16:372020-09-09T12:01.A B mRNA-1273-P301HOmRNA-1273-P301-US337-2102A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T21:312020-08-18T21:31.ApAp mRNA-1273-P301HOmRNA-1273-P301-US337-2137AUSA-US056-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-19 2021-01-22 .BŸB¢ mRNA-1273-P301HOmRNA-1273-P301-US337-2138A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US337-2151A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T22:292020-09-21T14:41.B!B$ mRNA-1273-P301HOmRNA-1273-P301-US337-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US337-2184AUSA-US056-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-02 2020-09-06 .AðB mRNA-1273-P301HOmRNA-1273-P301-US337-2184A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T06:002020-09-26T06:00.B'B' mRNA-1273-P301HOmRNA-1273-P301-US337-2189A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B|.. mRNA-1273-P301HOmRNA-1273-P301-US337-2196A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T21:062020-08-30T21:06.A°A° mRNA-1273-P301HOmRNA-1273-P301-US337-2209AUSA-US056-2020-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-16 2020-12-17 .BvBw mRNA-1273-P301HOmRNA-1273-P301-US337-2210A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T16:482020-10-01T16:48.B*B* mRNA-1273-P301HOmRNA-1273-P301-US337-2220A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T12:102020-08-24T12:10.AA mRNA-1273-P301HOmRNA-1273-P301-US337-2234A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US337-2237A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 BI.. mRNA-1273-P301HOmRNA-1273-P301-US337-2237A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 By.. mRNA-1273-P301HOmRNA-1273-P301-US337-2239A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T15:562020-08-30T15:56.A`A` mRNA-1273-P301HOmRNA-1273-P301-US337-2273A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B|.. mRNA-1273-P301HOmRNA-1273-P301-US337-2274AUSA-US056-2020-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-13 2020-12-14 .BmBn mRNA-1273-P301HOmRNA-1273-P301-US337-2281A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T18:052020-08-31T18:05.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US337-2282A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T04:582020-10-23T08:51.B6B9 mRNA-1273-P301HOmRNA-1273-P301-US337-2283A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T17:032020-08-30T17:03.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US337-2284A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US337-2290A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 BD.. mRNA-1273-P301HOmRNA-1273-P301-US337-2348AUSA-US056-2021-mRNA-1273-P301000014HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US337-2348A USA-US056-2021-mRNA-1273-P301000014HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-02 2021-04-04 .BÈBÊ mRNA-1273-P301HOmRNA-1273-P301-US337-2355A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-22 B·.. mRNA-1273-P301HOmRNA-1273-P301-US337-2356A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T18:352020-10-14T18:35.B#B# mRNA-1273-P301HOmRNA-1273-P301-US337-2363A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T15:292020-10-21T15:29.B,B, mRNA-1273-P301HOmRNA-1273-P301-US337-2390A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B\.. mRNA-1273-P301HOmRNA-1273-P301-US337-2391A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T12:482020-10-21T12:48.B*B* mRNA-1273-P301HOmRNA-1273-P301-US337-2394AUSA-US056-2020-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-11 2020-11-13 .B>B@ mRNA-1273-P301HOmRNA-1273-P301-US337-2409A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T22:302020-09-20T23:12.A@A` mRNA-1273-P301HOmRNA-1273-P301-US337-2427A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T21:062020-10-20T21:06.B#B# mRNA-1273-P301HOmRNA-1273-P301-US337-2428A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-26 B….. mRNA-1273-P301HOmRNA-1273-P301-US337-2429A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-04 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US337-2449A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T13:452020-09-27T13:45.APAP mRNA-1273-P301HOmRNA-1273-P301-US337-2451A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T23:412020-09-26T23:41.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US337-2482A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T12:292020-10-23T12:29.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US338-2002A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T02:092020-09-10T02:09.B B mRNA-1273-P301HOmRNA-1273-P301-US338-2016A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-26 B.. mRNA-1273-P301HOmRNA-1273-P301-US338-2035A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T12:332020-08-24T12:33.A°A° mRNA-1273-P301HOmRNA-1273-P301-US338-2035A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-22 A.. mRNA-1273-P301HOmRNA-1273-P301-US338-2036A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T22:562020-09-11T22:56.BB mRNA-1273-P301HOmRNA-1273-P301-US338-2047A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T13:432020-09-19T13:43.B"B" mRNA-1273-P301HOmRNA-1273-P301-US338-2048A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T17:022020-08-27T12:01.AA° mRNA-1273-P301HOmRNA-1273-P301-US338-2082A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T12:112020-08-25T12:11.A`A` mRNA-1273-P301HOmRNA-1273-P301-US338-2088A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T21:022020-08-26T21:02.ApAp mRNA-1273-P301HOmRNA-1273-P301-US338-2096A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T19:082020-08-25T19:08.A A mRNA-1273-P301HOmRNA-1273-P301-US338-2096A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-01-16 ÂÝ.. mRNA-1273-P301HOmRNA-1273-P301-US338-2097A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-05 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US338-2111A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T12:072020-08-28T12:07.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US338-2123A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T14:052020-09-26T14:05.BB mRNA-1273-P301HOmRNA-1273-P301-US338-2136A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T13:552020-08-28T13:55.AA mRNA-1273-P301HOmRNA-1273-P301-US338-2144A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T20:302020-09-28T20:30.BB mRNA-1273-P301HOmRNA-1273-P301-US338-2148A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T13:022020-08-31T13:02.AA mRNA-1273-P301HOmRNA-1273-P301-US338-2152A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 B@.. mRNA-1273-P301HOmRNA-1273-P301-US338-2156A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T19:362020-09-03T19:36.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US338-2163A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T21:462020-09-01T21:46.AA mRNA-1273-P301HOmRNA-1273-P301-US338-2170A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T19:302020-09-09T19:30.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US338-2194A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T13:182020-10-15T13:18.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US338-2203A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T21:122020-10-12T21:12.B'B' mRNA-1273-P301HOmRNA-1273-P301-US338-2209A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T22:512020-09-10T22:51.ApAp mRNA-1273-P301HOmRNA-1273-P301-US338-2211A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T13:592020-10-08T13:58.B"B# mRNA-1273-P301HOmRNA-1273-P301-US338-2217A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-04 B–.. mRNA-1273-P301HOmRNA-1273-P301-US338-2235A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T23:392020-09-12T23:39.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US338-2235A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T19:012020-10-14T19:01.B#B# mRNA-1273-P301HOmRNA-1273-P301-US338-2235A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 BU.. mRNA-1273-P301HOmRNA-1273-P301-US338-2256A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US338-2262A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T17:562020-09-18T17:56.ApAp mRNA-1273-P301HOmRNA-1273-P301-US338-2267A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T22:082020-10-17T19:01.B!B$ mRNA-1273-P301HOmRNA-1273-P301-US338-2281A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US338-2282A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T13:112020-10-15T13:11.BB mRNA-1273-P301HOmRNA-1273-P301-US338-2291A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T22:472020-10-20T22:47.B!B! mRNA-1273-P301HOmRNA-1273-P301-US339-2010A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US339-2049AUSA-US119-2020-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-21 2020-12-23 .B}B mRNA-1273-P301HOmRNA-1273-P301-US339-2056A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T17:002020-09-24T19:10.B"B$ mRNA-1273-P301HOmRNA-1273-P301-US339-2065AUSA-US119-2021-mRNA-1273-P301000009HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-24 2021-03-25 .BØBÙ mRNA-1273-P301HOmRNA-1273-P301-US339-2069A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-17 Bµ.. mRNA-1273-P301HOmRNA-1273-P301-US339-2071A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T22:282020-08-21T22:28.AA mRNA-1273-P301HOmRNA-1273-P301-US339-2078A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T07:292020-09-01T07:29.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US339-2082A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T20:532020-09-25T20:53.B B mRNA-1273-P301HOmRNA-1273-P301-US339-2100A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T18:022020-09-22T18:02.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2112AUSA-US119-2020-mRNA-1273-P301000014HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-27 2020-12-30 .BzB} mRNA-1273-P301HOmRNA-1273-P301-US339-2112A USA-US119-2021-mRNA-1273-P301000010HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-26 2021-03-01 .B·Bº mRNA-1273-P301HOmRNA-1273-P301-US339-2112A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T13:572020-09-03T13:57.ApAp mRNA-1273-P301HOmRNA-1273-P301-US339-2112A@ HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B5.. mRNA-1273-P301HOmRNA-1273-P301-US339-2120AUSA-US119-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-24 2020-10-26 .B7B9 mRNA-1273-P301HOmRNA-1273-P301-US339-2133AUSA-US119-2021-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-09 2021-03-12 .B¾BÁ mRNA-1273-P301HOmRNA-1273-P301-US339-2133A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T14:212020-09-29T14:21.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2135A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T18:182020-10-02T22:19.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2143A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-31 B<.. mRNA-1273-P301HOmRNA-1273-P301-US339-2149AUSA-US119-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-24 2020-09-25 .BB mRNA-1273-P301HOmRNA-1273-P301-US339-2169A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:302020-09-09T12:30.A`A` mRNA-1273-P301HOmRNA-1273-P301-US339-2184A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US339-2195A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T22:142020-09-09T22:14.AA mRNA-1273-P301HOmRNA-1273-P301-US339-2236A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T06:002020-10-13T06:00.B!B! mRNA-1273-P301HOmRNA-1273-P301-US339-2240A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T19:092020-09-18T20:09.A A€ mRNA-1273-P301HOmRNA-1273-P301-US339-2242A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T12:072020-10-09T13:05.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2249A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T17:362020-10-10T19:03.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2251AUSA-US119-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-20 2020-10-22 .B'B) mRNA-1273-P301HOmRNA-1273-P301-US339-2251A USA-US119-2020-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-25 2020-12-28 .BiBl mRNA-1273-P301HOmRNA-1273-P301-US339-2253A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-22 BH.. mRNA-1273-P301HOmRNA-1273-P301-US339-2263A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T19:452020-10-16T19:45.B#B# mRNA-1273-P301HOmRNA-1273-P301-US339-2272A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T12:022020-10-10T12:02.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2280A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T19:022020-09-17T19:02.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US339-2287AUSA-US119-2021-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-08 2021-02-09 .B’B“ mRNA-1273-P301HOmRNA-1273-P301-US339-2290A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T17:022020-09-19T17:02.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US339-2295A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T19:152020-10-15T19:12.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2307A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T17:132020-10-14T17:13.BB mRNA-1273-P301HOmRNA-1273-P301-US339-2309A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 BK.. mRNA-1273-P301HOmRNA-1273-P301-US339-2311A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 B1.. mRNA-1273-P301HOmRNA-1273-P301-US339-2342A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T17:522020-09-24T17:52.A A mRNA-1273-P301HOmRNA-1273-P301-US339-2349A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T17:102020-10-02T17:10.A A mRNA-1273-P301HOmRNA-1273-P301-US339-2349A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T13:182020-11-06T13:18.B%B% mRNA-1273-P301HOmRNA-1273-P301-US339-2355A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BX.. mRNA-1273-P301HOmRNA-1273-P301-US340-2001A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 BU.. mRNA-1273-P301HOmRNA-1273-P301-US340-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US340-2010A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T17:022020-09-02T14:09.B%B& mRNA-1273-P301HOmRNA-1273-P301-US340-2012A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T15:562020-07-30T15:56.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US340-2013A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-02T13:392020-08-02T13:39.ApAp mRNA-1273-P301HOmRNA-1273-P301-US340-2021A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T23:592020-08-30T23:59.B#B# mRNA-1273-P301HOmRNA-1273-P301-US340-2024A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-28T05:292020-07-29T17:13.A A0 mRNA-1273-P301HOmRNA-1273-P301-US340-2029AUSA-US059-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-07 2020-10-13 .BIBO mRNA-1273-P301HOmRNA-1273-P301-US340-2029A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-30 BB.. mRNA-1273-P301HOmRNA-1273-P301-US340-2030A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B–.. mRNA-1273-P301HOmRNA-1273-P301-US340-2033A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T21:462020-08-25T21:46.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2042AUSA-US059-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-13 2020-10-17 .BNBR mRNA-1273-P301HOmRNA-1273-P301-US340-2055A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T23:352020-08-26T23:35.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2066A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-19 C.. mRNA-1273-P301HOmRNA-1273-P301-US340-2082AUSA-US059-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-01 2021-02-03 .B¼B¾ mRNA-1273-P301HOmRNA-1273-P301-US340-2094A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T13:292020-08-07T13:29.A A mRNA-1273-P301HOmRNA-1273-P301-US340-2094A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-02 BB.. mRNA-1273-P301HOmRNA-1273-P301-US340-2101A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T19:242020-08-28T19:24.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2119A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 B¦.. mRNA-1273-P301HOmRNA-1273-P301-US340-2135A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T06:042020-08-11T06:04.A°A° mRNA-1273-P301HOmRNA-1273-P301-US340-2139AUSA-US059-2020-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-12 2020-10-14 .BIBK mRNA-1273-P301HOmRNA-1273-P301-US340-2147A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-24 BÐ.. mRNA-1273-P301HOmRNA-1273-P301-US340-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B¦.. mRNA-1273-P301HOmRNA-1273-P301-US340-2162A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T06:462020-08-07T06:46.ApAp mRNA-1273-P301HOmRNA-1273-P301-US340-2188A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T21:132020-09-02T21:13.B B mRNA-1273-P301HOmRNA-1273-P301-US340-2194AUSA-US059-2020-mRNA-1273-P301000018HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-16 2020-11-26 .BkBu mRNA-1273-P301HOmRNA-1273-P301-US340-2194A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US340-2196A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B•.. mRNA-1273-P301HOmRNA-1273-P301-US340-2201A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T12:492020-09-04T12:49.B!B! mRNA-1273-P301HOmRNA-1273-P301-US340-2204AUSA-US059-2021-mRNA-1273-P301000007HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-30 2021-01-31 .BµB¶ mRNA-1273-P301HOmRNA-1273-P301-US340-2204A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US340-2208A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-05 Bö.. mRNA-1273-P301HOmRNA-1273-P301-US340-2212AUSA-US059-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-23 2020-08-25 .BB mRNA-1273-P301HOmRNA-1273-P301-US340-2213A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T08:112020-09-10T08:11.B&B& mRNA-1273-P301HOmRNA-1273-P301-US340-2225AUSA-US059-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-08 2021-02-16 .B½BÅ mRNA-1273-P301HOmRNA-1273-P301-US340-2226A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T20:412020-09-03T20:41.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2232A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-26 Bê.. mRNA-1273-P301HOmRNA-1273-P301-US340-2236A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T18:162020-08-09T18:16.APAP mRNA-1273-P301HOmRNA-1273-P301-US340-2236A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 B«.. mRNA-1273-P301HOmRNA-1273-P301-US340-2243A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T12:382020-09-03T12:38.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2265A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T12:022020-08-07T12:02.A A mRNA-1273-P301HOmRNA-1273-P301-US340-2271A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T18:232020-09-04T18:23.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2284AUSA-US059-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-22 2020-09-23 .B.B/ mRNA-1273-P301HOmRNA-1273-P301-US340-2284A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T08:192020-09-24T08:19.B0B0 mRNA-1273-P301HOmRNA-1273-P301-US340-2288AUSA-US059-2021-mRNA-1273-P301000015HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-02 2021-04-11 .BîB÷ mRNA-1273-P301HOmRNA-1273-P301-US340-2299AUSA-US059-2020-mRNA-1273-P301000003HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US340-2299A USA-US059-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-26 2020-09-01 .BB mRNA-1273-P301HOmRNA-1273-P301-US340-2300A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T18:212020-08-13T18:21.A`A` mRNA-1273-P301HOmRNA-1273-P301-US340-2316A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-14 BC.. mRNA-1273-P301HOmRNA-1273-P301-US340-2328A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US340-2332A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US340-2337A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T22:182020-08-17T22:18.APAP mRNA-1273-P301HOmRNA-1273-P301-US340-2344A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-14 B=.. mRNA-1273-P301HOmRNA-1273-P301-US340-2358A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US340-2370A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-29 B¢.. mRNA-1273-P301HOmRNA-1273-P301-US340-2374A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T13:422020-08-21T13:42.A`A` mRNA-1273-P301HOmRNA-1273-P301-US340-2374A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T13:502020-09-18T13:50.B"B" mRNA-1273-P301HOmRNA-1273-P301-US340-2380A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T21:352020-09-15T21:35.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2382AUSA-US059-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-28 2020-09-01 .AÐB mRNA-1273-P301HOmRNA-1273-P301-US340-2387A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T12:072020-08-17T12:07.A A mRNA-1273-P301HOmRNA-1273-P301-US340-2406A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T14:062020-09-23T14:06.B"B" mRNA-1273-P301HOmRNA-1273-P301-US340-2408A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-27 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US340-2415A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BP.. mRNA-1273-P301HOmRNA-1273-P301-US340-2420AUSA-US059-2021-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-23 2021-03-24 .BÖB× mRNA-1273-P301HOmRNA-1273-P301-US340-2425AUSA-US059-2020-mRNA-1273-P301000019HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-17 2020-11-20 .BXB[ mRNA-1273-P301HOmRNA-1273-P301-US340-2448AUSA-US059-2020-mRNA-1273-P301000017HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-09 2020-11-11 .BB mRNA-1273-P301HOmRNA-1273-P301-US340-2453A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-29T14:222020-11-29T14:22.B'B' mRNA-1273-P301HOmRNA-1273-P301-US340-2455A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T07:422020-11-08T12:40.BB mRNA-1273-P301HOmRNA-1273-P301-US340-2472A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-30T22:032020-10-30T22:03.AA mRNA-1273-P301HOmRNA-1273-P301-US340-2472A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-12-03T20:422020-12-03T20:42.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US341-2006A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T08:192020-09-02T08:19.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US341-2010A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-29T22:062020-07-29T22:06.AA mRNA-1273-P301HOmRNA-1273-P301-US341-2012A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B™.. mRNA-1273-P301HOmRNA-1273-P301-US341-2013AUSA-US061-2020-mRNA-1273-P301000014HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-22 2020-11-24 .BuBw mRNA-1273-P301HOmRNA-1273-P301-US341-2016AUSA-US061-2020-mRNA-1273-P301000018HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-02 2020-12-04 .BB mRNA-1273-P301HOmRNA-1273-P301-US341-2022AUSA-US061-2021-mRNA-1273-P301000006HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-28 2021-02-02 .B¸B½ mRNA-1273-P301HOmRNA-1273-P301-US341-2022A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US341-2030AUSA-US061-2021-mRNA-1273-P301000019HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-18 2021-04-22 .CpC° mRNA-1273-P301HOmRNA-1273-P301-US341-2050A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T00:002020-08-30T00:00.B B mRNA-1273-P301HOmRNA-1273-P301-US341-2051A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T16:582020-08-01T16:58.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US341-2054A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-30T20:482020-07-30T20:48.AA mRNA-1273-P301HOmRNA-1273-P301-US341-2059AUSA-US061-2021-mRNA-1273-P301000014HO-AE-002/AE-003/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-06 2021-03-08 .BÛBÝ mRNA-1273-P301HOmRNA-1273-P301-US341-2062A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-16 Bå.. mRNA-1273-P301HOmRNA-1273-P301-US341-2067AUSA-US061-2021-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-03 .B. mRNA-1273-P301HOmRNA-1273-P301-US341-2067A USA-US061-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-02 .B». mRNA-1273-P301HOmRNA-1273-P301-US341-2073A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T23:082020-08-10T23:08.A°A° mRNA-1273-P301HOmRNA-1273-P301-US341-2081AUSA-US061-2020-mRNA-1273-P301000012HO-AE-001/AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US341-2081A USA-US061-2020-mRNA-1273-P301000012HO-AE-001/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-13 2020-11-26 .BjBw mRNA-1273-P301HOmRNA-1273-P301-US341-2081A0USA-US061-2020-mRNA-1273-P301000012HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-13 2021-01-13 .B§B§ mRNA-1273-P301HOmRNA-1273-P301-US341-2087A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-07-31T22:342020-07-31T22:34.AA mRNA-1273-P301HOmRNA-1273-P301-US341-2095A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T16:532020-08-17T16:44.AÀAà mRNA-1273-P301HOmRNA-1273-P301-US341-2096A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T16:192020-09-05T16:19.BB mRNA-1273-P301HOmRNA-1273-P301-US341-2108A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US341-2114A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T09:152020-08-04T09:15.AA mRNA-1273-P301HOmRNA-1273-P301-US341-2118AUSA-US061-2020-mRNA-1273-P301000015HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US341-2118A USA-US061-2020-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-19 2020-11-20 .BlBm mRNA-1273-P301HOmRNA-1273-P301-US341-2122A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T12:032020-08-07T14:27.A0A@ mRNA-1273-P301HOmRNA-1273-P301-US341-2125AUSA-US061-2020-mRNA-1273-P301000005HO-AE-001/AE-002/AE-003/AE-004/AE-005/AE-007/AE-008/AE-009/AE-010/AE-014ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P10DmRNA-1273-P301HOmRNA-1273-P301-US341-2125A USA-US061-2020-mRNA-1273-P301000005HO-AE-001/AE-002/AE-003/AE-004/AE-005/AE-007/AE-008/AE-009/AE-010/AE-014HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-08 2020-10-01 .B$B; mRNA-1273-P301HOmRNA-1273-P301-US341-2126AUSA-US061-2020-mRNA-1273-P301000004HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-22 2020-09-01 .BB mRNA-1273-P301HOmRNA-1273-P301-US341-2127AUSA-US061-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-16 2020-08-20 .AÀB mRNA-1273-P301HOmRNA-1273-P301-US341-2129A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-24 B.. mRNA-1273-P301HOmRNA-1273-P301-US341-2141A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B™.. mRNA-1273-P301HOmRNA-1273-P301-US341-2151AUSA-US061-2021-mRNA-1273-P301000017HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US341-2151A USA-US061-2021-mRNA-1273-P301000017HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-31 .Bî. mRNA-1273-P301HOmRNA-1273-P301-US341-2186A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T21:032020-09-11T21:03.B!B! mRNA-1273-P301HOmRNA-1273-P301-US341-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T17:582020-08-10T17:58.AA mRNA-1273-P301HOmRNA-1273-P301-US341-2200AUSA-US061-2021-mRNA-1273-P301000018HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-06 2021-04-14 .BïB÷ mRNA-1273-P301HOmRNA-1273-P301-US341-2200A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T19:182020-08-17T19:18.ApAp mRNA-1273-P301HOmRNA-1273-P301-US341-2205AUSA-US061-2021-mRNA-1273-P301000011HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-04 2021-02-05 .B²B³ mRNA-1273-P301HOmRNA-1273-P301-US341-2208A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T19:282020-09-09T19:28.BB mRNA-1273-P301HOmRNA-1273-P301-US341-2208A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US341-2215A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T14:092020-08-13T14:09.A A mRNA-1273-P301HOmRNA-1273-P301-US341-2224A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T18:172020-08-18T18:17.APAP mRNA-1273-P301HOmRNA-1273-P301-US341-2224A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US341-2231A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T21:382020-09-12T19:04.BB mRNA-1273-P301HOmRNA-1273-P301-US341-2240AUSA-US061-2020-mRNA-1273-P301000016HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US341-2240A USA-US061-2020-mRNA-1273-P301000016HO-AE-003/AE-004/AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P6D mRNA-1273-P301HOmRNA-1273-P301-US341-2240A0USA-US061-2020-mRNA-1273-P301000016HO-AE-001/AE-003/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-05 2020-12-24 .BrB… mRNA-1273-P301HOmRNA-1273-P301-US341-2243AUSA-US061-2021-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-13 2021-01-18 .B™Bž mRNA-1273-P301HOmRNA-1273-P301-US341-2245A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US341-2246AUSA-US061-2021-mRNA-1273-P301000013HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US341-2246A USA-US061-2021-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-02 2021-03-04 .BÉBË mRNA-1273-P301HOmRNA-1273-P301-US341-2259A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BU.. mRNA-1273-P301HOmRNA-1273-P301-US341-2262AUSA-US061-2021-mRNA-1273-P301000020HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-21 2021-04-24 .BøBû mRNA-1273-P301HOmRNA-1273-P301-US341-2266A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B“.. mRNA-1273-P301HOmRNA-1273-P301-US341-2270A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BM.. mRNA-1273-P301HOmRNA-1273-P301-US341-2281A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T22:012020-08-23T22:12.A@AP mRNA-1273-P301HOmRNA-1273-P301-US341-2286A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T21:312020-09-30T00:11.BB* mRNA-1273-P301HOmRNA-1273-P301-US341-2291A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-21 B?.. mRNA-1273-P301HOmRNA-1273-P301-US341-2296AUSA-US061-2021-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-08 2021-03-10 .BÉBË mRNA-1273-P301HOmRNA-1273-P301-US341-2300A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 BI.. mRNA-1273-P301HOmRNA-1273-P301-US341-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 BJ.. mRNA-1273-P301HOmRNA-1273-P301-US341-2314A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T21:062020-08-26T21:06.A A mRNA-1273-P301HOmRNA-1273-P301-US341-2314A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US341-2319A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T22:482020-09-23T22:48.BB mRNA-1273-P301HOmRNA-1273-P301-US341-2328AUSA-US061-2020-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-17 2020-09-18 .BB mRNA-1273-P301HOmRNA-1273-P301-US341-2337AUSA-US061-2021-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-22 2021-02-25 .B°B³ mRNA-1273-P301HOmRNA-1273-P301-US341-2349A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T21:212020-09-30T21:21.BB mRNA-1273-P301HOmRNA-1273-P301-US341-2362A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T02:052020-10-10T06:48.B"B& mRNA-1273-P301HOmRNA-1273-P301-US341-2368A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T18:502020-09-03T18:50.AA mRNA-1273-P301HOmRNA-1273-P301-US341-2378A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-12-09T12:002020-12-09T12:00.B9B9 mRNA-1273-P301HOmRNA-1273-P301-US341-2379A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T09:402020-10-22T14:38.A0Ap mRNA-1273-P301HOmRNA-1273-P301-US341-2379A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-13T13:532020-11-19T21:40.BB# mRNA-1273-P301HOmRNA-1273-P301-US341-2388A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-20T17:412020-11-20T17:41.BB mRNA-1273-P301HOmRNA-1273-P301-US342-2006A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T13:502020-08-14T13:50.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US342-2032A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T14:182020-08-28T14:18.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US342-2064A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T20:302020-09-18T20:30.BB mRNA-1273-P301HOmRNA-1273-P301-US342-2068A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B„.. mRNA-1273-P301HOmRNA-1273-P301-US342-2086A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T13:412020-08-23T13:18.A A0 mRNA-1273-P301HOmRNA-1273-P301-US342-2087A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-24 B{.. mRNA-1273-P301HOmRNA-1273-P301-US342-2090A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-28 Bø.. mRNA-1273-P301HOmRNA-1273-P301-US342-2099A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T08:072020-08-31T08:07.ApAp mRNA-1273-P301HOmRNA-1273-P301-US342-2101AUSA-US082-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-13 2021-02-15 .BB¯ mRNA-1273-P301HOmRNA-1273-P301-US342-2101A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T18:002020-09-02T18:00.AA mRNA-1273-P301HOmRNA-1273-P301-US342-2104A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T17:232020-09-24T17:23.BB mRNA-1273-P301HOmRNA-1273-P301-US342-2111A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T07:442020-10-01T07:46.B$B% mRNA-1273-P301HOmRNA-1273-P301-US342-2135AUSA-US082-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-06 2020-10-08 .B(B* mRNA-1273-P301HOmRNA-1273-P301-US342-2144A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-03 B.. mRNA-1273-P301HOmRNA-1273-P301-US342-2148A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T15:352020-10-06T15:35.B%B% mRNA-1273-P301HOmRNA-1273-P301-US342-2149A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 B9.. mRNA-1273-P301HOmRNA-1273-P301-US342-2153A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T16:462020-10-13T16:46.B,B, mRNA-1273-P301HOmRNA-1273-P301-US342-2155A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T21:082020-08-31T21:08.AA mRNA-1273-P301HOmRNA-1273-P301-US342-2168A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 BV.. mRNA-1273-P301HOmRNA-1273-P301-US342-2177A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T05:492020-09-04T05:49.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US342-2179A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T22:432020-09-03T22:43.A A mRNA-1273-P301HOmRNA-1273-P301-US342-2201A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US342-2210A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B.. mRNA-1273-P301HOmRNA-1273-P301-US342-2216A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T06:182020-10-10T06:18.B%B% mRNA-1273-P301HOmRNA-1273-P301-US342-2220A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T10:512020-09-17T10:51.A A mRNA-1273-P301HOmRNA-1273-P301-US342-2248A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T07:222020-09-14T07:22.A`A` mRNA-1273-P301HOmRNA-1273-P301-US342-2269A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T12:012020-09-14T12:15.A0A@ mRNA-1273-P301HOmRNA-1273-P301-US342-2269A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T12:062020-10-29T12:06.B1B1 mRNA-1273-P301HOmRNA-1273-P301-US342-2276A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 BY.. mRNA-1273-P301HOmRNA-1273-P301-US342-2281AUSA-US082-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-27 2020-10-28 .B+B, mRNA-1273-P301HOmRNA-1273-P301-US342-2310A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-04T22:472020-11-04T22:47.B&B& mRNA-1273-P301HOmRNA-1273-P301-US342-2311A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 B".. mRNA-1273-P301HOmRNA-1273-P301-US343-2016AUSA-US078-2020-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-24 2020-10-24 .BQBQ mRNA-1273-P301HOmRNA-1273-P301-US343-2023AUSA-US078-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-20 2020-08-21 .BB mRNA-1273-P301HOmRNA-1273-P301-US343-2023A USA-US078-2021-mRNA-1273-P301000011HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-29 2021-02-16 .B²BÄ mRNA-1273-P301HOmRNA-1273-P301-US343-2023A0USA-US078-2021-mRNA-1273-P301000020HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-04 2021-04-07 .BóBö mRNA-1273-P301HOmRNA-1273-P301-US343-2026A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T16:072020-08-05T16:07.AA mRNA-1273-P301HOmRNA-1273-P301-US343-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T22:222020-09-10T22:22.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US343-2051A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-08 Bº.. mRNA-1273-P301HOmRNA-1273-P301-US343-2053A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-12 BÌ.. mRNA-1273-P301HOmRNA-1273-P301-US343-2060A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T19:392020-08-18T06:32.A AÀ mRNA-1273-P301HOmRNA-1273-P301-US343-2064A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T15:182020-09-10T12:02.B!B" mRNA-1273-P301HOmRNA-1273-P301-US343-2068A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T19:562020-08-18T19:56.AA mRNA-1273-P301HOmRNA-1273-P301-US343-2079A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T16:272020-08-17T00:00.AA€ mRNA-1273-P301HOmRNA-1273-P301-US343-2081AUSA-US078-2021-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-20 2021-01-21 .B¤B¥ mRNA-1273-P301HOmRNA-1273-P301-US343-2090A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-03 B±.. mRNA-1273-P301HOmRNA-1273-P301-US343-2094AUSA-US078-2020-mRNA-1273-P301000015HO-AE-003/AE-009 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P24DmRNA-1273-P301HOmRNA-1273-P301-US343-2094A USA-US078-2020-mRNA-1273-P301000015HO-AE-003/AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-23 2020-12-23 .BiB‡ mRNA-1273-P301HOmRNA-1273-P301-US343-2094A0USA-US078-2020-mRNA-1273-P301000015HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-30 2021-01-04 .BŽB“ mRNA-1273-P301HOmRNA-1273-P301-US343-2094A@USA-US078-2021-mRNA-1273-P301000013HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-02 2021-02-05 .B°B³ mRNA-1273-P301HOmRNA-1273-P301-US343-2095A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T20:222020-08-12T20:22.A A mRNA-1273-P301HOmRNA-1273-P301-US343-2096A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T16:502020-08-17T16:50.ApAp mRNA-1273-P301HOmRNA-1273-P301-US343-2120AUSA-US078-2021-mRNA-1273-P301000012HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-31 2021-02-02 .BB¯ mRNA-1273-P301HOmRNA-1273-P301-US343-2124A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T09:352020-09-01T09:35.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2126A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 BU.. mRNA-1273-P301HOmRNA-1273-P301-US343-2137A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T18:102020-08-13T18:10.AA mRNA-1273-P301HOmRNA-1273-P301-US343-2140A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T18:202020-08-18T18:20.APAP mRNA-1273-P301HOmRNA-1273-P301-US343-2146A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 B|.. mRNA-1273-P301HOmRNA-1273-P301-US343-2162A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T21:472020-09-13T21:47.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2163A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T21:152020-09-17T21:15.B"B" mRNA-1273-P301HOmRNA-1273-P301-US343-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T17:022020-09-14T17:02.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2177A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-23 BŸ.. mRNA-1273-P301HOmRNA-1273-P301-US343-2186A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T19:042020-08-21T19:04.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US343-2188A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T15:212020-09-15T15:21.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2201A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T15:382020-08-28T19:55.A€A mRNA-1273-P301HOmRNA-1273-P301-US343-2202AUSA-US078-2020-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-25 2020-09-30 .B&B+ mRNA-1273-P301HOmRNA-1273-P301-US343-2202A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T22:052020-08-21T21:11.A A0 mRNA-1273-P301HOmRNA-1273-P301-US343-2208AUSA-US078-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-02 2020-10-05 .B,B/ mRNA-1273-P301HOmRNA-1273-P301-US343-2216A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-09 B.. mRNA-1273-P301HOmRNA-1273-P301-US343-2229AUSA-US078-2020-mRNA-1273-P301000007HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-24 2020-10-30 .BABG mRNA-1273-P301HOmRNA-1273-P301-US343-2229A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T12:552020-09-26T00:00.BB% mRNA-1273-P301HOmRNA-1273-P301-US343-2240AUSA-US078-2021-mRNA-1273-P301000018HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-08 2021-03-12 .BÇBË mRNA-1273-P301HOmRNA-1273-P301-US343-2240A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T22:412020-09-30T22:41.B(B( mRNA-1273-P301HOmRNA-1273-P301-US343-2241A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T05:592020-09-02T05:59.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US343-2258A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T12:312020-09-19T12:31.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2260A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T15:282020-09-05T15:28.AÐAÐ mRNA-1273-P301HOmRNA-1273-P301-US343-2260A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T13:362020-09-30T13:36.B&B& mRNA-1273-P301HOmRNA-1273-P301-US343-2261A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T14:262020-09-08T14:26.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2263A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T14:372020-08-24T14:37.AA mRNA-1273-P301HOmRNA-1273-P301-US343-2266A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T21:202020-09-28T18:35.B!B$ mRNA-1273-P301HOmRNA-1273-P301-US343-2266A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B.. mRNA-1273-P301HOmRNA-1273-P301-US343-2277A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T22:342020-09-25T22:34.B B mRNA-1273-P301HOmRNA-1273-P301-US343-2283A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T10:052020-09-29T10:05.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US343-2286A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T08:032020-08-29T08:03.APAP mRNA-1273-P301HOmRNA-1273-P301-US343-2289A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BM.. mRNA-1273-P301HOmRNA-1273-P301-US343-2292A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T19:002020-08-27T19:00.A A mRNA-1273-P301HOmRNA-1273-P301-US343-2295AUSA-US078-2020-mRNA-1273-P301000002HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US343-2295A USA-US078-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-17 2020-09-24 .BB mRNA-1273-P301HOmRNA-1273-P301-US343-2295A0USA-US078-2020-mRNA-1273-P301000002HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-01 2020-10-02 .B%B& mRNA-1273-P301HOmRNA-1273-P301-US343-2311A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T20:132020-08-29T20:13.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US343-2313A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T07:542020-10-03T07:54.B&B& mRNA-1273-P301HOmRNA-1273-P301-US343-2328A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US343-2344A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-14 B0.. mRNA-1273-P301HOmRNA-1273-P301-US343-2345A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T05:022020-09-01T05:02.APAP mRNA-1273-P301HOmRNA-1273-P301-US343-2349A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T07:092020-09-01T07:09.APAP mRNA-1273-P301HOmRNA-1273-P301-US343-2362A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T21:322020-10-12T21:32.B-B- mRNA-1273-P301HOmRNA-1273-P301-US343-2365A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T05:412020-10-06T05:41.B%B% mRNA-1273-P301HOmRNA-1273-P301-US343-2380AUSA-US078-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-09 2021-01-12 .BƒB† mRNA-1273-P301HOmRNA-1273-P301-US343-2380A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 B†.. mRNA-1273-P301HOmRNA-1273-P301-US343-2387A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 BN.. mRNA-1273-P301HOmRNA-1273-P301-US343-2388A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T00:442020-10-10T09:29.B!B( mRNA-1273-P301HOmRNA-1273-P301-US343-2394A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T09:502020-09-30T17:04.AB mRNA-1273-P301HOmRNA-1273-P301-US343-2396A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-09 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US343-2416A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 B\.. mRNA-1273-P301HOmRNA-1273-P301-US343-2424A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B{.. mRNA-1273-P301HOmRNA-1273-P301-US343-2425A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T13:392020-10-04T13:39.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2431A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-27 BU.. mRNA-1273-P301HOmRNA-1273-P301-US343-2437A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T21:342020-09-09T21:34.A`A` mRNA-1273-P301HOmRNA-1273-P301-US343-2438A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T02:232020-09-13T02:23.A A mRNA-1273-P301HOmRNA-1273-P301-US343-2438A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T07:552020-10-09T07:55.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US343-2449A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-12 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US343-2469A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T23:582020-09-10T23:58.A A mRNA-1273-P301HOmRNA-1273-P301-US343-2509A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-03T18:332020-11-03T18:33.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2517AUSA-US078-2021-mRNA-1273-P301000016HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-02 2021-02-03 .B‹BŒ mRNA-1273-P301HOmRNA-1273-P301-US343-2521A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US343-2522A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T06:502020-10-22T06:50.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US343-2545A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T13:212020-10-20T13:21.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2548A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T20:032020-10-23T20:03.B B mRNA-1273-P301HOmRNA-1273-P301-US343-2557A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T20:492020-09-25T20:49.AA mRNA-1273-P301HOmRNA-1273-P301-US343-2565A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T12:352020-09-28T12:35.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US343-2568A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T15:352020-09-30T15:35.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US343-2569A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-30T00:492020-10-30T00:49.B!B! mRNA-1273-P301HOmRNA-1273-P301-US343-2615A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-02 BO.. mRNA-1273-P301HOmRNA-1273-P301-US343-2617AUSA-US078-2021-mRNA-1273-P301000014HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-10 2021-02-03 .BSBk mRNA-1273-P301HOmRNA-1273-P301-US343-2617A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T07:272020-10-27T07:27.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US343-2618A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T23:272020-11-18T23:27.BB mRNA-1273-P301HOmRNA-1273-P301-US343-2627AUSA-US078-2020-mRNA-1273-P301000014HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-23 2020-11-24 .B"B# mRNA-1273-P301HOmRNA-1273-P301-US343-2635A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T10:182020-10-22T10:18.AA mRNA-1273-P301HOmRNA-1273-P301-US343-2638A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T20:562020-10-22T20:56.AA mRNA-1273-P301HOmRNA-1273-P301-US343-2642A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-09 BP.. mRNA-1273-P301HOmRNA-1273-P301-US343-2645A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T00:002020-10-24T00:00.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US343-2646A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-25T12:162020-11-25T12:16.B"B" mRNA-1273-P301HOmRNA-1273-P301-US344-2004A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T18:392020-09-10T18:39.BB mRNA-1273-P301HOmRNA-1273-P301-US344-2024AUSA-US017-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-07 2020-12-08 .BpBq mRNA-1273-P301HOmRNA-1273-P301-US344-2031AUSA-US017-2020-mRNA-1273-P301000003HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-03 2020-11-04 .BNBO mRNA-1273-P301HOmRNA-1273-P301-US344-2041A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B|.. mRNA-1273-P301HOmRNA-1273-P301-US344-2042A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T16:372020-08-25T16:37.A`A` mRNA-1273-P301HOmRNA-1273-P301-US344-2043A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US344-2048A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T20:172020-08-24T13:04.AAP mRNA-1273-P301HOmRNA-1273-P301-US344-2051AUSA-US017-2021-mRNA-1273-P301000005HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-19 2021-01-22 .B™Bœ mRNA-1273-P301HOmRNA-1273-P301-US344-2051A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-22 B@.. mRNA-1273-P301HOmRNA-1273-P301-US344-2051A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US344-2060AUSA-US017-2021-mRNA-1273-P301000009HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-11 2021-02-13 .B¯B± mRNA-1273-P301HOmRNA-1273-P301-US344-2065A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BX.. mRNA-1273-P301HOmRNA-1273-P301-US344-2068AUSA-US017-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-30 2020-12-31 .B„B… mRNA-1273-P301HOmRNA-1273-P301-US344-2069A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BN.. mRNA-1273-P301HOmRNA-1273-P301-US344-2074AUSA-US017-2021-mRNA-1273-P301000011HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US344-2074A USA-US017-2021-mRNA-1273-P301000011HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US344-2074A0USA-US017-2021-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-02 2021-04-06 .BÝBá mRNA-1273-P301HOmRNA-1273-P301-US344-2079A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T21:532020-08-30T21:53.A`A` mRNA-1273-P301HOmRNA-1273-P301-US344-2079A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T12:292020-09-26T12:29.B!B! mRNA-1273-P301HOmRNA-1273-P301-US344-2087A HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-22 2021-04-23 .BñBò mRNA-1273-P301HOmRNA-1273-P301-US344-2088A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:282020-09-25T12:28.B B mRNA-1273-P301HOmRNA-1273-P301-US344-2096A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B|.. mRNA-1273-P301HOmRNA-1273-P301-US344-2106A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T07:342020-09-02T07:34.A`A` mRNA-1273-P301HOmRNA-1273-P301-US344-2107A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B„.. mRNA-1273-P301HOmRNA-1273-P301-US344-2113AUSA-US017-2020-mRNA-1273-P301000001HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-03 2020-09-04 .A0A@ mRNA-1273-P301HOmRNA-1273-P301-US344-2113A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T14:392020-09-03T14:39.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US344-2119A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T19:102020-09-05T15:39.AA0 mRNA-1273-P301HOmRNA-1273-P301-US344-2122A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US344-2129A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T20:272020-09-30T20:27.BB mRNA-1273-P301HOmRNA-1273-P301-US344-2131A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bt.. mRNA-1273-P301HOmRNA-1273-P301-US344-2136A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T12:482020-10-14T12:48.BB mRNA-1273-P301HOmRNA-1273-P301-US344-2156A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T18:292020-09-16T18:29.A A mRNA-1273-P301HOmRNA-1273-P301-US344-2156A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T21:322020-10-26T18:51.B%B* mRNA-1273-P301HOmRNA-1273-P301-US344-2161A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T19:502020-09-21T19:50.ApAp mRNA-1273-P301HOmRNA-1273-P301-US344-2163A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T19:232020-10-21T19:23.B%B% mRNA-1273-P301HOmRNA-1273-P301-US344-2163A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-21 B%.. mRNA-1273-P301HOmRNA-1273-P301-US344-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T15:062020-10-15T15:06.BB mRNA-1273-P301HOmRNA-1273-P301-US344-2171A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 BW.. mRNA-1273-P301HOmRNA-1273-P301-US344-2173A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 BS.. mRNA-1273-P301HOmRNA-1273-P301-US344-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T14:052020-09-21T14:05.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US344-2222A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T12:452020-10-09T12:45.A A mRNA-1273-P301HOmRNA-1273-P301-US344-2223A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-05T06:402020-11-05T06:40.BB mRNA-1273-P301HOmRNA-1273-P301-US344-2248A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-19T18:042020-11-19T18:04.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2005A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T13:262020-08-27T13:26.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2021A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-23 B².. mRNA-1273-P301HOmRNA-1273-P301-US345-2023A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T12:222020-08-27T20:20.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2029A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T18:442020-08-04T18:44.A`A` mRNA-1273-P301HOmRNA-1273-P301-US345-2035A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US345-2041A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 B….. mRNA-1273-P301HOmRNA-1273-P301-US345-2071A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T10:192020-08-08T10:19.AA mRNA-1273-P301HOmRNA-1273-P301-US345-2071A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T04:412020-09-04T04:41.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US345-2076A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T12:122020-08-31T12:07.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2100A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T12:012020-08-06T12:01.A`A` mRNA-1273-P301HOmRNA-1273-P301-US345-2102A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B¤.. mRNA-1273-P301HOmRNA-1273-P301-US345-2115A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US345-2117A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T12:032020-08-30T12:03.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2127A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-13 BH.. mRNA-1273-P301HOmRNA-1273-P301-US345-2130A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US345-2168A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US345-2169A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T18:452020-09-03T18:45.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2176A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 B².. mRNA-1273-P301HOmRNA-1273-P301-US345-2177A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T19:522020-09-02T19:52.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2188A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T10:332020-08-09T09:35.A0A` mRNA-1273-P301HOmRNA-1273-P301-US345-2203A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US345-2212A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T17:532020-09-01T17:53.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2212A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US345-2216A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T19:502020-08-08T19:50.APAP mRNA-1273-P301HOmRNA-1273-P301-US345-2232A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 B.. mRNA-1273-P301HOmRNA-1273-P301-US345-2236A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T12:142020-08-07T13:22.A A0 mRNA-1273-P301HOmRNA-1273-P301-US345-2239A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T12:432020-08-08T12:43.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US345-2248A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T07:112020-08-14T07:11.A A mRNA-1273-P301HOmRNA-1273-P301-US345-2252A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T23:232020-08-11T23:23.ApAp mRNA-1273-P301HOmRNA-1273-P301-US345-2261A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T22:162020-09-05T22:16.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2264A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T09:122020-09-02T09:12.BB mRNA-1273-P301HOmRNA-1273-P301-US345-2268A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T21:032020-09-10T21:03.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US345-2278A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-28 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US345-2295A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-10 AP.. mRNA-1273-P301HOmRNA-1273-P301-US345-2329A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T18:592020-08-13T18:59.ApAp mRNA-1273-P301HOmRNA-1273-P301-US345-2331A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 BQ.. mRNA-1273-P301HOmRNA-1273-P301-US345-2332A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:022020-10-15T12:03.B(BF mRNA-1273-P301HOmRNA-1273-P301-US345-2332A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 BQ.. mRNA-1273-P301HOmRNA-1273-P301-US345-2340A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T06:072020-09-27T06:07.B"B" mRNA-1273-P301HOmRNA-1273-P301-US345-2348A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T12:322020-10-05T22:45.B&B) mRNA-1273-P301HOmRNA-1273-P301-US345-2354A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T17:242020-09-04T17:24.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US345-2355A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T12:012020-10-17T12:01.B/B/ mRNA-1273-P301HOmRNA-1273-P301-US345-2366A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T18:332020-10-19T18:33.B#B# mRNA-1273-P301HOmRNA-1273-P301-US345-2369A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 B>.. mRNA-1273-P301HOmRNA-1273-P301-US345-2373A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T11:152020-09-22T11:15.AA mRNA-1273-P301HOmRNA-1273-P301-US345-2378A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T21:312020-09-24T21:31.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US345-2391A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T22:252020-09-30T22:25.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US345-2391A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T18:122020-10-27T15:21.B"B# mRNA-1273-P301HOmRNA-1273-P301-US346-2025A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:562020-09-11T12:04.B&B' mRNA-1273-P301HOmRNA-1273-P301-US346-2027A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T06:582020-09-06T06:58.B"B" mRNA-1273-P301HOmRNA-1273-P301-US346-2051A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US346-2057A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T08:492020-08-09T08:49.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US346-2084A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-15 BÝ.. mRNA-1273-P301HOmRNA-1273-P301-US346-2091AUSA-US093-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-09 2020-10-14 .B=BB mRNA-1273-P301HOmRNA-1273-P301-US346-2101AUSA-US093-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-25 2020-09-26 .B/B0 mRNA-1273-P301HOmRNA-1273-P301-US346-2101A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T23:132020-09-16T23:13.B&B& mRNA-1273-P301HOmRNA-1273-P301-US346-2111AUSA-US093-2020-mRNA-1273-P301000004HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US346-2111A USA-US093-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-19 2020-09-20 .B(B) mRNA-1273-P301HOmRNA-1273-P301-US346-2111A0 HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T18:362020-09-22T04:08.B(B+ mRNA-1273-P301HOmRNA-1273-P301-US346-2116AUSA-US093-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-05 2020-09-09 .BB mRNA-1273-P301HOmRNA-1273-P301-US346-2133AUSA-US093-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-23 2020-08-26 .AÀAð mRNA-1273-P301HOmRNA-1273-P301-US346-2147A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T13:312020-09-21T13:31.B)B) mRNA-1273-P301HOmRNA-1273-P301-US346-2148A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T21:462020-08-16T21:46.APAP mRNA-1273-P301HOmRNA-1273-P301-US346-2149A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T22:472020-09-14T22:47.B"B" mRNA-1273-P301HOmRNA-1273-P301-US346-2161A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-12 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US346-2180A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BU.. mRNA-1273-P301HOmRNA-1273-P301-US346-2181A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-01 BP.. mRNA-1273-P301HOmRNA-1273-P301-US346-2192A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T12:132020-08-29T12:13.BB mRNA-1273-P301HOmRNA-1273-P301-US346-2202A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T20:402020-08-19T20:40.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US346-2205A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T18:442020-08-20T18:44.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US346-2213AUSA-US093-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-04 2021-01-09 .BB’ mRNA-1273-P301HOmRNA-1273-P301-US346-2246A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T18:322020-09-17T18:32.BB mRNA-1273-P301HOmRNA-1273-P301-US346-2255AUSA-US093-2020-mRNA-1273-P301000008HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-16 2020-10-17 .B;B< mRNA-1273-P301HOmRNA-1273-P301-US346-2283A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T01:452020-10-14T01:45.B7B7 mRNA-1273-P301HOmRNA-1273-P301-US346-2288A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T18:232020-08-27T18:23.ApAp mRNA-1273-P301HOmRNA-1273-P301-US346-2299A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BU.. mRNA-1273-P301HOmRNA-1273-P301-US346-2305A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T15:332020-08-31T15:33.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US346-2316A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T12:032020-09-22T12:03.BB mRNA-1273-P301HOmRNA-1273-P301-US346-2352A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T20:222020-09-23T20:22.BB mRNA-1273-P301HOmRNA-1273-P301-US346-2364AUSA-US093-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-07 2021-02-09 .B¥B§ mRNA-1273-P301HOmRNA-1273-P301-US346-2374A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-01 B€.. mRNA-1273-P301HOmRNA-1273-P301-US346-2375A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US346-2388AUSA-US093-2020-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-25 2020-09-25 .BB mRNA-1273-P301HOmRNA-1273-P301-US346-2388A USA-US093-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-26 2020-10-04 .BB# mRNA-1273-P301HOmRNA-1273-P301-US346-2388A0USA-US093-2020-mRNA-1273-P301000006HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-11 2020-12-14 .BgBj mRNA-1273-P301HOmRNA-1273-P301-US346-2388A@USA-US093-2020-mRNA-1273-P301000006HO-AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-28 2020-12-30 .BxBz mRNA-1273-P301HOmRNA-1273-P301-US346-2388APUSA-US093-2020-mRNA-1273-P301000006HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-14 2021-01-20 .B‰B mRNA-1273-P301HOmRNA-1273-P301-US346-2388A`USA-US093-2020-mRNA-1273-P301000006HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-26 2021-01-30 .B•B™ mRNA-1273-P301HOmRNA-1273-P301-US346-2400A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T19:382020-09-04T19:38.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US346-2404A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T17:302020-09-30T17:30.BB mRNA-1273-P301HOmRNA-1273-P301-US346-2416A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T00:122020-09-08T00:12.APAP mRNA-1273-P301HOmRNA-1273-P301-US347-2013AUSA-US122-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-21 2020-09-23 .BB mRNA-1273-P301HOmRNA-1273-P301-US347-2013A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T07:282020-10-02T07:28.BB mRNA-1273-P301HOmRNA-1273-P301-US347-2017A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T14:332020-09-05T14:33.A A mRNA-1273-P301HOmRNA-1273-P301-US347-2020A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 BW.. mRNA-1273-P301HOmRNA-1273-P301-US347-2022A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-05 BÒ.. mRNA-1273-P301HOmRNA-1273-P301-US347-2033A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US347-2040A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T16:122020-10-08T16:12.BB mRNA-1273-P301HOmRNA-1273-P301-US347-2055A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T10:382020-10-19T10:38.B!B! mRNA-1273-P301HOmRNA-1273-P301-US347-2057A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T19:032020-10-13T19:03.BB mRNA-1273-P301HOmRNA-1273-P301-US347-2068A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US347-2076A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T11:562020-10-23T11:56.BB mRNA-1273-P301HOmRNA-1273-P301-US347-2079A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T21:232020-09-28T21:23.AA mRNA-1273-P301HOmRNA-1273-P301-US347-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-04T20:422020-11-04T20:42.BB mRNA-1273-P301HOmRNA-1273-P301-US347-2096A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 B".. mRNA-1273-P301HOmRNA-1273-P301-US347-2099A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-27 BQ.. mRNA-1273-P301HOmRNA-1273-P301-US347-2114A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T19:482020-11-18T19:48.B"B" mRNA-1273-P301HOmRNA-1273-P301-US347-2122A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T12:002020-10-20T12:00.AA mRNA-1273-P301HOmRNA-1273-P301-US347-2130A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 Að.. mRNA-1273-P301HOmRNA-1273-P301-US348-2005A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 B˜.. mRNA-1273-P301HOmRNA-1273-P301-US348-2023AUSA-US106-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-04 2020-11-05 .BIBJ mRNA-1273-P301HOmRNA-1273-P301-US348-2027A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B¡.. mRNA-1273-P301HOmRNA-1273-P301-US348-2032A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:092020-09-11T15:03.BB mRNA-1273-P301HOmRNA-1273-P301-US348-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T18:392020-08-13T18:39.A A mRNA-1273-P301HOmRNA-1273-P301-US348-2036A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 B„.. mRNA-1273-P301HOmRNA-1273-P301-US348-2043A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T20:492020-08-25T20:49.AÐAÐ mRNA-1273-P301HOmRNA-1273-P301-US348-2043A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-10 B¶.. mRNA-1273-P301HOmRNA-1273-P301-US348-2045A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US348-2049A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B™.. mRNA-1273-P301HOmRNA-1273-P301-US348-2051A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T22:052020-08-25T19:00.A°AÀ mRNA-1273-P301HOmRNA-1273-P301-US348-2063A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:142020-09-17T12:14.B B mRNA-1273-P301HOmRNA-1273-P301-US348-2067A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T20:262020-08-20T20:26.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US348-2070A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:182020-11-25T12:02.B(Be mRNA-1273-P301HOmRNA-1273-P301-US348-2076A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T20:122020-08-20T20:12.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US348-2076A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US348-2078A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T18:432020-10-03T18:43.B!B! mRNA-1273-P301HOmRNA-1273-P301-US348-2081A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T12:072020-09-19T12:07.B B mRNA-1273-P301HOmRNA-1273-P301-US348-2086A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T12:092020-09-18T12:09.BB mRNA-1273-P301HOmRNA-1273-P301-US348-2094A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US348-2114A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T12:052020-08-26T12:05.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US348-2117A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T20:172020-08-28T20:17.APAP mRNA-1273-P301HOmRNA-1273-P301-US348-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T22:442020-09-27T22:44.B#B# mRNA-1273-P301HOmRNA-1273-P301-US348-2121A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BU.. mRNA-1273-P301HOmRNA-1273-P301-US348-2145AUSA-US106-2020-mRNA-1273-P301000001HO-AE-001/AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US348-2145A USA-US106-2020-mRNA-1273-P301000006HO-AE-004/AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US348-2145A0USA-US106-2020-mRNA-1273-P301000001HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-02 2020-09-13 .A€B mRNA-1273-P301HOmRNA-1273-P301-US348-2145A@USA-US106-2020-mRNA-1273-P301000006HO-AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-09-26 2020-09-30 .B B$ mRNA-1273-P301HOmRNA-1273-P301-US348-2145APUSA-US106-2020-mRNA-1273-P301000005HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-22 2020-10-26 .B:B> mRNA-1273-P301HOmRNA-1273-P301-US348-2145A`USA-US106-2020-mRNA-1273-P301000004HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-09 2020-11-10 .BLBM mRNA-1273-P301HOmRNA-1273-P301-US348-2177A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-01 BÖ.. mRNA-1273-P301HOmRNA-1273-P301-US348-2181A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T14:402020-09-02T14:40.A A mRNA-1273-P301HOmRNA-1273-P301-US348-2187A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B.. mRNA-1273-P301HOmRNA-1273-P301-US348-2227A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T20:152020-10-06T20:15.B!B! mRNA-1273-P301HOmRNA-1273-P301-US348-2227A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US348-2231A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:262020-09-15T12:26.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US348-2231A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T10:452020-10-03T10:45.BB mRNA-1273-P301HOmRNA-1273-P301-US348-2236A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T12:112020-10-08T12:11.B#B# mRNA-1273-P301HOmRNA-1273-P301-US348-2240AUSA-US106-2021-mRNA-1273-P301000005HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-19 2021-01-23 .BŠBŽ mRNA-1273-P301HOmRNA-1273-P301-US348-2257A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B†.. mRNA-1273-P301HOmRNA-1273-P301-US348-2267AUSA-US106-2020-mRNA-1273-P301000010HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-18 2020-12-21 .BdBg mRNA-1273-P301HOmRNA-1273-P301-US348-2272A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T10:552020-10-16T10:55.B%B% mRNA-1273-P301HOmRNA-1273-P301-US348-2277A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:042020-09-17T12:04.ApAp mRNA-1273-P301HOmRNA-1273-P301-US348-2284AUSA-US106-2020-mRNA-1273-P301000002HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US348-2284A USA-US106-2020-mRNA-1273-P301000002HO-AE-002/AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US348-2284A0USA-US106-2020-mRNA-1273-P301000002HO-AE-004/AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US348-2284A@USA-US106-2020-mRNA-1273-P301000002HO-AE-006 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US348-2284APUSA-US106-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-29 2020-10-31 .AàB mRNA-1273-P301HOmRNA-1273-P301-US348-2284A`USA-US106-2020-mRNA-1273-P301000002HO-AE-002/AE-003/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-05 2020-11-07 .BB mRNA-1273-P301HOmRNA-1273-P301-US348-2284ApUSA-US106-2020-mRNA-1273-P301000002HO-AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-17 2020-11-20 .B!B$ mRNA-1273-P301HOmRNA-1273-P301-US348-2286A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 BX.. mRNA-1273-P301HOmRNA-1273-P301-US348-2300A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T20:342020-11-18T20:34.B"B" mRNA-1273-P301HOmRNA-1273-P301-US348-2301A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T10:432020-10-23T10:43.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US348-2302AUSA-US106-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-21 2021-01-25 .B_Bc mRNA-1273-P301HOmRNA-1273-P301-US348-2302A USA-US106-2021-mRNA-1273-P301000011HO-AE-002/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-01 2021-02-03 .BjBl mRNA-1273-P301HOmRNA-1273-P301-US348-2302A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 BX.. mRNA-1273-P301HOmRNA-1273-P301-US348-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 B+.. mRNA-1273-P301HOmRNA-1273-P301-US349-2001A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T12:302020-08-31T12:30.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US349-2003A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T17:232020-09-22T17:23.BB mRNA-1273-P301HOmRNA-1273-P301-US349-2010A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T18:262020-10-09T18:26.B-B- mRNA-1273-P301HOmRNA-1273-P301-US349-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T20:402020-08-31T20:40.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US349-2021A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T11:222020-08-28T11:22.AA mRNA-1273-P301HOmRNA-1273-P301-US349-2027A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T20:392020-10-01T20:39.B"B" mRNA-1273-P301HOmRNA-1273-P301-US349-2040A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T12:432020-10-04T12:43.B"B" mRNA-1273-P301HOmRNA-1273-P301-US349-2064AUSA-US101-2020-mRNA-1273-P301000004HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P11DmRNA-1273-P301HOmRNA-1273-P301-US349-2064A USA-US101-2020-mRNA-1273-P301000004HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-30 2020-11-11 .B9BE mRNA-1273-P301HOmRNA-1273-P301-US349-2064A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T13:472020-09-04T13:47.AA mRNA-1273-P301HOmRNA-1273-P301-US349-2064A@ HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-10-31T16:102020-11-01T16:31.B:B; mRNA-1273-P301HOmRNA-1273-P301-US349-2070A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T19:362020-09-15T19:36.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US349-2071A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-14 BH.. mRNA-1273-P301HOmRNA-1273-P301-US349-2072A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T22:352020-09-05T22:35.A A mRNA-1273-P301HOmRNA-1273-P301-US349-2072A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T19:432020-10-05T19:43.B B mRNA-1273-P301HOmRNA-1273-P301-US349-2074A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T17:582020-10-07T17:58.B!B! mRNA-1273-P301HOmRNA-1273-P301-US349-2078AUSA-US101-2020-mRNA-1273-P301000006HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-10 2020-11-17 .BCBJ mRNA-1273-P301HOmRNA-1273-P301-US349-2078A USA-US101-2021-mRNA-1273-P301000012HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-24 .Bè. mRNA-1273-P301HOmRNA-1273-P301-US349-2085A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T22:402020-10-12T22:40.B#B# mRNA-1273-P301HOmRNA-1273-P301-US349-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T14:142020-10-10T14:14.B!B! mRNA-1273-P301HOmRNA-1273-P301-US349-2107AUSA-US101-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-08 2021-01-15 .BzB mRNA-1273-P301HOmRNA-1273-P301-US349-2107A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T18:502020-10-08T18:50.BB mRNA-1273-P301HOmRNA-1273-P301-US349-2115A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US349-2117A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-22 AÐ.. mRNA-1273-P301HOmRNA-1273-P301-US349-2134A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T20:112020-10-13T20:11.B B mRNA-1273-P301HOmRNA-1273-P301-US349-2142A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 BR.. mRNA-1273-P301HOmRNA-1273-P301-US349-2152A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T19:412020-09-14T19:41.AA mRNA-1273-P301HOmRNA-1273-P301-US349-2153A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T00:002020-09-23T00:00.A A mRNA-1273-P301HOmRNA-1273-P301-US349-2153A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T22:072020-10-15T22:07.B B mRNA-1273-P301HOmRNA-1273-P301-US349-2158A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-17 Bœ.. mRNA-1273-P301HOmRNA-1273-P301-US349-2169A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-08 B®.. mRNA-1273-P301HOmRNA-1273-P301-US349-2174A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T20:172020-09-22T22:01.AAp mRNA-1273-P301HOmRNA-1273-P301-US349-2178AUSA-US101-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-07 2021-01-11 .BqBu mRNA-1273-P301HOmRNA-1273-P301-US349-2191A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T21:252020-09-19T21:25.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US349-2210A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T20:422020-09-23T20:42.APAP mRNA-1273-P301HOmRNA-1273-P301-US349-2237A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-27 A`.. mRNA-1273-P301HOmRNA-1273-P301-US349-2238A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T17:032020-09-22T17:03.AA mRNA-1273-P301HOmRNA-1273-P301-US349-2242A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-03 A°.. mRNA-1273-P301HOmRNA-1273-P301-US349-2243A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-18 B9.. mRNA-1273-P301HOmRNA-1273-P301-US349-2247A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T16:412020-09-23T16:41.AA mRNA-1273-P301HOmRNA-1273-P301-US349-2273AUSA-US101-2021-mRNA-1273-P301000001HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-30 2020-12-31 .B\B] mRNA-1273-P301HOmRNA-1273-P301-US349-2273A USA-US101-2021-mRNA-1273-P301000005HO-AE-006/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-30 2021-02-05 .B{B mRNA-1273-P301HOmRNA-1273-P301-US349-2278A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US349-2279A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T15:082020-09-30T15:08.AA mRNA-1273-P301HOmRNA-1273-P301-US349-2281AUSA-US101-2021-mRNA-1273-P301000007HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-21 2020-12-22 .BRBS mRNA-1273-P301HOmRNA-1273-P301-US349-2288A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T19:242020-10-08T19:24.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US349-2299A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 B'.. mRNA-1273-P301HOmRNA-1273-P301-US350-2003A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T13:192020-09-22T13:19.B"B" mRNA-1273-P301HOmRNA-1273-P301-US350-2025A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T21:482020-08-30T21:48.A`A` mRNA-1273-P301HOmRNA-1273-P301-US350-2039A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T13:072020-09-26T13:07.BB mRNA-1273-P301HOmRNA-1273-P301-US350-2044A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T17:432020-09-03T07:28.A@A€ mRNA-1273-P301HOmRNA-1273-P301-US350-2044A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T11:002020-09-30T11:00.B#B# mRNA-1273-P301HOmRNA-1273-P301-US350-2045AUSA-US080-2020-mRNA-1273-P301000001HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-22 2020-09-23 .BB mRNA-1273-P301HOmRNA-1273-P301-US350-2054A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T16:302020-09-29T16:30.B!B! mRNA-1273-P301HOmRNA-1273-P301-US350-2056A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T14:192020-08-28T14:19.AA mRNA-1273-P301HOmRNA-1273-P301-US350-2058A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T13:512020-09-28T13:51.B B mRNA-1273-P301HOmRNA-1273-P301-US350-2071A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T17:022020-10-05T17:02.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US350-2076A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 BU.. mRNA-1273-P301HOmRNA-1273-P301-US350-2077A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T12:232020-10-06T12:11.BB$ mRNA-1273-P301HOmRNA-1273-P301-US350-2086A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US350-2097A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T19:542020-09-14T20:29.A A° mRNA-1273-P301HOmRNA-1273-P301-US350-2102A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T19:002020-09-21T19:00.BB mRNA-1273-P301HOmRNA-1273-P301-US350-2104A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T06:022020-09-10T06:02.ApAp mRNA-1273-P301HOmRNA-1273-P301-US350-2116A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T18:152020-09-08T18:15.AA mRNA-1273-P301HOmRNA-1273-P301-US350-2116A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T12:052020-10-08T12:05.BB mRNA-1273-P301HOmRNA-1273-P301-US350-2125AUSA-US080-2021-mRNA-1273-P301000001HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US350-2125A USA-US080-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-09 2021-04-10 .BÕBÖ mRNA-1273-P301HOmRNA-1273-P301-US350-2142AUSA-US080-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-12 2020-11-13 .B?B@ mRNA-1273-P301HOmRNA-1273-P301-US350-2150A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T13:402020-09-11T13:40.AA mRNA-1273-P301HOmRNA-1273-P301-US350-2161A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T13:232020-09-20T16:45.A Ap mRNA-1273-P301HOmRNA-1273-P301-US350-2162A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T14:072020-10-14T14:07.BB mRNA-1273-P301HOmRNA-1273-P301-US350-2171A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T12:062020-10-23T12:06.B!B! mRNA-1273-P301HOmRNA-1273-P301-US350-2172A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T22:582020-10-20T22:58.BB mRNA-1273-P301HOmRNA-1273-P301-US350-2190A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T16:392020-10-06T20:52.AA mRNA-1273-P301HOmRNA-1273-P301-US350-2195A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-05T23:272020-11-05T23:27.BB mRNA-1273-P301HOmRNA-1273-P301-US350-2204A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T15:162020-10-16T15:16.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US350-2212A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T12:072020-10-25T12:07.ApAp mRNA-1273-P301HOmRNA-1273-P301-US351-2009A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T18:152020-09-21T18:24.B-B0 mRNA-1273-P301HOmRNA-1273-P301-US351-2036AUSA-US065-2020-mRNA-1273-P301000005HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-11 2020-12-13 .BzB| mRNA-1273-P301HOmRNA-1273-P301-US351-2053A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T01:032020-09-13T01:03.B B mRNA-1273-P301HOmRNA-1273-P301-US351-2082AUSA-US065-2021-mRNA-1273-P301000004HO-AE-004/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-02 2021-02-04 .BB¯ mRNA-1273-P301HOmRNA-1273-P301-US351-2116A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 BU.. mRNA-1273-P301HOmRNA-1273-P301-US351-2141A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B~.. mRNA-1273-P301HOmRNA-1273-P301-US351-2144A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T10:412020-08-26T10:41.AA mRNA-1273-P301HOmRNA-1273-P301-US351-2151A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T21:282020-09-24T21:28.BB mRNA-1273-P301HOmRNA-1273-P301-US351-2159A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T19:392020-08-31T17:28.APA` mRNA-1273-P301HOmRNA-1273-P301-US351-2160A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T19:012020-08-31T19:01.A`A` mRNA-1273-P301HOmRNA-1273-P301-US351-2183A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T12:112020-08-31T12:11.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US351-2189A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T12:052020-09-04T12:05.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US351-2193AUSA-US065-2020-mRNA-1273-P301000002HO-AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-27 2020-10-30 .B8B; mRNA-1273-P301HOmRNA-1273-P301-US351-2203A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T22:102020-09-04T22:10.A A mRNA-1273-P301HOmRNA-1273-P301-US351-2215A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T15:352020-09-10T15:35.ApAp mRNA-1273-P301HOmRNA-1273-P301-US351-2217AUSA-US065-2021-mRNA-1273-P301000001HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-31 2021-01-02 .BwBy mRNA-1273-P301HOmRNA-1273-P301-US351-2230A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T00:432020-10-12T00:43.B&B& mRNA-1273-P301HOmRNA-1273-P301-US351-2234A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T19:182020-10-07T16:57.B B! mRNA-1273-P301HOmRNA-1273-P301-US351-2242A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B}.. mRNA-1273-P301HOmRNA-1273-P301-US351-2246A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T18:122020-11-10T19:04.B*B? mRNA-1273-P301HOmRNA-1273-P301-US351-2248AUSA-US065-2021-mRNA-1273-P301000005HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-02-25 2021-02-26 .B©Bª mRNA-1273-P301HOmRNA-1273-P301-US351-2263A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 BF.. mRNA-1273-P301HOmRNA-1273-P301-US351-2264A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T17:522020-10-17T20:30.B!B$ mRNA-1273-P301HOmRNA-1273-P301-US351-2270A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T09:102020-10-22T09:10.B%B% mRNA-1273-P301HOmRNA-1273-P301-US351-2278A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T19:412020-10-23T18:01.B#B$ mRNA-1273-P301HOmRNA-1273-P301-US351-2284A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T18:462020-10-29T18:46.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US351-2285A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T06:012020-10-09T06:01.A A mRNA-1273-P301HOmRNA-1273-P301-US351-2287A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T12:052020-10-26T12:02.BB mRNA-1273-P301HOmRNA-1273-P301-US351-2293A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T13:092020-10-20T12:02.AAp mRNA-1273-P301HOmRNA-1273-P301-US351-2293A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T00:292020-11-12T00:29.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2010A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T17:142020-08-06T17:14.A A mRNA-1273-P301HOmRNA-1273-P301-US352-2012A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T11:082020-08-12T08:42.A A€ mRNA-1273-P301HOmRNA-1273-P301-US352-2014A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-29 Bí.. mRNA-1273-P301HOmRNA-1273-P301-US352-2042A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-24 B.. mRNA-1273-P301HOmRNA-1273-P301-US352-2057A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:532020-09-09T12:53.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T11:282020-08-16T20:31.AAp mRNA-1273-P301HOmRNA-1273-P301-US352-2073A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T14:302020-08-11T14:30.AA mRNA-1273-P301HOmRNA-1273-P301-US352-2077AUSA-US131-2020-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-17 2020-10-19 .BDBF mRNA-1273-P301HOmRNA-1273-P301-US352-2082AUSA-US131-2021-mRNA-1273-P301000010HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-01 2021-03-02 .BËBÌ mRNA-1273-P301HOmRNA-1273-P301-US352-2105A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 BL.. mRNA-1273-P301HOmRNA-1273-P301-US352-2109AUSA-US131-2020-mRNA-1273-P301000011HO-AE-005/AE-006/AE-010/AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-26 2020-12-01 .BjBo mRNA-1273-P301HOmRNA-1273-P301-US352-2109A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T21:362020-09-15T21:36.B"B" mRNA-1273-P301HOmRNA-1273-P301-US352-2112AUSA-US131-2021-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-13 2021-04-14 .BôBõ mRNA-1273-P301HOmRNA-1273-P301-US352-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T20:102020-09-14T20:10.B!B! mRNA-1273-P301HOmRNA-1273-P301-US352-2127A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T06:302020-08-17T06:30.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US352-2127A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B{.. mRNA-1273-P301HOmRNA-1273-P301-US352-2128AUSA-US131-2020-mRNA-1273-P301000008HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-25 2020-09-27 .B+B- mRNA-1273-P301HOmRNA-1273-P301-US352-2128A USA-US131-2020-mRNA-1273-P301000008HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-08 2020-10-12 .B8B< mRNA-1273-P301HOmRNA-1273-P301-US352-2128A0USA-US131-2021-mRNA-1273-P301000015HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-01 2021-04-04 .BçBê mRNA-1273-P301HOmRNA-1273-P301-US352-2140A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T20:232020-09-11T20:23.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2163A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T16:412020-08-19T16:41.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US352-2166A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:342020-09-23T12:34.B%B% mRNA-1273-P301HOmRNA-1273-P301-US352-2173AUSA-US131-2021-mRNA-1273-P301000008HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-16 2021-03-18 .BÓBÕ mRNA-1273-P301HOmRNA-1273-P301-US352-2194A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T15:482020-08-20T15:48.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US352-2204A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T12:242020-09-19T12:24.B B mRNA-1273-P301HOmRNA-1273-P301-US352-2205A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T15:522020-09-18T15:52.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2218A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 B].. mRNA-1273-P301HOmRNA-1273-P301-US352-2219A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T13:172020-09-22T13:17.B#B# mRNA-1273-P301HOmRNA-1273-P301-US352-2227AUSA-US131-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-06 2021-01-07 .BBŽ mRNA-1273-P301HOmRNA-1273-P301-US352-2231A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T17:362020-09-17T17:36.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2248A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 B….. mRNA-1273-P301HOmRNA-1273-P301-US352-2269AUSA-US131-2020-mRNA-1273-P301000005HO-AE-001/AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-12 2020-09-16 .BB mRNA-1273-P301HOmRNA-1273-P301-US352-2274AUSA-US131-2021-mRNA-1273-P301000009HO-AE-001/AE-002/AE-003/AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P10DmRNA-1273-P301HOmRNA-1273-P301-US352-2274A USA-US131-2021-mRNA-1273-P301000009HO-AE-001/AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-02-16 2021-03-23 .B¯BÒ mRNA-1273-P301HOmRNA-1273-P301-US352-2274A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T11:132020-08-26T11:13.AA mRNA-1273-P301HOmRNA-1273-P301-US352-2297A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-18 B.. mRNA-1273-P301HOmRNA-1273-P301-US352-2299AUSA-US131-2021-mRNA-1273-P301000014HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-24 2021-03-26 .BÕB× mRNA-1273-P301HOmRNA-1273-P301-US352-2307A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T11:252020-09-25T12:38.B B! mRNA-1273-P301HOmRNA-1273-P301-US352-2307A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-23 B.. mRNA-1273-P301HOmRNA-1273-P301-US352-2312A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T19:122020-09-01T22:48.A€A mRNA-1273-P301HOmRNA-1273-P301-US352-2313A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US352-2325A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T15:592020-09-29T15:59.B%B% mRNA-1273-P301HOmRNA-1273-P301-US352-2336A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US352-2346A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T19:292020-10-01T19:29.B&B& mRNA-1273-P301HOmRNA-1273-P301-US352-2354A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T17:412020-09-28T17:41.B#B# mRNA-1273-P301HOmRNA-1273-P301-US352-2379A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T20:312020-09-25T20:31.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2396A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:592020-09-25T12:59.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2401A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-11-03T12:162020-11-20T12:51.BEBV mRNA-1273-P301HOmRNA-1273-P301-US352-2405A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T20:432020-10-07T20:43.B*B* mRNA-1273-P301HOmRNA-1273-P301-US352-2418A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T20:512020-10-07T20:51.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US352-2450A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T12:012020-10-01T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2455A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T21:072020-09-02T21:07.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US352-2459A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T15:292020-10-07T15:29.B&B& mRNA-1273-P301HOmRNA-1273-P301-US352-2460A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T19:252020-09-14T18:15.A€Að mRNA-1273-P301HOmRNA-1273-P301-US352-2460A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 By.. mRNA-1273-P301HOmRNA-1273-P301-US352-2483A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T19:202020-10-06T19:20.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US352-2492A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T19:072020-10-06T19:07.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US352-2506A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T09:362020-10-21T09:36.B3B3 mRNA-1273-P301HOmRNA-1273-P301-US352-2513AUSA-US131-2021-mRNA-1273-P301000017HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-24 2021-03-24 .BÌBÌ mRNA-1273-P301HOmRNA-1273-P301-US352-2529AUSA-US131-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-21 2020-09-23 .BB mRNA-1273-P301HOmRNA-1273-P301-US352-2565A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T16:382020-10-04T16:38.B B mRNA-1273-P301HOmRNA-1273-P301-US352-2581A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:502020-09-09T12:50.A`A` mRNA-1273-P301HOmRNA-1273-P301-US352-2585A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T09:532020-10-03T22:03.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2587A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T19:512020-09-08T19:51.APAP mRNA-1273-P301HOmRNA-1273-P301-US352-2613A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T17:122020-09-21T13:55.AAà mRNA-1273-P301HOmRNA-1273-P301-US352-2622A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T00:042020-10-10T00:04.B B mRNA-1273-P301HOmRNA-1273-P301-US352-2625A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T14:012020-09-11T14:01.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US352-2656A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T12:272020-10-09T12:27.BB mRNA-1273-P301HOmRNA-1273-P301-US352-2666AUSA-US131-2021-mRNA-1273-P301000013HO-AE-009 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US352-2666A USA-US131-2021-mRNA-1273-P301000013HO-AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-12 2021-03-26 .B·BÅ mRNA-1273-P301HOmRNA-1273-P301-US352-2672A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 B`.. mRNA-1273-P301HOmRNA-1273-P301-US352-2673A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T19:202020-10-16T19:20.B!B! mRNA-1273-P301HOmRNA-1273-P301-US352-2696AUSA-US131-2021-mRNA-1273-P301000006HO-AE-001/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-05 2021-02-11 .BB• mRNA-1273-P301HOmRNA-1273-P301-US352-2696A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T18:082020-09-18T18:08.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US352-2699A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T20:552020-10-26T20:55.B(B( mRNA-1273-P301HOmRNA-1273-P301-US352-2709AUSA-US131-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-10 2021-02-11 .B’B“ mRNA-1273-P301HOmRNA-1273-P301-US352-2719A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T22:232020-10-01T22:23.AA mRNA-1273-P301HOmRNA-1273-P301-US352-2720A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T14:322020-09-23T14:32.AA mRNA-1273-P301HOmRNA-1273-P301-US353-2002AUSA-US077-2020-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-16 2020-09-18 .B%B' mRNA-1273-P301HOmRNA-1273-P301-US353-2002A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T16:572020-09-12T16:57.B!B! mRNA-1273-P301HOmRNA-1273-P301-US353-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T20:142020-09-17T20:14.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US353-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T14:202020-09-16T13:46.BB# mRNA-1273-P301HOmRNA-1273-P301-US353-2049A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T13:442020-08-21T16:52.A@AP mRNA-1273-P301HOmRNA-1273-P301-US353-2055A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T09:262020-08-25T09:26.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US353-2063AUSA-US077-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-28 2020-11-01 .BHBL mRNA-1273-P301HOmRNA-1273-P301-US353-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T18:072020-09-29T18:07.B)B) mRNA-1273-P301HOmRNA-1273-P301-US353-2100A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T07:032020-08-27T07:03.ApAp mRNA-1273-P301HOmRNA-1273-P301-US353-2103A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-26 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US353-2106A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T20:432020-08-26T20:43.A`A` mRNA-1273-P301HOmRNA-1273-P301-US353-2108A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T20:472020-09-26T20:47.B%B% mRNA-1273-P301HOmRNA-1273-P301-US353-2133A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-10 Bª.. mRNA-1273-P301HOmRNA-1273-P301-US353-2158A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T00:232020-09-30T00:23.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US353-2163A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BE.. mRNA-1273-P301HOmRNA-1273-P301-US353-2165A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T08:482020-10-01T08:48.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US353-2165A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BD.. mRNA-1273-P301HOmRNA-1273-P301-US353-2170AUSA-US077-2020-mRNA-1273-P301000001HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P9D mRNA-1273-P301HOmRNA-1273-P301-US353-2170A USA-US077-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-07 2020-10-06 .AÀB) mRNA-1273-P301HOmRNA-1273-P301-US353-2170A0USA-US077-2021-mRNA-1273-P301000003HO-AE-010/AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-19 2021-02-24 .B±B¶ mRNA-1273-P301HOmRNA-1273-P301-US353-2174A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T17:142020-10-02T17:14.B%B% mRNA-1273-P301HOmRNA-1273-P301-US353-2192AUSA-US077-2020-mRNA-1273-P301000012HO-AE-002/AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US353-2192A USA-US077-2020-mRNA-1273-P301000012HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-18 2020-11-23 .BPBU mRNA-1273-P301HOmRNA-1273-P301-US353-2192A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T05:392020-09-01T05:39.A A mRNA-1273-P301HOmRNA-1273-P301-US353-2192A@ HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T01:432020-10-10T01:43.B)B) mRNA-1273-P301HOmRNA-1273-P301-US353-2211A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T19:382020-09-07T19:38.A`A` mRNA-1273-P301HOmRNA-1273-P301-US353-2212AUSA-US077-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-17 2020-11-19 .BMBO mRNA-1273-P301HOmRNA-1273-P301-US353-2224A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T21:322020-10-04T21:32.B!B! mRNA-1273-P301HOmRNA-1273-P301-US353-2230A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T04:482020-10-07T04:48.B#B# mRNA-1273-P301HOmRNA-1273-P301-US353-2231AUSA-US077-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-10 2020-10-16 .B&B, mRNA-1273-P301HOmRNA-1273-P301-US353-2231A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T22:192020-10-08T23:02.B"B$ mRNA-1273-P301HOmRNA-1273-P301-US353-2240A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T19:042020-10-01T19:04.BB mRNA-1273-P301HOmRNA-1273-P301-US353-2246A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 B3.. mRNA-1273-P301HOmRNA-1273-P301-US353-2251A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 BU.. mRNA-1273-P301HOmRNA-1273-P301-US353-2257A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T20:422020-10-08T20:42.BB mRNA-1273-P301HOmRNA-1273-P301-US353-2259A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-24 B... mRNA-1273-P301HOmRNA-1273-P301-US353-2276AUSA-US077-2021-mRNA-1273-P301000002HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-08 2021-02-09 .B˜B™ mRNA-1273-P301HOmRNA-1273-P301-US353-2279A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-07 B.. mRNA-1273-P301HOmRNA-1273-P301-US353-2281AUSA-US077-2020-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-23 2020-10-25 .B,B. mRNA-1273-P301HOmRNA-1273-P301-US354-2019A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B€.. mRNA-1273-P301HOmRNA-1273-P301-US354-2027A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T10:572020-08-20T10:57.AA mRNA-1273-P301HOmRNA-1273-P301-US354-2027A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T16:172020-09-25T16:17.B%B% mRNA-1273-P301HOmRNA-1273-P301-US354-2029AUSA-US084-2021-mRNA-1273-P301000006HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-18 2021-02-22 .B·B» mRNA-1273-P301HOmRNA-1273-P301-US354-2030AUSA-US084-2021-mRNA-1273-P301000011HO-AE-011/AE-012 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-22 2021-04-23 .BöB÷ mRNA-1273-P301HOmRNA-1273-P301-US354-2031A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T22:072020-09-18T22:07.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T07:072020-08-26T07:07.A`A` mRNA-1273-P301HOmRNA-1273-P301-US354-2043A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-08 B.. mRNA-1273-P301HOmRNA-1273-P301-US354-2053AUSA-US084-2021-mRNA-1273-P301000004HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-04 2021-02-08 .B¤B¨ mRNA-1273-P301HOmRNA-1273-P301-US354-2053A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T22:062020-09-26T22:06.B!B! mRNA-1273-P301HOmRNA-1273-P301-US354-2061AUSA-US084-2021-mRNA-1273-P301000010HO-AE-012 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-08 2021-04-16 .BâBê mRNA-1273-P301HOmRNA-1273-P301-US354-2064A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T13:312020-08-26T13:31.AA mRNA-1273-P301HOmRNA-1273-P301-US354-2067A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T17:502020-09-23T17:50.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2068A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T15:182020-09-23T15:18.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2071A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T23:532020-09-29T17:11.B"B# mRNA-1273-P301HOmRNA-1273-P301-US354-2091A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T18:072020-09-26T18:07.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2108A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T19:002020-10-05T21:38.B B$ mRNA-1273-P301HOmRNA-1273-P301-US354-2111A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T06:282020-09-04T06:28.APAP mRNA-1273-P301HOmRNA-1273-P301-US354-2111A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T22:272020-10-03T22:27.B"B" mRNA-1273-P301HOmRNA-1273-P301-US354-2131AUSA-US084-2021-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-08 2021-04-10 .BÛBÝ mRNA-1273-P301HOmRNA-1273-P301-US354-2139A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T15:192020-09-04T15:19.A A mRNA-1273-P301HOmRNA-1273-P301-US354-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-14 BH.. mRNA-1273-P301HOmRNA-1273-P301-US354-2165A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T23:262020-10-08T23:26.B#B# mRNA-1273-P301HOmRNA-1273-P301-US354-2168AUSA-US084-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-10 2020-09-18 .ApAð mRNA-1273-P301HOmRNA-1273-P301-US354-2168A USA-US084-2020-mRNA-1273-P301000001HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-19 2020-09-23 .BB mRNA-1273-P301HOmRNA-1273-P301-US354-2181A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T22:132020-10-06T22:13.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2199AUSA-US084-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-27 2020-10-29 .B0B2 mRNA-1273-P301HOmRNA-1273-P301-US354-2199A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T20:512020-10-09T20:51.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2206A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T13:562020-09-11T13:56.A A mRNA-1273-P301HOmRNA-1273-P301-US354-2211A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T20:552020-10-12T20:55.B B mRNA-1273-P301HOmRNA-1273-P301-US354-2214A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 B†.. mRNA-1273-P301HOmRNA-1273-P301-US354-2215A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 B†.. mRNA-1273-P301HOmRNA-1273-P301-US354-2222A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-09 B±.. mRNA-1273-P301HOmRNA-1273-P301-US354-2239A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T20:342020-09-21T20:34.ApAp mRNA-1273-P301HOmRNA-1273-P301-US354-2260A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T18:422020-10-16T18:42.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2261A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T12:162020-10-16T12:16.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2272A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T14:282020-09-25T14:28.APAP mRNA-1273-P301HOmRNA-1273-P301-US354-2272A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T21:282020-10-24T21:28.B"B" mRNA-1273-P301HOmRNA-1273-P301-US354-2276A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T00:312020-09-30T00:31.AA mRNA-1273-P301HOmRNA-1273-P301-US354-2285A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T18:362020-10-21T18:36.BB mRNA-1273-P301HOmRNA-1273-P301-US354-2309AUSA-US084-2020-mRNA-1273-P301000005HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-13 2020-11-15 .B,B. mRNA-1273-P301HOmRNA-1273-P301-US354-2332AUSA-US084-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-07 2020-11-08 .BB mRNA-1273-P301HOmRNA-1273-P301-US354-2332A USA-US084-2020-mRNA-1273-P301000004HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-12 2021-04-13 .BºB» mRNA-1273-P301HOmRNA-1273-P301-US354-2339A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-11 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US354-2346A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T22:422020-10-19T22:42.APAP mRNA-1273-P301HOmRNA-1273-P301-US355-2002A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-18 B(.. mRNA-1273-P301HOmRNA-1273-P301-US355-2005AUSA-US089-2021-mRNA-1273-P301000004HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US355-2005A USA-US089-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-08 2021-03-12 .BÒBÖ mRNA-1273-P301HOmRNA-1273-P301-US355-2010AUSA-US089-2021-mRNA-1273-P301000005HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-16 2021-03-17 .BÙBÚ mRNA-1273-P301HOmRNA-1273-P301-US355-2020A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US355-2022A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T08:172020-09-11T08:17.BB mRNA-1273-P301HOmRNA-1273-P301-US355-2023A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T21:582020-08-16T21:58.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US355-2023A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US355-2024AUSA-US089-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-29 2020-08-30 .BB mRNA-1273-P301HOmRNA-1273-P301-US355-2040A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T17:102020-09-17T17:10.B"B" mRNA-1273-P301HOmRNA-1273-P301-US355-2048A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 B].. mRNA-1273-P301HOmRNA-1273-P301-US355-2053AUSA-US089-2020-mRNA-1273-P301000003HO-AE-002/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-17 2020-09-18 .B B! mRNA-1273-P301HOmRNA-1273-P301-US355-2053A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:502020-09-18T13:38.B B! mRNA-1273-P301HOmRNA-1273-P301-US355-2063A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T12:082020-09-16T12:08.BB mRNA-1273-P301HOmRNA-1273-P301-US355-2082A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T20:052020-08-26T20:05.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US355-2094A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T20:542020-09-17T20:54.BB mRNA-1273-P301HOmRNA-1273-P301-US355-2140A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T23:442020-08-26T23:44.APAP mRNA-1273-P301HOmRNA-1273-P301-US355-2146A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T18:062020-09-24T18:06.B B mRNA-1273-P301HOmRNA-1273-P301-US355-2153A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T00:442020-08-29T00:44.A`A` mRNA-1273-P301HOmRNA-1273-P301-US355-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US355-2189AUSA-US089-2020-mRNA-1273-P301000020HO-AE-029 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-20 2020-12-24 .BuBy mRNA-1273-P301HOmRNA-1273-P301-US355-2189A USA-US089-2021-mRNA-1273-P301000003HO-AE-033 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-26 2021-02-01 .BšB mRNA-1273-P301HOmRNA-1273-P301-US355-2189A0USA-US089-2021-mRNA-1273-P301000003HO-AE-034 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-04 2021-02-09 .B£B¨ mRNA-1273-P301HOmRNA-1273-P301-US355-2191AUSA-US089-2021-mRNA-1273-P301000001HO-AE-012 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-09 2020-10-10 .B-B. mRNA-1273-P301HOmRNA-1273-P301-US355-2195A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T16:182020-09-23T16:18.BB mRNA-1273-P301HOmRNA-1273-P301-US355-2204A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T17:272020-09-01T17:27.A`A` mRNA-1273-P301HOmRNA-1273-P301-US355-2216A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T16:462020-08-27T16:46.AA mRNA-1273-P301HOmRNA-1273-P301-US355-2232AUSA-US089-2020-mRNA-1273-P301000006HO-AE-002/AE-003/AE-004/AE-005/AE-006/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-09-26 2020-10-08 .BB) mRNA-1273-P301HOmRNA-1273-P301-US355-2232A USA-US089-2021-mRNA-1273-P301000008HO-AE-014 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-04-05 2021-04-07 .BÜBÞ mRNA-1273-P301HOmRNA-1273-P301-US355-2232A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 B“.. mRNA-1273-P301HOmRNA-1273-P301-US355-2249A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T20:302020-08-31T20:30.AA mRNA-1273-P301HOmRNA-1273-P301-US355-2269A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 BH.. mRNA-1273-P301HOmRNA-1273-P301-US355-2270A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US355-2293A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T08:492020-09-09T08:49.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US355-2301A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T13:062020-10-06T13:06.B#B# mRNA-1273-P301HOmRNA-1273-P301-US355-2325A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 BY.. mRNA-1273-P301HOmRNA-1273-P301-US355-2331AUSA-US089-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-16 2020-09-21 .AÐB mRNA-1273-P301HOmRNA-1273-P301-US355-2340A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T04:072020-10-08T04:07.B#B# mRNA-1273-P301HOmRNA-1273-P301-US355-2355AUSA-US089-2021-mRNA-1273-P301000007HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-25 2021-03-26 .BÇBÈ mRNA-1273-P301HOmRNA-1273-P301-US355-2371AUSA-US089-2020-mRNA-1273-P301000012HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-12 2020-11-13 .BBBC mRNA-1273-P301HOmRNA-1273-P301-US355-2399A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-11T22:182020-10-14T21:39.B B# mRNA-1273-P301HOmRNA-1273-P301-US355-2457A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T21:322020-09-18T21:32.A A mRNA-1273-P301HOmRNA-1273-P301-US355-2462A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T14:372020-10-16T14:37.BB mRNA-1273-P301HOmRNA-1273-P301-US355-2464A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T16:472020-10-20T16:47.B!B! mRNA-1273-P301HOmRNA-1273-P301-US355-2465A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T20:412020-09-18T20:41.AA mRNA-1273-P301HOmRNA-1273-P301-US355-2473AUSA-US089-2020-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-24 2020-11-25 .BCBD mRNA-1273-P301HOmRNA-1273-P301-US355-2475A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T12:012020-10-15T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US355-2499AUSA-US089-2020-mRNA-1273-P301000016HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-06 2020-12-07 .BHBI mRNA-1273-P301HOmRNA-1273-P301-US355-2499A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T22:472020-10-23T23:11.A`B mRNA-1273-P301HOmRNA-1273-P301-US355-2504A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T17:282020-10-01T17:28.A A mRNA-1273-P301HOmRNA-1273-P301-US355-2504A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T19:092020-10-29T19:09.BB mRNA-1273-P301HOmRNA-1273-P301-US355-2525A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T17:252020-10-10T17:25.A A mRNA-1273-P301HOmRNA-1273-P301-US355-2530A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-18 AP.. mRNA-1273-P301HOmRNA-1273-P301-US355-2531A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T20:452020-11-17T20:45.B#B# mRNA-1273-P301HOmRNA-1273-P301-US355-2532A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-19T18:042020-11-19T18:04.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US356-2015A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 B“.. mRNA-1273-P301HOmRNA-1273-P301-US356-2028A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T21:332020-08-14T21:33.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US356-2040A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US356-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T16:452020-09-15T22:23.BB! mRNA-1273-P301HOmRNA-1273-P301-US356-2044A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T17:172020-09-17T17:17.B"B" mRNA-1273-P301HOmRNA-1273-P301-US356-2065A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T18:312020-08-23T18:31.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US356-2073A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B”.. mRNA-1273-P301HOmRNA-1273-P301-US356-2074A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:342020-09-23T12:34.BB mRNA-1273-P301HOmRNA-1273-P301-US356-2076A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 Bt.. mRNA-1273-P301HOmRNA-1273-P301-US356-2104A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T19:002020-10-04T19:00.B"B" mRNA-1273-P301HOmRNA-1273-P301-US356-2118A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T15:232020-10-08T15:23.B#B# mRNA-1273-P301HOmRNA-1273-P301-US356-2120A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T14:082020-09-04T14:08.AA mRNA-1273-P301HOmRNA-1273-P301-US356-2122A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T06:212020-09-10T06:21.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US356-2135A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:032020-09-10T12:03.A A mRNA-1273-P301HOmRNA-1273-P301-US356-2144A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 BR.. mRNA-1273-P301HOmRNA-1273-P301-US356-2177A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T12:572020-10-27T21:39.B)B* mRNA-1273-P301HOmRNA-1273-P301-US356-2181A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T17:312020-10-20T17:31.B"B" mRNA-1273-P301HOmRNA-1273-P301-US356-2182A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T21:102020-09-23T18:37.A@Ap mRNA-1273-P301HOmRNA-1273-P301-US356-2184A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T18:562020-10-15T18:56.BB mRNA-1273-P301HOmRNA-1273-P301-US356-2205AUSA-US071-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-21 2021-01-24 .BqBt mRNA-1273-P301HOmRNA-1273-P301-US356-2218A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 B2.. mRNA-1273-P301HOmRNA-1273-P301-US356-2220A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US356-2221A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T19:232020-10-08T19:23.AA mRNA-1273-P301HOmRNA-1273-P301-US356-2228AUSA-US071-2021-mRNA-1273-P301000006HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-22 2021-03-23 .B B¡ mRNA-1273-P301HOmRNA-1273-P301-US356-2229AUSA-US071-2021-mRNA-1273-P301000007HO-AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-16 2021-04-18 .B¸Bº mRNA-1273-P301HOmRNA-1273-P301-US356-2230AUSA-US071-2020-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-07 2020-11-17 .BB" mRNA-1273-P301HOmRNA-1273-P301-US356-2233A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T15:022020-10-20T15:02.APAP mRNA-1273-P301HOmRNA-1273-P301-US356-2236A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T13:102020-10-26T13:10.ApAp mRNA-1273-P301HOmRNA-1273-P301-US357-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US357-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T02:292020-09-17T02:29.BB mRNA-1273-P301HOmRNA-1273-P301-US357-2023A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T09:022020-09-26T09:02.B'B' mRNA-1273-P301HOmRNA-1273-P301-US357-2026A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T01:352020-08-21T01:35.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US357-2029A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T12:582020-08-25T12:58.ApAp mRNA-1273-P301HOmRNA-1273-P301-US357-2030A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US357-2036A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US357-2057A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T00:152020-09-25T23:32.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US357-2064A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T22:432020-08-26T22:43.A`A` mRNA-1273-P301HOmRNA-1273-P301-US357-2065A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T13:132020-09-25T13:13.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US357-2084A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T18:432020-09-23T18:43.BB mRNA-1273-P301HOmRNA-1273-P301-US357-2086AUSA-US091-2021-mRNA-1273-P301000001HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-03 2021-01-13 .B„BŽ mRNA-1273-P301HOmRNA-1273-P301-US357-2086A USA-US091-2021-mRNA-1273-P301000015HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-23 2021-02-12 .B˜B¬ mRNA-1273-P301HOmRNA-1273-P301-US357-2086A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 BŽ.. mRNA-1273-P301HOmRNA-1273-P301-US357-2091A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T22:242020-09-26T21:58.B B! mRNA-1273-P301HOmRNA-1273-P301-US357-2109A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T01:162020-09-10T01:56.A Að mRNA-1273-P301HOmRNA-1273-P301-US357-2116AUSA-US091-2021-mRNA-1273-P301000020HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-19 2021-04-23 .BìBð mRNA-1273-P301HOmRNA-1273-P301-US357-2120AUSA-US091-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-19 2020-12-24 .BsBx mRNA-1273-P301HOmRNA-1273-P301-US357-2122A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T11:072020-10-02T11:07.B%B% mRNA-1273-P301HOmRNA-1273-P301-US357-2125AUSA-US091-2021-mRNA-1273-P301000010HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-10 2021-01-13 .B‚B… mRNA-1273-P301HOmRNA-1273-P301-US357-2134AUSA-US091-2020-mRNA-1273-P301000003HO-AE-009/AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-09 2020-11-13 .BJBN mRNA-1273-P301HOmRNA-1273-P301-US357-2134A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T16:202020-10-24T03:43.B5B: mRNA-1273-P301HOmRNA-1273-P301-US357-2156A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US357-2161A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T18:392020-09-02T18:39.A A mRNA-1273-P301HOmRNA-1273-P301-US357-2162A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T12:542020-10-28T12:01.BB: mRNA-1273-P301HOmRNA-1273-P301-US357-2166A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T06:492020-09-11T20:32.APA mRNA-1273-P301HOmRNA-1273-P301-US357-2166A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T11:362020-10-01T11:36.BB mRNA-1273-P301HOmRNA-1273-P301-US357-2167A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T20:132020-09-09T20:37.A`A€ mRNA-1273-P301HOmRNA-1273-P301-US357-2167A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T18:112020-10-08T18:11.B%B% mRNA-1273-P301HOmRNA-1273-P301-US357-2170AUSA-US091-2021-mRNA-1273-P301000018HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-10 2021-04-14 .BÕBÙ mRNA-1273-P301HOmRNA-1273-P301-US357-2174A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US357-2181AUSA-US091-2021-mRNA-1273-P301000008HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-27 2021-02-03 .B“Bš mRNA-1273-P301HOmRNA-1273-P301-US357-2186A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 BN.. mRNA-1273-P301HOmRNA-1273-P301-US357-2199AUSA-US091-2020-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-19 2020-12-24 .BkBp mRNA-1273-P301HOmRNA-1273-P301-US357-2199A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-19 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US357-2199A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US357-2201A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US357-2210A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T12:012020-09-21T12:01.AðAð mRNA-1273-P301HOmRNA-1273-P301-US357-2214A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T09:162020-09-12T09:16.A`A` mRNA-1273-P301HOmRNA-1273-P301-US357-2219A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T14:172020-09-11T14:17.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US357-2225A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T14:162020-09-11T14:16.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US357-2239A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T19:222020-10-14T22:37.B"B$ mRNA-1273-P301HOmRNA-1273-P301-US357-2249A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T13:272020-10-10T12:20.BB mRNA-1273-P301HOmRNA-1273-P301-US357-2256A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US357-2292A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T13:022020-09-16T13:02.A A mRNA-1273-P301HOmRNA-1273-P301-US357-2293A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T13:272020-10-17T13:27.B!B! mRNA-1273-P301HOmRNA-1273-P301-US357-2306A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US357-2320A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 B\.. mRNA-1273-P301HOmRNA-1273-P301-US357-2322A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T11:512020-10-22T00:12.BB mRNA-1273-P301HOmRNA-1273-P301-US357-2323A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US357-2324A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-25 B_.. mRNA-1273-P301HOmRNA-1273-P301-US357-2327A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T18:232020-10-01T12:25.AAp mRNA-1273-P301HOmRNA-1273-P301-US357-2327A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-30T09:312020-11-05T13:59.B$B* mRNA-1273-P301HOmRNA-1273-P301-US357-2327A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 BM.. mRNA-1273-P301HOmRNA-1273-P301-US357-2330AUSA-US091-2021-mRNA-1273-P301000021HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-16 2021-01-18 .BvBx mRNA-1273-P301HOmRNA-1273-P301-US357-2337A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T13:032020-09-27T13:03.APAP mRNA-1273-P301HOmRNA-1273-P301-US357-2380A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T13:462020-10-13T13:46.A`A` mRNA-1273-P301HOmRNA-1273-P301-US357-2383A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T18:012020-11-02T17:13.A B mRNA-1273-P301HOmRNA-1273-P301-US357-2384A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-10T21:002020-11-11T12:06.B!B" mRNA-1273-P301HOmRNA-1273-P301-US358-2010A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T21:262020-09-19T21:26.B B mRNA-1273-P301HOmRNA-1273-P301-US358-2022A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T12:012020-09-18T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US358-2023A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T20:202020-09-22T20:20.B!B! mRNA-1273-P301HOmRNA-1273-P301-US358-2034A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T21:152020-08-29T21:15.A`A` mRNA-1273-P301HOmRNA-1273-P301-US358-2055A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T17:122020-08-29T17:09.A0A@ mRNA-1273-P301HOmRNA-1273-P301-US358-2081A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T20:592020-10-01T20:59.BB mRNA-1273-P301HOmRNA-1273-P301-US358-2082A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T17:532020-10-09T19:49.B&B' mRNA-1273-P301HOmRNA-1273-P301-US358-2087A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-26 B³.. mRNA-1273-P301HOmRNA-1273-P301-US358-2098A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T10:202020-09-03T10:20.AA mRNA-1273-P301HOmRNA-1273-P301-US358-2102AUSA-US124-2021-mRNA-1273-P301000002HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-21 2021-02-22 .B¬B mRNA-1273-P301HOmRNA-1273-P301-US358-2109A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T21:492020-10-14T21:49.B)B) mRNA-1273-P301HOmRNA-1273-P301-US358-2110A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US358-2127A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T18:242020-10-07T18:24.BB mRNA-1273-P301HOmRNA-1273-P301-US358-2130A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T10:422020-10-15T10:42.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US358-2142A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 BU.. mRNA-1273-P301HOmRNA-1273-P301-US358-2148A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T06:062020-09-22T06:06.ApAp mRNA-1273-P301HOmRNA-1273-P301-US358-2153A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T16:192020-10-20T16:19.B"B" mRNA-1273-P301HOmRNA-1273-P301-US358-2175A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-09T22:232020-11-09T22:23.B#B# mRNA-1273-P301HOmRNA-1273-P301-US358-2176A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-03T12:162020-11-03T12:16.BB mRNA-1273-P301HOmRNA-1273-P301-US358-2181A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T07:422020-11-17T07:42.B%B% mRNA-1273-P301HOmRNA-1273-P301-US358-2183A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-10 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US358-2194A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-16T11:462020-11-16T11:46.BB mRNA-1273-P301HOmRNA-1273-P301-US359-2003A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T18:262020-08-11T18:32.A`Ap mRNA-1273-P301HOmRNA-1273-P301-US359-2007A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-05 B¹.. mRNA-1273-P301HOmRNA-1273-P301-US359-2008A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-15 BÃ.. mRNA-1273-P301HOmRNA-1273-P301-US359-2014A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 Be.. mRNA-1273-P301HOmRNA-1273-P301-US359-2042A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B§.. mRNA-1273-P301HOmRNA-1273-P301-US359-2053A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US359-2061AUSA-US103-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-25 2021-03-28 .BæBé mRNA-1273-P301HOmRNA-1273-P301-US359-2063A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-26 B¬.. mRNA-1273-P301HOmRNA-1273-P301-US359-2075A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B.. mRNA-1273-P301HOmRNA-1273-P301-US359-2083A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T18:282020-08-14T18:28.A`A` mRNA-1273-P301HOmRNA-1273-P301-US359-2083A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-27 B¬.. mRNA-1273-P301HOmRNA-1273-P301-US359-2084A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 BW.. mRNA-1273-P301HOmRNA-1273-P301-US359-2096A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T22:232020-08-10T22:23.AA mRNA-1273-P301HOmRNA-1273-P301-US359-2103A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T12:432020-09-08T12:43.BB mRNA-1273-P301HOmRNA-1273-P301-US359-2111AUSA-US103-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-05 2020-11-15 .BXBb mRNA-1273-P301HOmRNA-1273-P301-US359-2114A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T18:252020-09-13T01:52.BB" mRNA-1273-P301HOmRNA-1273-P301-US359-2117A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BX.. mRNA-1273-P301HOmRNA-1273-P301-US359-2127A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 B^.. mRNA-1273-P301HOmRNA-1273-P301-US359-2132A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 BL.. mRNA-1273-P301HOmRNA-1273-P301-US359-2139A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T20:352020-08-22T20:35.A A mRNA-1273-P301HOmRNA-1273-P301-US359-2151A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T19:182020-08-17T19:18.APAP mRNA-1273-P301HOmRNA-1273-P301-US359-2159A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US359-2161A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-31 BO.. mRNA-1273-P301HOmRNA-1273-P301-US359-2163A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T06:452020-09-18T06:45.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US359-2185A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T16:442020-08-20T16:44.A`A` mRNA-1273-P301HOmRNA-1273-P301-US359-2187A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T23:382020-08-19T23:38.APAP mRNA-1273-P301HOmRNA-1273-P301-US359-2189A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BT.. mRNA-1273-P301HOmRNA-1273-P301-US359-2197A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-14 B<.. mRNA-1273-P301HOmRNA-1273-P301-US359-2219A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T02:462020-08-24T22:21.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US359-2226AUSA-US103-2021-mRNA-1273-P301000001HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-17 .Bz. mRNA-1273-P301HOmRNA-1273-P301-US359-2227A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T21:382020-09-16T21:38.BB mRNA-1273-P301HOmRNA-1273-P301-US359-2229AUSA-US103-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-16 2021-03-17 .BÓBÔ mRNA-1273-P301HOmRNA-1273-P301-US359-2229A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T08:522020-08-23T14:22.A`A` mRNA-1273-P301HOmRNA-1273-P301-US359-2232AUSA-US103-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-25 2020-08-28 .A`A mRNA-1273-P301HOmRNA-1273-P301-US359-2232A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T14:372020-08-26T14:37.ApAp mRNA-1273-P301HOmRNA-1273-P301-US359-2235A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T19:542020-08-28T00:00.A`A€ mRNA-1273-P301HOmRNA-1273-P301-US359-2238AUSA-US103-2021-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-23 2021-03-26 .BÏBÒ mRNA-1273-P301HOmRNA-1273-P301-US359-2247AUSA-US103-2020-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-10 2020-11-16 .BJBP mRNA-1273-P301HOmRNA-1273-P301-US360-2004AUSA-US079-2021-mRNA-1273-P301000003HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-03 2021-01-04 .B|B} mRNA-1273-P301HOmRNA-1273-P301-US360-2006A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T18:242020-10-06T17:04.B"B# mRNA-1273-P301HOmRNA-1273-P301-US360-2034A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-25 B-.. mRNA-1273-P301HOmRNA-1273-P301-US360-2038A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-07 B7.. mRNA-1273-P301HOmRNA-1273-P301-US360-2040A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T16:462020-09-22T16:46.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US360-2043A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T21:572020-09-23T21:57.AA mRNA-1273-P301HOmRNA-1273-P301-US360-2051AUSA-US079-2020-mRNA-1273-P301000004HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US360-2051A USA-US079-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-29 2020-11-02 .B+B/ mRNA-1273-P301HOmRNA-1273-P301-US360-2074AUSA-US079-2020-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-10 2020-12-20 .BQB[ mRNA-1273-P301HOmRNA-1273-P301-US360-2074A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-29 BF.. mRNA-1273-P301HOmRNA-1273-P301-US360-2098A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T19:582020-11-12T19:58.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US360-2101A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T23:402020-10-26T23:40.B!B! mRNA-1273-P301HOmRNA-1273-P301-US360-2111A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 B.. mRNA-1273-P301HOmRNA-1273-P301-US360-2116A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US360-2123A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-01T16:002020-11-01T16:00.BB mRNA-1273-P301HOmRNA-1273-P301-US360-2141A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-09 B].. mRNA-1273-P301HOmRNA-1273-P301-US360-2150A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-10T12:502020-11-10T12:50.BB mRNA-1273-P301HOmRNA-1273-P301-US360-2154AUSA-US079-2021-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-26 2021-02-27 .B‡Bˆ mRNA-1273-P301HOmRNA-1273-P301-US361-2005AUSA-US129-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-13 2021-04-17 .BáBå mRNA-1273-P301HOmRNA-1273-P301-US361-2008A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T20:502020-09-30T20:50.BB mRNA-1273-P301HOmRNA-1273-P301-US361-2013A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T20:172020-09-07T20:20.A0AP mRNA-1273-P301HOmRNA-1273-P301-US361-2031A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T11:222020-09-10T11:22.AA mRNA-1273-P301HOmRNA-1273-P301-US361-2031A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US361-2037A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US361-2052A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 BU.. mRNA-1273-P301HOmRNA-1273-P301-US361-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T12:332020-09-30T12:33.A A mRNA-1273-P301HOmRNA-1273-P301-US361-2060AUSA-US129-2021-mRNA-1273-P301000005HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-31 2021-04-02 .B·B¹ mRNA-1273-P301HOmRNA-1273-P301-US361-2070A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T12:292020-10-12T12:29.A`A` mRNA-1273-P301HOmRNA-1273-P301-US361-2079A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T09:592020-10-24T20:44.APAP mRNA-1273-P301HOmRNA-1273-P301-US361-2082A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 BE.. mRNA-1273-P301HOmRNA-1273-P301-US361-2084A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-21T12:092020-11-21T12:09.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2002A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T18:152020-09-10T18:15.B B mRNA-1273-P301HOmRNA-1273-P301-US362-2003A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-08 Bò.. mRNA-1273-P301HOmRNA-1273-P301-US362-2004A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T09:502020-09-04T09:50.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2011A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 B.. mRNA-1273-P301HOmRNA-1273-P301-US362-2019A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T21:352020-09-10T21:35.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2035A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T19:212020-08-21T17:29.A0AP mRNA-1273-P301HOmRNA-1273-P301-US362-2039A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T10:372020-09-17T18:06.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2041A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T20:472020-09-18T22:28.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2046A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T20:092020-08-21T20:09.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US362-2054A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T12:032020-09-27T12:03.B'B' mRNA-1273-P301HOmRNA-1273-P301-US362-2056A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T18:212020-08-22T18:21.A A mRNA-1273-P301HOmRNA-1273-P301-US362-2057A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T09:032020-09-21T09:03.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2110A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T12:022020-10-02T12:02.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2114A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T12:002020-09-03T12:00.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US362-2114A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T11:092020-09-29T11:09.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2115A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US362-2116AUSA-US085-2020-mRNA-1273-P301000003HO-AE-004/AE-005/AE-006/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-29 2020-12-02 .B[B^ mRNA-1273-P301HOmRNA-1273-P301-US362-2120A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T21:412020-09-01T21:41.A A mRNA-1273-P301HOmRNA-1273-P301-US362-2130A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B„.. mRNA-1273-P301HOmRNA-1273-P301-US362-2142AUSA-US085-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-29 2021-01-31 .B•B— mRNA-1273-P301HOmRNA-1273-P301-US362-2142A USA-US085-2021-mRNA-1273-P301000009HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-06 2021-02-09 .BB mRNA-1273-P301HOmRNA-1273-P301-US362-2142A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-02 B™.. mRNA-1273-P301HOmRNA-1273-P301-US362-2160AUSA-US085-2021-mRNA-1273-P301000016HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-05 .BÕ. mRNA-1273-P301HOmRNA-1273-P301-US362-2163A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T06:042020-10-05T06:04.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2169AUSA-US085-2020-mRNA-1273-P301000004HO-AE-003/AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US362-2169A USA-US085-2020-mRNA-1273-P301000004HO-AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US362-2169A0USA-US085-2020-mRNA-1273-P301000004HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-06 2021-01-04 .BYBv mRNA-1273-P301HOmRNA-1273-P301-US362-2169A@USA-US085-2020-mRNA-1273-P301000004HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-16 2021-01-21 .B‚B‡ mRNA-1273-P301HOmRNA-1273-P301-US362-2170A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T16:572020-10-08T16:57.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2192A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T20:232020-10-15T20:23.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2192A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-19 BØ.. mRNA-1273-P301HOmRNA-1273-P301-US362-2193A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T22:072020-10-15T22:07.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2194A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T10:122020-10-15T10:12.BB mRNA-1273-P301HOmRNA-1273-P301-US362-2197AUSA-US085-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-12 2021-01-15 .BvBy mRNA-1273-P301HOmRNA-1273-P301-US362-2203A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T00:072020-10-21T00:07.B"B" mRNA-1273-P301HOmRNA-1273-P301-US362-2206AUSA-US085-2021-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-11 2021-03-16 .B®B³ mRNA-1273-P301HOmRNA-1273-P301-US362-2211AUSA-US085-2021-mRNA-1273-P301000001HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-01 2021-01-02 .BgBh mRNA-1273-P301HOmRNA-1273-P301-US362-2233A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-28T19:102020-10-28T19:10.B!B! mRNA-1273-P301HOmRNA-1273-P301-US362-2249A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-12 BI.. mRNA-1273-P301HOmRNA-1273-P301-US362-2257A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 B$.. mRNA-1273-P301HOmRNA-1273-P301-US362-2263A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-03 BV.. mRNA-1273-P301HOmRNA-1273-P301-US362-2270A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T09:422020-10-24T09:42.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US362-2271A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T06:332020-11-05T10:51.A€B mRNA-1273-P301HOmRNA-1273-P301-US362-2274A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T19:582020-10-14T19:58.AA mRNA-1273-P301HOmRNA-1273-P301-US362-2282AUSA-US085-2020-mRNA-1273-P301000002HO-AE-001/AE-002/AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P7D mRNA-1273-P301HOmRNA-1273-P301-US362-2282A USA-US085-2020-mRNA-1273-P301000002HO-AE-017 HOSPITAL HOSPITALADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US362-2282A0USA-US085-2020-mRNA-1273-P301000002HO-AE-001/AE-002/AE-004/AE-012 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-06 2020-11-26 .BB% mRNA-1273-P301HOmRNA-1273-P301-US362-2282A@USA-US085-2021-mRNA-1273-P301000014HO-AE-021 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-25 .B€. mRNA-1273-P301HOmRNA-1273-P301-US363-2018A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US363-2032A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T21:222020-09-16T21:22.AA mRNA-1273-P301HOmRNA-1273-P301-US363-2039A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US363-2040A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T00:022020-10-08T00:02.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US363-2064AUSA-US120-2021-mRNA-1273-P301000001HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US363-2064A USA-US120-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-31 2021-01-04 .BrBv mRNA-1273-P301HOmRNA-1273-P301-US363-2075AUSA-US120-2021-mRNA-1273-P301000004HO-AE-004/AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-12 2021-03-03 .B›B® mRNA-1273-P301HOmRNA-1273-P301-US363-2082A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T12:062020-10-12T12:06.BB mRNA-1273-P301HOmRNA-1273-P301-US363-2085A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T21:512020-09-18T21:51.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US363-2090A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T23:132020-09-21T23:13.A`A` mRNA-1273-P301HOmRNA-1273-P301-US363-2094A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 B/.. mRNA-1273-P301HOmRNA-1273-P301-US363-2100A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T22:202020-10-26T22:20.B#B# mRNA-1273-P301HOmRNA-1273-P301-US363-2101A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T10:092020-10-23T10:09.B B mRNA-1273-P301HOmRNA-1273-P301-US363-2105A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T19:292020-09-27T21:18.A0AP mRNA-1273-P301HOmRNA-1273-P301-US363-2107A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 B=.. mRNA-1273-P301HOmRNA-1273-P301-US363-2109A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 BA.. mRNA-1273-P301HOmRNA-1273-P301-US363-2114A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 BF.. mRNA-1273-P301HOmRNA-1273-P301-US363-2116A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 B7.. mRNA-1273-P301HOmRNA-1273-P301-US363-2117A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-11T21:042020-10-14T06:44.APA€ mRNA-1273-P301HOmRNA-1273-P301-US363-2119A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-18 B*.. mRNA-1273-P301HOmRNA-1273-P301-US363-2129A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T08:582020-11-12T08:58.BB mRNA-1273-P301HOmRNA-1273-P301-US363-2129A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 B.. mRNA-1273-P301HOmRNA-1273-P301-US363-2134A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 BD.. mRNA-1273-P301HOmRNA-1273-P301-US363-2140A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T09:332020-10-23T20:08.APAP mRNA-1273-P301HOmRNA-1273-P301-US363-2146A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-21T18:552020-11-21T18:55.B!B! mRNA-1273-P301HOmRNA-1273-P301-US363-2152A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B>.. mRNA-1273-P301HOmRNA-1273-P301-US363-2154A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-20T19:592020-11-20T19:59.BB mRNA-1273-P301HOmRNA-1273-P301-US363-2154A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 B1.. mRNA-1273-P301HOmRNA-1273-P301-US364-2008A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T15:212020-09-24T15:21.B B mRNA-1273-P301HOmRNA-1273-P301-US364-2011A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T14:012020-10-01T14:01.B&B& mRNA-1273-P301HOmRNA-1273-P301-US364-2022A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T17:202020-10-03T20:22.B$B& mRNA-1273-P301HOmRNA-1273-P301-US364-2024AUSA-US109-2021-mRNA-1273-P301000013HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US364-2024A USA-US109-2021-mRNA-1273-P301000013HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-25 2020-09-30 .BB# mRNA-1273-P301HOmRNA-1273-P301-US364-2035AUSA-US109-2020-mRNA-1273-P301000008HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-12 2020-10-13 .B.B/ mRNA-1273-P301HOmRNA-1273-P301-US364-2035A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T08:322020-09-01T21:50.APAP mRNA-1273-P301HOmRNA-1273-P301-US364-2051A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T14:442020-09-01T14:44.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US364-2054A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T20:202020-09-29T20:20.B B mRNA-1273-P301HOmRNA-1273-P301-US364-2061A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T22:102020-10-02T22:10.B!B! mRNA-1273-P301HOmRNA-1273-P301-US364-2063A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T16:182020-09-03T16:18.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US364-2063A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T19:532020-09-29T19:53.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2065A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T20:172020-09-05T20:17.A`A` mRNA-1273-P301HOmRNA-1273-P301-US364-2072AUSA-US109-2020-mRNA-1273-P301000004HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-27 2020-11-30 .BXB[ mRNA-1273-P301HOmRNA-1273-P301-US364-2074A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BM.. mRNA-1273-P301HOmRNA-1273-P301-US364-2075A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T08:022020-10-01T08:02.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2076AUSA-US109-2021-mRNA-1273-P301000007HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-22 2021-02-24 .B¯B± mRNA-1273-P301HOmRNA-1273-P301-US364-2081AUSA-US109-2021-mRNA-1273-P301000012HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-28 2021-03-29 .BÐBÑ mRNA-1273-P301HOmRNA-1273-P301-US364-2086A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US364-2087A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T18:052020-09-05T18:05.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US364-2099A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T12:162020-09-08T12:16.APAP mRNA-1273-P301HOmRNA-1273-P301-US364-2099A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T15:042020-10-02T15:04.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2136A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T14:592020-10-04T14:59.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2142A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T16:582020-09-08T16:58.AA mRNA-1273-P301HOmRNA-1273-P301-US364-2152A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 BT.. mRNA-1273-P301HOmRNA-1273-P301-US364-2158A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T15:432020-09-11T15:43.A A mRNA-1273-P301HOmRNA-1273-P301-US364-2159A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-11T12:012020-10-11T12:01.B B mRNA-1273-P301HOmRNA-1273-P301-US364-2160A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T14:372020-10-15T14:37.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US364-2181A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T16:432020-09-22T16:43.A°A° mRNA-1273-P301HOmRNA-1273-P301-US364-2189A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T05:502020-09-14T12:04.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US364-2189A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T18:332020-10-10T18:33.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2193A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T16:472020-10-13T16:47.B B mRNA-1273-P301HOmRNA-1273-P301-US364-2193A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-27 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US364-2198A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T21:142020-10-12T21:14.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2203A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T12:092020-10-15T12:09.B B mRNA-1273-P301HOmRNA-1273-P301-US364-2207A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T16:412020-10-21T16:41.B&B& mRNA-1273-P301HOmRNA-1273-P301-US364-2212A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T22:272020-10-16T22:27.B!B! mRNA-1273-P301HOmRNA-1273-P301-US364-2212A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 B_.. mRNA-1273-P301HOmRNA-1273-P301-US364-2215A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T23:302020-09-17T23:30.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US364-2217AUSA-US109-2021-mRNA-1273-P301000006HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US364-2217A USA-US109-2021-mRNA-1273-P301000006HO-AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US364-2217A0USA-US109-2021-mRNA-1273-P301000006HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYSCREENING 2020-02-16 2020-02-17 .ÂÔÂÓ mRNA-1273-P301HOmRNA-1273-P301-US364-2217A@USA-US109-2021-mRNA-1273-P301000006HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-16 2021-02-17 .B›Bœ mRNA-1273-P301HOmRNA-1273-P301-US364-2220A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T15:522020-09-16T15:52.A A mRNA-1273-P301HOmRNA-1273-P301-US364-2224A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 BW.. mRNA-1273-P301HOmRNA-1273-P301-US364-2227A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 BB.. mRNA-1273-P301HOmRNA-1273-P301-US364-2229A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 B>.. mRNA-1273-P301HOmRNA-1273-P301-US364-2231A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US364-2243A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T20:252020-10-21T20:25.B"B" mRNA-1273-P301HOmRNA-1273-P301-US364-2244A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T16:002020-10-16T16:00.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2251A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:122020-09-26T12:01.APA€ mRNA-1273-P301HOmRNA-1273-P301-US364-2252A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T17:562020-09-21T17:56.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US364-2276A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T06:002020-09-29T06:00.APAP mRNA-1273-P301HOmRNA-1273-P301-US364-2276A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-28T21:412020-10-28T21:41.B"B" mRNA-1273-P301HOmRNA-1273-P301-US364-2283A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-03T09:352020-11-03T09:35.B%B% mRNA-1273-P301HOmRNA-1273-P301-US364-2285A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-08 B….. mRNA-1273-P301HOmRNA-1273-P301-US364-2287A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-03T22:002020-11-03T22:00.B#B# mRNA-1273-P301HOmRNA-1273-P301-US364-2292A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T02:342020-10-17T22:00.AÀB mRNA-1273-P301HOmRNA-1273-P301-US364-2306A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T15:352020-10-13T17:43.AAP mRNA-1273-P301HOmRNA-1273-P301-US364-2307A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T07:422020-10-16T07:42.ApAp mRNA-1273-P301HOmRNA-1273-P301-US364-2312A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-11T12:092020-11-11T12:09.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2330A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T17:122020-10-19T17:12.AA mRNA-1273-P301HOmRNA-1273-P301-US364-2333AUSA-US109-2021-mRNA-1273-P301000001HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P14DmRNA-1273-P301HOmRNA-1273-P301-US364-2333A USA-US109-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-19 2021-01-01 .B<BI mRNA-1273-P301HOmRNA-1273-P301-US364-2333A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T20:102020-10-26T20:10.A`A` mRNA-1273-P301HOmRNA-1273-P301-US364-2333A@ HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T15:072020-11-18T19:09.BB mRNA-1273-P301HOmRNA-1273-P301-US364-2333AP HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYYFOLLOW-UP BLINDED PHASE 2020-12-19 2021-01-01 .B<BI mRNA-1273-P301HOmRNA-1273-P301-US364-2345A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-25T23:042020-11-25T23:04.B"B" mRNA-1273-P301HOmRNA-1273-P301-US364-2345A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 B/.. mRNA-1273-P301HOmRNA-1273-P301-US365-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B€.. mRNA-1273-P301HOmRNA-1273-P301-US365-2006A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T13:292020-10-07T13:29.B#B# mRNA-1273-P301HOmRNA-1273-P301-US365-2010A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T15:082020-09-18T15:44.A`A mRNA-1273-P301HOmRNA-1273-P301-US365-2012A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T20:142020-10-08T20:14.BB mRNA-1273-P301HOmRNA-1273-P301-US365-2024A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T13:202020-10-14T13:20.BB mRNA-1273-P301HOmRNA-1273-P301-US365-2038AUSA-US132-2020-mRNA-1273-P301000003HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-04 2020-12-08 .BGBK mRNA-1273-P301HOmRNA-1273-P301-US365-2038A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-27 B!.. mRNA-1273-P301HOmRNA-1273-P301-US365-2039A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-27 B.. mRNA-1273-P301HOmRNA-1273-P301-US365-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-03T06:402020-11-03T06:40.B#B# mRNA-1273-P301HOmRNA-1273-P301-US365-2047A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T00:562020-10-09T00:56.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US365-2051A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T19:542020-10-13T19:54.AA mRNA-1273-P301HOmRNA-1273-P301-US366-2023A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US366-2025A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T21:532020-09-25T21:53.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US366-2026A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-11-20T05:242020-11-20T05:24.B@B@ mRNA-1273-P301HOmRNA-1273-P301-US366-2027A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T12:502020-10-13T12:50.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US366-2030A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US366-2032AUSA-US088-2021-mRNA-1273-P301000012HO-AE-013 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-08 2021-04-13 .BÜBá mRNA-1273-P301HOmRNA-1273-P301-US366-2033AUSA-US088-2020-mRNA-1273-P301000001HO-AE-001/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-08 2020-09-10 .A€A mRNA-1273-P301HOmRNA-1273-P301-US366-2041A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US366-2048A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T17:372020-10-04T17:37.B B mRNA-1273-P301HOmRNA-1273-P301-US366-2049AUSA-US088-2021-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-09 2021-04-10 .BÛBÜ mRNA-1273-P301HOmRNA-1273-P301-US366-2049A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T16:462020-09-09T16:46.ApAp mRNA-1273-P301HOmRNA-1273-P301-US366-2062A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US366-2063A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T20:472020-09-28T20:47.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US366-2071A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T20:482020-10-21T20:48.B&B& mRNA-1273-P301HOmRNA-1273-P301-US366-2075A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T14:002020-09-17T14:00.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US366-2085A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T21:072020-09-16T21:07.A`A` mRNA-1273-P301HOmRNA-1273-P301-US366-2094A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T19:502020-10-18T19:50.B#B# mRNA-1273-P301HOmRNA-1273-P301-US366-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T20:252020-10-22T20:25.B&B& mRNA-1273-P301HOmRNA-1273-P301-US366-2098A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 B*.. mRNA-1273-P301HOmRNA-1273-P301-US366-2101AUSA-US088-2021-mRNA-1273-P301000010HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US366-2101A USA-US088-2021-mRNA-1273-P301000010HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-08 2021-04-11 .BÍBÐ mRNA-1273-P301HOmRNA-1273-P301-US366-2116AUSA-US088-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-11 2021-02-16 .B“B˜ mRNA-1273-P301HOmRNA-1273-P301-US366-2119A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-23 B€.. mRNA-1273-P301HOmRNA-1273-P301-US366-2124A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T15:062020-10-22T15:06.B B mRNA-1273-P301HOmRNA-1273-P301-US366-2124A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US366-2136A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B`.. mRNA-1273-P301HOmRNA-1273-P301-US366-2138A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T20:462020-11-02T19:05.B B' mRNA-1273-P301HOmRNA-1273-P301-US366-2143A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-21 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US366-2145A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-04T09:032020-11-04T09:03.B%B% mRNA-1273-P301HOmRNA-1273-P301-US366-2156A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 B+.. mRNA-1273-P301HOmRNA-1273-P301-US366-2175A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T00:022020-10-29T22:44.A€A mRNA-1273-P301HOmRNA-1273-P301-US366-2180A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-18T14:062020-11-18T14:06.BB mRNA-1273-P301HOmRNA-1273-P301-US366-2181AUSA-US088-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-26 2020-10-30 .APA mRNA-1273-P301HOmRNA-1273-P301-US366-2184A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-26T12:102020-11-26T12:10.B#B# mRNA-1273-P301HOmRNA-1273-P301-US367-2012A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T12:592020-09-13T12:59.B'B' mRNA-1273-P301HOmRNA-1273-P301-US367-2015A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T22:392020-09-14T22:39.B'B' mRNA-1273-P301HOmRNA-1273-P301-US367-2018A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-04 B¶.. mRNA-1273-P301HOmRNA-1273-P301-US367-2021A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T13:552020-08-07T13:55.AA mRNA-1273-P301HOmRNA-1273-P301-US367-2036A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T23:462020-09-15T23:46.B%B% mRNA-1273-P301HOmRNA-1273-P301-US367-2048A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-05 BÏ.. mRNA-1273-P301HOmRNA-1273-P301-US367-2061A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 B].. mRNA-1273-P301HOmRNA-1273-P301-US367-2062A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T21:012020-08-18T21:01.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US367-2074A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B‹.. mRNA-1273-P301HOmRNA-1273-P301-US367-2078A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T00:002020-09-16T00:00.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US367-2082A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T17:312020-08-14T17:31.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US367-2082A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T19:392020-09-22T19:39.B*B* mRNA-1273-P301HOmRNA-1273-P301-US367-2097A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-11 B.. mRNA-1273-P301HOmRNA-1273-P301-US367-2108A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T16:192020-08-17T16:19.APAP mRNA-1273-P301HOmRNA-1273-P301-US367-2139A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T13:182020-08-18T13:18.A A mRNA-1273-P301HOmRNA-1273-P301-US367-2142A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T19:042020-09-20T19:04.B#B# mRNA-1273-P301HOmRNA-1273-P301-US367-2144A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T00:182020-08-24T00:18.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US367-2146A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 BX.. mRNA-1273-P301HOmRNA-1273-P301-US367-2151A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T06:192020-08-22T06:19.A`A` mRNA-1273-P301HOmRNA-1273-P301-US367-2183A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-11 BÍ.. mRNA-1273-P301HOmRNA-1273-P301-US367-2185A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T12:012020-08-23T21:10.A0AP mRNA-1273-P301HOmRNA-1273-P301-US367-2187AUSA-US116-2021-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-06 2021-03-09 .BÈBË mRNA-1273-P301HOmRNA-1273-P301-US367-2199AUSA-US116-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-06 2020-10-08 .B1B3 mRNA-1273-P301HOmRNA-1273-P301-US367-2203A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T12:082020-08-21T12:08.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US367-2213A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T13:152020-09-24T13:15.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US367-2214A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T07:342020-08-27T07:34.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US367-2230A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-20 B>.. mRNA-1273-P301HOmRNA-1273-P301-US367-2232A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 B\.. mRNA-1273-P301HOmRNA-1273-P301-US367-2242A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T07:262020-09-28T07:26.B'B' mRNA-1273-P301HOmRNA-1273-P301-US367-2243A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BX.. mRNA-1273-P301HOmRNA-1273-P301-US367-2244A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 BT.. mRNA-1273-P301HOmRNA-1273-P301-US367-2250A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US367-2255AUSA-US116-2021-mRNA-1273-P301000011HO-AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-27 2021-04-02 .BÛBá mRNA-1273-P301HOmRNA-1273-P301-US367-2255A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-11-16T17:492020-11-16T17:49.BXBX mRNA-1273-P301HOmRNA-1273-P301-US367-2278AUSA-US116-2020-mRNA-1273-P301000001HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-10 2020-09-11 .A°AÀ mRNA-1273-P301HOmRNA-1273-P301-US367-2305A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T05:312020-08-31T05:31.ApAp mRNA-1273-P301HOmRNA-1273-P301-US367-2312A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B’.. mRNA-1273-P301HOmRNA-1273-P301-US367-2325A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T22:042020-10-12T20:26.B+B0 mRNA-1273-P301HOmRNA-1273-P301-US367-2326A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T15:072020-08-31T15:07.A`A` mRNA-1273-P301HOmRNA-1273-P301-US367-2347A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T17:002020-09-25T17:00.BB mRNA-1273-P301HOmRNA-1273-P301-US367-2351A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T21:572020-09-23T20:57.AB mRNA-1273-P301HOmRNA-1273-P301-US367-2351A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T19:362020-09-24T19:36.BB mRNA-1273-P301HOmRNA-1273-P301-US367-2354A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T19:172020-08-29T22:53.A A0 mRNA-1273-P301HOmRNA-1273-P301-US367-2358A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-02 B .. mRNA-1273-P301HOmRNA-1273-P301-US367-2368A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-18 B.. mRNA-1273-P301HOmRNA-1273-P301-US367-2387A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T13:412020-10-01T13:41.B B mRNA-1273-P301HOmRNA-1273-P301-US367-2388AUSA-US116-2021-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-02 2020-11-04 .B@BB mRNA-1273-P301HOmRNA-1273-P301-US367-2390A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-02 B¸.. mRNA-1273-P301HOmRNA-1273-P301-US368-2001AUSA-US081-2020-mRNA-1273-P301000002HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-30 2020-12-01 .BfBg mRNA-1273-P301HOmRNA-1273-P301-US368-2009A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B”.. mRNA-1273-P301HOmRNA-1273-P301-US368-2011A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B”.. mRNA-1273-P301HOmRNA-1273-P301-US368-2014A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T11:272020-08-30T12:47.AAP mRNA-1273-P301HOmRNA-1273-P301-US368-2015A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US368-2016A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T12:032020-09-28T12:03.B"B" mRNA-1273-P301HOmRNA-1273-P301-US368-2017AUSA-US081-2020-mRNA-1273-P301000003HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-01 2020-12-02 .BbBc mRNA-1273-P301HOmRNA-1273-P301-US368-2018A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US368-2022A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B’.. mRNA-1273-P301HOmRNA-1273-P301-US368-2025A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T13:302020-09-26T13:30.BB mRNA-1273-P301HOmRNA-1273-P301-US368-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T12:042020-09-02T12:04.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US368-2036A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T12:342020-10-06T12:34.B%B% mRNA-1273-P301HOmRNA-1273-P301-US368-2040A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-24 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US368-2065A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US368-2074A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T22:242020-10-08T22:24.BB mRNA-1273-P301HOmRNA-1273-P301-US368-2077A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T20:242020-10-09T20:24.BB mRNA-1273-P301HOmRNA-1273-P301-US368-2101A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US368-2111A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T17:152020-09-19T17:15.APAP mRNA-1273-P301HOmRNA-1273-P301-US368-2114A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T23:032020-09-18T23:03.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US368-2133A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T15:202020-09-17T15:20.AA mRNA-1273-P301HOmRNA-1273-P301-US368-2134AUSA-US081-2021-mRNA-1273-P301000012HO-AE-005/AE-006 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P7D mRNA-1273-P301HOmRNA-1273-P301-US368-2134A USA-US081-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-21 2020-09-24 .APA€ mRNA-1273-P301HOmRNA-1273-P301-US368-2134A0USA-US081-2021-mRNA-1273-P301000012HO-AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-03 2021-03-09 .B¨B® mRNA-1273-P301HOmRNA-1273-P301-US368-2139A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T20:312020-10-19T20:31.B!B! mRNA-1273-P301HOmRNA-1273-P301-US368-2148A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T21:092020-10-22T21:09.B#B# mRNA-1273-P301HOmRNA-1273-P301-US368-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 BU.. mRNA-1273-P301HOmRNA-1273-P301-US368-2163AUSA-US081-2021-mRNA-1273-P301000008HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-02 2021-02-03 .B„B… mRNA-1273-P301HOmRNA-1273-P301-US368-2163A HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-15 2021-03-17 .BB¯ mRNA-1273-P301HOmRNA-1273-P301-US368-2166A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T17:252020-10-09T17:25.AðAð mRNA-1273-P301HOmRNA-1273-P301-US368-2178A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T00:002020-11-06T00:00.B%B% mRNA-1273-P301HOmRNA-1273-P301-US368-2179A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B`.. mRNA-1273-P301HOmRNA-1273-P301-US368-2180A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 BS.. mRNA-1273-P301HOmRNA-1273-P301-US368-2196A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T20:062020-10-18T20:06.ApAp mRNA-1273-P301HOmRNA-1273-P301-US368-2197A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B;.. mRNA-1273-P301HOmRNA-1273-P301-US369-2001AUSA-US123-2020-mRNA-1273-P301000004HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-14 2020-12-16 .BoBq mRNA-1273-P301HOmRNA-1273-P301-US369-2015A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T18:132020-09-30T18:13.B!B! mRNA-1273-P301HOmRNA-1273-P301-US369-2016AUSA-US123-2020-mRNA-1273-P301000001HO-AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US369-2016A USA-US123-2020-mRNA-1273-P301000001HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-01 2020-11-08 .BABH mRNA-1273-P301HOmRNA-1273-P301-US369-2029A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US369-2038A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T12:312020-09-07T12:31.A`A` mRNA-1273-P301HOmRNA-1273-P301-US369-2038A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T16:152020-09-30T16:15.BB mRNA-1273-P301HOmRNA-1273-P301-US369-2083A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T21:062020-09-10T21:06.A A mRNA-1273-P301HOmRNA-1273-P301-US369-2086A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T10:212020-09-11T12:01.AA mRNA-1273-P301HOmRNA-1273-P301-US369-2089A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T07:492020-09-16T07:49.ApAp mRNA-1273-P301HOmRNA-1273-P301-US369-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T12:232020-10-10T12:23.BB mRNA-1273-P301HOmRNA-1273-P301-US369-2096A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B[.. mRNA-1273-P301HOmRNA-1273-P301-US369-2105A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 Bz.. mRNA-1273-P301HOmRNA-1273-P301-US369-2110A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T08:262020-10-15T08:26.B B mRNA-1273-P301HOmRNA-1273-P301-US369-2121A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T18:152020-10-16T18:15.B B mRNA-1273-P301HOmRNA-1273-P301-US369-2138A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T13:322020-10-25T13:32.B&B& mRNA-1273-P301HOmRNA-1273-P301-US369-2144A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T16:382020-10-21T16:38.BB mRNA-1273-P301HOmRNA-1273-P301-US369-2149A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T22:552020-09-28T22:55.APAP mRNA-1273-P301HOmRNA-1273-P301-US369-2153A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-04T12:572020-11-04T12:57.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US369-2157A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-28T11:332020-10-28T14:48.B"B" mRNA-1273-P301HOmRNA-1273-P301-US369-2171A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T09:262020-10-12T09:26.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US369-2171A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 B`.. mRNA-1273-P301HOmRNA-1273-P301-US369-2179A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T14:332020-10-07T14:33.ApAp mRNA-1273-P301HOmRNA-1273-P301-US369-2191A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-13T13:282020-11-13T13:28.B B mRNA-1273-P301HOmRNA-1273-P301-US369-2194A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T13:312020-10-15T13:31.AA mRNA-1273-P301HOmRNA-1273-P301-US369-2197A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T15:022020-11-12T18:03.BB mRNA-1273-P301HOmRNA-1273-P301-US369-2205A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-20T13:232020-11-20T18:11.BB mRNA-1273-P301HOmRNA-1273-P301-US370-2007A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T11:122020-10-12T11:12.B'B' mRNA-1273-P301HOmRNA-1273-P301-US370-2010AUSA-US133-2021-mRNA-1273-P301000001HO-AE-013 ADMITTED TO ICU ICU ADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US370-2010A USA-US133-2021-mRNA-1273-P301000001HO-AE-013 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-05 .B|. mRNA-1273-P301HOmRNA-1273-P301-US370-2010A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYYFOLLOW-UP BLINDED PHASE 2021-01-24 2021-02-25 .BB¯ mRNA-1273-P301HOmRNA-1273-P301-US370-2044A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-10T09:362020-11-10T09:36.B0B0 mRNA-1273-P301HOmRNA-1273-P301-US370-2045A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T18:002020-09-26T18:00.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US370-2046AUSA-US133-2021-mRNA-1273-P301000005HO-AE-001/AE-003/AE-006 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US370-2046A USA-US133-2021-mRNA-1273-P301000005HO-AE-001/AE-003/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-26 2021-03-09 .B›B¦ mRNA-1273-P301HOmRNA-1273-P301-US370-2051A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B`.. mRNA-1273-P301HOmRNA-1273-P301-US370-2092A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B[.. mRNA-1273-P301HOmRNA-1273-P301-US371-2012A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T23:422020-10-09T23:42.B B mRNA-1273-P301HOmRNA-1273-P301-US371-2013AUSA-US068-2021-mRNA-1273-P301000017HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-21 2020-09-22 .AàAð mRNA-1273-P301HOmRNA-1273-P301-US371-2025A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US371-2035AUSA-US068-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-22 2020-10-23 .B+B, mRNA-1273-P301HOmRNA-1273-P301-US371-2041A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-18 A.. mRNA-1273-P301HOmRNA-1273-P301-US371-2052A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T23:492020-09-22T22:21.APA` mRNA-1273-P301HOmRNA-1273-P301-US371-2058A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 B?.. mRNA-1273-P301HOmRNA-1273-P301-US371-2059A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US371-2061A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T21:062020-09-27T08:05.A`A° mRNA-1273-P301HOmRNA-1273-P301-US371-2061A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T23:552020-10-18T23:55.B B mRNA-1273-P301HOmRNA-1273-P301-US371-2064AUSA-US068-2021-mRNA-1273-P301000013HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-04 2021-02-05 .BŒB mRNA-1273-P301HOmRNA-1273-P301-US371-2078A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T23:482020-10-17T23:48.BB mRNA-1273-P301HOmRNA-1273-P301-US371-2086A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T12:222020-09-21T07:52.A Ap mRNA-1273-P301HOmRNA-1273-P301-US371-2087A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T12:362020-09-21T12:36.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US371-2094AUSA-US068-2021-mRNA-1273-P301000015HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-21 2020-12-22 .B\B] mRNA-1273-P301HOmRNA-1273-P301-US371-2096AUSA-US068-2021-mRNA-1273-P301000020HO-AE-017 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-04-15 2021-04-20 .BÓBØ mRNA-1273-P301HOmRNA-1273-P301-US371-2096A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T04:252020-10-17T04:25.BB mRNA-1273-P301HOmRNA-1273-P301-US371-2096A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 BR.. mRNA-1273-P301HOmRNA-1273-P301-US371-2104A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T12:042020-10-20T12:04.BB mRNA-1273-P301HOmRNA-1273-P301-US371-2111A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T18:022020-10-25T18:02.B"B" mRNA-1273-P301HOmRNA-1273-P301-US371-2114AUSA-US068-2021-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-13 2020-11-14 .B3B4 mRNA-1273-P301HOmRNA-1273-P301-US371-2118A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T19:352020-10-25T19:35.B"B" mRNA-1273-P301HOmRNA-1273-P301-US371-2129A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US371-2142A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-21 By.. mRNA-1273-P301HOmRNA-1273-P301-US371-2150A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US371-2154A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T19:062020-10-05T19:06.AÐAÐ mRNA-1273-P301HOmRNA-1273-P301-US371-2159A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-21 B.. mRNA-1273-P301HOmRNA-1273-P301-US371-2168A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-28T22:192020-10-28T22:19.B"B" mRNA-1273-P301HOmRNA-1273-P301-US371-2171A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-01 Ap.. mRNA-1273-P301HOmRNA-1273-P301-US371-2174AUSA-US068-2021-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-11 2021-02-13 .BxBz mRNA-1273-P301HOmRNA-1273-P301-US371-2184A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-15 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US371-2192A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T20:042020-10-22T20:04.ApAp mRNA-1273-P301HOmRNA-1273-P301-US371-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T22:282020-10-17T17:52.AA mRNA-1273-P301HOmRNA-1273-P301-US371-2235A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-28T00:012020-10-28T00:01.ApAp mRNA-1273-P301HOmRNA-1273-P301-US371-2247A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 B7.. mRNA-1273-P301HOmRNA-1273-P301-US371-2250A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T15:052020-10-21T15:05.AA mRNA-1273-P301HOmRNA-1273-P301-US371-2271AUSA-US068-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-21 2020-12-24 .B=B@ mRNA-1273-P301HOmRNA-1273-P301-US371-2271A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B6.. mRNA-1273-P301HOmRNA-1273-P301-US371-2281A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-08 BN.. mRNA-1273-P301HOmRNA-1273-P301-US371-2286A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-23T17:412020-11-23T17:41.B!B! mRNA-1273-P301HOmRNA-1273-P301-US371-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-14 BT.. mRNA-1273-P301HOmRNA-1273-P301-US371-2308A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 BL.. mRNA-1273-P301HOmRNA-1273-P301-US372-2006A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US372-2046A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B.. mRNA-1273-P301HOmRNA-1273-P301-US372-2055A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T23:062020-09-18T21:29.B!B/ mRNA-1273-P301HOmRNA-1273-P301-US372-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T12:042020-08-04T12:04.A A mRNA-1273-P301HOmRNA-1273-P301-US372-2059A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T22:132020-09-04T22:13.B!B! mRNA-1273-P301HOmRNA-1273-P301-US372-2066AUSA-US083-2020-mRNA-1273-P301000007HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P8D mRNA-1273-P301HOmRNA-1273-P301-US372-2066A USA-US083-2020-mRNA-1273-P301000007HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-16 2020-12-24 .BjB mRNA-1273-P301HOmRNA-1273-P301-US372-2066A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US372-2070A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T14:502020-08-10T14:50.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US372-2075A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 Bœ.. mRNA-1273-P301HOmRNA-1273-P301-US372-2085A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B“.. mRNA-1273-P301HOmRNA-1273-P301-US372-2095A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 By.. mRNA-1273-P301HOmRNA-1273-P301-US372-2099A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B™.. mRNA-1273-P301HOmRNA-1273-P301-US372-2101A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T20:482020-08-05T20:48.AA mRNA-1273-P301HOmRNA-1273-P301-US372-2107A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 By.. mRNA-1273-P301HOmRNA-1273-P301-US372-2108A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T12:022020-08-11T12:02.ApAp mRNA-1273-P301HOmRNA-1273-P301-US372-2110A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T23:332020-09-08T23:33.B#B# mRNA-1273-P301HOmRNA-1273-P301-US372-2121A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 B“.. mRNA-1273-P301HOmRNA-1273-P301-US372-2125A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 B}.. mRNA-1273-P301HOmRNA-1273-P301-US372-2150A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T12:402020-08-12T12:40.A`A` mRNA-1273-P301HOmRNA-1273-P301-US372-2150A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 B….. mRNA-1273-P301HOmRNA-1273-P301-US372-2153A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T10:142020-09-10T10:14.B#B# mRNA-1273-P301HOmRNA-1273-P301-US372-2154A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 B~.. mRNA-1273-P301HOmRNA-1273-P301-US372-2158AUSA-US083-2021-mRNA-1273-P301000012HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-25 2021-02-28 .BËBÎ mRNA-1273-P301HOmRNA-1273-P301-US372-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T17:502020-09-13T17:50.B#B# mRNA-1273-P301HOmRNA-1273-P301-US372-2169A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T12:382020-09-11T12:38.B B mRNA-1273-P301HOmRNA-1273-P301-US372-2193A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T19:142020-08-11T19:14.AA mRNA-1273-P301HOmRNA-1273-P301-US372-2196A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B”.. mRNA-1273-P301HOmRNA-1273-P301-US372-2197A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T16:572020-08-19T16:57.AA mRNA-1273-P301HOmRNA-1273-P301-US372-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T13:232020-08-13T13:23.A A mRNA-1273-P301HOmRNA-1273-P301-US372-2198A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-26 Bã.. mRNA-1273-P301HOmRNA-1273-P301-US372-2202A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B›.. mRNA-1273-P301HOmRNA-1273-P301-US372-2211A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B‹.. mRNA-1273-P301HOmRNA-1273-P301-US372-2213A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B“.. mRNA-1273-P301HOmRNA-1273-P301-US372-2215AUSA-US083-2021-mRNA-1273-P301000019HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-11 2021-03-14 .BÔB× mRNA-1273-P301HOmRNA-1273-P301-US372-2221A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T21:012020-08-17T21:01.APAP mRNA-1273-P301HOmRNA-1273-P301-US372-2223A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T09:462020-08-15T12:10.AA0 mRNA-1273-P301HOmRNA-1273-P301-US372-2226A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T12:032020-08-15T12:03.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US372-2228A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US372-2232A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T22:352020-09-14T22:35.B!B! mRNA-1273-P301HOmRNA-1273-P301-US372-2236A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T13:572020-08-19T13:57.ApAp mRNA-1273-P301HOmRNA-1273-P301-US372-2245A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T09:352020-08-22T15:09.AA mRNA-1273-P301HOmRNA-1273-P301-US372-2255A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US372-2257A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T08:032020-08-15T08:03.A A mRNA-1273-P301HOmRNA-1273-P301-US372-2275A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US372-2277A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T16:372020-08-15T16:37.AA mRNA-1273-P301HOmRNA-1273-P301-US372-2294A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T08:432020-09-25T08:43.B(B( mRNA-1273-P301HOmRNA-1273-P301-US372-2313A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:052020-09-17T12:05.BB mRNA-1273-P301HOmRNA-1273-P301-US372-2316A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B’.. mRNA-1273-P301HOmRNA-1273-P301-US372-2322A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US372-2327A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T19:062020-08-23T19:06.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US372-2332A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T12:012020-08-21T12:01.A A mRNA-1273-P301HOmRNA-1273-P301-US372-2338AUSA-US083-2021-mRNA-1273-P301000003HO-AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US372-2338A USA-US083-2020-mRNA-1273-P301000002HO-AE-006 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US372-2338A0USA-US083-2020-mRNA-1273-P301000002HO-AE-003/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-12 2020-10-21 .B6B? mRNA-1273-P301HOmRNA-1273-P301-US372-2338A@USA-US083-2021-mRNA-1273-P301000003HO-AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-26 2020-10-28 .BDBF mRNA-1273-P301HOmRNA-1273-P301-US372-2345A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T23:072020-09-21T23:07.B B mRNA-1273-P301HOmRNA-1273-P301-US372-2347A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US372-2375A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T10:042020-09-30T10:04.B%B% mRNA-1273-P301HOmRNA-1273-P301-US372-2375A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BJ.. mRNA-1273-P301HOmRNA-1273-P301-US372-2382A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-20 B9.. mRNA-1273-P301HOmRNA-1273-P301-US372-2397A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T20:522020-10-08T20:52.B,B, mRNA-1273-P301HOmRNA-1273-P301-US372-2406AUSA-US083-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-13 2020-10-14 .B/B0 mRNA-1273-P301HOmRNA-1273-P301-US372-2406A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T02:322020-10-07T22:34.B)B) mRNA-1273-P301HOmRNA-1273-P301-US372-2419A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-26 B+.. mRNA-1273-P301HOmRNA-1273-P301-US372-2431A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US372-2436A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-11T12:082020-10-11T12:08.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US373-2009A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T12:232020-09-11T16:46.B#B& mRNA-1273-P301HOmRNA-1273-P301-US373-2023AUSA-US102-2021-mRNA-1273-P301000009HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-23 .C@. mRNA-1273-P301HOmRNA-1273-P301-US373-2063A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T11:472020-09-18T11:47.B%B% mRNA-1273-P301HOmRNA-1273-P301-US373-2064A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T12:012020-09-11T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US373-2069A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T22:022020-08-19T22:02.A`A` mRNA-1273-P301HOmRNA-1273-P301-US373-2073A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B’.. mRNA-1273-P301HOmRNA-1273-P301-US373-2075A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 BT.. mRNA-1273-P301HOmRNA-1273-P301-US373-2094AUSA-US102-2021-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-24 2020-12-25 .B€B mRNA-1273-P301HOmRNA-1273-P301-US373-2096A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T13:222020-09-21T13:22.B"B" mRNA-1273-P301HOmRNA-1273-P301-US373-2107A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T12:472020-08-21T12:47.A A mRNA-1273-P301HOmRNA-1273-P301-US373-2110AUSA-US102-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-08 2020-10-09 .B2B3 mRNA-1273-P301HOmRNA-1273-P301-US373-2121A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T21:532020-08-20T21:53.AA mRNA-1273-P301HOmRNA-1273-P301-US373-2128A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T15:362020-08-21T15:36.AA mRNA-1273-P301HOmRNA-1273-P301-US373-2130A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T00:192020-08-26T00:19.A`A` mRNA-1273-P301HOmRNA-1273-P301-US373-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:472020-09-23T12:47.BB mRNA-1273-P301HOmRNA-1273-P301-US373-2174A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US373-2176AUSA-US102-2020-mRNA-1273-P301000008HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-30 2020-12-06 .BaBg mRNA-1273-P301HOmRNA-1273-P301-US373-2176A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T20:082020-09-28T20:08.B"B" mRNA-1273-P301HOmRNA-1273-P301-US373-2176A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 BV.. mRNA-1273-P301HOmRNA-1273-P301-US373-2176A@ HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US373-2202A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-08 BJ.. mRNA-1273-P301HOmRNA-1273-P301-US373-2207A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-18 B.. mRNA-1273-P301HOmRNA-1273-P301-US373-2235AUSA-US102-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-14 2021-01-15 .B‰BŠ mRNA-1273-P301HOmRNA-1273-P301-US373-2235A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B.. mRNA-1273-P301HOmRNA-1273-P301-US373-2249AUSA-US102-2021-mRNA-1273-P301000007HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-29 2021-01-31 .B—B™ mRNA-1273-P301HOmRNA-1273-P301-US373-2262A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-08 Ap.. mRNA-1273-P301HOmRNA-1273-P301-US373-2267A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T19:432020-09-09T19:43.ApAp mRNA-1273-P301HOmRNA-1273-P301-US373-2272A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T19:292020-10-02T19:29.BB mRNA-1273-P301HOmRNA-1273-P301-US373-2280A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US373-2284A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T14:022020-10-04T14:02.BB mRNA-1273-P301HOmRNA-1273-P301-US373-2285A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T19:502020-10-18T07:03.B+B- mRNA-1273-P301HOmRNA-1273-P301-US373-2287A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T10:042020-10-10T10:04.B%B% mRNA-1273-P301HOmRNA-1273-P301-US373-2300A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:042020-09-10T12:04.A A mRNA-1273-P301HOmRNA-1273-P301-US373-2304AUSA-US102-2020-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-29 2020-11-05 .B3B: mRNA-1273-P301HOmRNA-1273-P301-US373-2306A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 B2.. mRNA-1273-P301HOmRNA-1273-P301-US373-2322A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T12:352020-09-14T12:35.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US373-2327A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T20:142020-10-20T20:14.B%B% mRNA-1273-P301HOmRNA-1273-P301-US373-2339A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T08:272020-10-20T08:27.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US373-2342A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T06:512020-10-08T22:25.BB mRNA-1273-P301HOmRNA-1273-P301-US373-2352A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T19:122020-09-18T13:05.A A0 mRNA-1273-P301HOmRNA-1273-P301-US373-2352A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T17:502020-10-14T17:50.BB mRNA-1273-P301HOmRNA-1273-P301-US373-2366A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T00:002020-10-21T00:00.BB mRNA-1273-P301HOmRNA-1273-P301-US373-2367A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T00:002020-09-26T00:00.A`A` mRNA-1273-P301HOmRNA-1273-P301-US373-2371A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US373-2373A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T21:392020-09-24T21:39.A A mRNA-1273-P301HOmRNA-1273-P301-US373-2376A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-30T22:412020-11-01T12:00.B$B& mRNA-1273-P301HOmRNA-1273-P301-US373-2389A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T18:182020-10-13T18:18.ApAp mRNA-1273-P301HOmRNA-1273-P301-US373-2390A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T13:542020-10-16T23:26.AAP mRNA-1273-P301HOmRNA-1273-P301-US373-2399A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T17:182020-10-26T17:18.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US373-2399A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 BB.. mRNA-1273-P301HOmRNA-1273-P301-US373-2401A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BE.. mRNA-1273-P301HOmRNA-1273-P301-US374-2022A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US374-2027A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T05:572020-09-18T05:57.BB mRNA-1273-P301HOmRNA-1273-P301-US374-2034AUSA-US127-2021-mRNA-1273-P301000011HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-09 2021-02-23 .B©B· mRNA-1273-P301HOmRNA-1273-P301-US374-2041A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US374-2047A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-13 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US374-2060A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T23:592020-08-29T23:59.A`A` mRNA-1273-P301HOmRNA-1273-P301-US374-2070A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 Br.. mRNA-1273-P301HOmRNA-1273-P301-US374-2072A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T19:012020-10-05T19:01.B*B* mRNA-1273-P301HOmRNA-1273-P301-US374-2076AUSA-US127-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-12 2021-01-15 .BB mRNA-1273-P301HOmRNA-1273-P301-US374-2077A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T12:022020-09-24T15:39.BB mRNA-1273-P301HOmRNA-1273-P301-US374-2080A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T23:502020-08-29T23:50.APAP mRNA-1273-P301HOmRNA-1273-P301-US374-2086A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T16:152020-10-01T16:15.B&B& mRNA-1273-P301HOmRNA-1273-P301-US374-2093A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T22:162020-09-24T22:16.BB mRNA-1273-P301HOmRNA-1273-P301-US374-2100A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T19:332020-08-31T19:33.A`A` mRNA-1273-P301HOmRNA-1273-P301-US374-2120A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US374-2121A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T13:142020-08-29T13:14.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US374-2121A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T13:032020-09-26T13:03.BB mRNA-1273-P301HOmRNA-1273-P301-US374-2123A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T00:592020-10-13T00:59.B)B) mRNA-1273-P301HOmRNA-1273-P301-US374-2123A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-23 B3.. mRNA-1273-P301HOmRNA-1273-P301-US374-2132AUSA-US127-2021-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-10 2021-01-11 .BˆB‰ mRNA-1273-P301HOmRNA-1273-P301-US374-2145A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T12:042020-10-01T21:09.BB# mRNA-1273-P301HOmRNA-1273-P301-US374-2152A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T21:002020-09-05T21:00.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US374-2153AUSA-US127-2021-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-16 2021-04-19 .BçBê mRNA-1273-P301HOmRNA-1273-P301-US374-2160A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 BX.. mRNA-1273-P301HOmRNA-1273-P301-US374-2167A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T09:072020-10-19T10:52.B B2 mRNA-1273-P301HOmRNA-1273-P301-US374-2176A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T13:572020-09-03T18:43.A0A@ mRNA-1273-P301HOmRNA-1273-P301-US374-2208A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-26 BÎ.. mRNA-1273-P301HOmRNA-1273-P301-US374-2216A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T12:142020-09-06T12:14.APAP mRNA-1273-P301HOmRNA-1273-P301-US374-2225AUSA-US127-2021-mRNA-1273-P301000017HO-AE-002 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US374-2225A USA-US127-2021-mRNA-1273-P301000017HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-14 2021-04-17 .BàBã mRNA-1273-P301HOmRNA-1273-P301-US374-2229AUSA-US127-2021-mRNA-1273-P301000015HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-04 .BÖ. mRNA-1273-P301HOmRNA-1273-P301-US374-2232A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T18:172020-10-08T18:17.BB mRNA-1273-P301HOmRNA-1273-P301-US374-2247A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-16 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US374-2253A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-25 B.. mRNA-1273-P301HOmRNA-1273-P301-US374-2273A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US374-2293A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B}.. mRNA-1273-P301HOmRNA-1273-P301-US374-2301AUSA-US127-2021-mRNA-1273-P301000009HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-16 2021-01-22 .B‚Bˆ mRNA-1273-P301HOmRNA-1273-P301-US374-2307A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T20:552020-09-10T20:55.AA mRNA-1273-P301HOmRNA-1273-P301-US374-2330AUSA-US127-2020-mRNA-1273-P301000012HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-29 2020-12-03 .BPBT mRNA-1273-P301HOmRNA-1273-P301-US374-2334A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T14:122020-09-11T14:12.AA mRNA-1273-P301HOmRNA-1273-P301-US374-2337A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-29 BÈ.. mRNA-1273-P301HOmRNA-1273-P301-US374-2341A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T22:012020-10-01T21:51.BB mRNA-1273-P301HOmRNA-1273-P301-US374-2342AUSA-US127-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-16 2020-09-17 .A`Ap mRNA-1273-P301HOmRNA-1273-P301-US374-2343A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T22:592020-09-16T22:59.A`A` mRNA-1273-P301HOmRNA-1273-P301-US374-2353A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T19:002020-09-20T19:00.APAP mRNA-1273-P301HOmRNA-1273-P301-US374-2357A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bg.. mRNA-1273-P301HOmRNA-1273-P301-US374-2358A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T01:152020-09-19T01:15.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US374-2359A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T01:102020-09-20T01:10.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US374-2364AUSA-US127-2021-mRNA-1273-P301000008HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-11 2021-01-11 .BuBu mRNA-1273-P301HOmRNA-1273-P301-US374-2364A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T01:482020-09-22T01:48.A`A` mRNA-1273-P301HOmRNA-1273-P301-US374-2375A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T22:532020-10-22T22:53.B&B& mRNA-1273-P301HOmRNA-1273-P301-US374-2384AUSA-US127-2020-mRNA-1273-P301000008HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-01 2020-11-09 .B/B7 mRNA-1273-P301HOmRNA-1273-P301-US374-2384A USA-US127-2021-mRNA-1273-P301000014HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-05 2021-04-09 .BÊBÎ mRNA-1273-P301HOmRNA-1273-P301-US374-2390A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T03:032020-09-22T03:03.ApAp mRNA-1273-P301HOmRNA-1273-P301-US374-2393A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T16:202020-10-20T19:31.B!B" mRNA-1273-P301HOmRNA-1273-P301-US374-2395A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T15:142020-09-17T15:14.AA mRNA-1273-P301HOmRNA-1273-P301-US374-2408A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 BK.. mRNA-1273-P301HOmRNA-1273-P301-US374-2420A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T06:002020-10-24T06:00.B%B% mRNA-1273-P301HOmRNA-1273-P301-US374-2450A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T00:262020-09-30T21:33.A@Ap mRNA-1273-P301HOmRNA-1273-P301-US374-2450A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-31T09:552020-10-31T09:55.B&B& mRNA-1273-P301HOmRNA-1273-P301-US374-2477A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B.. mRNA-1273-P301HOmRNA-1273-P301-US374-2491A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 BL.. mRNA-1273-P301HOmRNA-1273-P301-US375-2003A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T12:072020-08-11T12:07.APAP mRNA-1273-P301HOmRNA-1273-P301-US375-2010AUSA-US113-2021-mRNA-1273-P301000004HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-21 2021-01-23 .B¨Bª mRNA-1273-P301HOmRNA-1273-P301-US375-2025AUSA-US113-2020-mRNA-1273-P301000013HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-10 2020-11-13 .B]B` mRNA-1273-P301HOmRNA-1273-P301-US375-2025A USA-US113-2021-mRNA-1273-P301000005HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-22 2021-01-23 .B¦B§ mRNA-1273-P301HOmRNA-1273-P301-US375-2025A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 B_.. mRNA-1273-P301HOmRNA-1273-P301-US375-2036A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-14T17:222020-08-14T17:22.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US375-2039A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T19:472020-09-11T19:47.B B mRNA-1273-P301HOmRNA-1273-P301-US375-2043A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T10:552020-08-12T10:55.A A mRNA-1273-P301HOmRNA-1273-P301-US375-2069A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 BS.. mRNA-1273-P301HOmRNA-1273-P301-US375-2096A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T21:012020-11-06T18:36.B(BU mRNA-1273-P301HOmRNA-1273-P301-US375-2129AUSA-US113-2020-mRNA-1273-P301000010HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-02 2020-10-03 .B.B/ mRNA-1273-P301HOmRNA-1273-P301-US375-2130A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T16:092020-09-19T16:09.B!B! mRNA-1273-P301HOmRNA-1273-P301-US375-2142A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T20:322020-08-27T20:32.A A mRNA-1273-P301HOmRNA-1273-P301-US375-2156A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T19:452020-08-20T19:45.A A mRNA-1273-P301HOmRNA-1273-P301-US375-2156A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T19:352020-09-16T19:35.BB mRNA-1273-P301HOmRNA-1273-P301-US375-2161A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T09:542020-09-17T09:54.BB mRNA-1273-P301HOmRNA-1273-P301-US375-2161A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-21 B@.. mRNA-1273-P301HOmRNA-1273-P301-US375-2162A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T09:362020-08-25T09:36.ApAp mRNA-1273-P301HOmRNA-1273-P301-US375-2162A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T09:562020-09-21T15:59.BB" mRNA-1273-P301HOmRNA-1273-P301-US375-2162A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B>.. mRNA-1273-P301HOmRNA-1273-P301-US375-2184AUSA-US113-2021-mRNA-1273-P301000007HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-31 2021-04-02 .BàBâ mRNA-1273-P301HOmRNA-1273-P301-US375-2207A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T23:222020-09-02T23:35.A°AÐ mRNA-1273-P301HOmRNA-1273-P301-US375-2208A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 B`.. mRNA-1273-P301HOmRNA-1273-P301-US375-2212A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T23:012020-08-27T23:01.ApAp mRNA-1273-P301HOmRNA-1273-P301-US375-2213A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US375-2225A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B†.. mRNA-1273-P301HOmRNA-1273-P301-US375-2229A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-27 BA.. mRNA-1273-P301HOmRNA-1273-P301-US375-2245AUSA-US113-2020-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-06 2020-11-07 .BJBK mRNA-1273-P301HOmRNA-1273-P301-US375-2245A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T21:002020-08-28T21:00.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US375-2250A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-08 BL.. mRNA-1273-P301HOmRNA-1273-P301-US375-2252A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T20:462020-10-03T10:49.B%B( mRNA-1273-P301HOmRNA-1273-P301-US375-2258A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T12:062020-10-03T12:06.B'B' mRNA-1273-P301HOmRNA-1273-P301-US375-2259AUSA-US113-2020-mRNA-1273-P301000015HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-20 2020-12-21 .BuBv mRNA-1273-P301HOmRNA-1273-P301-US375-2288A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T22:472020-09-07T22:47.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US375-2288A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T20:532020-12-04T00:39.B+Bd mRNA-1273-P301HOmRNA-1273-P301-US375-2290A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T22:142020-08-31T22:14.APAP mRNA-1273-P301HOmRNA-1273-P301-US375-2319A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 Bk.. mRNA-1273-P301HOmRNA-1273-P301-US375-2342A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T13:372020-09-29T17:02.BB mRNA-1273-P301HOmRNA-1273-P301-US375-2344A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B1.. mRNA-1273-P301HOmRNA-1273-P301-US375-2347A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-12 B*.. mRNA-1273-P301HOmRNA-1273-P301-US375-2359A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T00:122020-10-02T00:12.BB mRNA-1273-P301HOmRNA-1273-P301-US375-2362A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T00:012020-09-10T00:01.AA mRNA-1273-P301HOmRNA-1273-P301-US375-2366A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T12:052020-09-05T12:05.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US375-2366A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-06 AP.. mRNA-1273-P301HOmRNA-1273-P301-US375-2373A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-11T15:452020-10-11T15:45.B'B' mRNA-1273-P301HOmRNA-1273-P301-US375-2390A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T15:202020-10-02T15:20.BB mRNA-1273-P301HOmRNA-1273-P301-US375-2393A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B|.. mRNA-1273-P301HOmRNA-1273-P301-US375-2394A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-10-27T00:552020-10-29T11:44.B7B9 mRNA-1273-P301HOmRNA-1273-P301-US375-2397A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T20:232020-09-06T20:23.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US375-2402AUSA-US113-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-25 2021-02-26 .B¯B° mRNA-1273-P301HOmRNA-1273-P301-US376-2004A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T19:582020-09-21T19:58.B!B! mRNA-1273-P301HOmRNA-1273-P301-US376-2015A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T07:202020-09-28T07:20.B'B' mRNA-1273-P301HOmRNA-1273-P301-US376-2017A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T13:002020-08-22T13:00.A A mRNA-1273-P301HOmRNA-1273-P301-US376-2018A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T19:042020-08-25T19:04.APAP mRNA-1273-P301HOmRNA-1273-P301-US376-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T00:042020-09-24T00:04.B#B# mRNA-1273-P301HOmRNA-1273-P301-US376-2023AUSA-US130-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-26 2021-01-30 .BŸB£ mRNA-1273-P301HOmRNA-1273-P301-US376-2041A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T12:112020-09-26T12:11.B"B" mRNA-1273-P301HOmRNA-1273-P301-US376-2042A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T17:312020-08-24T17:31.AA mRNA-1273-P301HOmRNA-1273-P301-US376-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T20:032020-09-22T20:03.BB mRNA-1273-P301HOmRNA-1273-P301-US376-2044A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T19:412020-08-30T19:41.A`A` mRNA-1273-P301HOmRNA-1273-P301-US376-2061A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 B„.. mRNA-1273-P301HOmRNA-1273-P301-US376-2071A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T22:072020-09-27T22:07.B!B! mRNA-1273-P301HOmRNA-1273-P301-US376-2097A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T16:222020-10-01T16:22.B#B# mRNA-1273-P301HOmRNA-1273-P301-US376-2105A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T17:062020-09-04T17:06.APAP mRNA-1273-P301HOmRNA-1273-P301-US376-2119A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T11:332020-09-01T12:28.A A mRNA-1273-P301HOmRNA-1273-P301-US376-2120AUSA-US130-2021-mRNA-1273-P301000005HO-AE-001/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-21 2021-02-25 .B¯B³ mRNA-1273-P301HOmRNA-1273-P301-US376-2120A USA-US130-2021-mRNA-1273-P301000005HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-14 2021-03-17 .BÄBÇ mRNA-1273-P301HOmRNA-1273-P301-US376-2126A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 BH.. mRNA-1273-P301HOmRNA-1273-P301-US376-2126A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US376-2131AUSA-US130-2021-mRNA-1273-P301000006HO-AE-002/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-20 2021-03-23 .BÉBÌ mRNA-1273-P301HOmRNA-1273-P301-US376-2137A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 B.. mRNA-1273-P301HOmRNA-1273-P301-US376-2140A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T21:582020-10-03T21:58.B!B! mRNA-1273-P301HOmRNA-1273-P301-US376-2146A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T16:512020-09-02T16:51.AA mRNA-1273-P301HOmRNA-1273-P301-US376-2161AUSA-US130-2020-mRNA-1273-P301000001HO-AE-001/AE-002/AE-003/AE-004/AE-005/AE-006/AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-10 2020-11-15 .BFBK mRNA-1273-P301HOmRNA-1273-P301-US376-2161A USA-US130-2020-mRNA-1273-P301000004HO-AE-009 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-24 2020-12-25 .BrBs mRNA-1273-P301HOmRNA-1273-P301-US376-2164A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T17:102020-10-06T17:10.B"B" mRNA-1273-P301HOmRNA-1273-P301-US376-2172A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T12:052020-09-10T12:05.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US376-2175AUSA-US130-2020-mRNA-1273-P301000003HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-16 2020-12-18 .BiBk mRNA-1273-P301HOmRNA-1273-P301-US376-2177A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T20:272020-09-18T20:27.BB mRNA-1273-P301HOmRNA-1273-P301-US376-2212A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T12:172020-10-12T12:17.B#B# mRNA-1273-P301HOmRNA-1273-P301-US376-2230A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T07:092020-09-11T07:09.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US376-2237A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:022020-09-15T12:02.A`A` mRNA-1273-P301HOmRNA-1273-P301-US376-2251A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US376-2266A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T22:022020-10-09T22:02.BB mRNA-1273-P301HOmRNA-1273-P301-US377-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US377-2004A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US377-2011A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T18:562020-09-15T18:56.B*B* mRNA-1273-P301HOmRNA-1273-P301-US377-2026A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bƒ.. mRNA-1273-P301HOmRNA-1273-P301-US377-2035A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-15 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US377-2036A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T20:362020-08-13T20:36.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US377-2037AUSA-US107-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-08 2020-11-12 .BZB^ mRNA-1273-P301HOmRNA-1273-P301-US377-2037A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 B[.. mRNA-1273-P301HOmRNA-1273-P301-US377-2041AUSA-US107-2021-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-15 2021-02-16 .B½B¾ mRNA-1273-P301HOmRNA-1273-P301-US377-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T21:342020-09-16T19:11.B$B% mRNA-1273-P301HOmRNA-1273-P301-US377-2048A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T19:022020-08-18T19:02.ApAp mRNA-1273-P301HOmRNA-1273-P301-US377-2051AUSA-US107-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-05 2020-09-14 .BB" mRNA-1273-P301HOmRNA-1273-P301-US377-2063A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T12:012020-08-15T12:01.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US377-2064A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 B[.. mRNA-1273-P301HOmRNA-1273-P301-US377-2094A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T07:542020-09-24T07:54.B&B& mRNA-1273-P301HOmRNA-1273-P301-US377-2095A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US377-2103AUSA-US107-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-31 2021-01-03 .B†B‰ mRNA-1273-P301HOmRNA-1273-P301-US377-2106A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 B‹.. mRNA-1273-P301HOmRNA-1273-P301-US377-2106A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 BŒ.. mRNA-1273-P301HOmRNA-1273-P301-US377-2134A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T19:112020-10-29T14:39.B'BE mRNA-1273-P301HOmRNA-1273-P301-US377-2148A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T20:362020-09-28T20:36.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US377-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 B•.. mRNA-1273-P301HOmRNA-1273-P301-US377-2159A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US377-2162A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US377-2175A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T13:122020-10-22T14:34.B5B8 mRNA-1273-P301HOmRNA-1273-P301-US377-2182A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BN.. mRNA-1273-P301HOmRNA-1273-P301-US377-2183A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T11:402020-10-06T15:55.B%B% mRNA-1273-P301HOmRNA-1273-P301-US377-2184A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 BR.. mRNA-1273-P301HOmRNA-1273-P301-US377-2187AUSA-US107-2020-mRNA-1273-P301000008HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US377-2187A USA-US107-2020-mRNA-1273-P301000008HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-07 .Bc. mRNA-1273-P301HOmRNA-1273-P301-US377-2205A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T20:152020-09-28T20:15.BB mRNA-1273-P301HOmRNA-1273-P301-US377-2208A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-31 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US377-2226A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T22:192020-09-06T22:19.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US377-2229A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T19:202020-10-09T19:20.B#B# mRNA-1273-P301HOmRNA-1273-P301-US377-2235A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T21:232020-09-14T21:23.APAP mRNA-1273-P301HOmRNA-1273-P301-US377-2246A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 BA.. mRNA-1273-P301HOmRNA-1273-P301-US377-2251A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US377-2252AUSA-US107-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-01 2021-02-04 .BB“ mRNA-1273-P301HOmRNA-1273-P301-US377-2252A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US377-2258A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T22:352020-09-11T22:35.AA mRNA-1273-P301HOmRNA-1273-P301-US377-2268A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T21:482020-10-16T21:48.B#B# mRNA-1273-P301HOmRNA-1273-P301-US377-2277A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T12:272020-10-27T12:27.B%B% mRNA-1273-P301HOmRNA-1273-P301-US377-2285A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T17:292020-10-16T18:49.A@AP mRNA-1273-P301HOmRNA-1273-P301-US378-2001A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T21:222020-08-16T21:22.A`A` mRNA-1273-P301HOmRNA-1273-P301-US378-2014AUSA-US125-2021-mRNA-1273-P301000003HO-AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P12DmRNA-1273-P301HOmRNA-1273-P301-US378-2014A USA-US125-2021-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-08 2021-03-12 .BÐBÔ mRNA-1273-P301HOmRNA-1273-P301-US378-2014A0USA-US125-2021-mRNA-1273-P301000003HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-17 2021-04-02 .BÙBé mRNA-1273-P301HOmRNA-1273-P301-US378-2016A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-11 B;.. mRNA-1273-P301HOmRNA-1273-P301-US378-2021A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T16:212020-08-19T16:21.A`A` mRNA-1273-P301HOmRNA-1273-P301-US378-2024A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-18T10:062020-08-18T10:06.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US378-2024A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T14:332020-09-17T14:33.B"B" mRNA-1273-P301HOmRNA-1273-P301-US378-2028AUSA-US125-2021-mRNA-1273-P301000002HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US378-2028A USA-US125-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-22 2021-02-25 .B¼B¿ mRNA-1273-P301HOmRNA-1273-P301-US378-2033A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-30 BK.. mRNA-1273-P301HOmRNA-1273-P301-US378-2035A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T23:092020-09-18T23:09.B!B! mRNA-1273-P301HOmRNA-1273-P301-US378-2050A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B>.. mRNA-1273-P301HOmRNA-1273-P301-US378-2053A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-28 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US378-2062A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T19:172020-08-26T19:17.ApAp mRNA-1273-P301HOmRNA-1273-P301-US378-2067A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T14:052020-09-21T12:23.BB mRNA-1273-P301HOmRNA-1273-P301-US378-2071A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-26 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US378-2073A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T20:412020-08-28T20:41.APAP mRNA-1273-P301HOmRNA-1273-P301-US378-2082A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 BG.. mRNA-1273-P301HOmRNA-1273-P301-US378-2093A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T09:432020-09-23T09:43.BB mRNA-1273-P301HOmRNA-1273-P301-US378-2100AUSA-US125-2020-mRNA-1273-P301000012HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-30 2020-12-04 .B`Bd mRNA-1273-P301HOmRNA-1273-P301-US378-2110A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T20:492020-09-26T20:49.BB mRNA-1273-P301HOmRNA-1273-P301-US378-2136A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BE.. mRNA-1273-P301HOmRNA-1273-P301-US378-2162AUSA-US125-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-21 2020-09-24 .AàB mRNA-1273-P301HOmRNA-1273-P301-US378-2162A USA-US125-2021-mRNA-1273-P301000001HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-22 2021-01-23 .B‰BŠ mRNA-1273-P301HOmRNA-1273-P301-US378-2162A0 HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T20:292020-10-15T20:14.B%B& mRNA-1273-P301HOmRNA-1273-P301-US378-2167A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T15:212020-09-10T15:21.AA mRNA-1273-P301HOmRNA-1273-P301-US378-2168A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 B=.. mRNA-1273-P301HOmRNA-1273-P301-US378-2172A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T19:352020-10-17T19:35.B B mRNA-1273-P301HOmRNA-1273-P301-US378-2176A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T23:552020-10-15T23:55.A A mRNA-1273-P301HOmRNA-1273-P301-US378-2196A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-24T06:062020-11-24T06:06.B"B" mRNA-1273-P301HOmRNA-1273-P301-US379-2008A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T14:332020-09-11T14:33.B!B! mRNA-1273-P301HOmRNA-1273-P301-US379-2012AUSA-US057-2021-mRNA-1273-P301000002HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-17 2021-02-19 .B¾BÀ mRNA-1273-P301HOmRNA-1273-P301-US379-2016AUSA-US057-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-13 2021-04-19 .BõBû mRNA-1273-P301HOmRNA-1273-P301-US379-2031A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T09:492020-09-03T12:00.A A° mRNA-1273-P301HOmRNA-1273-P301-US379-2043A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T22:302020-09-10T22:30.AA mRNA-1273-P301HOmRNA-1273-P301-US379-2052A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 BF.. mRNA-1273-P301HOmRNA-1273-P301-US379-2055A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T17:462020-09-19T17:46.APAP mRNA-1273-P301HOmRNA-1273-P301-US379-2065A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T05:142020-10-20T05:14.B!B! mRNA-1273-P301HOmRNA-1273-P301-US379-2067A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T18:512020-10-23T18:51.B B mRNA-1273-P301HOmRNA-1273-P301-US379-2078A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-04T23:212020-11-04T23:21.B%B% mRNA-1273-P301HOmRNA-1273-P301-US379-2080A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 BA.. mRNA-1273-P301HOmRNA-1273-P301-US379-2089A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T22:172020-10-10T22:17.APAP mRNA-1273-P301HOmRNA-1273-P301-US379-2090A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 BE.. mRNA-1273-P301HOmRNA-1273-P301-US379-2093A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-04-26 BÉ.. mRNA-1273-P301HOmRNA-1273-P301-US379-2094AUSA-US057-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-20 2020-10-22 .AÀAà mRNA-1273-P301HOmRNA-1273-P301-US380-2003A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T12:582020-08-25T12:58.AA mRNA-1273-P301HOmRNA-1273-P301-US380-2009A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T18:572020-09-21T18:57.B"B" mRNA-1273-P301HOmRNA-1273-P301-US380-2010A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T19:352020-08-29T18:30.A`A° mRNA-1273-P301HOmRNA-1273-P301-US380-2012A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T20:442020-09-21T20:44.B"B" mRNA-1273-P301HOmRNA-1273-P301-US380-2023A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T12:032020-08-28T12:03.APAP mRNA-1273-P301HOmRNA-1273-P301-US380-2027A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T22:442020-08-26T22:44.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US380-2034A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 BI.. mRNA-1273-P301HOmRNA-1273-P301-US380-2036A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T12:242020-09-19T12:24.BB mRNA-1273-P301HOmRNA-1273-P301-US380-2040A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T19:202020-09-24T19:20.BB mRNA-1273-P301HOmRNA-1273-P301-US380-2041A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T06:572020-09-02T06:57.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US380-2046AUSA-US098-2020-mRNA-1273-P301000005HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-21 2020-11-23 .BXBZ mRNA-1273-P301HOmRNA-1273-P301-US380-2046A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 BP.. mRNA-1273-P301HOmRNA-1273-P301-US380-2057A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T15:012020-09-23T15:01.BB mRNA-1273-P301HOmRNA-1273-P301-US380-2074AUSA-US098-2021-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-27 2021-03-29 .BÑBÓ mRNA-1273-P301HOmRNA-1273-P301-US380-2085A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T20:302020-09-29T20:30.BB mRNA-1273-P301HOmRNA-1273-P301-US380-2091A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 B@.. mRNA-1273-P301HOmRNA-1273-P301-US380-2098A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T15:162020-10-01T15:16.BB mRNA-1273-P301HOmRNA-1273-P301-US380-2107A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T17:382020-09-04T17:38.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US380-2109A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B„.. mRNA-1273-P301HOmRNA-1273-P301-US380-2120A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US380-2145A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-12-04T05:062020-12-04T05:06.BYBY mRNA-1273-P301HOmRNA-1273-P301-US380-2149AUSA-US098-2020-mRNA-1273-P301000006HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-01 2020-12-03 .BVBX mRNA-1273-P301HOmRNA-1273-P301-US380-2149A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 BN.. mRNA-1273-P301HOmRNA-1273-P301-US380-2150A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T19:242020-09-11T19:24.APAP mRNA-1273-P301HOmRNA-1273-P301-US380-2150A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T07:032020-10-13T07:03.B%B% mRNA-1273-P301HOmRNA-1273-P301-US380-2168AUSA-US098-2021-mRNA-1273-P301000004HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-30 2021-04-03 .BÌBÐ mRNA-1273-P301HOmRNA-1273-P301-US380-2168A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T19:322020-09-13T19:32.A`A` mRNA-1273-P301HOmRNA-1273-P301-US380-2172A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T15:012020-10-09T15:01.B B mRNA-1273-P301HOmRNA-1273-P301-US380-2185A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 B@.. mRNA-1273-P301HOmRNA-1273-P301-US380-2197A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T10:492020-09-10T10:49.AA mRNA-1273-P301HOmRNA-1273-P301-US380-2199A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T01:272020-09-11T01:27.A A mRNA-1273-P301HOmRNA-1273-P301-US380-2215A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-10 B™.. mRNA-1273-P301HOmRNA-1273-P301-US380-2218AUSA-US098-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-28 2020-11-05 .B0B8 mRNA-1273-P301HOmRNA-1273-P301-US380-2220A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-21 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US380-2225A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T20:572020-09-14T20:57.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US380-2226A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T21:532020-09-11T21:53.AA mRNA-1273-P301HOmRNA-1273-P301-US380-2226A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T22:382020-10-09T22:38.BB mRNA-1273-P301HOmRNA-1273-P301-US380-2227A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T09:092020-09-18T09:09.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US380-2249A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T19:042020-10-20T19:52.B$B% mRNA-1273-P301HOmRNA-1273-P301-US380-2255A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T09:412020-10-20T09:41.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US380-2257A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T09:352020-10-16T21:00.BB mRNA-1273-P301HOmRNA-1273-P301-US380-2261A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T05:582020-09-22T05:58.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US381-2010AUSA-US111-2020-mRNA-1273-P301000024HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-26 2020-12-28 .B’B” mRNA-1273-P301HOmRNA-1273-P301-US381-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T19:162020-09-06T19:16.B#B# mRNA-1273-P301HOmRNA-1273-P301-US381-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T00:012020-08-08T17:07.A0A` mRNA-1273-P301HOmRNA-1273-P301-US381-2044A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-28 B7.. mRNA-1273-P301HOmRNA-1273-P301-US381-2045A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-13T08:372020-08-13T08:37.AA mRNA-1273-P301HOmRNA-1273-P301-US381-2046A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 B}.. mRNA-1273-P301HOmRNA-1273-P301-US381-2054A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T00:442020-08-09T00:44.APAP mRNA-1273-P301HOmRNA-1273-P301-US381-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T12:512020-08-10T12:51.APAP mRNA-1273-P301HOmRNA-1273-P301-US381-2059AUSA-US111-2020-mRNA-1273-P301000006HO-AE-003/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-26 2020-11-10 .BRBa mRNA-1273-P301HOmRNA-1273-P301-US381-2059A USA-US111-2020-mRNA-1273-P301000013HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-18 2020-11-30 .BiBu mRNA-1273-P301HOmRNA-1273-P301-US381-2062AUSA-US111-2021-mRNA-1273-P301000007HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US381-2062A USA-US111-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-16 2021-01-20 .B¤B¨ mRNA-1273-P301HOmRNA-1273-P301-US381-2071A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T16:262020-09-02T16:26.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2080A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T14:052020-09-05T14:05.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2081AUSA-US111-2021-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-31 2021-04-01 .BíBî mRNA-1273-P301HOmRNA-1273-P301-US381-2084A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T12:022020-09-04T12:02.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2090A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T05:122020-09-07T05:12.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2094A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T12:012020-08-09T12:01.A A mRNA-1273-P301HOmRNA-1273-P301-US381-2105A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T01:012020-08-22T01:01.AÐAÐ mRNA-1273-P301HOmRNA-1273-P301-US381-2111A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 B.. mRNA-1273-P301HOmRNA-1273-P301-US381-2114A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US381-2132AUSA-US101-2021-mRNA-1273-P301000004HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-24 2020-12-26 .BˆBŠ mRNA-1273-P301HOmRNA-1273-P301-US381-2132A USA-US101-2021-mRNA-1273-P301000006HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-30 2021-02-06 .BB´ mRNA-1273-P301HOmRNA-1273-P301-US381-2137A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US381-2139A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US381-2148A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 B•.. mRNA-1273-P301HOmRNA-1273-P301-US381-2150A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T21:182020-08-16T21:18.APAP mRNA-1273-P301HOmRNA-1273-P301-US381-2150A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T16:512020-09-20T16:51.B(B( mRNA-1273-P301HOmRNA-1273-P301-US381-2153A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 B….. mRNA-1273-P301HOmRNA-1273-P301-US381-2159A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T16:042020-09-11T16:04.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2168A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-06 BU.. mRNA-1273-P301HOmRNA-1273-P301-US381-2169AUSA-US111-2021-mRNA-1273-P301000005HO-AE-002/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-21 2021-01-07 .B‚B“ mRNA-1273-P301HOmRNA-1273-P301-US381-2174A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-10 B.. mRNA-1273-P301HOmRNA-1273-P301-US381-2175A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T19:132020-08-21T19:13.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US381-2175A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 Bf.. mRNA-1273-P301HOmRNA-1273-P301-US381-2178A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T17:352020-09-22T17:35.B'B' mRNA-1273-P301HOmRNA-1273-P301-US381-2183A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-20T05:072020-08-20T05:07.A`A` mRNA-1273-P301HOmRNA-1273-P301-US381-2188A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-11 Bµ.. mRNA-1273-P301HOmRNA-1273-P301-US381-2197A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-08-27 A°.. mRNA-1273-P301HOmRNA-1273-P301-US381-2199A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T12:262020-09-24T12:26.B&B& mRNA-1273-P301HOmRNA-1273-P301-US381-2200A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T19:232020-08-19T19:23.A A mRNA-1273-P301HOmRNA-1273-P301-US381-2203A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T21:202020-09-17T21:20.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2216A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-13 B8.. mRNA-1273-P301HOmRNA-1273-P301-US381-2224A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-11 B‘.. mRNA-1273-P301HOmRNA-1273-P301-US381-2226A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T22:532020-08-26T22:53.ApAp mRNA-1273-P301HOmRNA-1273-P301-US381-2226A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T21:312020-09-17T21:31.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2229AUSA-US111-2021-mRNA-1273-P301000012HO-AE-005 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US381-2229A USA-US111-2021-mRNA-1273-P301000012HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-25 2021-02-27 .B½B¿ mRNA-1273-P301HOmRNA-1273-P301-US381-2235A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T16:212020-08-24T16:21.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US381-2239A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T12:212020-08-25T15:21.A@AP mRNA-1273-P301HOmRNA-1273-P301-US381-2251A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T21:112020-08-29T21:11.A`A` mRNA-1273-P301HOmRNA-1273-P301-US381-2251A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T21:302020-09-26T21:30.B"B" mRNA-1273-P301HOmRNA-1273-P301-US381-2263A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-10 BM.. mRNA-1273-P301HOmRNA-1273-P301-US381-2263A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US381-2270AUSA-US111-2021-mRNA-1273-P301000004HO-AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-08 2021-01-09 .BˆB‰ mRNA-1273-P301HOmRNA-1273-P301-US381-2270A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US381-2272A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-13 BP.. mRNA-1273-P301HOmRNA-1273-P301-US381-2275A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T15:142020-09-24T15:14.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2280AUSA-US111-2020-mRNA-1273-P301000009HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-13 2020-11-17 .BOBS mRNA-1273-P301HOmRNA-1273-P301-US381-2280A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 BU.. mRNA-1273-P301HOmRNA-1273-P301-US381-2285A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US381-2291A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T13:592020-09-29T13:59.B!B! mRNA-1273-P301HOmRNA-1273-P301-US381-2293A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T16:292020-09-09T12:01.AÀAÐ mRNA-1273-P301HOmRNA-1273-P301-US381-2294A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T12:482020-09-25T12:48.BB mRNA-1273-P301HOmRNA-1273-P301-US381-2306A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 BU.. mRNA-1273-P301HOmRNA-1273-P301-US381-2316A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T22:512020-09-10T22:51.ApAp mRNA-1273-P301HOmRNA-1273-P301-US381-2317A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bn.. mRNA-1273-P301HOmRNA-1273-P301-US381-2318A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T22:322020-10-12T22:32.B'B' mRNA-1273-P301HOmRNA-1273-P301-US381-2323A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 B5.. mRNA-1273-P301HOmRNA-1273-P301-US381-2343A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T19:202020-10-05T22:08.AAÀ mRNA-1273-P301HOmRNA-1273-P301-US381-2348A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T18:392020-10-09T18:39.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US382-2003AUSA-US126-2020-mRNA-1273-P301000007HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-24 2020-10-27 .BRBU mRNA-1273-P301HOmRNA-1273-P301-US382-2003A USA-US126-2020-mRNA-1273-P301000008HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-12 2020-11-13 .BeBf mRNA-1273-P301HOmRNA-1273-P301-US382-2015AUSA-US126-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-09 2020-09-12 .B$B' mRNA-1273-P301HOmRNA-1273-P301-US382-2019A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-10T12:382020-08-10T12:38.A`A` mRNA-1273-P301HOmRNA-1273-P301-US382-2035A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T06:002020-09-16T06:00.B)B) mRNA-1273-P301HOmRNA-1273-P301-US382-2048A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-20 BK.. mRNA-1273-P301HOmRNA-1273-P301-US382-2055A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:312020-09-12T20:15.BB" mRNA-1273-P301HOmRNA-1273-P301-US382-2059A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T22:082020-09-17T22:08.B'B' mRNA-1273-P301HOmRNA-1273-P301-US382-2065A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T17:302020-09-10T17:30.B B mRNA-1273-P301HOmRNA-1273-P301-US382-2068A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T12:162020-09-11T12:16.B!B! mRNA-1273-P301HOmRNA-1273-P301-US382-2074A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-15T15:062020-08-15T15:06.APAP mRNA-1273-P301HOmRNA-1273-P301-US382-2088AUSA-US126-2021-mRNA-1273-P301000007HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-20 2021-03-26 .BÞBä mRNA-1273-P301HOmRNA-1273-P301-US382-2119AUSA-US126-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-04 2020-09-06 .BB mRNA-1273-P301HOmRNA-1273-P301-US382-2129A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-19T10:182020-08-19T10:18.A`A` mRNA-1273-P301HOmRNA-1273-P301-US382-2143A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-19 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US382-2145A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T06:022020-09-23T06:02.B)B) mRNA-1273-P301HOmRNA-1273-P301-US382-2152A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T14:452020-08-22T14:45.A`A` mRNA-1273-P301HOmRNA-1273-P301-US382-2154AUSA-US126-2021-mRNA-1273-P301000001HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-28 2021-01-09 .B†B’ mRNA-1273-P301HOmRNA-1273-P301-US382-2154A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T23:342020-08-24T23:34.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US382-2162A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 B….. mRNA-1273-P301HOmRNA-1273-P301-US382-2177A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T18:402020-09-28T18:40.B*B* mRNA-1273-P301HOmRNA-1273-P301-US382-2180A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-11 BV.. mRNA-1273-P301HOmRNA-1273-P301-US382-2181AUSA-US126-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-03 2021-03-04 .BÅBÆ mRNA-1273-P301HOmRNA-1273-P301-US382-2181A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T18:522020-09-25T18:52.B&B& mRNA-1273-P301HOmRNA-1273-P301-US382-2200A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-09 B3.. mRNA-1273-P301HOmRNA-1273-P301-US382-2206A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T12:012020-08-28T12:01.AA mRNA-1273-P301HOmRNA-1273-P301-US382-2214A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T22:232020-09-24T13:12.B#B$ mRNA-1273-P301HOmRNA-1273-P301-US382-2215A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T19:022020-09-19T19:02.BB mRNA-1273-P301HOmRNA-1273-P301-US382-2226A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T09:412020-08-27T09:41.ApAp mRNA-1273-P301HOmRNA-1273-P301-US382-2244A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 B\.. mRNA-1273-P301HOmRNA-1273-P301-US382-2248A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T02:392020-09-05T02:39.AÐAÐ mRNA-1273-P301HOmRNA-1273-P301-US382-2254A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T13:042020-10-20T14:09.B-B9 mRNA-1273-P301HOmRNA-1273-P301-US382-2259A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T15:002020-10-06T18:46.B#B+ mRNA-1273-P301HOmRNA-1273-P301-US382-2260A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T12:032020-08-27T12:03.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US382-2278AUSA-US126-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-26 2020-09-28 .B B" mRNA-1273-P301HOmRNA-1273-P301-US382-2278A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T13:302020-09-29T01:00.B!B# mRNA-1273-P301HOmRNA-1273-P301-US382-2296A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T19:412020-08-31T19:41.APAP mRNA-1273-P301HOmRNA-1273-P301-US382-2301A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T12:172020-09-01T12:17.A`A` mRNA-1273-P301HOmRNA-1273-P301-US382-2304A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T12:132020-10-03T12:13.B%B% mRNA-1273-P301HOmRNA-1273-P301-US382-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-14 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US382-2319A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T09:392020-08-31T09:39.AA mRNA-1273-P301HOmRNA-1273-P301-US382-2342AUSA-US126-2021-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-05 2021-02-07 .B–B˜ mRNA-1273-P301HOmRNA-1273-P301-US382-2354A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T20:282020-09-07T20:28.A`A` mRNA-1273-P301HOmRNA-1273-P301-US382-2381A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T18:502020-10-09T18:50.BB mRNA-1273-P301HOmRNA-1273-P301-US382-2405A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T00:182020-10-27T00:18.B)B) mRNA-1273-P301HOmRNA-1273-P301-US382-2428A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T20:112020-09-26T20:11.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US382-2432A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T16:462020-10-27T16:46.B"B" mRNA-1273-P301HOmRNA-1273-P301-US382-2443AUSA-US126-2020-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-04 2020-12-14 .BDBN mRNA-1273-P301HOmRNA-1273-P301-US382-2456A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-19T04:392020-11-19T04:39.B#B# mRNA-1273-P301HOmRNA-1273-P301-US382-2465AUSA-US126-2021-mRNA-1273-P301000008HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-11 2021-04-14 .B«B® mRNA-1273-P301HOmRNA-1273-P301-US383-2010A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-01T16:052020-08-01T16:05.A A mRNA-1273-P301HOmRNA-1273-P301-US383-2011A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 B™.. mRNA-1273-P301HOmRNA-1273-P301-US383-2012A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US383-2014AUSA-US100-2020-mRNA-1273-P301000003HO-AE-001/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-31 2020-09-02 .B B" mRNA-1273-P301HOmRNA-1273-P301-US383-2015A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-04T12:332020-08-04T12:33.APAP mRNA-1273-P301HOmRNA-1273-P301-US383-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-07T19:332020-08-07T19:33.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US383-2020A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T10:012020-08-30T17:05.BB mRNA-1273-P301HOmRNA-1273-P301-US383-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T18:342020-08-06T18:34.A`A` mRNA-1273-P301HOmRNA-1273-P301-US383-2043AUSA-US100-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-23 2020-08-25 .BB mRNA-1273-P301HOmRNA-1273-P301-US383-2044A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T07:242020-09-04T07:24.B"B" mRNA-1273-P301HOmRNA-1273-P301-US383-2052A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US383-2055AUSA-US100-2020-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-20 2020-09-23 .B1B4 mRNA-1273-P301HOmRNA-1273-P301-US383-2059A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-07 Bž.. mRNA-1273-P301HOmRNA-1273-P301-US383-2060A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-06T12:232020-08-06T12:23.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US383-2071AUSA-US100-2021-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-26 2021-03-31 .BëBð mRNA-1273-P301HOmRNA-1273-P301-US383-2074AUSA-US100-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-09-16 2020-09-18 .B,B. mRNA-1273-P301HOmRNA-1273-P301-US383-2082A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T22:152020-09-05T22:15.B!B! mRNA-1273-P301HOmRNA-1273-P301-US383-2095A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T18:072020-08-11T18:07.APAP mRNA-1273-P301HOmRNA-1273-P301-US383-2102A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-05T16:522020-08-05T16:52.AA mRNA-1273-P301HOmRNA-1273-P301-US383-2104A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T19:562020-08-09T19:56.APAP mRNA-1273-P301HOmRNA-1273-P301-US383-2118A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-22 B0.. mRNA-1273-P301HOmRNA-1273-P301-US383-2119A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bw.. mRNA-1273-P301HOmRNA-1273-P301-US383-2121A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-22 BN.. mRNA-1273-P301HOmRNA-1273-P301-US383-2122A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T21:372020-09-06T21:37.B B mRNA-1273-P301HOmRNA-1273-P301-US383-2135A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T22:552020-09-05T22:55.BB mRNA-1273-P301HOmRNA-1273-P301-US383-2140A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T16:172020-08-11T16:17.A A mRNA-1273-P301HOmRNA-1273-P301-US383-2151A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-24 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US383-2155A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 B.. mRNA-1273-P301HOmRNA-1273-P301-US383-2156A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T00:002020-10-03T07:33.B2B6 mRNA-1273-P301HOmRNA-1273-P301-US383-2173A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-12T19:462020-08-12T19:46.AA mRNA-1273-P301HOmRNA-1273-P301-US383-2176AUSA-US100-2021-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-02 2021-03-08 .BËBÑ mRNA-1273-P301HOmRNA-1273-P301-US383-2176A USA-US100-2021-mRNA-1273-P301000012HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-23 2021-04-25 .BÿC mRNA-1273-P301HOmRNA-1273-P301-US383-2181A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-14T00:002020-09-14T00:00.B!B! mRNA-1273-P301HOmRNA-1273-P301-US383-2197A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T21:112020-09-17T21:11.B B mRNA-1273-P301HOmRNA-1273-P301-US383-2206A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T20:402020-10-28T08:33.B!BI mRNA-1273-P301HOmRNA-1273-P301-US383-2209A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T18:192020-08-23T18:19.A`A` mRNA-1273-P301HOmRNA-1273-P301-US383-2211AUSA-US100-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-08 2020-10-09 .B4B5 mRNA-1273-P301HOmRNA-1273-P301-US383-2211A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:212020-09-17T12:21.BB mRNA-1273-P301HOmRNA-1273-P301-US383-2239A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-23T14:552020-08-23T14:55.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US383-2240A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T20:532020-08-24T20:53.APAP mRNA-1273-P301HOmRNA-1273-P301-US383-2257A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B“.. mRNA-1273-P301HOmRNA-1273-P301-US383-2264A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T15:242020-09-02T16:07.APA` mRNA-1273-P301HOmRNA-1273-P301-US383-2274A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-29 B\.. mRNA-1273-P301HOmRNA-1273-P301-US384-2007A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T12:012020-10-02T12:01.B!B! mRNA-1273-P301HOmRNA-1273-P301-US384-2017A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T17:542020-09-10T06:01.A@Ap mRNA-1273-P301HOmRNA-1273-P301-US384-2017A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T11:422020-09-30T11:42.BB mRNA-1273-P301HOmRNA-1273-P301-US384-2026A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T20:002020-10-15T20:00.B%B% mRNA-1273-P301HOmRNA-1273-P301-US384-2027AUSA-US110-2020-mRNA-1273-P301000003HO-AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-19 2020-12-23 .BeBi mRNA-1273-P301HOmRNA-1273-P301-US384-2039A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 BY.. mRNA-1273-P301HOmRNA-1273-P301-US384-2040A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-03 B/.. mRNA-1273-P301HOmRNA-1273-P301-US384-2051A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-02 B”.. mRNA-1273-P301HOmRNA-1273-P301-US384-2052A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T19:212020-10-08T19:21.AA mRNA-1273-P301HOmRNA-1273-P301-US384-2057A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-23 BL.. mRNA-1273-P301HOmRNA-1273-P301-US385-2002A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T12:012020-09-22T12:01.B"B" mRNA-1273-P301HOmRNA-1273-P301-US385-2012A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T16:042020-09-07T12:00.AÀAð mRNA-1273-P301HOmRNA-1273-P301-US385-2015AUSA-US076-2021-mRNA-1273-P301000003HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-28 2021-03-31 .BÙBÜ mRNA-1273-P301HOmRNA-1273-P301-US385-2015A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 Bu.. mRNA-1273-P301HOmRNA-1273-P301-US385-2019A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US385-2021A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 B.. mRNA-1273-P301HOmRNA-1273-P301-US385-2031A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T18:042020-09-28T18:04.B"B" mRNA-1273-P301HOmRNA-1273-P301-US385-2044A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T12:012020-08-31T12:01.APAP mRNA-1273-P301HOmRNA-1273-P301-US385-2045A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-16 B3.. mRNA-1273-P301HOmRNA-1273-P301-US385-2048A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-16 BÊ.. mRNA-1273-P301HOmRNA-1273-P301-US385-2050A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T19:462020-09-03T13:48.A@A€ mRNA-1273-P301HOmRNA-1273-P301-US385-2064A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Ba.. mRNA-1273-P301HOmRNA-1273-P301-US385-2065A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T14:512020-09-22T14:51.BB mRNA-1273-P301HOmRNA-1273-P301-US385-2070A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-09 B(.. mRNA-1273-P301HOmRNA-1273-P301-US385-2085A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T20:182020-09-02T20:18.A A mRNA-1273-P301HOmRNA-1273-P301-US385-2086A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US385-2090A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T18:012020-10-02T18:01.BB mRNA-1273-P301HOmRNA-1273-P301-US385-2090A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-05 BA.. mRNA-1273-P301HOmRNA-1273-P301-US385-2096A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T15:312020-09-10T15:31.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US385-2108A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T12:412020-10-12T12:41.B'B' mRNA-1273-P301HOmRNA-1273-P301-US385-2114A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-22 B.. mRNA-1273-P301HOmRNA-1273-P301-US385-2122A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bj.. mRNA-1273-P301HOmRNA-1273-P301-US385-2132A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-18 Be.. mRNA-1273-P301HOmRNA-1273-P301-US385-2143A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-11-20T02:202020-12-03T06:39.BIBV mRNA-1273-P301HOmRNA-1273-P301-US385-2147A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 B>.. mRNA-1273-P301HOmRNA-1273-P301-US385-2165A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T22:082020-10-08T18:39.BB mRNA-1273-P301HOmRNA-1273-P301-US385-2174A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T18:292020-09-16T18:29.A`A` mRNA-1273-P301HOmRNA-1273-P301-US385-2177AUSA-US076-2021-mRNA-1273-P301000004HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-16 2021-04-19 .BÚBÝ mRNA-1273-P301HOmRNA-1273-P301-US385-2178A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 B<.. mRNA-1273-P301HOmRNA-1273-P301-US385-2185A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bh.. mRNA-1273-P301HOmRNA-1273-P301-US385-2188A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T12:132020-09-22T12:13.APAP mRNA-1273-P301HOmRNA-1273-P301-US385-2191A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T21:452020-10-25T21:45.B#B# mRNA-1273-P301HOmRNA-1273-P301-US385-2200AUSA-US076-2020-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-23 2020-11-29 .B!B' mRNA-1273-P301HOmRNA-1273-P301-US386-2005A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T20:172020-09-16T20:17.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US386-2007AUSA-US121-2021-mRNA-1273-P301000005HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-11 2021-03-14 .BÓBÖ mRNA-1273-P301HOmRNA-1273-P301-US386-2020AUSA-US121-2021-mRNA-1273-P301000009HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-28 .Bÿ. mRNA-1273-P301HOmRNA-1273-P301-US386-2021AUSA-US121-2020-mRNA-1273-P301000002HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US386-2021A USA-US121-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-04 2020-10-07 .B1B4 mRNA-1273-P301HOmRNA-1273-P301-US386-2035A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T21:132020-09-21T21:13.B"B" mRNA-1273-P301HOmRNA-1273-P301-US386-2036A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T16:092020-08-21T16:09.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US386-2044A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T12:042020-08-27T12:04.ApAp mRNA-1273-P301HOmRNA-1273-P301-US386-2045A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T06:192020-09-24T06:19.B#B# mRNA-1273-P301HOmRNA-1273-P301-US386-2050A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T11:162020-08-29T11:16.A`A` mRNA-1273-P301HOmRNA-1273-P301-US386-2050A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-01 A.. mRNA-1273-P301HOmRNA-1273-P301-US386-2053AUSA-US121-2020-mRNA-1273-P301000004HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-26 2020-10-31 .B@BE mRNA-1273-P301HOmRNA-1273-P301-US386-2053A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-26T22:352020-08-26T22:35.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US386-2053A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 B9.. mRNA-1273-P301HOmRNA-1273-P301-US386-2069A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T20:142020-08-30T20:14.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US386-2075A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T21:482020-09-25T21:48.BB mRNA-1273-P301HOmRNA-1273-P301-US386-2082A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T17:472020-09-25T17:47.BB mRNA-1273-P301HOmRNA-1273-P301-US386-2088A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T19:462020-08-31T14:12.A0A@ mRNA-1273-P301HOmRNA-1273-P301-US386-2099AUSA-US121-2021-mRNA-1273-P301000006HO-AE-003/AE-004/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-14 2021-03-15 .BÄBÅ mRNA-1273-P301HOmRNA-1273-P301-US386-2106A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-04T21:302020-10-04T21:30.B"B" mRNA-1273-P301HOmRNA-1273-P301-US386-2110AUSA-US121-2021-mRNA-1273-P301000007HO-AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-29 2021-03-31 .BÑBÓ mRNA-1273-P301HOmRNA-1273-P301-US386-2112A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T12:052020-10-05T15:44.B B" mRNA-1273-P301HOmRNA-1273-P301-US386-2119AUSA-US121-2021-mRNA-1273-P301000002HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-23 2021-02-24 .B®B¯ mRNA-1273-P301HOmRNA-1273-P301-US386-2119A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T20:192020-09-04T20:19.A A mRNA-1273-P301HOmRNA-1273-P301-US386-2128AUSA-US121-2021-mRNA-1273-P301000008HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-27 .Bì. mRNA-1273-P301HOmRNA-1273-P301-US386-2140A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T13:032020-10-07T13:03.BB mRNA-1273-P301HOmRNA-1273-P301-US386-2141AUSA-US121-2021-mRNA-1273-P301000004HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US386-2141A USA-US121-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-09 2021-03-09 .B·B· mRNA-1273-P301HOmRNA-1273-P301-US386-2141A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T14:512020-09-09T14:51.A A mRNA-1273-P301HOmRNA-1273-P301-US386-2141A@ HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-11T13:362020-10-11T13:36.B"B" mRNA-1273-P301HOmRNA-1273-P301-US386-2144AUSA-US121-2021-mRNA-1273-P301000003HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-21 2021-02-24 .B§Bª mRNA-1273-P301HOmRNA-1273-P301-US386-2157A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 B[.. mRNA-1273-P301HOmRNA-1273-P301-US386-2160A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T13:082020-09-12T13:08.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US386-2169A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-27 Bl.. mRNA-1273-P301HOmRNA-1273-P301-US386-2178A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T22:052020-09-19T09:56.A0A mRNA-1273-P301HOmRNA-1273-P301-US386-2178A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T23:322020-10-16T23:32.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US386-2196A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-20 B`.. mRNA-1273-P301HOmRNA-1273-P301-US386-2200A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T22:332020-09-22T22:33.ApAp mRNA-1273-P301HOmRNA-1273-P301-US386-2206A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T12:002020-10-21T12:00.B#B# mRNA-1273-P301HOmRNA-1273-P301-US386-2258A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T00:432020-10-29T00:43.BB mRNA-1273-P301HOmRNA-1273-P301-US386-2262A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T03:422020-10-06T03:42.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US386-2285A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-14T20:402020-11-14T20:40.BB mRNA-1273-P301HOmRNA-1273-P301-US387-2001AUSA-US094-2020-mRNA-1273-P301000016HO-AE-004/AE-008 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P8D mRNA-1273-P301HOmRNA-1273-P301-US387-2001A USA-US094-2020-mRNA-1273-P301000016HO-AE-001/AE-004/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-01 2020-12-17 .B|BŒ mRNA-1273-P301HOmRNA-1273-P301-US387-2001A0USA-US094-2020-mRNA-1273-P301000016HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-24 2021-01-06 .B“B mRNA-1273-P301HOmRNA-1273-P301-US387-2001A@USA-US094-2021-mRNA-1273-P301000010HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-25 2021-02-08 .B³BÁ mRNA-1273-P301HOmRNA-1273-P301-US387-2016AUSA-US094-2021-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-30 2021-01-02 .B–B™ mRNA-1273-P301HOmRNA-1273-P301-US387-2022A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-08T10:132020-08-08T10:13.A`A` mRNA-1273-P301HOmRNA-1273-P301-US387-2031A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T12:132020-09-15T12:13.B,B, mRNA-1273-P301HOmRNA-1273-P301-US387-2052A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T19:252020-09-05T19:25.B B mRNA-1273-P301HOmRNA-1273-P301-US387-2062AUSA-US094-2020-mRNA-1273-P301000005HO-AE-014/AE-018/AE-022/AE-023 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-18 2020-10-23 .BKBP mRNA-1273-P301HOmRNA-1273-P301-US387-2070A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T10:132020-08-09T10:13.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US387-2083AUSA-US094-2021-mRNA-1273-P301000013HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-28 2021-01-30 .B¯B± mRNA-1273-P301HOmRNA-1273-P301-US387-2086A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-09T18:262020-08-09T18:26.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US387-2090AUSA-US094-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-08-18 2020-08-22 .AÀB mRNA-1273-P301HOmRNA-1273-P301-US387-2090A USA-US094-2020-mRNA-1273-P301000013HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-25 2020-11-27 .BoBq mRNA-1273-P301HOmRNA-1273-P301-US387-2090A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-16T17:382020-08-26T16:10.A B mRNA-1273-P301HOmRNA-1273-P301-US387-2095AUSA-US094-2020-mRNA-1273-P301000015HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-23 2020-12-28 .B‹B mRNA-1273-P301HOmRNA-1273-P301-US387-2095A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 BŠ.. mRNA-1273-P301HOmRNA-1273-P301-US387-2101A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bv.. mRNA-1273-P301HOmRNA-1273-P301-US387-2110A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-11T13:572020-08-11T13:57.A A mRNA-1273-P301HOmRNA-1273-P301-US387-2112A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-17 B‚.. mRNA-1273-P301HOmRNA-1273-P301-US387-2118AUSA-US094-2020-mRNA-1273-P301000011HO-AE-014 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-15 2020-11-16 .BbBc mRNA-1273-P301HOmRNA-1273-P301-US387-2154A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-26 B‰.. mRNA-1273-P301HOmRNA-1273-P301-US387-2173AUSA-US094-2021-mRNA-1273-P301000011HO-AE-003/AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-13 2021-01-17 .BšBž mRNA-1273-P301HOmRNA-1273-P301-US387-2187AUSA-US094-2021-mRNA-1273-P301000017HO-AE-012/AE-013/AE-014 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-23 2021-03-24 .BÞBß mRNA-1273-P301HOmRNA-1273-P301-US387-2205A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-30 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US387-2218A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-17T15:032020-08-17T15:03.AA mRNA-1273-P301HOmRNA-1273-P301-US387-2223A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-28 B).. mRNA-1273-P301HOmRNA-1273-P301-US387-2229A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-22T12:452020-08-22T12:45.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US387-2245A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T21:452020-08-25T21:45.APAP mRNA-1273-P301HOmRNA-1273-P301-US387-2250A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-25T18:472020-08-25T18:47.APAP mRNA-1273-P301HOmRNA-1273-P301-US387-2253A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 BL.. mRNA-1273-P301HOmRNA-1273-P301-US387-2257A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T12:012020-08-24T12:01.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US387-2263A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-04 BI.. mRNA-1273-P301HOmRNA-1273-P301-US387-2272A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T12:142020-09-02T12:14.A A mRNA-1273-P301HOmRNA-1273-P301-US387-2295A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-11 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US387-2314A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-30T12:062020-08-30T12:06.APAP mRNA-1273-P301HOmRNA-1273-P301-US387-2317A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US387-2320A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-25 BÓ.. mRNA-1273-P301HOmRNA-1273-P301-US387-2337A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T05:472020-09-27T05:47.BB mRNA-1273-P301HOmRNA-1273-P301-US387-2343A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T15:232020-10-01T15:23.B#B# mRNA-1273-P301HOmRNA-1273-P301-US387-2348A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T18:242020-08-29T18:24.A A mRNA-1273-P301HOmRNA-1273-P301-US387-2354A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T15:452020-08-28T15:45.AA mRNA-1273-P301HOmRNA-1273-P301-US387-2356A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T16:302020-08-28T16:30.AA mRNA-1273-P301HOmRNA-1273-P301-US387-2370A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T17:112020-10-07T17:11.B(B( mRNA-1273-P301HOmRNA-1273-P301-US387-2377A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 BV.. mRNA-1273-P301HOmRNA-1273-P301-US387-2381A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T12:042020-09-03T12:04.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US387-2382A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T12:532020-09-01T12:53.A A mRNA-1273-P301HOmRNA-1273-P301-US387-2384A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-07 Bc.. mRNA-1273-P301HOmRNA-1273-P301-US387-2385A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T21:342020-08-31T21:34.AA mRNA-1273-P301HOmRNA-1273-P301-US387-2391A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T20:212020-10-07T20:21.B&B& mRNA-1273-P301HOmRNA-1273-P301-US387-2402AUSA-US094-2020-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-03 2020-11-06 .B@BC mRNA-1273-P301HOmRNA-1273-P301-US387-2409A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-05 B`.. mRNA-1273-P301HOmRNA-1273-P301-US387-2416A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-09 B&.. mRNA-1273-P301HOmRNA-1273-P301-US387-2449A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T20:292020-10-22T20:29.B2B2 mRNA-1273-P301HOmRNA-1273-P301-US387-2451A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:072020-09-09T12:07.ApAp mRNA-1273-P301HOmRNA-1273-P301-US387-2456A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-04T10:192020-09-04T10:19.AA mRNA-1273-P301HOmRNA-1273-P301-US387-2470A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T22:012020-10-13T22:01.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US387-2480A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T21:062020-09-18T21:06.A A mRNA-1273-P301HOmRNA-1273-P301-US387-2482A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-01 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US387-2483A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-12 B_.. mRNA-1273-P301HOmRNA-1273-P301-US387-2488A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T19:182020-09-11T20:39.A A0 mRNA-1273-P301HOmRNA-1273-P301-US387-2496AUSA-US094-2021-mRNA-1273-P301000016HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US387-2506A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYFOLLOW-UP BLINDED PHASE 2020-10-21T12:512020-11-15T12:40.B*BC mRNA-1273-P301HOmRNA-1273-P301-US387-2506A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-05 B.. mRNA-1273-P301HOmRNA-1273-P301-US388-2002A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-28T09:142020-08-28T13:24.A A mRNA-1273-P301HOmRNA-1273-P301-US388-2016AUSA-US095-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-20 2020-12-07 .BNB_ mRNA-1273-P301HOmRNA-1273-P301-US388-2016A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-06T16:022020-09-06T16:02.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US388-2019A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bi.. mRNA-1273-P301HOmRNA-1273-P301-US388-2049A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-22 B.. mRNA-1273-P301HOmRNA-1273-P301-US388-2051A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T14:592020-10-30T15:21.ApA€ mRNA-1273-P301HOmRNA-1273-P301-US388-2059A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-26T12:012020-11-26T12:01.B#B# mRNA-1273-P301HOmRNA-1273-P301-US388-2070A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-24T13:122020-11-24T13:12.B!B! mRNA-1273-P301HOmRNA-1273-P301-US389-2017A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T18:182020-10-06T19:53.B"B% mRNA-1273-P301HOmRNA-1273-P301-US389-2017A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-16 BN.. mRNA-1273-P301HOmRNA-1273-P301-US389-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T21:592020-09-01T21:59.A`A` mRNA-1273-P301HOmRNA-1273-P301-US389-2026A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T19:262020-09-26T19:26.BB mRNA-1273-P301HOmRNA-1273-P301-US389-2032AUSA-US209-2021-mRNA-1273-P301000005HO-AE-019 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-22 2021-04-26 .BëBï mRNA-1273-P301HOmRNA-1273-P301-US389-2032A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-03T21:212020-09-03T21:21.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US389-2032A0 HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T20:072020-10-08T00:23.BB' mRNA-1273-P301HOmRNA-1273-P301-US389-2033AUSA-US209-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-20 2020-12-22 .BpBr mRNA-1273-P301HOmRNA-1273-P301-US389-2033A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T12:202020-09-08T13:05.A€A mRNA-1273-P301HOmRNA-1273-P301-US389-2034AUSA-US209-2021-mRNA-1273-P301000001HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-07 2021-01-08 .B‚Bƒ mRNA-1273-P301HOmRNA-1273-P301-US389-2042AUSA-US209-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-20 2021-02-23 .BB° mRNA-1273-P301HOmRNA-1273-P301-US389-2054AUSA-US209-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-20 2021-03-25 .BÆBË mRNA-1273-P301HOmRNA-1273-P301-US389-2059A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-28 BR.. mRNA-1273-P301HOmRNA-1273-P301-US389-2067A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T14:402020-10-10T14:40.B B mRNA-1273-P301HOmRNA-1273-P301-US389-2076A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T23:382020-09-18T23:38.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US389-2077A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T08:392020-09-16T08:39.A`A` mRNA-1273-P301HOmRNA-1273-P301-US390-2006A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T13:302020-09-29T13:30.BB mRNA-1273-P301HOmRNA-1273-P301-US390-2015A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-27 B2.. mRNA-1273-P301HOmRNA-1273-P301-US390-2019A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-07T22:452020-09-07T22:45.A`A` mRNA-1273-P301HOmRNA-1273-P301-US390-2020AUSA-US210-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-15 2021-02-18 .B§Bª mRNA-1273-P301HOmRNA-1273-P301-US390-2021AUSA-US210-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-22 2021-02-25 .B®B± mRNA-1273-P301HOmRNA-1273-P301-US390-2030A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T16:222020-09-08T16:22.A`A` mRNA-1273-P301HOmRNA-1273-P301-US390-2037A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T03:512020-09-08T03:51.APAP mRNA-1273-P301HOmRNA-1273-P301-US390-2051AUSA-US210-2021-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-21 .BÂ. mRNA-1273-P301HOmRNA-1273-P301-US390-2060AUSA-US210-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-02 .B®. mRNA-1273-P301HOmRNA-1273-P301-US390-2064A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T05:462020-09-19T08:08.A€A mRNA-1273-P301HOmRNA-1273-P301-US390-2064A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-15 A`.. mRNA-1273-P301HOmRNA-1273-P301-US390-2083A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T17:322020-10-21T17:32.B%B% mRNA-1273-P301HOmRNA-1273-P301-US390-2085A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-19T16:262020-10-19T16:26.B#B# mRNA-1273-P301HOmRNA-1273-P301-US390-2087A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T21:302020-10-18T22:45.BB! mRNA-1273-P301HOmRNA-1273-P301-US390-2106A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T17:482020-10-27T17:48.B(B( mRNA-1273-P301HOmRNA-1273-P301-US390-2132A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 B1.. mRNA-1273-P301HOmRNA-1273-P301-US391-2012A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T20:112020-09-30T20:11.B#B# mRNA-1273-P301HOmRNA-1273-P301-US391-2021A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T15:172020-09-29T15:17.B!B! mRNA-1273-P301HOmRNA-1273-P301-US391-2022A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T12:042020-08-31T12:04.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US391-2024AUSA-US211-2020-mRNA-1273-P301000006HO-AE-007/AE-010/AE-012 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US391-2024A USA-US211-2020-mRNA-1273-P301000006HO-AE-004/AE-005/AE-007/AE-008/AE-009/AE-010/AE-011/AE-012/AE-018/AE-020HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-03 2020-11-22 .BDBW mRNA-1273-P301HOmRNA-1273-P301-US391-2034A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T17:482020-09-30T17:48.B!B! mRNA-1273-P301HOmRNA-1273-P301-US391-2040A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T07:192020-10-05T07:19.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US391-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T16:382020-09-30T16:38.BB mRNA-1273-P301HOmRNA-1273-P301-US391-2046AUSA-US211-2021-mRNA-1273-P301000003HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-22 2021-03-30 .BÌBÔ mRNA-1273-P301HOmRNA-1273-P301-US391-2046A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T21:062020-08-31T21:06.AA mRNA-1273-P301HOmRNA-1273-P301-US391-2052A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-06T20:162020-10-06T20:16.B%B% mRNA-1273-P301HOmRNA-1273-P301-US391-2058A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T20:132020-09-11T20:13.A°A° mRNA-1273-P301HOmRNA-1273-P301-US391-2073A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T22:462020-10-12T21:56.B%B* mRNA-1273-P301HOmRNA-1273-P301-US391-2089A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T12:402020-10-07T12:40.B#B# mRNA-1273-P301HOmRNA-1273-P301-US391-2107A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T20:182020-10-03T20:18.BB mRNA-1273-P301HOmRNA-1273-P301-US391-2114AUSA-US211-2020-mRNA-1273-P301000005HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-10 2020-11-11 .BDBE mRNA-1273-P301HOmRNA-1273-P301-US391-2116A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T12:152020-10-09T12:15.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US391-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T20:062020-10-16T19:25.B$B' mRNA-1273-P301HOmRNA-1273-P301-US391-2119A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-09 B .. mRNA-1273-P301HOmRNA-1273-P301-US391-2121AUSA-US211-2020-mRNA-1273-P301000009HO-AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P10DmRNA-1273-P301HOmRNA-1273-P301-US391-2121A USA-US211-2020-mRNA-1273-P301000009HO-AE-002/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-18 2020-12-28 .BfBp mRNA-1273-P301HOmRNA-1273-P301-US391-2122A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T16:162020-09-10T16:16.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US391-2124A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T15:202020-09-08T15:20.AA mRNA-1273-P301HOmRNA-1273-P301-US391-2124A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T00:362020-10-13T23:21.B#B$ mRNA-1273-P301HOmRNA-1273-P301-US391-2129A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T22:492020-10-10T22:49.B!B! mRNA-1273-P301HOmRNA-1273-P301-US391-2151A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T16:102020-09-11T16:10.AA mRNA-1273-P301HOmRNA-1273-P301-US391-2161A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T19:202020-10-23T19:20.B'B' mRNA-1273-P301HOmRNA-1273-P301-US391-2163AUSA-US211-2021-mRNA-1273-P301000002HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-01 2021-02-02 .BŒB mRNA-1273-P301HOmRNA-1273-P301-US391-2163A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-09 BV.. mRNA-1273-P301HOmRNA-1273-P301-US391-2165A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T21:412020-09-22T21:41.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US391-2222A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T12:452020-10-23T12:45.BB mRNA-1273-P301HOmRNA-1273-P301-US391-2232A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T22:262020-10-08T22:26.A A mRNA-1273-P301HOmRNA-1273-P301-US391-2233A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T15:152020-11-12T15:15.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US391-2241AUSA-US211-2020-mRNA-1273-P301000004HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-11-04 2020-11-05 .BB mRNA-1273-P301HOmRNA-1273-P301-US391-2241A USA-US211-2020-mRNA-1273-P301000007HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-01 2020-12-04 .B3B6 mRNA-1273-P301HOmRNA-1273-P301-US392-2006A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B›.. mRNA-1273-P301HOmRNA-1273-P301-US392-2013A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T00:012020-09-19T12:01.BB mRNA-1273-P301HOmRNA-1273-P301-US392-2043AUSA-US212-2021-mRNA-1273-P301000010HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-09 2021-04-14 .BâBç mRNA-1273-P301HOmRNA-1273-P301-US392-2052A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-02T16:202020-09-02T16:20.APAP mRNA-1273-P301HOmRNA-1273-P301-US392-2060A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 Bx.. mRNA-1273-P301HOmRNA-1273-P301-US392-2064A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-31T17:282020-08-31T17:28.AA mRNA-1273-P301HOmRNA-1273-P301-US392-2067AUSA-US212-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-07 2020-09-09 .ApA mRNA-1273-P301HOmRNA-1273-P301-US392-2074A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T17:342020-10-12T17:34.B)B) mRNA-1273-P301HOmRNA-1273-P301-US392-2080AUSA-US212-2021-mRNA-1273-P301000006HO-AE-002/AE-011 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P4D mRNA-1273-P301HOmRNA-1273-P301-US392-2080A USA-US212-2021-mRNA-1273-P301000006HO-AE-002/AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-03 2021-03-23 .BšBÊ mRNA-1273-P301HOmRNA-1273-P301-US392-2088AUSA-US212-2021-mRNA-1273-P301000007HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-11 .B¹. mRNA-1273-P301HOmRNA-1273-P301-US392-2160A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-05 BO.. mRNA-1273-P301HOmRNA-1273-P301-US392-2161A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T17:532020-10-22T17:53.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US392-2164A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-28 BF.. mRNA-1273-P301HOmRNA-1273-P301-US392-2166A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-18 B–.. mRNA-1273-P301HOmRNA-1273-P301-US392-2168A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-01T15:572020-11-01T15:57.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US393-2004A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T18:112020-10-09T18:11.B(B( mRNA-1273-P301HOmRNA-1273-P301-US393-2005AUSA-US213-2020-mRNA-1273-P301000002HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-20 2020-10-22 .B9B; mRNA-1273-P301HOmRNA-1273-P301-US393-2009A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T23:072020-09-28T23:07.B!B! mRNA-1273-P301HOmRNA-1273-P301-US393-2012A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T19:042020-08-27T19:04.AA mRNA-1273-P301HOmRNA-1273-P301-US393-2018AUSA-US213-2021-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-04 2021-03-15 .B‚BÈ mRNA-1273-P301HOmRNA-1273-P301-US393-2049A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-22 Bq.. mRNA-1273-P301HOmRNA-1273-P301-US393-2050A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-28 B–.. mRNA-1273-P301HOmRNA-1273-P301-US393-2051AUSA-US213-2020-mRNA-1273-P301000009HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-19 2020-11-20 .BPBQ mRNA-1273-P301HOmRNA-1273-P301-US393-2066AUSA-US213-2021-mRNA-1273-P301000013HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-10 2021-02-11 .B¢B£ mRNA-1273-P301HOmRNA-1273-P301-US393-2066A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-23 BS.. mRNA-1273-P301HOmRNA-1273-P301-US393-2069A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T19:062020-10-26T19:06.B*B* mRNA-1273-P301HOmRNA-1273-P301-US393-2071A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T19:202020-10-02T19:20.BB mRNA-1273-P301HOmRNA-1273-P301-US393-2074A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T18:112020-09-08T18:11.AA mRNA-1273-P301HOmRNA-1273-P301-US393-2077AUSA-US213-2020-mRNA-1273-P301000006HO-AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-11 2020-11-12 .BEBF mRNA-1273-P301HOmRNA-1273-P301-US393-2080A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-19T01:592020-09-19T01:59.AÀAÀ mRNA-1273-P301HOmRNA-1273-P301-US393-2083AUSA-US213-2020-mRNA-1273-P301000007HO-AE-001/AE-003/AE-011 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US393-2083A USA-US213-2020-mRNA-1273-P301000007HO-AE-001/AE-003/AE-011 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-16 2020-12-09 .BDB[ mRNA-1273-P301HOmRNA-1273-P301-US393-2083A0USA-US213-2021-mRNA-1273-P301000020HO-AE-010 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-05 2021-03-11 .B±B· mRNA-1273-P301HOmRNA-1273-P301-US393-2083A@ HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T16:072020-09-16T16:07.ApAp mRNA-1273-P301HOmRNA-1273-P301-US393-2083AP HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYYFOLLOW-UP BLINDED PHASE 2020-11-21 2020-11-29 .BIBQ mRNA-1273-P301HOmRNA-1273-P301-US393-2095A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T07:122020-10-15T07:12.B%B% mRNA-1273-P301HOmRNA-1273-P301-US393-2099A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 B6.. mRNA-1273-P301HOmRNA-1273-P301-US393-2100A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-28 B1.. mRNA-1273-P301HOmRNA-1273-P301-US393-2117A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-13T19:022020-09-13T19:02.A A mRNA-1273-P301HOmRNA-1273-P301-US393-2117A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T06:302020-10-24T06:30.B+B+ mRNA-1273-P301HOmRNA-1273-P301-US393-2118A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bs.. mRNA-1273-P301HOmRNA-1273-P301-US393-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-13T17:002020-10-13T17:00.B B mRNA-1273-P301HOmRNA-1273-P301-US393-2120A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 BJ.. mRNA-1273-P301HOmRNA-1273-P301-US393-2122A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T13:082020-09-12T13:08.AA mRNA-1273-P301HOmRNA-1273-P301-US393-2124A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-25 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US393-2131A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T14:192020-09-16T14:19.A0A0 mRNA-1273-P301HOmRNA-1273-P301-US393-2144A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-08 BT.. mRNA-1273-P301HOmRNA-1273-P301-US393-2147AUSA-US213-2021-mRNA-1273-P301000002HO-AE-022 HOSPITAL HOSPITALADVERSE EVENTS YY ... mRNA-1273-P301HOmRNA-1273-P301-US393-2147A USA-US213-2020-mRNA-1273-P301000001HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-05 2020-10-11 .BB mRNA-1273-P301HOmRNA-1273-P301-US393-2147A0USA-US213-2021-mRNA-1273-P301000002HO-AE-011/AE-013/AE-014/AE-016/AE-018/AE-019/AE-020 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-29 2021-01-21 .BiB€ mRNA-1273-P301HOmRNA-1273-P301-US393-2147A@ HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-21T13:192020-09-25T14:21.A`A mRNA-1273-P301HOmRNA-1273-P301-US393-2147AP HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-06 BR.. mRNA-1273-P301HOmRNA-1273-P301-US393-2147A` HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-04 Bo.. mRNA-1273-P301HOmRNA-1273-P301-US393-2149A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T01:102020-09-20T01:10.APAP mRNA-1273-P301HOmRNA-1273-P301-US393-2149A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T16:542020-10-20T23:36.BB# mRNA-1273-P301HOmRNA-1273-P301-US393-2151AUSA-US213-2021-mRNA-1273-P301000006HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-08 2021-01-13 .BrBw mRNA-1273-P301HOmRNA-1273-P301-US393-2156A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-18 Bš.. mRNA-1273-P301HOmRNA-1273-P301-US393-2164A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T08:372020-09-28T08:37.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US393-2176A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T11:592020-10-22T11:59.BB mRNA-1273-P301HOmRNA-1273-P301-US393-2178A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T14:282020-10-26T14:28.B"B" mRNA-1273-P301HOmRNA-1273-P301-US393-2182AUSA-US213-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-26 2020-10-28 .B!B# mRNA-1273-P301HOmRNA-1273-P301-US393-2187A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T09:432020-09-29T09:43.AA mRNA-1273-P301HOmRNA-1273-P301-US393-2192AUSA-US213-2021-mRNA-1273-P301000021HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-12 2021-03-14 .B¨Bª mRNA-1273-P301HOmRNA-1273-P301-US393-2200A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T12:452020-09-26T12:45.AA mRNA-1273-P301HOmRNA-1273-P301-US393-2206AUSA-US213-2021-mRNA-1273-P301000014HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-04 2021-02-05 .B‚Bƒ mRNA-1273-P301HOmRNA-1273-P301-US393-2207A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T09:382020-09-29T09:38.A A mRNA-1273-P301HOmRNA-1273-P301-US393-2215AUSA-US213-2021-mRNA-1273-P301000009HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-28 2021-01-30 .ByB{ mRNA-1273-P301HOmRNA-1273-P301-US393-2230A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B\.. mRNA-1273-P301HOmRNA-1273-P301-US393-2238A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 B$.. mRNA-1273-P301HOmRNA-1273-P301-US393-2272A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-16T18:432020-11-16T18:43.B!B! mRNA-1273-P301HOmRNA-1273-P301-US393-2277A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-17T20:152020-11-17T20:15.B!B! mRNA-1273-P301HOmRNA-1273-P301-US393-2286AUSA-US213-2020-mRNA-1273-P301000010HO-AE-001/AE-002/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-12-03 2020-12-05 .B0B2 mRNA-1273-P301HOmRNA-1273-P301-US393-2286A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-12-01T12:022020-12-06T00:01.B.B3 mRNA-1273-P301HOmRNA-1273-P301-US393-2286A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYYBLINDED TREATMENT 2020-12-03 2020-12-06 .B0B3 mRNA-1273-P301HOmRNA-1273-P301-US393-2292A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-15 BY.. mRNA-1273-P301HOmRNA-1273-P301-US393-2293A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-25T16:362020-11-25T16:36.B&B& mRNA-1273-P301HOmRNA-1273-P301-US393-2296AUSA-US213-2021-mRNA-1273-P301000011HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-31 2021-02-02 .BfBh mRNA-1273-P301HOmRNA-1273-P301-US393-2304A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-04 B-.. mRNA-1273-P301HOmRNA-1273-P301-US394-2001A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T06:032020-09-23T06:03.B#B# mRNA-1273-P301HOmRNA-1273-P301-US394-2007A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-23T14:142020-09-23T14:14.BB mRNA-1273-P301HOmRNA-1273-P301-US394-2021AUSA-US214-2020-mRNA-1273-P301000002HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P7D mRNA-1273-P301HOmRNA-1273-P301-US394-2021A USA-US214-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-06 2020-09-22 .A B mRNA-1273-P301HOmRNA-1273-P301-US394-2036AUSA-US214-2020-mRNA-1273-P301000004HO-AE-001/AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US394-2036A USA-US214-2020-mRNA-1273-P301000004HO-AE-001/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-12 2020-12-24 .BhBt mRNA-1273-P301HOmRNA-1273-P301-US394-2041A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-01T15:012020-09-01T15:01.AA mRNA-1273-P301HOmRNA-1273-P301-US394-2064AUSA-US214-2021-mRNA-1273-P301000001HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P3D mRNA-1273-P301HOmRNA-1273-P301-US394-2064A USA-US214-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-08 2021-02-19 .BŸBª mRNA-1273-P301HOmRNA-1273-P301-US394-2072AUSA-US214-2021-mRNA-1273-P301000003HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-23 2021-03-28 .BÃBÈ mRNA-1273-P301HOmRNA-1273-P301-US394-2079A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-24 B.. mRNA-1273-P301HOmRNA-1273-P301-US394-2080A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-09T09:362020-10-10T05:01.B B! mRNA-1273-P301HOmRNA-1273-P301-US394-2088A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T12:012020-10-16T12:01.B%B% mRNA-1273-P301HOmRNA-1273-P301-US394-2098A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-24T07:572020-10-24T07:57.B,B, mRNA-1273-P301HOmRNA-1273-P301-US394-2118A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T15:152020-09-24T15:15.AA mRNA-1273-P301HOmRNA-1273-P301-US394-2119A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-27T21:262020-10-27T21:26.B"B" mRNA-1273-P301HOmRNA-1273-P301-US394-2151AUSA-US214-2020-mRNA-1273-P301000003HO-AE-002/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-17 2020-10-22 .A`A° mRNA-1273-P301HOmRNA-1273-P301-US395-2004AUSA-US215-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-22 2020-12-24 .BnBp mRNA-1273-P301HOmRNA-1273-P301-US395-2016A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T19:032020-10-15T19:03.B*B* mRNA-1273-P301HOmRNA-1273-P301-US395-2022A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-11 B¤.. mRNA-1273-P301HOmRNA-1273-P301-US395-2033AUSA-US215-2020-mRNA-1273-P301000001HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-26 2020-09-30 .BB mRNA-1273-P301HOmRNA-1273-P301-US395-2033A USA-US215-2020-mRNA-1273-P301000004HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-31 2020-11-03 .B<B? mRNA-1273-P301HOmRNA-1273-P301-US395-2033A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T20:392020-09-08T20:39.ApAp mRNA-1273-P301HOmRNA-1273-P301-US395-2033A@ HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-07 B$.. mRNA-1273-P301HOmRNA-1273-P301-US395-2041A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T21:272020-10-08T21:27.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US395-2052AUSA-US215-2021-mRNA-1273-P301000005HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-06 2021-03-08 .B´B¶ mRNA-1273-P301HOmRNA-1273-P301-US395-2058A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T22:392020-10-12T22:39.B#B# mRNA-1273-P301HOmRNA-1273-P301-US395-2060A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T19:162020-09-08T19:16.AA mRNA-1273-P301HOmRNA-1273-P301-US395-2094AUSA-US215-2021-mRNA-1273-P301000001HO-AE-001 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P17DmRNA-1273-P301HOmRNA-1273-P301-US395-2094A USA-US215-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-24 2021-01-30 .BeBŠ mRNA-1273-P301HOmRNA-1273-P301-US395-2094A0 HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYYFOLLOW-UP BLINDED PHASE 2021-01-19 2021-01-30 .BBŠ mRNA-1273-P301HOmRNA-1273-P301-US395-2095A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T00:582020-09-18T00:58.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US395-2102A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T19:172020-09-18T19:17.A A mRNA-1273-P301HOmRNA-1273-P301-US395-2103A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T15:222020-10-16T15:22.BB mRNA-1273-P301HOmRNA-1273-P301-US395-2104AUSA-US215-2020-mRNA-1273-P301000003HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-07 2020-10-12 .BB mRNA-1273-P301HOmRNA-1273-P301-US395-2105A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-20T18:272020-09-20T18:27.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US395-2107A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-17T13:442020-10-17T13:44.BB mRNA-1273-P301HOmRNA-1273-P301-US395-2110A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-05T17:182020-11-05T17:18.B1B1 mRNA-1273-P301HOmRNA-1273-P301-US395-2140A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-28T12:032020-10-28T12:03.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US395-2141AUSA-US215-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-10 2021-03-16 .B©B¯ mRNA-1273-P301HOmRNA-1273-P301-US395-2154A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-17 B6.. mRNA-1273-P301HOmRNA-1273-P301-US395-2169A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-28T14:582020-10-28T14:58.BB mRNA-1273-P301HOmRNA-1273-P301-US395-2171A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-30T20:482020-09-30T20:48.A A mRNA-1273-P301HOmRNA-1273-P301-US395-2173AUSA-US215-2021-mRNA-1273-P301000007HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-29 2021-03-31 .B¶B¸ mRNA-1273-P301HOmRNA-1273-P301-US395-2173A USA-US215-2021-mRNA-1273-P301000008HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-09 2021-04-12 .BÁBÄ mRNA-1273-P301HOmRNA-1273-P301-US395-2185A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T19:212020-10-08T19:21.AA mRNA-1273-P301HOmRNA-1273-P301-US395-2214A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-06T18:182020-11-06T18:18.BB mRNA-1273-P301HOmRNA-1273-P301-US396-2005AUSA-US216-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-23 .Bø. mRNA-1273-P301HOmRNA-1273-P301-US396-2010A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-24T19:112020-08-24T19:11.APAP mRNA-1273-P301HOmRNA-1273-P301-US396-2016A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bp.. mRNA-1273-P301HOmRNA-1273-P301-US396-2018A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-21T17:292020-08-21T17:29.AA mRNA-1273-P301HOmRNA-1273-P301-US396-2037A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-06 B.. mRNA-1273-P301HOmRNA-1273-P301-US396-2041A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-30 B\.. mRNA-1273-P301HOmRNA-1273-P301-US396-2042AUSA-US216-2021-mRNA-1273-P301000004HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-19 2021-02-23 .BB± mRNA-1273-P301HOmRNA-1273-P301-US396-2056A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 Bd.. mRNA-1273-P301HOmRNA-1273-P301-US396-2063AUSA-US216-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-10-30 2020-10-31 .B:B; mRNA-1273-P301HOmRNA-1273-P301-US396-2063A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-02-01 B˜.. mRNA-1273-P301HOmRNA-1273-P301-US396-2064A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T20:142020-10-03T20:14.BB mRNA-1273-P301HOmRNA-1273-P301-US396-2065A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-20 Bm.. mRNA-1273-P301HOmRNA-1273-P301-US396-2066A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-16 Bˆ.. mRNA-1273-P301HOmRNA-1273-P301-US396-2072A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T17:402020-09-11T17:40.A€A€ mRNA-1273-P301HOmRNA-1273-P301-US396-2075A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T20:132020-10-08T20:13.BB mRNA-1273-P301HOmRNA-1273-P301-US396-2082A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-12T14:052020-10-12T14:05.B#B# mRNA-1273-P301HOmRNA-1273-P301-US396-2113A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T22:192020-10-21T22:33.AA mRNA-1273-P301HOmRNA-1273-P301-US396-2113A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-20 B .. mRNA-1273-P301HOmRNA-1273-P301-US397-2022A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-09 BM.. mRNA-1273-P301HOmRNA-1273-P301-US397-2026A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T21:472020-09-29T21:47.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US397-2037A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-27T10:422020-08-31T17:20.AAP mRNA-1273-P301HOmRNA-1273-P301-US397-2037A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T13:172020-09-27T13:17.B B mRNA-1273-P301HOmRNA-1273-P301-US397-2041A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-02 BD.. mRNA-1273-P301HOmRNA-1273-P301-US397-2045A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-02T12:242020-10-02T12:24.B%B% mRNA-1273-P301HOmRNA-1273-P301-US397-2049AUSA-US217-2020-mRNA-1273-P301000005HO-AE-001/AE-003 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P1D mRNA-1273-P301HOmRNA-1273-P301-US397-2049A USA-US217-2020-mRNA-1273-P301000005HO-AE-001/AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-15 2020-11-20 .BQBV mRNA-1273-P301HOmRNA-1273-P301-US397-2051A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T23:052020-09-26T19:13.BB mRNA-1273-P301HOmRNA-1273-P301-US397-2064AUSA-US217-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-02 2020-09-05 .A0A` mRNA-1273-P301HOmRNA-1273-P301-US397-2064A USA-US217-2021-mRNA-1273-P301000010HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-23 .Bì. mRNA-1273-P301HOmRNA-1273-P301-US397-2064A0 HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-05T22:242020-09-06T15:24.A`Ap mRNA-1273-P301HOmRNA-1273-P301-US397-2069A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-08T22:002020-09-24T23:10.AB mRNA-1273-P301HOmRNA-1273-P301-US397-2069A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-03T23:132020-10-16T22:47.B"B/ mRNA-1273-P301HOmRNA-1273-P301-US397-2097AUSA-US217-2021-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-09 2021-01-10 .BB‚ mRNA-1273-P301HOmRNA-1273-P301-US397-2104AUSA-US217-2021-mRNA-1273-P301000008HO-AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-28 2021-03-29 .BÏBÐ mRNA-1273-P301HOmRNA-1273-P301-US397-2104A USA-US217-2021-mRNA-1273-P301000009HO-AE-007/AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-08 2021-04-13 .BÚBß mRNA-1273-P301HOmRNA-1273-P301-US397-2106A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-03 BO.. mRNA-1273-P301HOmRNA-1273-P301-US397-2116AUSA-US217-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-28 2020-12-30 .BtBv mRNA-1273-P301HOmRNA-1273-P301-US397-2116A USA-US217-2021-mRNA-1273-P301000006HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-06 .Bœ. mRNA-1273-P301HOmRNA-1273-P301-US397-2117A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-07T10:542020-10-07T10:54.B"B" mRNA-1273-P301HOmRNA-1273-P301-US397-2129A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-20 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US397-2137A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-29T18:322020-10-31T17:32.B2B4 mRNA-1273-P301HOmRNA-1273-P301-US397-2144A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T14:072020-10-15T14:07.B#B# mRNA-1273-P301HOmRNA-1273-P301-US397-2149A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-23T12:112020-10-24T19:25.B(B) mRNA-1273-P301HOmRNA-1273-P301-US397-2149A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-23 B(.. mRNA-1273-P301HOmRNA-1273-P301-US397-2158A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-15T11:072020-09-15T11:07.AA mRNA-1273-P301HOmRNA-1273-P301-US397-2184A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-21T19:242020-10-21T19:24.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US397-2186AUSA-US217-2021-mRNA-1273-P301000005HO-AE-002/AE-003/AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-21 2021-01-23 .BB mRNA-1273-P301HOmRNA-1273-P301-US397-2196A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-01 BK.. mRNA-1273-P301HOmRNA-1273-P301-US397-2208A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-20T23:202020-10-20T23:20.BB mRNA-1273-P301HOmRNA-1273-P301-US397-2218A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-25T11:582020-09-25T11:58.AA mRNA-1273-P301HOmRNA-1273-P301-US397-2225A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-18T22:462020-10-18T22:46.ApAp mRNA-1273-P301HOmRNA-1273-P301-US397-2225A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-19 A€.. mRNA-1273-P301HOmRNA-1273-P301-US398-2013AUSA-US218-2021-mRNA-1273-P301000020HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-04-11 2021-04-13 .BåBç mRNA-1273-P301HOmRNA-1273-P301-US398-2014AUSA-US218-2021-mRNA-1273-P301000016HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-14 2021-03-15 .BÉBÊ mRNA-1273-P301HOmRNA-1273-P301-US398-2017A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-10-20 B8.. mRNA-1273-P301HOmRNA-1273-P301-US398-2018A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-24T17:442020-09-24T17:44.BB mRNA-1273-P301HOmRNA-1273-P301-US398-2022AUSA-US218-2021-mRNA-1273-P301000003HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-15 2021-01-18 .BŽB‘ mRNA-1273-P301HOmRNA-1273-P301-US398-2024A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-10T21:492020-09-10T21:49.ApAp mRNA-1273-P301HOmRNA-1273-P301-US398-2025A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-02 Bb.. mRNA-1273-P301HOmRNA-1273-P301-US398-2028AUSA-US218-2021-mRNA-1273-P301000004HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-20 2021-01-24 .BŒB mRNA-1273-P301HOmRNA-1273-P301-US398-2028A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-11T19:012020-09-11T19:01.AA mRNA-1273-P301HOmRNA-1273-P301-US398-2031AUSA-US218-2020-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-09-25 2020-09-26 .BB mRNA-1273-P301HOmRNA-1273-P301-US398-2042A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-05T21:482020-10-05T21:48.B'B' mRNA-1273-P301HOmRNA-1273-P301-US398-2047A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-08-29T12:352020-08-29T12:35.A A mRNA-1273-P301HOmRNA-1273-P301-US398-2050AUSA-US218-2021-mRNA-1273-P301000014HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-03 2021-03-07 .B¹B½ mRNA-1273-P301HOmRNA-1273-P301-US398-2051A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T08:352020-09-29T08:35.BB mRNA-1273-P301HOmRNA-1273-P301-US398-2052A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T19:232020-09-29T20:18.BB mRNA-1273-P301HOmRNA-1273-P301-US398-2069AUSA-US218-2021-mRNA-1273-P301000001HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-29 2020-12-30 .BxBy mRNA-1273-P301HOmRNA-1273-P301-US398-2075A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-18 BÇ.. mRNA-1273-P301HOmRNA-1273-P301-US398-2088AUSA-US218-2021-mRNA-1273-P301000011HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-03 2020-12-07 .B]Ba mRNA-1273-P301HOmRNA-1273-P301-US398-2101A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-09T12:072020-09-09T12:07.ApAp mRNA-1273-P301HOmRNA-1273-P301-US398-2101A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-08T00:002020-10-08T12:00.B$B$ mRNA-1273-P301HOmRNA-1273-P301-US398-2110A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-03-01 B³.. mRNA-1273-P301HOmRNA-1273-P301-US398-2112AUSA-US218-2021-mRNA-1273-P301000007HO-AE-004 ADMITTED TO ICU ICU ADVERSE EVENTS YY ...P2D mRNA-1273-P301HOmRNA-1273-P301-US398-2112A USA-US218-2021-mRNA-1273-P301000007HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-28 2021-02-12 .B“B¢ mRNA-1273-P301HOmRNA-1273-P301-US398-2114A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-10T21:532020-10-13T15:32.B%B( mRNA-1273-P301HOmRNA-1273-P301-US398-2125AUSA-US218-2021-mRNA-1273-P301000005HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-01-26 2021-01-30 .BŽB’ mRNA-1273-P301HOmRNA-1273-P301-US398-2129A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-19 B‡.. mRNA-1273-P301HOmRNA-1273-P301-US398-2132A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-12T12:402020-09-14T13:30.APAp mRNA-1273-P301HOmRNA-1273-P301-US398-2132A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-14T09:542020-10-14T09:54.B%B% mRNA-1273-P301HOmRNA-1273-P301-US398-2144AUSA-US218-2021-mRNA-1273-P301000012HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-18 2021-02-20 .B›B mRNA-1273-P301HOmRNA-1273-P301-US398-2147AUSA-US218-2021-mRNA-1273-P301000018HO-AE-005/AE-006 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-03-11 2021-03-18 .B·B¾ mRNA-1273-P301HOmRNA-1273-P301-US398-2147A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T13:132020-10-16T13:13.B%B% mRNA-1273-P301HOmRNA-1273-P301-US398-2151AUSA-US218-2021-mRNA-1273-P301000002HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-12-28 2020-12-31 .BnBq mRNA-1273-P301HOmRNA-1273-P301-US398-2157A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-09-30 B.. mRNA-1273-P301HOmRNA-1273-P301-US398-2169AUSA-US218-2021-mRNA-1273-P301000008HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-20 2021-01-23 .BB„ mRNA-1273-P301HOmRNA-1273-P301-US398-2169A USA-US218-2021-mRNA-1273-P301000010HO-AE-004 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-02-05 2021-02-06 .B‘B’ mRNA-1273-P301HOmRNA-1273-P301-US398-2173A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-17T12:342020-09-17T12:34.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US398-2180A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-16T13:242020-09-16T13:24.AA mRNA-1273-P301HOmRNA-1273-P301-US398-2185A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-15T21:422020-10-15T21:42.BB mRNA-1273-P301HOmRNA-1273-P301-US398-2192A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T20:302020-09-22T20:30.A`A` mRNA-1273-P301HOmRNA-1273-P301-US398-2194AUSA-US218-2021-mRNA-1273-P301000019HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-04-06 2021-04-08 .BÊBÌ mRNA-1273-P301HOmRNA-1273-P301-US398-2196A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-15 BZ.. mRNA-1273-P301HOmRNA-1273-P301-US398-2198A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T22:212020-09-18T22:21.A A mRNA-1273-P301HOmRNA-1273-P301-US398-2198A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-16T22:022020-10-16T22:02.BB mRNA-1273-P301HOmRNA-1273-P301-US398-2213A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T00:262020-10-01T00:26.A°A° mRNA-1273-P301HOmRNA-1273-P301-US398-2214A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T06:362020-10-25T06:36.B#B# mRNA-1273-P301HOmRNA-1273-P301-US398-2229A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-26T23:592020-09-26T23:59.A@A@ mRNA-1273-P301HOmRNA-1273-P301-US398-2229A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T16:512020-10-26T16:51.B"B" mRNA-1273-P301HOmRNA-1273-P301-US398-2232A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T12:022020-09-29T12:02.A`A` mRNA-1273-P301HOmRNA-1273-P301-US398-2233A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-25T18:102020-10-25T18:10.B B mRNA-1273-P301HOmRNA-1273-P301-US398-2241A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T13:072020-09-28T13:07.AA mRNA-1273-P301HOmRNA-1273-P301-US398-2244AUSA-US218-2021-mRNA-1273-P301000013HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-03 2021-02-12 .BBŠ mRNA-1273-P301HOmRNA-1273-P301-US398-2246AUSA-US218-2020-mRNA-1273-P301000006HO-AE-003 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2020-11-28 2020-12-01 .B>BA mRNA-1273-P301HOmRNA-1273-P301-US398-2246A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-31T12:522020-10-31T12:52.B"B" mRNA-1273-P301HOmRNA-1273-P301-US398-2256A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 B9.. mRNA-1273-P301HOmRNA-1273-P301-US398-2269AUSA-US218-2020-mRNA-1273-P301000007HO-AE-001/AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-12-02 2020-12-17 .B7BF mRNA-1273-P301HOmRNA-1273-P301-US398-2269A USA-US218-2021-mRNA-1273-P301000009HO-AE-005 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP BLINDED PHASE 2021-02-05 2021-02-08 .BxB{ mRNA-1273-P301HOmRNA-1273-P301-US398-2269A0USA-US218-2021-mRNA-1273-P301000017HO-AE-008 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-03-03 2021-03-08 .B’B— mRNA-1273-P301HOmRNA-1273-P301-US398-2269A@USA-US218-2021-mRNA-1273-P301000017HO-AE-007 HOSPITAL HOSPITALADVERSE EVENTS YYFOLLOW-UP OPEN LABEL PHASE 2021-03-18 2021-03-22 .B¡B¥ mRNA-1273-P301HOmRNA-1273-P301-US398-2272AUSA-US218-2020-mRNA-1273-P301000002HO-AE-001 HOSPITAL HOSPITALADVERSE EVENTS YYBLINDED TREATMENT 2020-10-20 2020-10-22 .A€A mRNA-1273-P301HOmRNA-1273-P301-US398-2275A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-22T16:442020-10-22T16:44.AA mRNA-1273-P301HOmRNA-1273-P301-US399-2005A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-18T11:152020-09-18T11:15.AA mRNA-1273-P301HOmRNA-1273-P301-US399-2010A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-12 B7.. mRNA-1273-P301HOmRNA-1273-P301-US399-2013A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-22T07:112020-09-22T07:11.A A mRNA-1273-P301HOmRNA-1273-P301-US399-2020A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-27T16:462020-09-27T16:46.APAP mRNA-1273-P301HOmRNA-1273-P301-US399-2024A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2021-01-21 By.. mRNA-1273-P301HOmRNA-1273-P301-US399-2028A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-12-10 BN.. mRNA-1273-P301HOmRNA-1273-P301-US399-2030A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-01T23:592020-10-01T23:59.ApAp mRNA-1273-P301HOmRNA-1273-P301-US399-2030A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-10-26T20:122020-10-29T12:00.B B# mRNA-1273-P301HOmRNA-1273-P301-US399-2032A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-29T00:002020-09-29T00:00.APAP mRNA-1273-P301HOmRNA-1273-P301-US399-2037AUSA-US219-2021-mRNA-1273-P301000002HO-AE-002 HOSPITAL HOSPITALADVERSE EVENTS YYOPEN LABEL TREATMENT 2021-01-13 2021-01-14 .BnBo mRNA-1273-P301HOmRNA-1273-P301-US399-2039A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-25 B=.. mRNA-1273-P301HOmRNA-1273-P301-US399-2042A HO-CE-DOSE1 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-09-28T17:482020-09-28T17:48.AA mRNA-1273-P301HOmRNA-1273-P301-US399-2076A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-24 B0.. mRNA-1273-P301HOmRNA-1273-P301-US399-2077A HO-SCOVID-19 ADMITTED TO ICU ICU EFFICACY COVID-19 SEVERITYYN 2020-11-27 B3.. mRNA-1273-P301HOmRNA-1273-P301-US399-2081A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-12T06:002020-11-12T06:00.B#B# mRNA-1273-P301HOmRNA-1273-P301-US399-2116A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-20T12:442020-11-21T13:13.B B! mRNA-1273-P301HOmRNA-1273-P301-US399-2117A HO-CE-DOSE2 MEDICALLY ATTENDEDMAAE E-DIARY YYBLINDED TREATMENT 2020-11-21T09:022020-11-21T09:02.B!B!